source name	characteristics[organism]	characteristics[organism part]	characteristics[individual]	characteristics[cell type]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[developmental stage]	characteristics[disease]	characteristics[depletion]	characteristics[sampling time]	assay name	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[fractionation method]	comment[label]	comment[technical replicate]	comment[cleavage agent details]	comment[cleavage agent details]	comment[MS2 mass analyzer]	comment[instrument]	comment[separation]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[sampling time]	sampleChecksum	sampleAccession
PXD004242-1 plasma at -8 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150618_qep1_lc7_phge_sa_plate1b_1_1	20150618_QEp1_LC7_PhGe_SA_Plate1B_1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_1_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	1fb5258914c1da5de3745d62bde23c9e86bdb8a9aa47aacb985b8015346c9cf1	SAMEA7711472
PXD004242-1 plasma at 0 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150618_qep1_lc7_phge_sa_plate1b_1_2	20150618_QEp1_LC7_PhGe_SA_Plate1B_1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_1_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	7b94ccbed360aa1bfab2009ec82b5bf9dfa652eb7b5ae013deaabed2d343d8fb	SAMEA7711473
PXD004242-1 plasma at 4 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150618_qep1_lc7_phge_sa_plate1b_1_3	20150618_QEp1_LC7_PhGe_SA_Plate1B_1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_1_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	afde77b02d20a76490364467462ff25c3b629018bbc9658e816b360e07433834	SAMEA7711474
PXD004242-1 plasma at 13 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150618_qep1_lc7_phge_sa_plate1b_1_4	20150618_QEp1_LC7_PhGe_SA_Plate1B_1_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_1_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	5d9e73964736f3e351e2331cb9a0a9b1f40b3910c8d87e6fdfa13ad23c284273	SAMEA7711475
PXD004242-1 plasma at 26 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150618_qep1_lc7_phge_sa_plate1b_1_5	20150618_QEp1_LC7_PhGe_SA_Plate1B_1_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_1_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	5b9dafa52d711623003212c3905eca5310fb39c07a9799e56b4d24f012a597e8	SAMEA7711476
PXD004242-1 plasma at 39 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150618_qep1_lc7_phge_sa_plate1b_1_6	20150618_QEp1_LC7_PhGe_SA_Plate1B_1_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_1_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	d2ecc5ef570b57a0f5e818db3dc90fe1d45f6f24e07c3b580849570b15693ac2	SAMEA7711477
PXD004242-1 plasma at 52 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150618_qep1_lc7_phge_sa_plate1b_1_7	20150618_QEp1_LC7_PhGe_SA_Plate1B_1_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_1_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	3a4551494f9d0a8787b69f437ae54cac7d4fc7a30e966276f05d0f8c6c043b63	SAMEA7711478
PXD004242-1 plasma at -8 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150708_qep1_lc7_phge_sa_plate1c_1_1	20150708_QEp1_LC7_PhGe_SA_Plate1C_1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_1_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	1fb5258914c1da5de3745d62bde23c9e86bdb8a9aa47aacb985b8015346c9cf1	SAMEA7711472
PXD004242-1 plasma at 0 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150708_qep1_lc7_phge_sa_plate1c_1_2	20150708_QEp1_LC7_PhGe_SA_Plate1C_1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_1_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	7b94ccbed360aa1bfab2009ec82b5bf9dfa652eb7b5ae013deaabed2d343d8fb	SAMEA7711473
PXD004242-1 plasma at 4 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150708_qep1_lc7_phge_sa_plate1c_1_3	20150708_QEp1_LC7_PhGe_SA_Plate1C_1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_1_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	afde77b02d20a76490364467462ff25c3b629018bbc9658e816b360e07433834	SAMEA7711474
PXD004242-1 plasma at 13 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150708_qep1_lc7_phge_sa_plate1c_1_4	20150708_QEp1_LC7_PhGe_SA_Plate1C_1_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_1_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	5d9e73964736f3e351e2331cb9a0a9b1f40b3910c8d87e6fdfa13ad23c284273	SAMEA7711475
PXD004242-1 plasma at 26 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150708_qep1_lc7_phge_sa_plate1c_1_5	20150708_QEp1_LC7_PhGe_SA_Plate1C_1_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_1_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	5b9dafa52d711623003212c3905eca5310fb39c07a9799e56b4d24f012a597e8	SAMEA7711476
PXD004242-1 plasma at 39 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150708_qep1_lc7_phge_sa_plate1c_1_6	20150708_QEp1_LC7_PhGe_SA_Plate1C_1_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_1_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	d2ecc5ef570b57a0f5e818db3dc90fe1d45f6f24e07c3b580849570b15693ac2	SAMEA7711477
PXD004242-1 plasma at 52 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150708_qep1_lc7_phge_sa_plate1c_1_7	20150708_QEp1_LC7_PhGe_SA_Plate1C_1_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_1_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	3a4551494f9d0a8787b69f437ae54cac7d4fc7a30e966276f05d0f8c6c043b63	SAMEA7711478
PXD004242-1 plasma at -8 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150805_qep1_lc7_phge_sa_plate1d_1_1	20150805_QEp1_LC7_PhGe_SA_Plate1D_1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_1_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	1fb5258914c1da5de3745d62bde23c9e86bdb8a9aa47aacb985b8015346c9cf1	SAMEA7711472
PXD004242-1 plasma at 0 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150805_qep1_lc7_phge_sa_plate1d_1_2	20150805_QEp1_LC7_PhGe_SA_Plate1D_1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_1_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	7b94ccbed360aa1bfab2009ec82b5bf9dfa652eb7b5ae013deaabed2d343d8fb	SAMEA7711473
PXD004242-1 plasma at 4 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150805_qep1_lc7_phge_sa_plate1d_1_3	20150805_QEp1_LC7_PhGe_SA_Plate1D_1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_1_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	afde77b02d20a76490364467462ff25c3b629018bbc9658e816b360e07433834	SAMEA7711474
PXD004242-1 plasma at 13 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150805_qep1_lc7_phge_sa_plate1d_1_4	20150805_QEp1_LC7_PhGe_SA_Plate1D_1_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_1_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	5d9e73964736f3e351e2331cb9a0a9b1f40b3910c8d87e6fdfa13ad23c284273	SAMEA7711475
PXD004242-1 plasma at 26 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150805_qep1_lc7_phge_sa_plate1d_1_5	20150805_QEp1_LC7_PhGe_SA_Plate1D_1_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_1_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	5b9dafa52d711623003212c3905eca5310fb39c07a9799e56b4d24f012a597e8	SAMEA7711476
PXD004242-1 plasma at 39 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150805_qep1_lc7_phge_sa_plate1d_1_6	20150805_QEp1_LC7_PhGe_SA_Plate1D_1_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_1_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	d2ecc5ef570b57a0f5e818db3dc90fe1d45f6f24e07c3b580849570b15693ac2	SAMEA7711477
PXD004242-1 plasma at 52 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150805_qep1_lc7_phge_sa_plate1d_1_7	20150805_QEp1_LC7_PhGe_SA_Plate1D_1_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_1_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	3a4551494f9d0a8787b69f437ae54cac7d4fc7a30e966276f05d0f8c6c043b63	SAMEA7711478
PXD004242-1 plasma at -8 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150901_qep1_lc7_phge_sa_plate1e_1_1	20150901_QEp1_LC7_PhGe_SA_Plate1E_1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_1_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	1fb5258914c1da5de3745d62bde23c9e86bdb8a9aa47aacb985b8015346c9cf1	SAMEA7711472
PXD004242-1 plasma at 0 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150901_qep1_lc7_phge_sa_plate1e_1_2	20150901_QEp1_LC7_PhGe_SA_Plate1E_1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_1_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	7b94ccbed360aa1bfab2009ec82b5bf9dfa652eb7b5ae013deaabed2d343d8fb	SAMEA7711473
PXD004242-1 plasma at 4 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150901_qep1_lc7_phge_sa_plate1e_1_3	20150901_QEp1_LC7_PhGe_SA_Plate1E_1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_1_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	afde77b02d20a76490364467462ff25c3b629018bbc9658e816b360e07433834	SAMEA7711474
PXD004242-1 plasma at 13 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150901_qep1_lc7_phge_sa_plate1e_1_4	20150901_QEp1_LC7_PhGe_SA_Plate1E_1_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_1_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	5d9e73964736f3e351e2331cb9a0a9b1f40b3910c8d87e6fdfa13ad23c284273	SAMEA7711475
PXD004242-1 plasma at 26 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150901_qep1_lc7_phge_sa_plate1e_1_5	20150901_QEp1_LC7_PhGe_SA_Plate1E_1_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_1_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	5b9dafa52d711623003212c3905eca5310fb39c07a9799e56b4d24f012a597e8	SAMEA7711476
PXD004242-1 plasma at 39 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150901_qep1_lc7_phge_sa_plate1e_1_6	20150901_QEp1_LC7_PhGe_SA_Plate1E_1_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_1_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	d2ecc5ef570b57a0f5e818db3dc90fe1d45f6f24e07c3b580849570b15693ac2	SAMEA7711477
PXD004242-1 plasma at 52 weeks	Homo sapiens	blood plasma	1	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150901_qep1_lc7_phge_sa_plate1e_1_7	20150901_QEp1_LC7_PhGe_SA_Plate1E_1_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_1_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	3a4551494f9d0a8787b69f437ae54cac7d4fc7a30e966276f05d0f8c6c043b63	SAMEA7711478
PXD004242-2 plasma at -8 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150618_qep1_lc7_phge_sa_plate1b_02_1	20150618_QEp1_LC7_PhGe_SA_Plate1B_02_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_02_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	48d0a7118bc7ee7d132df9d97c2d897393d1405da23cba6ba2829707c9dfc1b0	SAMEA7711479
PXD004242-2 plasma at 0 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150618_qep1_lc7_phge_sa_plate1b_02_2	20150618_QEp1_LC7_PhGe_SA_Plate1B_02_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_02_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	ce0109e919d62502cb1afdbcea57326e6b55319688fd9e76fa9bb514edb028d8	SAMEA7711480
PXD004242-2 plasma at 4 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150618_qep1_lc7_phge_sa_plate1b_02_3	20150618_QEp1_LC7_PhGe_SA_Plate1B_02_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_02_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	079264d378ba03587ebe5b03724e8ba71a31efa43b63d0e972bc579f18cacf90	SAMEA7711481
PXD004242-2 plasma at 13 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150618_qep1_lc7_phge_sa_plate1b_02_4	20150618_QEp1_LC7_PhGe_SA_Plate1B_02_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_02_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	307e7c186dacc0befa0372f1dfb8a0317075596677dda51bacad8fa0d443c491	SAMEA7711482
PXD004242-2 plasma at 26 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150618_qep1_lc7_phge_sa_plate1b_02_5	20150618_QEp1_LC7_PhGe_SA_Plate1B_02_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_02_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	0d12ad4b30ff028e6d9dd82cda3e40b1b8fec7706f40950820d83b9b968a2257	SAMEA7711483
PXD004242-2 plasma at 39 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150618_qep1_lc7_phge_sa_plate1b_02_6	20150618_QEp1_LC7_PhGe_SA_Plate1B_02_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_02_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	231555a6eeacc0c30ca0674f0a5c024905f2873397ad5abbf5bc6dc8050557da	SAMEA7711484
PXD004242-2 plasma at 52 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150618_qep1_lc7_phge_sa_plate1b_02_7	20150618_QEp1_LC7_PhGe_SA_Plate1B_02_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_02_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	63f052b58dd011ac8382018d2e4bb29ec16d6f56d1f4ba1009ad090d33ee1ff3	SAMEA7711485
PXD004242-2 plasma at -8 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150708_qep1_lc7_phge_sa_plate1c_02_1	20150708_QEp1_LC7_PhGe_SA_Plate1C_02_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_02_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	48d0a7118bc7ee7d132df9d97c2d897393d1405da23cba6ba2829707c9dfc1b0	SAMEA7711479
PXD004242-2 plasma at 0 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150708_qep1_lc7_phge_sa_plate1c_02_2	20150708_QEp1_LC7_PhGe_SA_Plate1C_02_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_02_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	ce0109e919d62502cb1afdbcea57326e6b55319688fd9e76fa9bb514edb028d8	SAMEA7711480
PXD004242-2 plasma at 4 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150708_qep1_lc7_phge_sa_plate1c_02_3	20150708_QEp1_LC7_PhGe_SA_Plate1C_02_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_02_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	079264d378ba03587ebe5b03724e8ba71a31efa43b63d0e972bc579f18cacf90	SAMEA7711481
PXD004242-2 plasma at 13 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150708_qep1_lc7_phge_sa_plate1c_02_4	20150708_QEp1_LC7_PhGe_SA_Plate1C_02_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_02_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	307e7c186dacc0befa0372f1dfb8a0317075596677dda51bacad8fa0d443c491	SAMEA7711482
PXD004242-2 plasma at 26 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150708_qep1_lc7_phge_sa_plate1c_02_5	20150708_QEp1_LC7_PhGe_SA_Plate1C_02_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_02_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	0d12ad4b30ff028e6d9dd82cda3e40b1b8fec7706f40950820d83b9b968a2257	SAMEA7711483
PXD004242-2 plasma at 39 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150708_qep1_lc7_phge_sa_plate1c_02_6	20150708_QEp1_LC7_PhGe_SA_Plate1C_02_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_02_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	231555a6eeacc0c30ca0674f0a5c024905f2873397ad5abbf5bc6dc8050557da	SAMEA7711484
PXD004242-2 plasma at 52 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150708_qep1_lc7_phge_sa_plate1c_02_7	20150708_QEp1_LC7_PhGe_SA_Plate1C_02_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_02_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	63f052b58dd011ac8382018d2e4bb29ec16d6f56d1f4ba1009ad090d33ee1ff3	SAMEA7711485
PXD004242-2 plasma at -8 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150805_qep1_lc7_phge_sa_plate1d_02_1	20150805_QEp1_LC7_PhGe_SA_Plate1D_02_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_02_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	48d0a7118bc7ee7d132df9d97c2d897393d1405da23cba6ba2829707c9dfc1b0	SAMEA7711479
PXD004242-2 plasma at 0 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150805_qep1_lc7_phge_sa_plate1d_02_2	20150805_QEp1_LC7_PhGe_SA_Plate1D_02_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_02_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	ce0109e919d62502cb1afdbcea57326e6b55319688fd9e76fa9bb514edb028d8	SAMEA7711480
PXD004242-2 plasma at 4 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150805_qep1_lc7_phge_sa_plate1d_02_3	20150805_QEp1_LC7_PhGe_SA_Plate1D_02_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_02_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	079264d378ba03587ebe5b03724e8ba71a31efa43b63d0e972bc579f18cacf90	SAMEA7711481
PXD004242-2 plasma at 13 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150805_qep1_lc7_phge_sa_plate1d_02_4	20150805_QEp1_LC7_PhGe_SA_Plate1D_02_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_02_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	307e7c186dacc0befa0372f1dfb8a0317075596677dda51bacad8fa0d443c491	SAMEA7711482
PXD004242-2 plasma at 26 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150805_qep1_lc7_phge_sa_plate1d_02_5	20150805_QEp1_LC7_PhGe_SA_Plate1D_02_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_02_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	0d12ad4b30ff028e6d9dd82cda3e40b1b8fec7706f40950820d83b9b968a2257	SAMEA7711483
PXD004242-2 plasma at 39 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150805_qep1_lc7_phge_sa_plate1d_02_6	20150805_QEp1_LC7_PhGe_SA_Plate1D_02_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_02_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	231555a6eeacc0c30ca0674f0a5c024905f2873397ad5abbf5bc6dc8050557da	SAMEA7711484
PXD004242-2 plasma at 52 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150805_qep1_lc7_phge_sa_plate1d_02_7	20150805_QEp1_LC7_PhGe_SA_Plate1D_02_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_02_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	63f052b58dd011ac8382018d2e4bb29ec16d6f56d1f4ba1009ad090d33ee1ff3	SAMEA7711485
PXD004242-2 plasma at -8 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150901_qep1_lc7_phge_sa_plate1e_02_1	20150901_QEp1_LC7_PhGe_SA_Plate1E_02_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_02_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	48d0a7118bc7ee7d132df9d97c2d897393d1405da23cba6ba2829707c9dfc1b0	SAMEA7711479
PXD004242-2 plasma at 0 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150901_qep1_lc7_phge_sa_plate1e_02_2	20150901_QEp1_LC7_PhGe_SA_Plate1E_02_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_02_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	ce0109e919d62502cb1afdbcea57326e6b55319688fd9e76fa9bb514edb028d8	SAMEA7711480
PXD004242-2 plasma at 4 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150901_qep1_lc7_phge_sa_plate1e_02_3	20150901_QEp1_LC7_PhGe_SA_Plate1E_02_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_02_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	079264d378ba03587ebe5b03724e8ba71a31efa43b63d0e972bc579f18cacf90	SAMEA7711481
PXD004242-2 plasma at 13 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150901_qep1_lc7_phge_sa_plate1e_02_4	20150901_QEp1_LC7_PhGe_SA_Plate1E_02_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_02_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	307e7c186dacc0befa0372f1dfb8a0317075596677dda51bacad8fa0d443c491	SAMEA7711482
PXD004242-2 plasma at 26 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150901_qep1_lc7_phge_sa_plate1e_02_5	20150901_QEp1_LC7_PhGe_SA_Plate1E_02_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_02_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	0d12ad4b30ff028e6d9dd82cda3e40b1b8fec7706f40950820d83b9b968a2257	SAMEA7711483
PXD004242-2 plasma at 39 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150901_qep1_lc7_phge_sa_plate1e_02_6	20150901_QEp1_LC7_PhGe_SA_Plate1E_02_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_02_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	231555a6eeacc0c30ca0674f0a5c024905f2873397ad5abbf5bc6dc8050557da	SAMEA7711484
PXD004242-2 plasma at 52 weeks	Homo sapiens	blood plasma	2	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150901_qep1_lc7_phge_sa_plate1e_02_7	20150901_QEp1_LC7_PhGe_SA_Plate1E_02_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_02_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	63f052b58dd011ac8382018d2e4bb29ec16d6f56d1f4ba1009ad090d33ee1ff3	SAMEA7711485
PXD004242-3 plasma at -8 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150731_qep1_lc7_phge_sa_plate4b_03_1	20150731_QEp1_LC7_PhGe_SA_Plate4B_03_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_03_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	67eeefdd9638aae791e6452eb8930039703695c14f457b983f209fea9fb8c2fe	SAMEA7711486
PXD004242-3 plasma at 0 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150731_qep1_lc7_phge_sa_plate4b_03_2	20150731_QEp1_LC7_PhGe_SA_Plate4B_03_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_03_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	0ad5a3b4a8cb4e36ab09ffa86595bb503505c68007e6dd8a88d6b2499a0043b7	SAMEA7711487
PXD004242-3 plasma at 4 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150731_qep1_lc7_phge_sa_plate4b_03_3	20150731_QEp1_LC7_PhGe_SA_Plate4B_03_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_03_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	643bb887804bcaf31794775691139661e3797c1fbdfab8c34eb3e86cdab0c8c4	SAMEA7711488
PXD004242-3 plasma at 13 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150731_qep1_lc7_phge_sa_plate4b_03_4	20150731_QEp1_LC7_PhGe_SA_Plate4B_03_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_03_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	9b9613979962065a14ae7a5bde8f61c6ea9579d71776de55022906d62e506068	SAMEA7711489
PXD004242-3 plasma at 26 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150731_qep1_lc7_phge_sa_plate4b_03_5	20150731_QEp1_LC7_PhGe_SA_Plate4B_03_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_03_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	12ec74871a4f48fec9f8920b0fc79a07646f0492a5bb360abd547f7fa506b52a	SAMEA7711490
PXD004242-3 plasma at 39 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150731_qep1_lc7_phge_sa_plate4b_03_6	20150731_QEp1_LC7_PhGe_SA_Plate4B_03_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_03_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	26bf389a593b2f83aaaf6c1997afd3616b56f3ae959f48e74da61e536c35560d	SAMEA7711491
PXD004242-3 plasma at 52 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150731_qep1_lc7_phge_sa_plate4b_03_7	20150731_QEp1_LC7_PhGe_SA_Plate4B_03_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_03_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	95d317504a3736e704faf687e9eca375f91fa5454e70c4f0235f1b5a0cfca874	SAMEA7711492
PXD004242-3 plasma at -8 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150731_qep1_lc7_phge_sa_plate4e_03_1	20150731_QEp1_LC7_PhGe_SA_Plate4E_03_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_03_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	67eeefdd9638aae791e6452eb8930039703695c14f457b983f209fea9fb8c2fe	SAMEA7711486
PXD004242-3 plasma at 0 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150731_qep1_lc7_phge_sa_plate4e_03_2	20150731_QEp1_LC7_PhGe_SA_Plate4E_03_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_03_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	0ad5a3b4a8cb4e36ab09ffa86595bb503505c68007e6dd8a88d6b2499a0043b7	SAMEA7711487
PXD004242-3 plasma at 4 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150731_qep1_lc7_phge_sa_plate4e_03_3	20150731_QEp1_LC7_PhGe_SA_Plate4E_03_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_03_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	643bb887804bcaf31794775691139661e3797c1fbdfab8c34eb3e86cdab0c8c4	SAMEA7711488
PXD004242-3 plasma at 13 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150731_qep1_lc7_phge_sa_plate4e_03_4	20150731_QEp1_LC7_PhGe_SA_Plate4E_03_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_03_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	9b9613979962065a14ae7a5bde8f61c6ea9579d71776de55022906d62e506068	SAMEA7711489
PXD004242-3 plasma at 26 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150731_qep1_lc7_phge_sa_plate4e_03_5	20150731_QEp1_LC7_PhGe_SA_Plate4E_03_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_03_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	12ec74871a4f48fec9f8920b0fc79a07646f0492a5bb360abd547f7fa506b52a	SAMEA7711490
PXD004242-3 plasma at 39 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150731_qep1_lc7_phge_sa_plate4e_03_6	20150731_QEp1_LC7_PhGe_SA_Plate4E_03_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_03_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	26bf389a593b2f83aaaf6c1997afd3616b56f3ae959f48e74da61e536c35560d	SAMEA7711491
PXD004242-3 plasma at 52 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150731_qep1_lc7_phge_sa_plate4e_03_7	20150731_QEp1_LC7_PhGe_SA_Plate4E_03_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_03_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	95d317504a3736e704faf687e9eca375f91fa5454e70c4f0235f1b5a0cfca874	SAMEA7711492
PXD004242-3 plasma at -8 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150824_qep1_lc7_phge_sa_plate4d_03_1	20150824_QEp1_LC7_PhGe_SA_Plate4D_03_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_03_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	67eeefdd9638aae791e6452eb8930039703695c14f457b983f209fea9fb8c2fe	SAMEA7711486
PXD004242-3 plasma at 0 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150824_qep1_lc7_phge_sa_plate4d_03_2	20150824_QEp1_LC7_PhGe_SA_Plate4D_03_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_03_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	0ad5a3b4a8cb4e36ab09ffa86595bb503505c68007e6dd8a88d6b2499a0043b7	SAMEA7711487
PXD004242-3 plasma at 4 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150824_qep1_lc7_phge_sa_plate4d_03_3	20150824_QEp1_LC7_PhGe_SA_Plate4D_03_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_03_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	643bb887804bcaf31794775691139661e3797c1fbdfab8c34eb3e86cdab0c8c4	SAMEA7711488
PXD004242-3 plasma at 13 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150824_qep1_lc7_phge_sa_plate4d_03_4	20150824_QEp1_LC7_PhGe_SA_Plate4D_03_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_03_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	9b9613979962065a14ae7a5bde8f61c6ea9579d71776de55022906d62e506068	SAMEA7711489
PXD004242-3 plasma at 26 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150824_qep1_lc7_phge_sa_plate4d_03_5	20150824_QEp1_LC7_PhGe_SA_Plate4D_03_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_03_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	12ec74871a4f48fec9f8920b0fc79a07646f0492a5bb360abd547f7fa506b52a	SAMEA7711490
PXD004242-3 plasma at 39 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150824_qep1_lc7_phge_sa_plate4d_03_6	20150824_QEp1_LC7_PhGe_SA_Plate4D_03_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_03_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	26bf389a593b2f83aaaf6c1997afd3616b56f3ae959f48e74da61e536c35560d	SAMEA7711491
PXD004242-3 plasma at 52 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150824_qep1_lc7_phge_sa_plate4d_03_7	20150824_QEp1_LC7_PhGe_SA_Plate4D_03_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_03_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	95d317504a3736e704faf687e9eca375f91fa5454e70c4f0235f1b5a0cfca874	SAMEA7711492
PXD004242-3 plasma at -8 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150917_qep1_lc7_phge_sa_plate4c_03_1	20150917_QEp1_LC7_PhGe_SA_Plate4C_03_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_03_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	67eeefdd9638aae791e6452eb8930039703695c14f457b983f209fea9fb8c2fe	SAMEA7711486
PXD004242-3 plasma at 0 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150917_qep1_lc7_phge_sa_plate4c_03_2	20150917_QEp1_LC7_PhGe_SA_Plate4C_03_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_03_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	0ad5a3b4a8cb4e36ab09ffa86595bb503505c68007e6dd8a88d6b2499a0043b7	SAMEA7711487
PXD004242-3 plasma at 4 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150917_qep1_lc7_phge_sa_plate4c_03_3	20150917_QEp1_LC7_PhGe_SA_Plate4C_03_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_03_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	643bb887804bcaf31794775691139661e3797c1fbdfab8c34eb3e86cdab0c8c4	SAMEA7711488
PXD004242-3 plasma at 13 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150917_qep1_lc7_phge_sa_plate4c_03_4	20150917_QEp1_LC7_PhGe_SA_Plate4C_03_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_03_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	9b9613979962065a14ae7a5bde8f61c6ea9579d71776de55022906d62e506068	SAMEA7711489
PXD004242-3 plasma at 26 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150917_qep1_lc7_phge_sa_plate4c_03_5	20150917_QEp1_LC7_PhGe_SA_Plate4C_03_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_03_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	12ec74871a4f48fec9f8920b0fc79a07646f0492a5bb360abd547f7fa506b52a	SAMEA7711490
PXD004242-3 plasma at 39 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150917_qep1_lc7_phge_sa_plate4c_03_6	20150917_QEp1_LC7_PhGe_SA_Plate4C_03_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_03_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	26bf389a593b2f83aaaf6c1997afd3616b56f3ae959f48e74da61e536c35560d	SAMEA7711491
PXD004242-3 plasma at 52 weeks	Homo sapiens	blood plasma	3	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150917_qep1_lc7_phge_sa_plate4c_03_7	20150917_QEp1_LC7_PhGe_SA_Plate4C_03_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_03_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	95d317504a3736e704faf687e9eca375f91fa5454e70c4f0235f1b5a0cfca874	SAMEA7711492
PXD004242-5 plasma at -8 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150701_qep1_lc7_phge_sa_plate3a_05_1	20150701_QEp1_LC7_PhGe_SA_Plate3A_05_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_05_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	71cdf03121466f846175e7a870cab0783ccdf609d030d0faa6b35acf120bb5eb	SAMEA7711493
PXD004242-5 plasma at 0 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150701_qep1_lc7_phge_sa_plate3a_05_2	20150701_QEp1_LC7_PhGe_SA_Plate3A_05_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_05_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	8e1fb5087521e0dc10fbb4d28d51b3832e92566814af5040e941430ddc54b77b	SAMEA7711494
PXD004242-5 plasma at 4 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150701_qep1_lc7_phge_sa_plate3a_05_3	20150701_QEp1_LC7_PhGe_SA_Plate3A_05_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_05_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	fa39dd46265286b9755dc8101cf50125adef4ba969b2c686842fdaf821a73d6c	SAMEA7711495
PXD004242-5 plasma at 13 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150701_qep1_lc7_phge_sa_plate3a_05_4	20150701_QEp1_LC7_PhGe_SA_Plate3A_05_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_05_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	8a076fe79b86fb2e98dc6998a7df8f0a9f72d6a5361993e5eb7c5a21ace007c2	SAMEA7711496
PXD004242-5 plasma at 26 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150701_qep1_lc7_phge_sa_plate3a_05_5	20150701_QEp1_LC7_PhGe_SA_Plate3A_05_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_05_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	ceffdf723b138dec7b589bf9ab4fcd59be9005653b20ab6c68ce1b7750de860c	SAMEA7711497
PXD004242-5 plasma at 39 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150701_qep1_lc7_phge_sa_plate3a_05_6	20150701_QEp1_LC7_PhGe_SA_Plate3A_05_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_05_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	6a5c891280cad36ce59e2f75f65ab45e14fc3ab3b359c489e06184f8d3693b88	SAMEA7711498
PXD004242-5 plasma at 52 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150701_qep1_lc7_phge_sa_plate3a_05_7	20150701_QEp1_LC7_PhGe_SA_Plate3A_05_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_05_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f826f4ec8e665b8ebc26eb484e2042989c4b2da5fb3b6b48de41a615cd0fcc33	SAMEA7711499
PXD004242-5 plasma at 4 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150725_qep1_lc7_phge_sa_plate3b_05_3	20150725_QEp1_LC7_PhGe_SA_Plate3B_05_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_05_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	fa39dd46265286b9755dc8101cf50125adef4ba969b2c686842fdaf821a73d6c	SAMEA7711495
PXD004242-5 plasma at 13 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150725_qep1_lc7_phge_sa_plate3b_05_4	20150725_QEp1_LC7_PhGe_SA_Plate3B_05_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_05_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	8a076fe79b86fb2e98dc6998a7df8f0a9f72d6a5361993e5eb7c5a21ace007c2	SAMEA7711496
PXD004242-5 plasma at 39 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150725_qep1_lc7_phge_sa_plate3b_05_6	20150725_QEp1_LC7_PhGe_SA_Plate3B_05_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_05_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	6a5c891280cad36ce59e2f75f65ab45e14fc3ab3b359c489e06184f8d3693b88	SAMEA7711498
PXD004242-5 plasma at 52 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150725_qep1_lc7_phge_sa_plate3b_05_7	20150725_QEp1_LC7_PhGe_SA_Plate3B_05_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_05_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f826f4ec8e665b8ebc26eb484e2042989c4b2da5fb3b6b48de41a615cd0fcc33	SAMEA7711499
PXD004242-5 plasma at -8 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150818_qep1_lc7_phge_sa_plate3c_05_1	20150818_QEp1_LC7_PhGe_SA_Plate3C_05_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_05_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	71cdf03121466f846175e7a870cab0783ccdf609d030d0faa6b35acf120bb5eb	SAMEA7711493
PXD004242-5 plasma at 0 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150818_qep1_lc7_phge_sa_plate3c_05_2	20150818_QEp1_LC7_PhGe_SA_Plate3C_05_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_05_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	8e1fb5087521e0dc10fbb4d28d51b3832e92566814af5040e941430ddc54b77b	SAMEA7711494
PXD004242-5 plasma at 4 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150818_qep1_lc7_phge_sa_plate3c_05_3	20150818_QEp1_LC7_PhGe_SA_Plate3C_05_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_05_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	fa39dd46265286b9755dc8101cf50125adef4ba969b2c686842fdaf821a73d6c	SAMEA7711495
PXD004242-5 plasma at 13 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150818_qep1_lc7_phge_sa_plate3c_05_4	20150818_QEp1_LC7_PhGe_SA_Plate3C_05_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_05_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	8a076fe79b86fb2e98dc6998a7df8f0a9f72d6a5361993e5eb7c5a21ace007c2	SAMEA7711496
PXD004242-5 plasma at 26 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150818_qep1_lc7_phge_sa_plate3c_05_5	20150818_QEp1_LC7_PhGe_SA_Plate3C_05_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_05_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	ceffdf723b138dec7b589bf9ab4fcd59be9005653b20ab6c68ce1b7750de860c	SAMEA7711497
PXD004242-5 plasma at 52 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150818_qep1_lc7_phge_sa_plate3c_05_7	20150818_QEp1_LC7_PhGe_SA_Plate3C_05_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_05_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f826f4ec8e665b8ebc26eb484e2042989c4b2da5fb3b6b48de41a615cd0fcc33	SAMEA7711499
PXD004242-5 plasma at -8 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150912_qep1_lc7_phge_sa_plate3d_05_1	20150912_QEp1_LC7_PhGe_SA_Plate3D_05_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_05_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	71cdf03121466f846175e7a870cab0783ccdf609d030d0faa6b35acf120bb5eb	SAMEA7711493
PXD004242-5 plasma at 4 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150912_qep1_lc7_phge_sa_plate3d_05_3	20150912_QEp1_LC7_PhGe_SA_Plate3D_05_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_05_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	fa39dd46265286b9755dc8101cf50125adef4ba969b2c686842fdaf821a73d6c	SAMEA7711495
PXD004242-5 plasma at 13 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150912_qep1_lc7_phge_sa_plate3d_05_4	20150912_QEp1_LC7_PhGe_SA_Plate3D_05_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_05_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	8a076fe79b86fb2e98dc6998a7df8f0a9f72d6a5361993e5eb7c5a21ace007c2	SAMEA7711496
PXD004242-5 plasma at 26 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150912_qep1_lc7_phge_sa_plate3d_05_5	20150912_QEp1_LC7_PhGe_SA_Plate3D_05_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_05_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	ceffdf723b138dec7b589bf9ab4fcd59be9005653b20ab6c68ce1b7750de860c	SAMEA7711497
PXD004242-5 plasma at 39 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150912_qep1_lc7_phge_sa_plate3d_05_6	20150912_QEp1_LC7_PhGe_SA_Plate3D_05_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_05_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	6a5c891280cad36ce59e2f75f65ab45e14fc3ab3b359c489e06184f8d3693b88	SAMEA7711498
PXD004242-5 plasma at 52 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150912_qep1_lc7_phge_sa_plate3d_05_7	20150912_QEp1_LC7_PhGe_SA_Plate3D_05_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_05_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f826f4ec8e665b8ebc26eb484e2042989c4b2da5fb3b6b48de41a615cd0fcc33	SAMEA7711499
PXD004242-5 plasma at -8 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150917_qep1_lc7_phge_sa_plate3b_05_1	20150917_QEp1_LC7_PhGe_SA_Plate3B_05_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_05_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	71cdf03121466f846175e7a870cab0783ccdf609d030d0faa6b35acf120bb5eb	SAMEA7711493
PXD004242-5 plasma at 0 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150917_qep1_lc7_phge_sa_plate3b_05_2	20150917_QEp1_LC7_PhGe_SA_Plate3B_05_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_05_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	8e1fb5087521e0dc10fbb4d28d51b3832e92566814af5040e941430ddc54b77b	SAMEA7711494
PXD004242-5 plasma at 26 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150917_qep1_lc7_phge_sa_plate3b_05_5	20150917_QEp1_LC7_PhGe_SA_Plate3B_05_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_05_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	ceffdf723b138dec7b589bf9ab4fcd59be9005653b20ab6c68ce1b7750de860c	SAMEA7711497
PXD004242-5 plasma at 39 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150917_qep1_lc7_phge_sa_plate3c_05_6	20150917_QEp1_LC7_PhGe_SA_Plate3C_05_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3C_05_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	6a5c891280cad36ce59e2f75f65ab45e14fc3ab3b359c489e06184f8d3693b88	SAMEA7711498
PXD004242-5 plasma at 0 weeks	Homo sapiens	blood plasma	5	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150917_qep1_lc8_phge_sa_plate3d_05_2	20150917_QEp1_LC8_PhGe_SA_Plate3D_05_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_Plate3D_05_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	8e1fb5087521e0dc10fbb4d28d51b3832e92566814af5040e941430ddc54b77b	SAMEA7711494
PXD004242-6 plasma at -8 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150624_qep1_lc7_phge_sa_plate2a_06_1	20150624_QEp1_LC7_PhGe_SA_Plate2A_06_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_06_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	550ec0a89a105cac67898ac046b8c4317da4d6796f620db58defbd834b6a4aa1	SAMEA7711500
PXD004242-6 plasma at 0 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150624_qep1_lc7_phge_sa_plate2a_06_2	20150624_QEp1_LC7_PhGe_SA_Plate2A_06_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_06_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	b38b7968e467420b6b62f5b971b015055ea013c46118e9b239bd39a0c56d80ed	SAMEA7711501
PXD004242-6 plasma at 4 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150624_qep1_lc7_phge_sa_plate2a_06_3	20150624_QEp1_LC7_PhGe_SA_Plate2A_06_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_06_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	2e12238594c42cc5e89bcc4056db4031d8478a5b491585d6fb37efedce38feec	SAMEA7711502
PXD004242-6 plasma at 13 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150624_qep1_lc7_phge_sa_plate2a_06_4	20150624_QEp1_LC7_PhGe_SA_Plate2A_06_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_06_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	4edd9ea772be4a95454a7e855a643e02a31510db75670d16467940daecc5dd3f	SAMEA7711503
PXD004242-6 plasma at 26 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150624_qep1_lc7_phge_sa_plate2a_06_5	20150624_QEp1_LC7_PhGe_SA_Plate2A_06_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_06_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	3f523529295c48631e8925ab3dc45a09c3d59e67ea4f3fcead71da5587755df3	SAMEA7711504
PXD004242-6 plasma at 39 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150624_qep1_lc7_phge_sa_plate2a_06_6	20150624_QEp1_LC7_PhGe_SA_Plate2A_06_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_06_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	5c4f638a7e423afe46a364f12afeb387314c7cb12e9b71b563b13b6f99e90e99	SAMEA7711505
PXD004242-6 plasma at 52 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150624_qep1_lc7_phge_sa_plate2a_06_7	20150624_QEp1_LC7_PhGe_SA_Plate2A_06_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_06_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	cce368ee5011e2cd49876a7dfe202f8e5c555501aaeacb7cd0615466f3ee1bc0	SAMEA7711506
PXD004242-6 plasma at -8 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150811_qep1_lc7_phge_sa_plate2b_06_1	20150811_QEp1_LC7_PhGe_SA_Plate2B_06_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_06_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	550ec0a89a105cac67898ac046b8c4317da4d6796f620db58defbd834b6a4aa1	SAMEA7711500
PXD004242-6 plasma at 0 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150811_qep1_lc7_phge_sa_plate2b_06_2	20150811_QEp1_LC7_PhGe_SA_Plate2B_06_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_06_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	b38b7968e467420b6b62f5b971b015055ea013c46118e9b239bd39a0c56d80ed	SAMEA7711501
PXD004242-6 plasma at 4 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150811_qep1_lc7_phge_sa_plate2b_06_3	20150811_QEp1_LC7_PhGe_SA_Plate2B_06_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_06_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	2e12238594c42cc5e89bcc4056db4031d8478a5b491585d6fb37efedce38feec	SAMEA7711502
PXD004242-6 plasma at 13 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150811_qep1_lc7_phge_sa_plate2b_06_4	20150811_QEp1_LC7_PhGe_SA_Plate2B_06_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_06_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	4edd9ea772be4a95454a7e855a643e02a31510db75670d16467940daecc5dd3f	SAMEA7711503
PXD004242-6 plasma at 26 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150811_qep1_lc7_phge_sa_plate2b_06_5	20150811_QEp1_LC7_PhGe_SA_Plate2B_06_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_06_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	3f523529295c48631e8925ab3dc45a09c3d59e67ea4f3fcead71da5587755df3	SAMEA7711504
PXD004242-6 plasma at 39 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150811_qep1_lc7_phge_sa_plate2b_06_6	20150811_QEp1_LC7_PhGe_SA_Plate2B_06_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_06_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	5c4f638a7e423afe46a364f12afeb387314c7cb12e9b71b563b13b6f99e90e99	SAMEA7711505
PXD004242-6 plasma at 52 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150811_qep1_lc7_phge_sa_plate2b_06_7	20150811_QEp1_LC7_PhGe_SA_Plate2B_06_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_06_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	cce368ee5011e2cd49876a7dfe202f8e5c555501aaeacb7cd0615466f3ee1bc0	SAMEA7711506
PXD004242-6 plasma at -8 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150827_qep1_lc7_phge_sa_plate2c_06_1	20150827_QEp1_LC7_PhGe_SA_Plate2C_06_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_06_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	550ec0a89a105cac67898ac046b8c4317da4d6796f620db58defbd834b6a4aa1	SAMEA7711500
PXD004242-6 plasma at 4 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150827_qep1_lc7_phge_sa_plate2c_06_3	20150827_QEp1_LC7_PhGe_SA_Plate2C_06_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_06_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	2e12238594c42cc5e89bcc4056db4031d8478a5b491585d6fb37efedce38feec	SAMEA7711502
PXD004242-6 plasma at 13 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150827_qep1_lc7_phge_sa_plate2c_06_4	20150827_QEp1_LC7_PhGe_SA_Plate2C_06_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_06_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	4edd9ea772be4a95454a7e855a643e02a31510db75670d16467940daecc5dd3f	SAMEA7711503
PXD004242-6 plasma at 26 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150827_qep1_lc7_phge_sa_plate2c_06_5	20150827_QEp1_LC7_PhGe_SA_Plate2C_06_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_06_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	3f523529295c48631e8925ab3dc45a09c3d59e67ea4f3fcead71da5587755df3	SAMEA7711504
PXD004242-6 plasma at 39 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150827_qep1_lc7_phge_sa_plate2c_06_6	20150827_QEp1_LC7_PhGe_SA_Plate2C_06_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_06_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	5c4f638a7e423afe46a364f12afeb387314c7cb12e9b71b563b13b6f99e90e99	SAMEA7711505
PXD004242-6 plasma at 52 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150827_qep1_lc7_phge_sa_plate2c_06_7	20150827_QEp1_LC7_PhGe_SA_Plate2C_06_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_06_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	cce368ee5011e2cd49876a7dfe202f8e5c555501aaeacb7cd0615466f3ee1bc0	SAMEA7711506
PXD004242-6 plasma at -8 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150907_qep1_lc7_phge_sa_plate2d_06_1	20150907_QEp1_LC7_PhGe_SA_Plate2D_06_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_06_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	550ec0a89a105cac67898ac046b8c4317da4d6796f620db58defbd834b6a4aa1	SAMEA7711500
PXD004242-6 plasma at 0 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150907_qep1_lc7_phge_sa_plate2d_06_2	20150907_QEp1_LC7_PhGe_SA_Plate2D_06_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_06_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	b38b7968e467420b6b62f5b971b015055ea013c46118e9b239bd39a0c56d80ed	SAMEA7711501
PXD004242-6 plasma at 4 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150907_qep1_lc7_phge_sa_plate2d_06_3	20150907_QEp1_LC7_PhGe_SA_Plate2D_06_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_06_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	2e12238594c42cc5e89bcc4056db4031d8478a5b491585d6fb37efedce38feec	SAMEA7711502
PXD004242-6 plasma at 13 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150907_qep1_lc7_phge_sa_plate2d_06_4	20150907_QEp1_LC7_PhGe_SA_Plate2D_06_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_06_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	4edd9ea772be4a95454a7e855a643e02a31510db75670d16467940daecc5dd3f	SAMEA7711503
PXD004242-6 plasma at 26 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150907_qep1_lc7_phge_sa_plate2d_06_5	20150907_QEp1_LC7_PhGe_SA_Plate2D_06_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_06_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	3f523529295c48631e8925ab3dc45a09c3d59e67ea4f3fcead71da5587755df3	SAMEA7711504
PXD004242-6 plasma at 39 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150907_qep1_lc7_phge_sa_plate2d_06_6	20150907_QEp1_LC7_PhGe_SA_Plate2D_06_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_06_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	5c4f638a7e423afe46a364f12afeb387314c7cb12e9b71b563b13b6f99e90e99	SAMEA7711505
PXD004242-6 plasma at 52 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150907_qep1_lc7_phge_sa_plate2d_06_7	20150907_QEp1_LC7_PhGe_SA_Plate2D_06_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_06_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	cce368ee5011e2cd49876a7dfe202f8e5c555501aaeacb7cd0615466f3ee1bc0	SAMEA7711506
PXD004242-6 plasma at 0 weeks	Homo sapiens	blood plasma	6	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150917_qep1_lc7_phge_sa_plate2c_06_2	20150917_QEp1_LC7_PhGe_SA_Plate2C_06_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate2C_06_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	b38b7968e467420b6b62f5b971b015055ea013c46118e9b239bd39a0c56d80ed	SAMEA7711501
PXD004242-7 plasma at -8 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150618_qep1_lc7_phge_sa_plate1b_07_1	20150618_QEp1_LC7_PhGe_SA_Plate1B_07_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_07_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	76b75702f89080207bfed327bebb56057dbed7fab46809bf4e7d380a242bc9ef	SAMEA7711507
PXD004242-7 plasma at 0 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150618_qep1_lc7_phge_sa_plate1b_07_2	20150618_QEp1_LC7_PhGe_SA_Plate1B_07_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_07_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	bb7ca8bbf97702ed179e53278c7700ecf6fd8b05d72c716a157556eed5038075	SAMEA7711508
PXD004242-7 plasma at 4 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150618_qep1_lc7_phge_sa_plate1b_07_3	20150618_QEp1_LC7_PhGe_SA_Plate1B_07_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_07_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	0b3af9c7fd04004f93b693e5d59e861644999ae9857e4d13719c44b329170e2c	SAMEA7711509
PXD004242-7 plasma at 13 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150618_qep1_lc7_phge_sa_plate1b_07_4	20150618_QEp1_LC7_PhGe_SA_Plate1B_07_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_07_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	ee76f8cdaa02ff0ad1a7e53948cc60b1033510ca1e779ac9c352e99dab55d419	SAMEA7711510
PXD004242-7 plasma at 26 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150618_qep1_lc7_phge_sa_plate1b_07_5	20150618_QEp1_LC7_PhGe_SA_Plate1B_07_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_07_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	880552ecbe2ca967e0728f7c9df834052c57d82a8d5bcf1a08a196f999c04c24	SAMEA7711511
PXD004242-7 plasma at 39 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150618_qep1_lc7_phge_sa_plate1b_07_6	20150618_QEp1_LC7_PhGe_SA_Plate1B_07_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_07_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	53904e69f6c2605455b5ad71efc4d0350c8ed6c56b3863e1b420df464097f327	SAMEA7711512
PXD004242-7 plasma at 52 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150618_qep1_lc7_phge_sa_plate1b_07_7	20150618_QEp1_LC7_PhGe_SA_Plate1B_07_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_07_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f7f5826611ca1d49158b44900226d7d2cd77006ba95d04877e53c8ab3906418e	SAMEA7711513
PXD004242-7 plasma at -8 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150708_qep1_lc7_phge_sa_plate1c_07_1	20150708_QEp1_LC7_PhGe_SA_Plate1C_07_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_07_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	76b75702f89080207bfed327bebb56057dbed7fab46809bf4e7d380a242bc9ef	SAMEA7711507
PXD004242-7 plasma at 0 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150708_qep1_lc7_phge_sa_plate1c_07_2	20150708_QEp1_LC7_PhGe_SA_Plate1C_07_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_07_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	bb7ca8bbf97702ed179e53278c7700ecf6fd8b05d72c716a157556eed5038075	SAMEA7711508
PXD004242-7 plasma at 4 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150708_qep1_lc7_phge_sa_plate1c_07_3	20150708_QEp1_LC7_PhGe_SA_Plate1C_07_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_07_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	0b3af9c7fd04004f93b693e5d59e861644999ae9857e4d13719c44b329170e2c	SAMEA7711509
PXD004242-7 plasma at 13 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150708_qep1_lc7_phge_sa_plate1c_07_4	20150708_QEp1_LC7_PhGe_SA_Plate1C_07_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_07_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	ee76f8cdaa02ff0ad1a7e53948cc60b1033510ca1e779ac9c352e99dab55d419	SAMEA7711510
PXD004242-7 plasma at 26 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150708_qep1_lc7_phge_sa_plate1c_07_5	20150708_QEp1_LC7_PhGe_SA_Plate1C_07_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_07_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	880552ecbe2ca967e0728f7c9df834052c57d82a8d5bcf1a08a196f999c04c24	SAMEA7711511
PXD004242-7 plasma at 39 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150708_qep1_lc7_phge_sa_plate1c_07_6	20150708_QEp1_LC7_PhGe_SA_Plate1C_07_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_07_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	53904e69f6c2605455b5ad71efc4d0350c8ed6c56b3863e1b420df464097f327	SAMEA7711512
PXD004242-7 plasma at 52 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150708_qep1_lc7_phge_sa_plate1c_07_7	20150708_QEp1_LC7_PhGe_SA_Plate1C_07_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_07_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f7f5826611ca1d49158b44900226d7d2cd77006ba95d04877e53c8ab3906418e	SAMEA7711513
PXD004242-7 plasma at -8 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150805_qep1_lc7_phge_sa_plate1d_07_1	20150805_QEp1_LC7_PhGe_SA_Plate1D_07_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_07_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	76b75702f89080207bfed327bebb56057dbed7fab46809bf4e7d380a242bc9ef	SAMEA7711507
PXD004242-7 plasma at 0 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150805_qep1_lc7_phge_sa_plate1d_07_2	20150805_QEp1_LC7_PhGe_SA_Plate1D_07_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_07_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	bb7ca8bbf97702ed179e53278c7700ecf6fd8b05d72c716a157556eed5038075	SAMEA7711508
PXD004242-7 plasma at 13 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150805_qep1_lc7_phge_sa_plate1d_07_4	20150805_QEp1_LC7_PhGe_SA_Plate1D_07_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_07_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	ee76f8cdaa02ff0ad1a7e53948cc60b1033510ca1e779ac9c352e99dab55d419	SAMEA7711510
PXD004242-7 plasma at 26 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150805_qep1_lc7_phge_sa_plate1d_07_5	20150805_QEp1_LC7_PhGe_SA_Plate1D_07_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_07_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	880552ecbe2ca967e0728f7c9df834052c57d82a8d5bcf1a08a196f999c04c24	SAMEA7711511
PXD004242-7 plasma at 39 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150805_qep1_lc7_phge_sa_plate1d_07_6	20150805_QEp1_LC7_PhGe_SA_Plate1D_07_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_07_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	53904e69f6c2605455b5ad71efc4d0350c8ed6c56b3863e1b420df464097f327	SAMEA7711512
PXD004242-7 plasma at 52 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150805_qep1_lc7_phge_sa_plate1d_07_7	20150805_QEp1_LC7_PhGe_SA_Plate1D_07_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_07_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f7f5826611ca1d49158b44900226d7d2cd77006ba95d04877e53c8ab3906418e	SAMEA7711513
PXD004242-7 plasma at -8 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150901_qep1_lc7_phge_sa_plate1e_07_1	20150901_QEp1_LC7_PhGe_SA_Plate1E_07_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_07_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	76b75702f89080207bfed327bebb56057dbed7fab46809bf4e7d380a242bc9ef	SAMEA7711507
PXD004242-7 plasma at 0 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150901_qep1_lc7_phge_sa_plate1e_07_2	20150901_QEp1_LC7_PhGe_SA_Plate1E_07_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_07_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	bb7ca8bbf97702ed179e53278c7700ecf6fd8b05d72c716a157556eed5038075	SAMEA7711508
PXD004242-7 plasma at 4 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150901_qep1_lc7_phge_sa_plate1e_07_3	20150901_QEp1_LC7_PhGe_SA_Plate1E_07_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_07_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	0b3af9c7fd04004f93b693e5d59e861644999ae9857e4d13719c44b329170e2c	SAMEA7711509
PXD004242-7 plasma at 13 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150901_qep1_lc7_phge_sa_plate1e_07_4	20150901_QEp1_LC7_PhGe_SA_Plate1E_07_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_07_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	ee76f8cdaa02ff0ad1a7e53948cc60b1033510ca1e779ac9c352e99dab55d419	SAMEA7711510
PXD004242-7 plasma at 26 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150901_qep1_lc7_phge_sa_plate1e_07_5	20150901_QEp1_LC7_PhGe_SA_Plate1E_07_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_07_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	880552ecbe2ca967e0728f7c9df834052c57d82a8d5bcf1a08a196f999c04c24	SAMEA7711511
PXD004242-7 plasma at 39 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150901_qep1_lc7_phge_sa_plate1e_07_6	20150901_QEp1_LC7_PhGe_SA_Plate1E_07_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_07_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	53904e69f6c2605455b5ad71efc4d0350c8ed6c56b3863e1b420df464097f327	SAMEA7711512
PXD004242-7 plasma at 52 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150901_qep1_lc7_phge_sa_plate1e_07_7	20150901_QEp1_LC7_PhGe_SA_Plate1E_07_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_07_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f7f5826611ca1d49158b44900226d7d2cd77006ba95d04877e53c8ab3906418e	SAMEA7711513
PXD004242-7 plasma at 4 weeks	Homo sapiens	blood plasma	7	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150917_qep1_lc7_phge_sa_plate1d_07_3	20150917_QEp1_LC7_PhGe_SA_Plate1D_07_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate1D_07_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	0b3af9c7fd04004f93b693e5d59e861644999ae9857e4d13719c44b329170e2c	SAMEA7711509
PXD004242-8 plasma at -8 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150618_qep1_lc7_phge_sa_plate1b_08_1	20150618_QEp1_LC7_PhGe_SA_Plate1B_08_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_08_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	c376d92b3e97bbfe98909191989b873869b9820487a5e8db5af9813798cdfb06	SAMEA7711514
PXD004242-8 plasma at 0 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150618_qep1_lc7_phge_sa_plate1b_08_2	20150618_QEp1_LC7_PhGe_SA_Plate1B_08_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_08_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	52b6fda8dc0a251d18a5e8237dbd753b084e7e1731aab2a2eaea8c9a206cf206	SAMEA7711515
PXD004242-8 plasma at 4 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150618_qep1_lc7_phge_sa_plate1b_08_3	20150618_QEp1_LC7_PhGe_SA_Plate1B_08_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_08_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	dead4d00685b38866363d0edb42558f0af505d79b104c3f1d8dbeb73e273e112	SAMEA7711516
PXD004242-8 plasma at 13 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150618_qep1_lc7_phge_sa_plate1b_08_4	20150618_QEp1_LC7_PhGe_SA_Plate1B_08_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_08_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	80b833ca7dab170f2155feb056415291ec0aa32a9fedc7ed40fd155cdcc4ab77	SAMEA7711517
PXD004242-8 plasma at 26 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150618_qep1_lc7_phge_sa_plate1b_08_5	20150618_QEp1_LC7_PhGe_SA_Plate1B_08_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_08_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	8ffa4d94a38e82fcf40e9a05f9e1423002424486906a4176d7021942071d16c9	SAMEA7711518
PXD004242-8 plasma at 39 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150618_qep1_lc7_phge_sa_plate1b_08_6	20150618_QEp1_LC7_PhGe_SA_Plate1B_08_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_08_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	6cc0aef5575c92b5566a81fed30d730fef60ca7102746b813e743d247c5a1c6d	SAMEA7711519
PXD004242-8 plasma at 52 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150618_qep1_lc7_phge_sa_plate1b_08_7	20150618_QEp1_LC7_PhGe_SA_Plate1B_08_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_08_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f960a9272bee0a52c98fc66318995e1acf8d420e39f2efc9bdbe42030e3dd070	SAMEA7711520
PXD004242-8 plasma at -8 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150708_qep1_lc7_phge_sa_plate1c_08_1	20150708_QEp1_LC7_PhGe_SA_Plate1C_08_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_08_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	c376d92b3e97bbfe98909191989b873869b9820487a5e8db5af9813798cdfb06	SAMEA7711514
PXD004242-8 plasma at 0 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150708_qep1_lc7_phge_sa_plate1c_08_2	20150708_QEp1_LC7_PhGe_SA_Plate1C_08_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_08_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	52b6fda8dc0a251d18a5e8237dbd753b084e7e1731aab2a2eaea8c9a206cf206	SAMEA7711515
PXD004242-8 plasma at 4 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150708_qep1_lc7_phge_sa_plate1c_08_3	20150708_QEp1_LC7_PhGe_SA_Plate1C_08_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_08_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	dead4d00685b38866363d0edb42558f0af505d79b104c3f1d8dbeb73e273e112	SAMEA7711516
PXD004242-8 plasma at 13 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150708_qep1_lc7_phge_sa_plate1c_08_4	20150708_QEp1_LC7_PhGe_SA_Plate1C_08_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_08_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	80b833ca7dab170f2155feb056415291ec0aa32a9fedc7ed40fd155cdcc4ab77	SAMEA7711517
PXD004242-8 plasma at 26 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150708_qep1_lc7_phge_sa_plate1c_08_5	20150708_QEp1_LC7_PhGe_SA_Plate1C_08_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_08_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	8ffa4d94a38e82fcf40e9a05f9e1423002424486906a4176d7021942071d16c9	SAMEA7711518
PXD004242-8 plasma at 39 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150708_qep1_lc7_phge_sa_plate1c_08_6	20150708_QEp1_LC7_PhGe_SA_Plate1C_08_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_08_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	6cc0aef5575c92b5566a81fed30d730fef60ca7102746b813e743d247c5a1c6d	SAMEA7711519
PXD004242-8 plasma at 52 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150708_qep1_lc7_phge_sa_plate1c_08_7	20150708_QEp1_LC7_PhGe_SA_Plate1C_08_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_08_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f960a9272bee0a52c98fc66318995e1acf8d420e39f2efc9bdbe42030e3dd070	SAMEA7711520
PXD004242-8 plasma at -8 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150805_qep1_lc7_phge_sa_plate1d_08_1	20150805_QEp1_LC7_PhGe_SA_Plate1D_08_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_08_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	c376d92b3e97bbfe98909191989b873869b9820487a5e8db5af9813798cdfb06	SAMEA7711514
PXD004242-8 plasma at 0 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150805_qep1_lc7_phge_sa_plate1d_08_2	20150805_QEp1_LC7_PhGe_SA_Plate1D_08_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_08_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	52b6fda8dc0a251d18a5e8237dbd753b084e7e1731aab2a2eaea8c9a206cf206	SAMEA7711515
PXD004242-8 plasma at 4 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150805_qep1_lc7_phge_sa_plate1d_08_3	20150805_QEp1_LC7_PhGe_SA_Plate1D_08_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_08_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	dead4d00685b38866363d0edb42558f0af505d79b104c3f1d8dbeb73e273e112	SAMEA7711516
PXD004242-8 plasma at 13 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150805_qep1_lc7_phge_sa_plate1d_08_4	20150805_QEp1_LC7_PhGe_SA_Plate1D_08_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_08_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	80b833ca7dab170f2155feb056415291ec0aa32a9fedc7ed40fd155cdcc4ab77	SAMEA7711517
PXD004242-8 plasma at 26 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150805_qep1_lc7_phge_sa_plate1d_08_5	20150805_QEp1_LC7_PhGe_SA_Plate1D_08_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_08_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	8ffa4d94a38e82fcf40e9a05f9e1423002424486906a4176d7021942071d16c9	SAMEA7711518
PXD004242-8 plasma at 39 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150805_qep1_lc7_phge_sa_plate1d_08_6	20150805_QEp1_LC7_PhGe_SA_Plate1D_08_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_08_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	6cc0aef5575c92b5566a81fed30d730fef60ca7102746b813e743d247c5a1c6d	SAMEA7711519
PXD004242-8 plasma at 52 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150805_qep1_lc7_phge_sa_plate1d_08_7	20150805_QEp1_LC7_PhGe_SA_Plate1D_08_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_08_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f960a9272bee0a52c98fc66318995e1acf8d420e39f2efc9bdbe42030e3dd070	SAMEA7711520
PXD004242-8 plasma at -8 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150901_qep1_lc7_phge_sa_plate1e_08_1	20150901_QEp1_LC7_PhGe_SA_Plate1E_08_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_08_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	c376d92b3e97bbfe98909191989b873869b9820487a5e8db5af9813798cdfb06	SAMEA7711514
PXD004242-8 plasma at 0 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150901_qep1_lc7_phge_sa_plate1e_08_2	20150901_QEp1_LC7_PhGe_SA_Plate1E_08_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_08_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	52b6fda8dc0a251d18a5e8237dbd753b084e7e1731aab2a2eaea8c9a206cf206	SAMEA7711515
PXD004242-8 plasma at 4 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150901_qep1_lc7_phge_sa_plate1e_08_3	20150901_QEp1_LC7_PhGe_SA_Plate1E_08_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_08_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	dead4d00685b38866363d0edb42558f0af505d79b104c3f1d8dbeb73e273e112	SAMEA7711516
PXD004242-8 plasma at 13 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150901_qep1_lc7_phge_sa_plate1e_08_4	20150901_QEp1_LC7_PhGe_SA_Plate1E_08_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_08_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	80b833ca7dab170f2155feb056415291ec0aa32a9fedc7ed40fd155cdcc4ab77	SAMEA7711517
PXD004242-8 plasma at 26 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150901_qep1_lc7_phge_sa_plate1e_08_5	20150901_QEp1_LC7_PhGe_SA_Plate1E_08_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_08_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	8ffa4d94a38e82fcf40e9a05f9e1423002424486906a4176d7021942071d16c9	SAMEA7711518
PXD004242-8 plasma at 39 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150901_qep1_lc7_phge_sa_plate1e_08_6	20150901_QEp1_LC7_PhGe_SA_Plate1E_08_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_08_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	6cc0aef5575c92b5566a81fed30d730fef60ca7102746b813e743d247c5a1c6d	SAMEA7711519
PXD004242-8 plasma at 52 weeks	Homo sapiens	blood plasma	8	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150901_qep1_lc7_phge_sa_plate1e_08_7	20150901_QEp1_LC7_PhGe_SA_Plate1E_08_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_08_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f960a9272bee0a52c98fc66318995e1acf8d420e39f2efc9bdbe42030e3dd070	SAMEA7711520
PXD004242-9 plasma at -8 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150731_qep1_lc7_phge_sa_plate4b_09_1	20150731_QEp1_LC7_PhGe_SA_Plate4B_09_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_09_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	4987353a6c4ae14d691fd34c1d758a8c7f1fd0f31dc4e86ce1fc9cea8676480e	SAMEA7711521
PXD004242-9 plasma at 0 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150731_qep1_lc7_phge_sa_plate4b_09_2	20150731_QEp1_LC7_PhGe_SA_Plate4B_09_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_09_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	2eea31dfd25dd19abdadf248a18248e3c9f9948f591b894748efaa1d1879fbc6	SAMEA7711522
PXD004242-9 plasma at 4 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150731_qep1_lc7_phge_sa_plate4b_09_3	20150731_QEp1_LC7_PhGe_SA_Plate4B_09_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_09_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	80cc13b1555e5f0efc51fa42fb64423edac8701932db5f10258492e9120a02a9	SAMEA7711523
PXD004242-9 plasma at 13 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150731_qep1_lc7_phge_sa_plate4b_09_4	20150731_QEp1_LC7_PhGe_SA_Plate4B_09_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_09_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	d855b624eaa676d3603eb5ba046fa2ed7789e782403ffa5bcbad526e4469c0c2	SAMEA7711524
PXD004242-9 plasma at 26 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150731_qep1_lc7_phge_sa_plate4b_09_5	20150731_QEp1_LC7_PhGe_SA_Plate4B_09_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_09_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	09f8889da8b0f5df16d825cc7fd7d222c763589c0fb9fc3a56d0a1be597989c5	SAMEA7711525
PXD004242-9 plasma at 39 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150731_qep1_lc7_phge_sa_plate4b_09_6	20150731_QEp1_LC7_PhGe_SA_Plate4B_09_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_09_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	6591566dcd851bd96d5c363ae07af68977bc4cb5e734ed4b9aeccc60b380b0c7	SAMEA7711526
PXD004242-9 plasma at 52 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150731_qep1_lc7_phge_sa_plate4b_09_7	20150731_QEp1_LC7_PhGe_SA_Plate4B_09_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_09_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	0631be118b463136bc2d1da9e32d3956b13f6a7ba068522b43d51d717ceb4017	SAMEA7711527
PXD004242-9 plasma at -8 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150731_qep1_lc7_phge_sa_plate4e_09_1	20150731_QEp1_LC7_PhGe_SA_Plate4E_09_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_09_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	4987353a6c4ae14d691fd34c1d758a8c7f1fd0f31dc4e86ce1fc9cea8676480e	SAMEA7711521
PXD004242-9 plasma at 0 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150731_qep1_lc7_phge_sa_plate4e_09_2	20150731_QEp1_LC7_PhGe_SA_Plate4E_09_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_09_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	2eea31dfd25dd19abdadf248a18248e3c9f9948f591b894748efaa1d1879fbc6	SAMEA7711522
PXD004242-9 plasma at 4 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150731_qep1_lc7_phge_sa_plate4e_09_3	20150731_QEp1_LC7_PhGe_SA_Plate4E_09_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_09_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	80cc13b1555e5f0efc51fa42fb64423edac8701932db5f10258492e9120a02a9	SAMEA7711523
PXD004242-9 plasma at 13 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150731_qep1_lc7_phge_sa_plate4e_09_4	20150731_QEp1_LC7_PhGe_SA_Plate4E_09_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_09_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	d855b624eaa676d3603eb5ba046fa2ed7789e782403ffa5bcbad526e4469c0c2	SAMEA7711524
PXD004242-9 plasma at 26 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150731_qep1_lc7_phge_sa_plate4e_09_5	20150731_QEp1_LC7_PhGe_SA_Plate4E_09_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_09_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	09f8889da8b0f5df16d825cc7fd7d222c763589c0fb9fc3a56d0a1be597989c5	SAMEA7711525
PXD004242-9 plasma at 39 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150731_qep1_lc7_phge_sa_plate4e_09_6	20150731_QEp1_LC7_PhGe_SA_Plate4E_09_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_09_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	6591566dcd851bd96d5c363ae07af68977bc4cb5e734ed4b9aeccc60b380b0c7	SAMEA7711526
PXD004242-9 plasma at 52 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150731_qep1_lc7_phge_sa_plate4e_09_7	20150731_QEp1_LC7_PhGe_SA_Plate4E_09_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_09_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	0631be118b463136bc2d1da9e32d3956b13f6a7ba068522b43d51d717ceb4017	SAMEA7711527
PXD004242-9 plasma at -8 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150824_qep1_lc7_phge_sa_plate4d_09_1	20150824_QEp1_LC7_PhGe_SA_Plate4D_09_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_09_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	4987353a6c4ae14d691fd34c1d758a8c7f1fd0f31dc4e86ce1fc9cea8676480e	SAMEA7711521
PXD004242-9 plasma at 0 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150824_qep1_lc7_phge_sa_plate4d_09_2	20150824_QEp1_LC7_PhGe_SA_Plate4D_09_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_09_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	2eea31dfd25dd19abdadf248a18248e3c9f9948f591b894748efaa1d1879fbc6	SAMEA7711522
PXD004242-9 plasma at 4 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150824_qep1_lc7_phge_sa_plate4d_09_3	20150824_QEp1_LC7_PhGe_SA_Plate4D_09_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_09_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	80cc13b1555e5f0efc51fa42fb64423edac8701932db5f10258492e9120a02a9	SAMEA7711523
PXD004242-9 plasma at 13 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150824_qep1_lc7_phge_sa_plate4d_09_4	20150824_QEp1_LC7_PhGe_SA_Plate4D_09_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_09_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	d855b624eaa676d3603eb5ba046fa2ed7789e782403ffa5bcbad526e4469c0c2	SAMEA7711524
PXD004242-9 plasma at 26 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150824_qep1_lc7_phge_sa_plate4d_09_5	20150824_QEp1_LC7_PhGe_SA_Plate4D_09_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_09_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	09f8889da8b0f5df16d825cc7fd7d222c763589c0fb9fc3a56d0a1be597989c5	SAMEA7711525
PXD004242-9 plasma at 39 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150824_qep1_lc7_phge_sa_plate4d_09_6	20150824_QEp1_LC7_PhGe_SA_Plate4D_09_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_09_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	6591566dcd851bd96d5c363ae07af68977bc4cb5e734ed4b9aeccc60b380b0c7	SAMEA7711526
PXD004242-9 plasma at 52 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150824_qep1_lc7_phge_sa_plate4d_09_7	20150824_QEp1_LC7_PhGe_SA_Plate4D_09_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_09_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	0631be118b463136bc2d1da9e32d3956b13f6a7ba068522b43d51d717ceb4017	SAMEA7711527
PXD004242-9 plasma at -8 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150917_qep1_lc7_phge_sa_plate4c_09_1	20150917_QEp1_LC7_PhGe_SA_Plate4C_09_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_09_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	4987353a6c4ae14d691fd34c1d758a8c7f1fd0f31dc4e86ce1fc9cea8676480e	SAMEA7711521
PXD004242-9 plasma at 0 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150917_qep1_lc7_phge_sa_plate4c_09_2	20150917_QEp1_LC7_PhGe_SA_Plate4C_09_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_09_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	2eea31dfd25dd19abdadf248a18248e3c9f9948f591b894748efaa1d1879fbc6	SAMEA7711522
PXD004242-9 plasma at 4 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150917_qep1_lc7_phge_sa_plate4c_09_3	20150917_QEp1_LC7_PhGe_SA_Plate4C_09_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_09_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	80cc13b1555e5f0efc51fa42fb64423edac8701932db5f10258492e9120a02a9	SAMEA7711523
PXD004242-9 plasma at 13 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150917_qep1_lc7_phge_sa_plate4c_09_4	20150917_QEp1_LC7_PhGe_SA_Plate4C_09_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_09_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	d855b624eaa676d3603eb5ba046fa2ed7789e782403ffa5bcbad526e4469c0c2	SAMEA7711524
PXD004242-9 plasma at 26 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150917_qep1_lc7_phge_sa_plate4c_09_5	20150917_QEp1_LC7_PhGe_SA_Plate4C_09_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_09_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	09f8889da8b0f5df16d825cc7fd7d222c763589c0fb9fc3a56d0a1be597989c5	SAMEA7711525
PXD004242-9 plasma at 39 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150917_qep1_lc7_phge_sa_plate4c_09_6	20150917_QEp1_LC7_PhGe_SA_Plate4C_09_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_09_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	6591566dcd851bd96d5c363ae07af68977bc4cb5e734ed4b9aeccc60b380b0c7	SAMEA7711526
PXD004242-9 plasma at 52 weeks	Homo sapiens	blood plasma	9	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150917_qep1_lc7_phge_sa_plate4c_09_7	20150917_QEp1_LC7_PhGe_SA_Plate4C_09_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_09_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	0631be118b463136bc2d1da9e32d3956b13f6a7ba068522b43d51d717ceb4017	SAMEA7711527
PXD004242-10 plasma at -8 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150701_qep1_lc7_phge_sa_plate3a_10_1	20150701_QEp1_LC7_PhGe_SA_Plate3A_10_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_10_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	6e213338182f39f55602b939aab5c80fe0e67d33ad4e63cdcd02de0b0782db1f	SAMEA7711528
PXD004242-10 plasma at 0 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150701_qep1_lc7_phge_sa_plate3a_10_2	20150701_QEp1_LC7_PhGe_SA_Plate3A_10_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_10_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	0b6c2973e0f655dbc3b7d4e293544e2117101e4e047389e2ce2117f9cd8fedc0	SAMEA7711529
PXD004242-10 plasma at 4 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150701_qep1_lc7_phge_sa_plate3a_10_3	20150701_QEp1_LC7_PhGe_SA_Plate3A_10_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_10_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	b651e702877c41e183635624f410dbc5fc067a355c151e0104ec97fef1426967	SAMEA7711530
PXD004242-10 plasma at 13 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150701_qep1_lc7_phge_sa_plate3a_10_4	20150701_QEp1_LC7_PhGe_SA_Plate3A_10_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_10_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	8d1d426ccb8f5688181a0959f48397e9430916675039b4b78c92244e27aca9c2	SAMEA7711531
PXD004242-10 plasma at 26 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150701_qep1_lc7_phge_sa_plate3a_10_5	20150701_QEp1_LC7_PhGe_SA_Plate3A_10_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_10_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	4fa3525778a250066194a6c6f220163ad55e30ee3feefeb4d7ce7820eb69bc8c	SAMEA7711532
PXD004242-10 plasma at 39 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150701_qep1_lc7_phge_sa_plate3a_10_6	20150701_QEp1_LC7_PhGe_SA_Plate3A_10_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_10_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	9b3dd6aca0989e2b302c1b36a927950fd5af4452649f77e926e20841506f190d	SAMEA7711533
PXD004242-10 plasma at 52 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150701_qep1_lc7_phge_sa_plate3a_10_7	20150701_QEp1_LC7_PhGe_SA_Plate3A_10_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_10_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	25bcc6d7f6c518468ef26cd81eebdc678be54b887c03339769d4ca25a99415e8	SAMEA7711534
PXD004242-10 plasma at 0 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150725_qep1_lc7_phge_sa_plate3b_10_2	20150725_QEp1_LC7_PhGe_SA_Plate3B_10_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_10_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	0b6c2973e0f655dbc3b7d4e293544e2117101e4e047389e2ce2117f9cd8fedc0	SAMEA7711529
PXD004242-10 plasma at 4 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150725_qep1_lc7_phge_sa_plate3b_10_3	20150725_QEp1_LC7_PhGe_SA_Plate3B_10_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_10_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	b651e702877c41e183635624f410dbc5fc067a355c151e0104ec97fef1426967	SAMEA7711530
PXD004242-10 plasma at 13 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150725_qep1_lc7_phge_sa_plate3b_10_4	20150725_QEp1_LC7_PhGe_SA_Plate3B_10_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_10_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	8d1d426ccb8f5688181a0959f48397e9430916675039b4b78c92244e27aca9c2	SAMEA7711531
PXD004242-10 plasma at 26 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150725_qep1_lc7_phge_sa_plate3b_10_5	20150725_QEp1_LC7_PhGe_SA_Plate3B_10_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_10_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	4fa3525778a250066194a6c6f220163ad55e30ee3feefeb4d7ce7820eb69bc8c	SAMEA7711532
PXD004242-10 plasma at 39 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150725_qep1_lc7_phge_sa_plate3b_10_6	20150725_QEp1_LC7_PhGe_SA_Plate3B_10_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_10_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	9b3dd6aca0989e2b302c1b36a927950fd5af4452649f77e926e20841506f190d	SAMEA7711533
PXD004242-10 plasma at -8 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150818_qep1_lc7_phge_sa_plate3c_10_1	20150818_QEp1_LC7_PhGe_SA_Plate3C_10_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_10_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	6e213338182f39f55602b939aab5c80fe0e67d33ad4e63cdcd02de0b0782db1f	SAMEA7711528
PXD004242-10 plasma at 0 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150818_qep1_lc7_phge_sa_plate3c_10_2	20150818_QEp1_LC7_PhGe_SA_Plate3C_10_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_10_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	0b6c2973e0f655dbc3b7d4e293544e2117101e4e047389e2ce2117f9cd8fedc0	SAMEA7711529
PXD004242-10 plasma at 4 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150818_qep1_lc7_phge_sa_plate3c_10_3	20150818_QEp1_LC7_PhGe_SA_Plate3C_10_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_10_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	b651e702877c41e183635624f410dbc5fc067a355c151e0104ec97fef1426967	SAMEA7711530
PXD004242-10 plasma at 13 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150818_qep1_lc7_phge_sa_plate3c_10_4	20150818_QEp1_LC7_PhGe_SA_Plate3C_10_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_10_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	8d1d426ccb8f5688181a0959f48397e9430916675039b4b78c92244e27aca9c2	SAMEA7711531
PXD004242-10 plasma at 26 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150818_qep1_lc7_phge_sa_plate3c_10_5	20150818_QEp1_LC7_PhGe_SA_Plate3C_10_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_10_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	4fa3525778a250066194a6c6f220163ad55e30ee3feefeb4d7ce7820eb69bc8c	SAMEA7711532
PXD004242-10 plasma at 39 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150818_qep1_lc7_phge_sa_plate3c_10_6	20150818_QEp1_LC7_PhGe_SA_Plate3C_10_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_10_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	9b3dd6aca0989e2b302c1b36a927950fd5af4452649f77e926e20841506f190d	SAMEA7711533
PXD004242-10 plasma at 52 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150818_qep1_lc7_phge_sa_plate3c_10_7	20150818_QEp1_LC7_PhGe_SA_Plate3C_10_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_10_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	25bcc6d7f6c518468ef26cd81eebdc678be54b887c03339769d4ca25a99415e8	SAMEA7711534
PXD004242-10 plasma at -8 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150912_qep1_lc7_phge_sa_plate3d_10_1	20150912_QEp1_LC7_PhGe_SA_Plate3D_10_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_10_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	6e213338182f39f55602b939aab5c80fe0e67d33ad4e63cdcd02de0b0782db1f	SAMEA7711528
PXD004242-10 plasma at 0 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150912_qep1_lc7_phge_sa_plate3d_10_2	20150912_QEp1_LC7_PhGe_SA_Plate3D_10_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_10_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	0b6c2973e0f655dbc3b7d4e293544e2117101e4e047389e2ce2117f9cd8fedc0	SAMEA7711529
PXD004242-10 plasma at 4 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150912_qep1_lc7_phge_sa_plate3d_10_3	20150912_QEp1_LC7_PhGe_SA_Plate3D_10_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_10_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	b651e702877c41e183635624f410dbc5fc067a355c151e0104ec97fef1426967	SAMEA7711530
PXD004242-10 plasma at 13 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150912_qep1_lc7_phge_sa_plate3d_10_4	20150912_QEp1_LC7_PhGe_SA_Plate3D_10_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_10_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	8d1d426ccb8f5688181a0959f48397e9430916675039b4b78c92244e27aca9c2	SAMEA7711531
PXD004242-10 plasma at 26 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150912_qep1_lc7_phge_sa_plate3d_10_5	20150912_QEp1_LC7_PhGe_SA_Plate3D_10_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_10_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	4fa3525778a250066194a6c6f220163ad55e30ee3feefeb4d7ce7820eb69bc8c	SAMEA7711532
PXD004242-10 plasma at 39 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150912_qep1_lc7_phge_sa_plate3d_10_6	20150912_QEp1_LC7_PhGe_SA_Plate3D_10_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_10_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	9b3dd6aca0989e2b302c1b36a927950fd5af4452649f77e926e20841506f190d	SAMEA7711533
PXD004242-10 plasma at 52 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150912_qep1_lc7_phge_sa_plate3d_10_7	20150912_QEp1_LC7_PhGe_SA_Plate3D_10_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_10_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	25bcc6d7f6c518468ef26cd81eebdc678be54b887c03339769d4ca25a99415e8	SAMEA7711534
PXD004242-10 plasma at -8 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150917_qep1_lc7_phge_sa_plate3b_10_1	20150917_QEp1_LC7_PhGe_SA_Plate3B_10_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_10_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	6e213338182f39f55602b939aab5c80fe0e67d33ad4e63cdcd02de0b0782db1f	SAMEA7711528
PXD004242-10 plasma at 52 weeks	Homo sapiens	blood plasma	10	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150917_qep1_lc7_phge_sa_plate3b_10_7	20150917_QEp1_LC7_PhGe_SA_Plate3B_10_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_10_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	25bcc6d7f6c518468ef26cd81eebdc678be54b887c03339769d4ca25a99415e8	SAMEA7711534
PXD004242-11 plasma at -8 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150618_qep1_lc7_phge_sa_plate1b_11_1	20150618_QEp1_LC7_PhGe_SA_Plate1B_11_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_11_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	0a6c1b3a990e5150cdc2ecf24c791827e76d1956f2f6d4f7205973c7c1341530	SAMEA7711535
PXD004242-11 plasma at 0 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150618_qep1_lc7_phge_sa_plate1b_11_2	20150618_QEp1_LC7_PhGe_SA_Plate1B_11_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_11_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	71ca445ba119c9cb04c1c08a97a8dcf50038412bf69d2873e8808043bbbdc07e	SAMEA7711536
PXD004242-11 plasma at 4 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150618_qep1_lc7_phge_sa_plate1b_11_3	20150618_QEp1_LC7_PhGe_SA_Plate1B_11_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_11_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	84a5dfc637373e00afced69a7aa70b2544e581cc48fb3d5e17d30c586309b5be	SAMEA7711537
PXD004242-11 plasma at 13 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150618_qep1_lc7_phge_sa_plate1b_11_4	20150618_QEp1_LC7_PhGe_SA_Plate1B_11_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_11_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	84a5291bf9e32ba3f08a849a847ed7c2a6f956b9d868f415f78568556278610f	SAMEA7711538
PXD004242-11 plasma at 26 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150618_qep1_lc7_phge_sa_plate1b_11_5	20150618_QEp1_LC7_PhGe_SA_Plate1B_11_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_11_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	4bc4bc67da4f55c4d3ab3c70aed6e2ab0605b80f48b367dfff5e18857b8f1cee	SAMEA7711539
PXD004242-11 plasma at 39 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150618_qep1_lc7_phge_sa_plate1b_11_6	20150618_QEp1_LC7_PhGe_SA_Plate1B_11_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_11_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	6660a6492d5499d4ebf60583acd84789542ecd04c01284adf95b9dd6f9ebeee0	SAMEA7711540
PXD004242-11 plasma at 52 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150618_qep1_lc7_phge_sa_plate1b_11_7	20150618_QEp1_LC7_PhGe_SA_Plate1B_11_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_11_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	9ee6f4aa9674899731e12950178ea2fa999bdb39269eb791de91d678cb0b8f78	SAMEA7711541
PXD004242-11 plasma at -8 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150708_qep1_lc7_phge_sa_plate1c_11_1	20150708_QEp1_LC7_PhGe_SA_Plate1C_11_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_11_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	0a6c1b3a990e5150cdc2ecf24c791827e76d1956f2f6d4f7205973c7c1341530	SAMEA7711535
PXD004242-11 plasma at 0 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150708_qep1_lc7_phge_sa_plate1c_11_2	20150708_QEp1_LC7_PhGe_SA_Plate1C_11_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_11_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	71ca445ba119c9cb04c1c08a97a8dcf50038412bf69d2873e8808043bbbdc07e	SAMEA7711536
PXD004242-11 plasma at 4 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150708_qep1_lc7_phge_sa_plate1c_11_3	20150708_QEp1_LC7_PhGe_SA_Plate1C_11_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_11_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	84a5dfc637373e00afced69a7aa70b2544e581cc48fb3d5e17d30c586309b5be	SAMEA7711537
PXD004242-11 plasma at 13 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150708_qep1_lc7_phge_sa_plate1c_11_4	20150708_QEp1_LC7_PhGe_SA_Plate1C_11_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_11_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	84a5291bf9e32ba3f08a849a847ed7c2a6f956b9d868f415f78568556278610f	SAMEA7711538
PXD004242-11 plasma at 26 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150708_qep1_lc7_phge_sa_plate1c_11_5	20150708_QEp1_LC7_PhGe_SA_Plate1C_11_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_11_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	4bc4bc67da4f55c4d3ab3c70aed6e2ab0605b80f48b367dfff5e18857b8f1cee	SAMEA7711539
PXD004242-11 plasma at 39 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150708_qep1_lc7_phge_sa_plate1c_11_6	20150708_QEp1_LC7_PhGe_SA_Plate1C_11_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_11_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	6660a6492d5499d4ebf60583acd84789542ecd04c01284adf95b9dd6f9ebeee0	SAMEA7711540
PXD004242-11 plasma at 52 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150708_qep1_lc7_phge_sa_plate1c_11_7	20150708_QEp1_LC7_PhGe_SA_Plate1C_11_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_11_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	9ee6f4aa9674899731e12950178ea2fa999bdb39269eb791de91d678cb0b8f78	SAMEA7711541
PXD004242-11 plasma at -8 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150805_qep1_lc7_phge_sa_plate1d_11_1	20150805_QEp1_LC7_PhGe_SA_Plate1D_11_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_11_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	0a6c1b3a990e5150cdc2ecf24c791827e76d1956f2f6d4f7205973c7c1341530	SAMEA7711535
PXD004242-11 plasma at 0 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150805_qep1_lc7_phge_sa_plate1d_11_2	20150805_QEp1_LC7_PhGe_SA_Plate1D_11_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_11_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	71ca445ba119c9cb04c1c08a97a8dcf50038412bf69d2873e8808043bbbdc07e	SAMEA7711536
PXD004242-11 plasma at 4 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150805_qep1_lc7_phge_sa_plate1d_11_3	20150805_QEp1_LC7_PhGe_SA_Plate1D_11_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_11_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	84a5dfc637373e00afced69a7aa70b2544e581cc48fb3d5e17d30c586309b5be	SAMEA7711537
PXD004242-11 plasma at 13 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150805_qep1_lc7_phge_sa_plate1d_11_4	20150805_QEp1_LC7_PhGe_SA_Plate1D_11_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_11_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	84a5291bf9e32ba3f08a849a847ed7c2a6f956b9d868f415f78568556278610f	SAMEA7711538
PXD004242-11 plasma at 26 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150805_qep1_lc7_phge_sa_plate1d_11_5	20150805_QEp1_LC7_PhGe_SA_Plate1D_11_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_11_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	4bc4bc67da4f55c4d3ab3c70aed6e2ab0605b80f48b367dfff5e18857b8f1cee	SAMEA7711539
PXD004242-11 plasma at 39 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150805_qep1_lc7_phge_sa_plate1d_11_6	20150805_QEp1_LC7_PhGe_SA_Plate1D_11_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_11_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	6660a6492d5499d4ebf60583acd84789542ecd04c01284adf95b9dd6f9ebeee0	SAMEA7711540
PXD004242-11 plasma at 52 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150805_qep1_lc7_phge_sa_plate1d_11_7	20150805_QEp1_LC7_PhGe_SA_Plate1D_11_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_11_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	9ee6f4aa9674899731e12950178ea2fa999bdb39269eb791de91d678cb0b8f78	SAMEA7711541
PXD004242-11 plasma at -8 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150901_qep1_lc7_phge_sa_plate1e_11_1	20150901_QEp1_LC7_PhGe_SA_Plate1E_11_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_11_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	0a6c1b3a990e5150cdc2ecf24c791827e76d1956f2f6d4f7205973c7c1341530	SAMEA7711535
PXD004242-11 plasma at 0 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150901_qep1_lc7_phge_sa_plate1e_11_2	20150901_QEp1_LC7_PhGe_SA_Plate1E_11_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_11_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	71ca445ba119c9cb04c1c08a97a8dcf50038412bf69d2873e8808043bbbdc07e	SAMEA7711536
PXD004242-11 plasma at 4 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150901_qep1_lc7_phge_sa_plate1e_11_3	20150901_QEp1_LC7_PhGe_SA_Plate1E_11_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_11_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	84a5dfc637373e00afced69a7aa70b2544e581cc48fb3d5e17d30c586309b5be	SAMEA7711537
PXD004242-11 plasma at 13 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150901_qep1_lc7_phge_sa_plate1e_11_4	20150901_QEp1_LC7_PhGe_SA_Plate1E_11_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_11_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	84a5291bf9e32ba3f08a849a847ed7c2a6f956b9d868f415f78568556278610f	SAMEA7711538
PXD004242-11 plasma at 26 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150901_qep1_lc7_phge_sa_plate1e_11_5	20150901_QEp1_LC7_PhGe_SA_Plate1E_11_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_11_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	4bc4bc67da4f55c4d3ab3c70aed6e2ab0605b80f48b367dfff5e18857b8f1cee	SAMEA7711539
PXD004242-11 plasma at 39 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150901_qep1_lc7_phge_sa_plate1e_11_6	20150901_QEp1_LC7_PhGe_SA_Plate1E_11_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_11_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	6660a6492d5499d4ebf60583acd84789542ecd04c01284adf95b9dd6f9ebeee0	SAMEA7711540
PXD004242-11 plasma at 52 weeks	Homo sapiens	blood plasma	11	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150901_qep1_lc7_phge_sa_plate1e_11_7	20150901_QEp1_LC7_PhGe_SA_Plate1E_11_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_11_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	9ee6f4aa9674899731e12950178ea2fa999bdb39269eb791de91d678cb0b8f78	SAMEA7711541
PXD004242-12 plasma at -8 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150624_qep1_lc7_phge_sa_plate2a_12_1	20150624_QEp1_LC7_PhGe_SA_Plate2A_12_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_12_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	f959142aa531f9f3f2c54adcd4bfa218dc011309ced28ebc2e8a885a3df5e613	SAMEA7711542
PXD004242-12 plasma at 0 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150624_qep1_lc7_phge_sa_plate2a_12_2	20150624_QEp1_LC7_PhGe_SA_Plate2A_12_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_12_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	71887e4851b68ecf7a6dadbd38705b46ce7dd518ecfc843473007b01e17ff199	SAMEA7711543
PXD004242-12 plasma at 13 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150624_qep1_lc7_phge_sa_plate2a_12_4	20150624_QEp1_LC7_PhGe_SA_Plate2A_12_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_12_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	16cdadb1101e2469a77a8c98bcc7c7818e47aee806cf7caaa3cde820e4200736	SAMEA7711544
PXD004242-12 plasma at 26 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150624_qep1_lc7_phge_sa_plate2a_12_5	20150624_QEp1_LC7_PhGe_SA_Plate2A_12_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_12_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	07bb2f225643fc3d3ae81ec0b25a0156cbe219a5cdef14a35bbe7268c3be2e9b	SAMEA7711545
PXD004242-12 plasma at 39 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150624_qep1_lc7_phge_sa_plate2a_12_6	20150624_QEp1_LC7_PhGe_SA_Plate2A_12_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_12_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	ff26fb4d5f82ecc981412263c4176663e272eff5acca951955fa804d1e2ce8d8	SAMEA7711546
PXD004242-12 plasma at 52 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150624_qep1_lc7_phge_sa_plate2a_12_7	20150624_QEp1_LC7_PhGe_SA_Plate2A_12_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_12_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	2d4636e73ba9685c2d2a39c83fa8cd4eced53f7982c59c116f0cb574891ca806	SAMEA7711547
PXD004242-12 plasma at -8 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150811_qep1_lc7_phge_sa_plate2b_12_1	20150811_QEp1_LC7_PhGe_SA_Plate2B_12_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_12_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	f959142aa531f9f3f2c54adcd4bfa218dc011309ced28ebc2e8a885a3df5e613	SAMEA7711542
PXD004242-12 plasma at 0 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150811_qep1_lc7_phge_sa_plate2b_12_2	20150811_QEp1_LC7_PhGe_SA_Plate2B_12_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_12_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	71887e4851b68ecf7a6dadbd38705b46ce7dd518ecfc843473007b01e17ff199	SAMEA7711543
PXD004242-12 plasma at 4 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150811_qep1_lc7_phge_sa_plate2b_12_3	20150811_QEp1_LC7_PhGe_SA_Plate2B_12_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_12_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	176bd3ceb3298a5b06c87a7063b35a1bda59a88074246f39900a9e7f13f2b8fe	SAMEA7711548
PXD004242-12 plasma at 13 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150811_qep1_lc7_phge_sa_plate2b_12_4	20150811_QEp1_LC7_PhGe_SA_Plate2B_12_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_12_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	16cdadb1101e2469a77a8c98bcc7c7818e47aee806cf7caaa3cde820e4200736	SAMEA7711544
PXD004242-12 plasma at 26 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150811_qep1_lc7_phge_sa_plate2b_12_5	20150811_QEp1_LC7_PhGe_SA_Plate2B_12_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_12_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	07bb2f225643fc3d3ae81ec0b25a0156cbe219a5cdef14a35bbe7268c3be2e9b	SAMEA7711545
PXD004242-12 plasma at 39 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150811_qep1_lc7_phge_sa_plate2b_12_6	20150811_QEp1_LC7_PhGe_SA_Plate2B_12_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_12_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	ff26fb4d5f82ecc981412263c4176663e272eff5acca951955fa804d1e2ce8d8	SAMEA7711546
PXD004242-12 plasma at 52 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150811_qep1_lc7_phge_sa_plate2b_12_7	20150811_QEp1_LC7_PhGe_SA_Plate2B_12_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_12_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	2d4636e73ba9685c2d2a39c83fa8cd4eced53f7982c59c116f0cb574891ca806	SAMEA7711547
PXD004242-12 plasma at -8 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150827_qep1_lc7_phge_sa_plate2c_12_1	20150827_QEp1_LC7_PhGe_SA_Plate2C_12_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_12_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	f959142aa531f9f3f2c54adcd4bfa218dc011309ced28ebc2e8a885a3df5e613	SAMEA7711542
PXD004242-12 plasma at 0 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150827_qep1_lc7_phge_sa_plate2c_12_2	20150827_QEp1_LC7_PhGe_SA_Plate2C_12_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_12_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	71887e4851b68ecf7a6dadbd38705b46ce7dd518ecfc843473007b01e17ff199	SAMEA7711543
PXD004242-12 plasma at 4 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150827_qep1_lc7_phge_sa_plate2c_12_3	20150827_QEp1_LC7_PhGe_SA_Plate2C_12_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_12_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	176bd3ceb3298a5b06c87a7063b35a1bda59a88074246f39900a9e7f13f2b8fe	SAMEA7711548
PXD004242-12 plasma at 13 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150827_qep1_lc7_phge_sa_plate2c_12_4	20150827_QEp1_LC7_PhGe_SA_Plate2C_12_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_12_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	16cdadb1101e2469a77a8c98bcc7c7818e47aee806cf7caaa3cde820e4200736	SAMEA7711544
PXD004242-12 plasma at 26 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150827_qep1_lc7_phge_sa_plate2c_12_5	20150827_QEp1_LC7_PhGe_SA_Plate2C_12_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_12_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	07bb2f225643fc3d3ae81ec0b25a0156cbe219a5cdef14a35bbe7268c3be2e9b	SAMEA7711545
PXD004242-12 plasma at 39 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150827_qep1_lc7_phge_sa_plate2c_12_6	20150827_QEp1_LC7_PhGe_SA_Plate2C_12_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_12_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	ff26fb4d5f82ecc981412263c4176663e272eff5acca951955fa804d1e2ce8d8	SAMEA7711546
PXD004242-12 plasma at 52 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150827_qep1_lc7_phge_sa_plate2c_12_7	20150827_QEp1_LC7_PhGe_SA_Plate2C_12_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_12_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	2d4636e73ba9685c2d2a39c83fa8cd4eced53f7982c59c116f0cb574891ca806	SAMEA7711547
PXD004242-12 plasma at -8 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150907_qep1_lc7_phge_sa_plate2d_12_1	20150907_QEp1_LC7_PhGe_SA_Plate2D_12_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_12_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	f959142aa531f9f3f2c54adcd4bfa218dc011309ced28ebc2e8a885a3df5e613	SAMEA7711542
PXD004242-12 plasma at 0 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150907_qep1_lc7_phge_sa_plate2d_12_2	20150907_QEp1_LC7_PhGe_SA_Plate2D_12_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_12_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	71887e4851b68ecf7a6dadbd38705b46ce7dd518ecfc843473007b01e17ff199	SAMEA7711543
PXD004242-12 plasma at 4 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150907_qep1_lc7_phge_sa_plate2d_12_3	20150907_QEp1_LC7_PhGe_SA_Plate2D_12_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_12_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	176bd3ceb3298a5b06c87a7063b35a1bda59a88074246f39900a9e7f13f2b8fe	SAMEA7711548
PXD004242-12 plasma at 13 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150907_qep1_lc7_phge_sa_plate2d_12_4	20150907_QEp1_LC7_PhGe_SA_Plate2D_12_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_12_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	16cdadb1101e2469a77a8c98bcc7c7818e47aee806cf7caaa3cde820e4200736	SAMEA7711544
PXD004242-12 plasma at 26 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150907_qep1_lc7_phge_sa_plate2d_12_5	20150907_QEp1_LC7_PhGe_SA_Plate2D_12_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_12_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	07bb2f225643fc3d3ae81ec0b25a0156cbe219a5cdef14a35bbe7268c3be2e9b	SAMEA7711545
PXD004242-12 plasma at 39 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150907_qep1_lc7_phge_sa_plate2d_12_6	20150907_QEp1_LC7_PhGe_SA_Plate2D_12_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_12_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	ff26fb4d5f82ecc981412263c4176663e272eff5acca951955fa804d1e2ce8d8	SAMEA7711546
PXD004242-12 plasma at 52 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150907_qep1_lc7_phge_sa_plate2d_12_7	20150907_QEp1_LC7_PhGe_SA_Plate2D_12_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_12_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	2d4636e73ba9685c2d2a39c83fa8cd4eced53f7982c59c116f0cb574891ca806	SAMEA7711547
PXD004242-12 plasma at 4 weeks	Homo sapiens	blood plasma	12	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150917_qep1_lc7_phge_sa_plate2a_12_3	20150917_QEp1_LC7_PhGe_SA_Plate2A_12_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate2A_12_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	176bd3ceb3298a5b06c87a7063b35a1bda59a88074246f39900a9e7f13f2b8fe	SAMEA7711548
PXD004242-14 plasma at -8 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150731_qep1_lc7_phge_sa_plate4b_14_1	20150731_QEp1_LC7_PhGe_SA_Plate4B_14_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_14_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	2680db50a96ad9094549070270a5c91b02311706382b04dc58fcb5c5677ffd1c	SAMEA7711549
PXD004242-14 plasma at 0 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150731_qep1_lc7_phge_sa_plate4b_14_2	20150731_QEp1_LC7_PhGe_SA_Plate4B_14_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_14_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	9be71f6235dd7e274128a39224c35f211ea34dfdab19f34265cce78ef2953bd5	SAMEA7711550
PXD004242-14 plasma at 4 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150731_qep1_lc7_phge_sa_plate4b_14_3	20150731_QEp1_LC7_PhGe_SA_Plate4B_14_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_14_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	545fa806d54259385361876687226ddd6b64bad993fc64066729ebc1862ecd9f	SAMEA7711551
PXD004242-14 plasma at 13 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150731_qep1_lc7_phge_sa_plate4b_14_4	20150731_QEp1_LC7_PhGe_SA_Plate4B_14_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_14_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	b8e27b61feccbfec2964e8e7aeb19779db0e2dd471baf4fe6d6a893b32882da9	SAMEA7711552
PXD004242-14 plasma at 26 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150731_qep1_lc7_phge_sa_plate4b_14_5	20150731_QEp1_LC7_PhGe_SA_Plate4B_14_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_14_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	eb0ab54c0879cd94df61fa4a16122e5be70d612604462f11956e33139d4c0b47	SAMEA7711553
PXD004242-14 plasma at 39 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150731_qep1_lc7_phge_sa_plate4b_14_6	20150731_QEp1_LC7_PhGe_SA_Plate4B_14_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_14_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	1554a03e205e3a24a2bb0f4c805a93a62d76d6e66c19ad2e15e2e8d80d18f8be	SAMEA7711554
PXD004242-14 plasma at 52 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150731_qep1_lc7_phge_sa_plate4b_14_7	20150731_QEp1_LC7_PhGe_SA_Plate4B_14_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_14_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	72d453202c81d502ae304f64811997daf825cc1fc5cf5f6c5246909c7537f3cc	SAMEA7711555
PXD004242-14 plasma at -8 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150731_qep1_lc7_phge_sa_plate4e_14_1	20150731_QEp1_LC7_PhGe_SA_Plate4E_14_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_14_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	2680db50a96ad9094549070270a5c91b02311706382b04dc58fcb5c5677ffd1c	SAMEA7711549
PXD004242-14 plasma at 0 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150731_qep1_lc7_phge_sa_plate4e_14_2	20150731_QEp1_LC7_PhGe_SA_Plate4E_14_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_14_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	9be71f6235dd7e274128a39224c35f211ea34dfdab19f34265cce78ef2953bd5	SAMEA7711550
PXD004242-14 plasma at 4 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150731_qep1_lc7_phge_sa_plate4e_14_3	20150731_QEp1_LC7_PhGe_SA_Plate4E_14_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_14_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	545fa806d54259385361876687226ddd6b64bad993fc64066729ebc1862ecd9f	SAMEA7711551
PXD004242-14 plasma at 13 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150731_qep1_lc7_phge_sa_plate4e_14_4	20150731_QEp1_LC7_PhGe_SA_Plate4E_14_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_14_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	b8e27b61feccbfec2964e8e7aeb19779db0e2dd471baf4fe6d6a893b32882da9	SAMEA7711552
PXD004242-14 plasma at 26 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150731_qep1_lc7_phge_sa_plate4e_14_5	20150731_QEp1_LC7_PhGe_SA_Plate4E_14_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_14_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	eb0ab54c0879cd94df61fa4a16122e5be70d612604462f11956e33139d4c0b47	SAMEA7711553
PXD004242-14 plasma at 39 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150731_qep1_lc7_phge_sa_plate4e_14_6	20150731_QEp1_LC7_PhGe_SA_Plate4E_14_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_14_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	1554a03e205e3a24a2bb0f4c805a93a62d76d6e66c19ad2e15e2e8d80d18f8be	SAMEA7711554
PXD004242-14 plasma at 52 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150731_qep1_lc7_phge_sa_plate4e_14_7	20150731_QEp1_LC7_PhGe_SA_Plate4E_14_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_14_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	72d453202c81d502ae304f64811997daf825cc1fc5cf5f6c5246909c7537f3cc	SAMEA7711555
PXD004242-14 plasma at -8 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150824_qep1_lc7_phge_sa_plate4d_14_1	20150824_QEp1_LC7_PhGe_SA_Plate4D_14_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_14_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	2680db50a96ad9094549070270a5c91b02311706382b04dc58fcb5c5677ffd1c	SAMEA7711549
PXD004242-14 plasma at 0 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150824_qep1_lc7_phge_sa_plate4d_14_2	20150824_QEp1_LC7_PhGe_SA_Plate4D_14_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_14_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	9be71f6235dd7e274128a39224c35f211ea34dfdab19f34265cce78ef2953bd5	SAMEA7711550
PXD004242-14 plasma at 4 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150824_qep1_lc7_phge_sa_plate4d_14_3	20150824_QEp1_LC7_PhGe_SA_Plate4D_14_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_14_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	545fa806d54259385361876687226ddd6b64bad993fc64066729ebc1862ecd9f	SAMEA7711551
PXD004242-14 plasma at 13 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150824_qep1_lc7_phge_sa_plate4d_14_4	20150824_QEp1_LC7_PhGe_SA_Plate4D_14_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_14_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	b8e27b61feccbfec2964e8e7aeb19779db0e2dd471baf4fe6d6a893b32882da9	SAMEA7711552
PXD004242-14 plasma at 26 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150824_qep1_lc7_phge_sa_plate4d_14_5	20150824_QEp1_LC7_PhGe_SA_Plate4D_14_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_14_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	eb0ab54c0879cd94df61fa4a16122e5be70d612604462f11956e33139d4c0b47	SAMEA7711553
PXD004242-14 plasma at 39 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150824_qep1_lc7_phge_sa_plate4d_14_6	20150824_QEp1_LC7_PhGe_SA_Plate4D_14_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_14_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	1554a03e205e3a24a2bb0f4c805a93a62d76d6e66c19ad2e15e2e8d80d18f8be	SAMEA7711554
PXD004242-14 plasma at 52 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150824_qep1_lc7_phge_sa_plate4d_14_7	20150824_QEp1_LC7_PhGe_SA_Plate4D_14_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_14_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	72d453202c81d502ae304f64811997daf825cc1fc5cf5f6c5246909c7537f3cc	SAMEA7711555
PXD004242-14 plasma at -8 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150917_qep1_lc7_phge_sa_plate4c_14_1	20150917_QEp1_LC7_PhGe_SA_Plate4C_14_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_14_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	2680db50a96ad9094549070270a5c91b02311706382b04dc58fcb5c5677ffd1c	SAMEA7711549
PXD004242-14 plasma at 0 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150917_qep1_lc7_phge_sa_plate4c_14_2	20150917_QEp1_LC7_PhGe_SA_Plate4C_14_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_14_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	9be71f6235dd7e274128a39224c35f211ea34dfdab19f34265cce78ef2953bd5	SAMEA7711550
PXD004242-14 plasma at 4 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150917_qep1_lc7_phge_sa_plate4c_14_3	20150917_QEp1_LC7_PhGe_SA_Plate4C_14_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_14_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	545fa806d54259385361876687226ddd6b64bad993fc64066729ebc1862ecd9f	SAMEA7711551
PXD004242-14 plasma at 13 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150917_qep1_lc7_phge_sa_plate4c_14_4	20150917_QEp1_LC7_PhGe_SA_Plate4C_14_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_14_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	b8e27b61feccbfec2964e8e7aeb19779db0e2dd471baf4fe6d6a893b32882da9	SAMEA7711552
PXD004242-14 plasma at 26 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150917_qep1_lc7_phge_sa_plate4c_14_5	20150917_QEp1_LC7_PhGe_SA_Plate4C_14_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_14_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	eb0ab54c0879cd94df61fa4a16122e5be70d612604462f11956e33139d4c0b47	SAMEA7711553
PXD004242-14 plasma at 39 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150917_qep1_lc7_phge_sa_plate4c_14_6	20150917_QEp1_LC7_PhGe_SA_Plate4C_14_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_14_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	1554a03e205e3a24a2bb0f4c805a93a62d76d6e66c19ad2e15e2e8d80d18f8be	SAMEA7711554
PXD004242-14 plasma at 52 weeks	Homo sapiens	blood plasma	14	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150917_qep1_lc7_phge_sa_plate4c_14_7	20150917_QEp1_LC7_PhGe_SA_Plate4C_14_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_14_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	72d453202c81d502ae304f64811997daf825cc1fc5cf5f6c5246909c7537f3cc	SAMEA7711555
PXD004242-15 plasma at -8 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150701_qep1_lc7_phge_sa_plate3a_15_1	20150701_QEp1_LC7_PhGe_SA_Plate3A_15_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_15_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	5bc2c6817fe75b263431dab8e6e1f14af1a7476f5e7d513cbf24f9765d61f3ba	SAMEA7711556
PXD004242-15 plasma at 0 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150701_qep1_lc7_phge_sa_plate3a_15_2	20150701_QEp1_LC7_PhGe_SA_Plate3A_15_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_15_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	65979f8e3c5e590903eceb242c239fabe73cc477fdf83624657bb1828b419e0e	SAMEA7711557
PXD004242-15 plasma at 4 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150701_qep1_lc7_phge_sa_plate3a_15_3	20150701_QEp1_LC7_PhGe_SA_Plate3A_15_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_15_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	3c16df69af67843a89bad577f58b61b5ecbce2505a1269f4d9ca03487a6ba043	SAMEA7711558
PXD004242-15 plasma at 13 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150701_qep1_lc7_phge_sa_plate3a_15_4	20150701_QEp1_LC7_PhGe_SA_Plate3A_15_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_15_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	9946355b5ef27fee4e63b910514f35159edbe1547bf5b43d70acfe0db0e94784	SAMEA7711559
PXD004242-15 plasma at 26 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150701_qep1_lc7_phge_sa_plate3a_15_5	20150701_QEp1_LC7_PhGe_SA_Plate3A_15_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_15_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	db7ae3b16f54e6459f73a98d7482da644c04d303e155091132d460eb77edb56e	SAMEA7711560
PXD004242-15 plasma at 39 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150701_qep1_lc7_phge_sa_plate3a_15_6	20150701_QEp1_LC7_PhGe_SA_Plate3A_15_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_15_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	a970fcbfbdab534ff202472238e0bc3d25423de42d541d3fe04b4aa910137eb3	SAMEA7711561
PXD004242-15 plasma at 52 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150701_qep1_lc7_phge_sa_plate3a_15_7	20150701_QEp1_LC7_PhGe_SA_Plate3A_15_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_15_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	bad6409e9442c703dea971cd52a416920433c9983fb19dcea93bc45435d910ce	SAMEA7711562
PXD004242-15 plasma at -8 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150725_qep1_lc7_phge_sa_plate3b_15_1	20150725_QEp1_LC7_PhGe_SA_Plate3B_15_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_15_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	5bc2c6817fe75b263431dab8e6e1f14af1a7476f5e7d513cbf24f9765d61f3ba	SAMEA7711556
PXD004242-15 plasma at 0 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150725_qep1_lc7_phge_sa_plate3b_15_2	20150725_QEp1_LC7_PhGe_SA_Plate3B_15_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_15_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	65979f8e3c5e590903eceb242c239fabe73cc477fdf83624657bb1828b419e0e	SAMEA7711557
PXD004242-15 plasma at 4 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150725_qep1_lc7_phge_sa_plate3b_15_3	20150725_QEp1_LC7_PhGe_SA_Plate3B_15_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_15_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	3c16df69af67843a89bad577f58b61b5ecbce2505a1269f4d9ca03487a6ba043	SAMEA7711558
PXD004242-15 plasma at 13 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150725_qep1_lc7_phge_sa_plate3b_15_4	20150725_QEp1_LC7_PhGe_SA_Plate3B_15_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_15_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	9946355b5ef27fee4e63b910514f35159edbe1547bf5b43d70acfe0db0e94784	SAMEA7711559
PXD004242-15 plasma at 26 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150725_qep1_lc7_phge_sa_plate3b_15_5	20150725_QEp1_LC7_PhGe_SA_Plate3B_15_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_15_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	db7ae3b16f54e6459f73a98d7482da644c04d303e155091132d460eb77edb56e	SAMEA7711560
PXD004242-15 plasma at 39 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150725_qep1_lc7_phge_sa_plate3b_15_6	20150725_QEp1_LC7_PhGe_SA_Plate3B_15_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_15_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	a970fcbfbdab534ff202472238e0bc3d25423de42d541d3fe04b4aa910137eb3	SAMEA7711561
PXD004242-15 plasma at -8 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150818_qep1_lc7_phge_sa_plate3c_15_1	20150818_QEp1_LC7_PhGe_SA_Plate3C_15_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_15_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	5bc2c6817fe75b263431dab8e6e1f14af1a7476f5e7d513cbf24f9765d61f3ba	SAMEA7711556
PXD004242-15 plasma at 0 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150818_qep1_lc7_phge_sa_plate3c_15_2	20150818_QEp1_LC7_PhGe_SA_Plate3C_15_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_15_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	65979f8e3c5e590903eceb242c239fabe73cc477fdf83624657bb1828b419e0e	SAMEA7711557
PXD004242-15 plasma at 4 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150818_qep1_lc7_phge_sa_plate3c_15_3	20150818_QEp1_LC7_PhGe_SA_Plate3C_15_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_15_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	3c16df69af67843a89bad577f58b61b5ecbce2505a1269f4d9ca03487a6ba043	SAMEA7711558
PXD004242-15 plasma at 13 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150818_qep1_lc7_phge_sa_plate3c_15_4	20150818_QEp1_LC7_PhGe_SA_Plate3C_15_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_15_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	9946355b5ef27fee4e63b910514f35159edbe1547bf5b43d70acfe0db0e94784	SAMEA7711559
PXD004242-15 plasma at 26 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150818_qep1_lc7_phge_sa_plate3c_15_5	20150818_QEp1_LC7_PhGe_SA_Plate3C_15_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_15_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	db7ae3b16f54e6459f73a98d7482da644c04d303e155091132d460eb77edb56e	SAMEA7711560
PXD004242-15 plasma at 39 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150818_qep1_lc7_phge_sa_plate3c_15_6	20150818_QEp1_LC7_PhGe_SA_Plate3C_15_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_15_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	a970fcbfbdab534ff202472238e0bc3d25423de42d541d3fe04b4aa910137eb3	SAMEA7711561
PXD004242-15 plasma at 52 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150818_qep1_lc7_phge_sa_plate3c_15_7	20150818_QEp1_LC7_PhGe_SA_Plate3C_15_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_15_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	bad6409e9442c703dea971cd52a416920433c9983fb19dcea93bc45435d910ce	SAMEA7711562
PXD004242-15 plasma at -8 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150912_qep1_lc7_phge_sa_plate3d_15_1	20150912_QEp1_LC7_PhGe_SA_Plate3D_15_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_15_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	5bc2c6817fe75b263431dab8e6e1f14af1a7476f5e7d513cbf24f9765d61f3ba	SAMEA7711556
PXD004242-15 plasma at 0 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150912_qep1_lc7_phge_sa_plate3d_15_2	20150912_QEp1_LC7_PhGe_SA_Plate3D_15_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_15_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	65979f8e3c5e590903eceb242c239fabe73cc477fdf83624657bb1828b419e0e	SAMEA7711557
PXD004242-15 plasma at 4 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150912_qep1_lc7_phge_sa_plate3d_15_3	20150912_QEp1_LC7_PhGe_SA_Plate3D_15_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_15_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	3c16df69af67843a89bad577f58b61b5ecbce2505a1269f4d9ca03487a6ba043	SAMEA7711558
PXD004242-15 plasma at 13 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150912_qep1_lc7_phge_sa_plate3d_15_4	20150912_QEp1_LC7_PhGe_SA_Plate3D_15_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_15_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	9946355b5ef27fee4e63b910514f35159edbe1547bf5b43d70acfe0db0e94784	SAMEA7711559
PXD004242-15 plasma at 26 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150912_qep1_lc7_phge_sa_plate3d_15_5	20150912_QEp1_LC7_PhGe_SA_Plate3D_15_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_15_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	db7ae3b16f54e6459f73a98d7482da644c04d303e155091132d460eb77edb56e	SAMEA7711560
PXD004242-15 plasma at 39 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150912_qep1_lc7_phge_sa_plate3d_15_6	20150912_QEp1_LC7_PhGe_SA_Plate3D_15_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_15_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	a970fcbfbdab534ff202472238e0bc3d25423de42d541d3fe04b4aa910137eb3	SAMEA7711561
PXD004242-15 plasma at 52 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150912_qep1_lc7_phge_sa_plate3d_15_7	20150912_QEp1_LC7_PhGe_SA_Plate3D_15_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_15_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	bad6409e9442c703dea971cd52a416920433c9983fb19dcea93bc45435d910ce	SAMEA7711562
PXD004242-15 plasma at 52 weeks	Homo sapiens	blood plasma	15	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150917_qep1_lc7_phge_sa_plate3b_15_7	20150917_QEp1_LC7_PhGe_SA_Plate3B_15_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_15_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	bad6409e9442c703dea971cd52a416920433c9983fb19dcea93bc45435d910ce	SAMEA7711562
PXD004242-16 plasma at -8 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150731_qep1_lc7_phge_sa_plate4b_16_1	20150731_QEp1_LC7_PhGe_SA_Plate4B_16_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_16_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	e86acb875d78911d2a21c005579bc5a203af3d95eb449e8adedd57aa58d98273	SAMEA7711563
PXD004242-16 plasma at 0 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150731_qep1_lc7_phge_sa_plate4b_16_2	20150731_QEp1_LC7_PhGe_SA_Plate4B_16_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_16_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	372787016b9a5cebe7bacd8c7da593c0dfde188ee21a1cfa2b613617014fbc69	SAMEA7711564
PXD004242-16 plasma at 4 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150731_qep1_lc7_phge_sa_plate4b_16_3	20150731_QEp1_LC7_PhGe_SA_Plate4B_16_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_16_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	568785405de781e141130d8217d75e622ec54bde7f5f4be42ce16852aa5b6bc7	SAMEA7711565
PXD004242-16 plasma at 13 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150731_qep1_lc7_phge_sa_plate4b_16_4	20150731_QEp1_LC7_PhGe_SA_Plate4B_16_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_16_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	7993b32dc720f3251815c9a4aae26b3d2e35faa21bc45340472658390d66d2e2	SAMEA7711566
PXD004242-16 plasma at 26 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150731_qep1_lc7_phge_sa_plate4b_16_5	20150731_QEp1_LC7_PhGe_SA_Plate4B_16_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_16_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	042485ea55617631af681a3e349dd6bf8d54aba8064b23367afd645646a713f8	SAMEA7711567
PXD004242-16 plasma at 39 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150731_qep1_lc7_phge_sa_plate4b_16_6	20150731_QEp1_LC7_PhGe_SA_Plate4B_16_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_16_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	204040da08e38c93db56b7229fbd06d5f80f535f4b030c3e807cadb96a59267e	SAMEA7711568
PXD004242-16 plasma at 52 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150731_qep1_lc7_phge_sa_plate4b_16_7	20150731_QEp1_LC7_PhGe_SA_Plate4B_16_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_16_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	0129152d4206ba68fa5abe8b7a3063402d0693a9f07421d574c9629c37be9009	SAMEA7711569
PXD004242-16 plasma at -8 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150731_qep1_lc7_phge_sa_plate4e_16_1	20150731_QEp1_LC7_PhGe_SA_Plate4E_16_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_16_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	e86acb875d78911d2a21c005579bc5a203af3d95eb449e8adedd57aa58d98273	SAMEA7711563
PXD004242-16 plasma at 0 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150731_qep1_lc7_phge_sa_plate4e_16_2	20150731_QEp1_LC7_PhGe_SA_Plate4E_16_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_16_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	372787016b9a5cebe7bacd8c7da593c0dfde188ee21a1cfa2b613617014fbc69	SAMEA7711564
PXD004242-16 plasma at 4 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150731_qep1_lc7_phge_sa_plate4e_16_3	20150731_QEp1_LC7_PhGe_SA_Plate4E_16_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_16_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	568785405de781e141130d8217d75e622ec54bde7f5f4be42ce16852aa5b6bc7	SAMEA7711565
PXD004242-16 plasma at 13 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150731_qep1_lc7_phge_sa_plate4e_16_4	20150731_QEp1_LC7_PhGe_SA_Plate4E_16_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_16_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	7993b32dc720f3251815c9a4aae26b3d2e35faa21bc45340472658390d66d2e2	SAMEA7711566
PXD004242-16 plasma at 26 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150731_qep1_lc7_phge_sa_plate4e_16_5	20150731_QEp1_LC7_PhGe_SA_Plate4E_16_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_16_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	042485ea55617631af681a3e349dd6bf8d54aba8064b23367afd645646a713f8	SAMEA7711567
PXD004242-16 plasma at 39 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150731_qep1_lc7_phge_sa_plate4e_16_6	20150731_QEp1_LC7_PhGe_SA_Plate4E_16_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_16_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	204040da08e38c93db56b7229fbd06d5f80f535f4b030c3e807cadb96a59267e	SAMEA7711568
PXD004242-16 plasma at 52 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150731_qep1_lc7_phge_sa_plate4e_16_7	20150731_QEp1_LC7_PhGe_SA_Plate4E_16_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_16_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	0129152d4206ba68fa5abe8b7a3063402d0693a9f07421d574c9629c37be9009	SAMEA7711569
PXD004242-16 plasma at 0 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150824_qep1_lc7_phge_sa_plate4d_16_2	20150824_QEp1_LC7_PhGe_SA_Plate4D_16_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_16_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	372787016b9a5cebe7bacd8c7da593c0dfde188ee21a1cfa2b613617014fbc69	SAMEA7711564
PXD004242-16 plasma at 4 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150824_qep1_lc7_phge_sa_plate4d_16_3	20150824_QEp1_LC7_PhGe_SA_Plate4D_16_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_16_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	568785405de781e141130d8217d75e622ec54bde7f5f4be42ce16852aa5b6bc7	SAMEA7711565
PXD004242-16 plasma at 13 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150824_qep1_lc7_phge_sa_plate4d_16_4	20150824_QEp1_LC7_PhGe_SA_Plate4D_16_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_16_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	7993b32dc720f3251815c9a4aae26b3d2e35faa21bc45340472658390d66d2e2	SAMEA7711566
PXD004242-16 plasma at 26 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150824_qep1_lc7_phge_sa_plate4d_16_5	20150824_QEp1_LC7_PhGe_SA_Plate4D_16_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_16_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	042485ea55617631af681a3e349dd6bf8d54aba8064b23367afd645646a713f8	SAMEA7711567
PXD004242-16 plasma at 39 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150824_qep1_lc7_phge_sa_plate4d_16_6	20150824_QEp1_LC7_PhGe_SA_Plate4D_16_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_16_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	204040da08e38c93db56b7229fbd06d5f80f535f4b030c3e807cadb96a59267e	SAMEA7711568
PXD004242-16 plasma at 52 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150824_qep1_lc7_phge_sa_plate4d_16_7	20150824_QEp1_LC7_PhGe_SA_Plate4D_16_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_16_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	0129152d4206ba68fa5abe8b7a3063402d0693a9f07421d574c9629c37be9009	SAMEA7711569
PXD004242-16 plasma at -8 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150917_qep1_lc7_phge_sa_plate4c_16_1	20150917_QEp1_LC7_PhGe_SA_Plate4C_16_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_16_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	e86acb875d78911d2a21c005579bc5a203af3d95eb449e8adedd57aa58d98273	SAMEA7711563
PXD004242-16 plasma at 0 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150917_qep1_lc7_phge_sa_plate4c_16_2	20150917_QEp1_LC7_PhGe_SA_Plate4C_16_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_16_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	372787016b9a5cebe7bacd8c7da593c0dfde188ee21a1cfa2b613617014fbc69	SAMEA7711564
PXD004242-16 plasma at 4 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150917_qep1_lc7_phge_sa_plate4c_16_3	20150917_QEp1_LC7_PhGe_SA_Plate4C_16_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_16_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	568785405de781e141130d8217d75e622ec54bde7f5f4be42ce16852aa5b6bc7	SAMEA7711565
PXD004242-16 plasma at 13 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150917_qep1_lc7_phge_sa_plate4c_16_4	20150917_QEp1_LC7_PhGe_SA_Plate4C_16_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_16_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	7993b32dc720f3251815c9a4aae26b3d2e35faa21bc45340472658390d66d2e2	SAMEA7711566
PXD004242-16 plasma at 26 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150917_qep1_lc7_phge_sa_plate4c_16_5	20150917_QEp1_LC7_PhGe_SA_Plate4C_16_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_16_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	042485ea55617631af681a3e349dd6bf8d54aba8064b23367afd645646a713f8	SAMEA7711567
PXD004242-16 plasma at 39 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150917_qep1_lc7_phge_sa_plate4c_16_6	20150917_QEp1_LC7_PhGe_SA_Plate4C_16_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_16_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	204040da08e38c93db56b7229fbd06d5f80f535f4b030c3e807cadb96a59267e	SAMEA7711568
PXD004242-16 plasma at 52 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150917_qep1_lc7_phge_sa_plate4c_16_7	20150917_QEp1_LC7_PhGe_SA_Plate4C_16_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_16_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	0129152d4206ba68fa5abe8b7a3063402d0693a9f07421d574c9629c37be9009	SAMEA7711569
PXD004242-16 plasma at -8 weeks	Homo sapiens	blood plasma	16	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150917_qep1_lc7_phge_sa_plate4d_16_1	20150917_QEp1_LC7_PhGe_SA_Plate4D_16_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4D_16_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	e86acb875d78911d2a21c005579bc5a203af3d95eb449e8adedd57aa58d98273	SAMEA7711563
PXD004242-17 plasma at -8 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150624_qep1_lc7_phge_sa_plate2a_17_1	20150624_QEp1_LC7_PhGe_SA_Plate2A_17_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_17_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	c9d4ba717ce5ba6679d6330811cbc361de61802a289cb9a45797965c2a170566	SAMEA7711570
PXD004242-17 plasma at 0 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150624_qep1_lc7_phge_sa_plate2a_17_2	20150624_QEp1_LC7_PhGe_SA_Plate2A_17_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_17_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	daeb5503db425270f5564e0c9ef8a224bc13ae9ea182a81863a43179d138cd85	SAMEA7711571
PXD004242-17 plasma at 4 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150624_qep1_lc7_phge_sa_plate2a_17_3	20150624_QEp1_LC7_PhGe_SA_Plate2A_17_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_17_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	f201029c843f373a0a8a4305bbfce6f8c26b796d3a595402e4ad807d50e98509	SAMEA7711572
PXD004242-17 plasma at 13 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150624_qep1_lc7_phge_sa_plate2a_17_4	20150624_QEp1_LC7_PhGe_SA_Plate2A_17_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_17_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	1a02670f750cfffd6d13f9f42a2713c04bb91bb53fda83ca5697ce5b8c0d91fc	SAMEA7711573
PXD004242-17 plasma at 26 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150624_qep1_lc7_phge_sa_plate2a_17_5	20150624_QEp1_LC7_PhGe_SA_Plate2A_17_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_17_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	d5d01e87d5b1dbb26c4e886a8d05aeee200ecda12b03391af50901765a388b9a	SAMEA7711574
PXD004242-17 plasma at 39 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150624_qep1_lc7_phge_sa_plate2a_17_6	20150624_QEp1_LC7_PhGe_SA_Plate2A_17_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_17_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	45a7e6ab3cfe4e271d1f48a310414ec65440aa0ad5ec10d2d8b450ff89900d93	SAMEA7711575
PXD004242-17 plasma at 52 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150624_qep1_lc7_phge_sa_plate2a_17_7	20150624_QEp1_LC7_PhGe_SA_Plate2A_17_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_17_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	c1e6901b62ec3f1bc1880560f46dd06540a1ec425eb7c78f8b6569b33ee7ac35	SAMEA7711576
PXD004242-17 plasma at -8 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150811_qep1_lc7_phge_sa_plate2b_17_1	20150811_QEp1_LC7_PhGe_SA_Plate2B_17_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_17_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	c9d4ba717ce5ba6679d6330811cbc361de61802a289cb9a45797965c2a170566	SAMEA7711570
PXD004242-17 plasma at 0 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150811_qep1_lc7_phge_sa_plate2b_17_2	20150811_QEp1_LC7_PhGe_SA_Plate2B_17_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_17_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	daeb5503db425270f5564e0c9ef8a224bc13ae9ea182a81863a43179d138cd85	SAMEA7711571
PXD004242-17 plasma at 4 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150811_qep1_lc7_phge_sa_plate2b_17_3	20150811_QEp1_LC7_PhGe_SA_Plate2B_17_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_17_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	f201029c843f373a0a8a4305bbfce6f8c26b796d3a595402e4ad807d50e98509	SAMEA7711572
PXD004242-17 plasma at 13 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150811_qep1_lc7_phge_sa_plate2b_17_4	20150811_QEp1_LC7_PhGe_SA_Plate2B_17_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_17_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	1a02670f750cfffd6d13f9f42a2713c04bb91bb53fda83ca5697ce5b8c0d91fc	SAMEA7711573
PXD004242-17 plasma at 26 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150811_qep1_lc7_phge_sa_plate2b_17_5	20150811_QEp1_LC7_PhGe_SA_Plate2B_17_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_17_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	d5d01e87d5b1dbb26c4e886a8d05aeee200ecda12b03391af50901765a388b9a	SAMEA7711574
PXD004242-17 plasma at 39 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150811_qep1_lc7_phge_sa_plate2b_17_6	20150811_QEp1_LC7_PhGe_SA_Plate2B_17_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_17_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	45a7e6ab3cfe4e271d1f48a310414ec65440aa0ad5ec10d2d8b450ff89900d93	SAMEA7711575
PXD004242-17 plasma at 52 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150811_qep1_lc7_phge_sa_plate2b_17_7	20150811_QEp1_LC7_PhGe_SA_Plate2B_17_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_17_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	c1e6901b62ec3f1bc1880560f46dd06540a1ec425eb7c78f8b6569b33ee7ac35	SAMEA7711576
PXD004242-17 plasma at -8 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150827_qep1_lc7_phge_sa_plate2c_17_1	20150827_QEp1_LC7_PhGe_SA_Plate2C_17_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_17_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	c9d4ba717ce5ba6679d6330811cbc361de61802a289cb9a45797965c2a170566	SAMEA7711570
PXD004242-17 plasma at 0 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150827_qep1_lc7_phge_sa_plate2c_17_2	20150827_QEp1_LC7_PhGe_SA_Plate2C_17_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_17_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	daeb5503db425270f5564e0c9ef8a224bc13ae9ea182a81863a43179d138cd85	SAMEA7711571
PXD004242-17 plasma at 4 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150827_qep1_lc7_phge_sa_plate2c_17_3	20150827_QEp1_LC7_PhGe_SA_Plate2C_17_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_17_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	f201029c843f373a0a8a4305bbfce6f8c26b796d3a595402e4ad807d50e98509	SAMEA7711572
PXD004242-17 plasma at 13 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150827_qep1_lc7_phge_sa_plate2c_17_4	20150827_QEp1_LC7_PhGe_SA_Plate2C_17_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_17_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	1a02670f750cfffd6d13f9f42a2713c04bb91bb53fda83ca5697ce5b8c0d91fc	SAMEA7711573
PXD004242-17 plasma at 26 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150827_qep1_lc7_phge_sa_plate2c_17_5	20150827_QEp1_LC7_PhGe_SA_Plate2C_17_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_17_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	d5d01e87d5b1dbb26c4e886a8d05aeee200ecda12b03391af50901765a388b9a	SAMEA7711574
PXD004242-17 plasma at 39 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150827_qep1_lc7_phge_sa_plate2c_17_6	20150827_QEp1_LC7_PhGe_SA_Plate2C_17_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_17_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	45a7e6ab3cfe4e271d1f48a310414ec65440aa0ad5ec10d2d8b450ff89900d93	SAMEA7711575
PXD004242-17 plasma at 52 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150827_qep1_lc7_phge_sa_plate2c_17_7	20150827_QEp1_LC7_PhGe_SA_Plate2C_17_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_17_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	c1e6901b62ec3f1bc1880560f46dd06540a1ec425eb7c78f8b6569b33ee7ac35	SAMEA7711576
PXD004242-17 plasma at -8 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150907_qep1_lc7_phge_sa_plate2d_17_1	20150907_QEp1_LC7_PhGe_SA_Plate2D_17_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_17_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	c9d4ba717ce5ba6679d6330811cbc361de61802a289cb9a45797965c2a170566	SAMEA7711570
PXD004242-17 plasma at 0 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150907_qep1_lc7_phge_sa_plate2d_17_2	20150907_QEp1_LC7_PhGe_SA_Plate2D_17_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_17_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	daeb5503db425270f5564e0c9ef8a224bc13ae9ea182a81863a43179d138cd85	SAMEA7711571
PXD004242-17 plasma at 4 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150907_qep1_lc7_phge_sa_plate2d_17_3	20150907_QEp1_LC7_PhGe_SA_Plate2D_17_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_17_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	f201029c843f373a0a8a4305bbfce6f8c26b796d3a595402e4ad807d50e98509	SAMEA7711572
PXD004242-17 plasma at 13 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150907_qep1_lc7_phge_sa_plate2d_17_4	20150907_QEp1_LC7_PhGe_SA_Plate2D_17_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_17_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	1a02670f750cfffd6d13f9f42a2713c04bb91bb53fda83ca5697ce5b8c0d91fc	SAMEA7711573
PXD004242-17 plasma at 26 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150907_qep1_lc7_phge_sa_plate2d_17_5	20150907_QEp1_LC7_PhGe_SA_Plate2D_17_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_17_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	d5d01e87d5b1dbb26c4e886a8d05aeee200ecda12b03391af50901765a388b9a	SAMEA7711574
PXD004242-17 plasma at 39 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150907_qep1_lc7_phge_sa_plate2d_17_6	20150907_QEp1_LC7_PhGe_SA_Plate2D_17_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_17_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	45a7e6ab3cfe4e271d1f48a310414ec65440aa0ad5ec10d2d8b450ff89900d93	SAMEA7711575
PXD004242-17 plasma at 52 weeks	Homo sapiens	blood plasma	17	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150907_qep1_lc7_phge_sa_plate2d_17_7	20150907_QEp1_LC7_PhGe_SA_Plate2D_17_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_17_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	c1e6901b62ec3f1bc1880560f46dd06540a1ec425eb7c78f8b6569b33ee7ac35	SAMEA7711576
PXD004242-19 plasma at -8 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150618_qep1_lc7_phge_sa_plate1b_19_1	20150618_QEp1_LC7_PhGe_SA_Plate1B_19_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_19_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	7e08199f2ce65f3d61763f35b7ea0e445ec357297508493de443359047988352	SAMEA7711577
PXD004242-19 plasma at 0 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150618_qep1_lc7_phge_sa_plate1b_19_2	20150618_QEp1_LC7_PhGe_SA_Plate1B_19_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_19_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	9f3e39805d0abc4741f477f0ec470c3030cf67e230ca1e7a5312e6b631969e0d	SAMEA7711578
PXD004242-19 plasma at 4 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150618_qep1_lc7_phge_sa_plate1b_19_3	20150618_QEp1_LC7_PhGe_SA_Plate1B_19_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_19_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	fe62f42f7364fef257ac69336b1d672965936a57d424d544ddf53af7107bb44c	SAMEA7711579
PXD004242-19 plasma at 13 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150618_qep1_lc7_phge_sa_plate1b_19_4	20150618_QEp1_LC7_PhGe_SA_Plate1B_19_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_19_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	1d006ca4ce38a05dfcda43e0eac5baab5bf9692c936aa97845a8b519b8c32d2f	SAMEA7711580
PXD004242-19 plasma at 26 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150618_qep1_lc7_phge_sa_plate1b_19_5	20150618_QEp1_LC7_PhGe_SA_Plate1B_19_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_19_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	c8dedc8a7e1e35e4528e67da1ee64ab587f70507e00d1696c69f3b39dd147516	SAMEA7711581
PXD004242-19 plasma at 39 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150618_qep1_lc7_phge_sa_plate1b_19_6	20150618_QEp1_LC7_PhGe_SA_Plate1B_19_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_19_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	80374a1050a4071a36adf13c34b7c6b5ef22d5f9e3507c83415a9c8a4f848389	SAMEA7711582
PXD004242-19 plasma at 52 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150618_qep1_lc7_phge_sa_plate1b_19_7	20150618_QEp1_LC7_PhGe_SA_Plate1B_19_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_19_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	3704aa7f26b6d64eb94b61988341c978911b082789f0d2fc5c09f672d0229dda	SAMEA7711583
PXD004242-19 plasma at -8 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150708_qep1_lc7_phge_sa_plate1c_19_1	20150708_QEp1_LC7_PhGe_SA_Plate1C_19_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_19_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	7e08199f2ce65f3d61763f35b7ea0e445ec357297508493de443359047988352	SAMEA7711577
PXD004242-19 plasma at 0 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150708_qep1_lc7_phge_sa_plate1c_19_2	20150708_QEp1_LC7_PhGe_SA_Plate1C_19_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_19_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	9f3e39805d0abc4741f477f0ec470c3030cf67e230ca1e7a5312e6b631969e0d	SAMEA7711578
PXD004242-19 plasma at 4 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150708_qep1_lc7_phge_sa_plate1c_19_3	20150708_QEp1_LC7_PhGe_SA_Plate1C_19_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_19_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	fe62f42f7364fef257ac69336b1d672965936a57d424d544ddf53af7107bb44c	SAMEA7711579
PXD004242-19 plasma at 13 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150708_qep1_lc7_phge_sa_plate1c_19_4	20150708_QEp1_LC7_PhGe_SA_Plate1C_19_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_19_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	1d006ca4ce38a05dfcda43e0eac5baab5bf9692c936aa97845a8b519b8c32d2f	SAMEA7711580
PXD004242-19 plasma at 26 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150708_qep1_lc7_phge_sa_plate1c_19_5	20150708_QEp1_LC7_PhGe_SA_Plate1C_19_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_19_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	c8dedc8a7e1e35e4528e67da1ee64ab587f70507e00d1696c69f3b39dd147516	SAMEA7711581
PXD004242-19 plasma at 39 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150708_qep1_lc7_phge_sa_plate1c_19_6	20150708_QEp1_LC7_PhGe_SA_Plate1C_19_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_19_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	80374a1050a4071a36adf13c34b7c6b5ef22d5f9e3507c83415a9c8a4f848389	SAMEA7711582
PXD004242-19 plasma at 52 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150708_qep1_lc7_phge_sa_plate1c_19_7	20150708_QEp1_LC7_PhGe_SA_Plate1C_19_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_19_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	3704aa7f26b6d64eb94b61988341c978911b082789f0d2fc5c09f672d0229dda	SAMEA7711583
PXD004242-19 plasma at -8 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150805_qep1_lc7_phge_sa_plate1d_19_1	20150805_QEp1_LC7_PhGe_SA_Plate1D_19_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_19_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	7e08199f2ce65f3d61763f35b7ea0e445ec357297508493de443359047988352	SAMEA7711577
PXD004242-19 plasma at 0 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150805_qep1_lc7_phge_sa_plate1d_19_2	20150805_QEp1_LC7_PhGe_SA_Plate1D_19_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_19_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	9f3e39805d0abc4741f477f0ec470c3030cf67e230ca1e7a5312e6b631969e0d	SAMEA7711578
PXD004242-19 plasma at 4 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150805_qep1_lc7_phge_sa_plate1d_19_3	20150805_QEp1_LC7_PhGe_SA_Plate1D_19_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_19_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	fe62f42f7364fef257ac69336b1d672965936a57d424d544ddf53af7107bb44c	SAMEA7711579
PXD004242-19 plasma at 13 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150805_qep1_lc7_phge_sa_plate1d_19_4	20150805_QEp1_LC7_PhGe_SA_Plate1D_19_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_19_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	1d006ca4ce38a05dfcda43e0eac5baab5bf9692c936aa97845a8b519b8c32d2f	SAMEA7711580
PXD004242-19 plasma at 26 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150805_qep1_lc7_phge_sa_plate1d_19_5	20150805_QEp1_LC7_PhGe_SA_Plate1D_19_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_19_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	c8dedc8a7e1e35e4528e67da1ee64ab587f70507e00d1696c69f3b39dd147516	SAMEA7711581
PXD004242-19 plasma at 39 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150805_qep1_lc7_phge_sa_plate1d_19_6	20150805_QEp1_LC7_PhGe_SA_Plate1D_19_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_19_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	80374a1050a4071a36adf13c34b7c6b5ef22d5f9e3507c83415a9c8a4f848389	SAMEA7711582
PXD004242-19 plasma at 52 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150805_qep1_lc7_phge_sa_plate1d_19_7	20150805_QEp1_LC7_PhGe_SA_Plate1D_19_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_19_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	3704aa7f26b6d64eb94b61988341c978911b082789f0d2fc5c09f672d0229dda	SAMEA7711583
PXD004242-19 plasma at -8 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150901_qep1_lc7_phge_sa_plate1e_19_1	20150901_QEp1_LC7_PhGe_SA_Plate1E_19_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_19_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	7e08199f2ce65f3d61763f35b7ea0e445ec357297508493de443359047988352	SAMEA7711577
PXD004242-19 plasma at 0 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150901_qep1_lc7_phge_sa_plate1e_19_2	20150901_QEp1_LC7_PhGe_SA_Plate1E_19_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_19_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	9f3e39805d0abc4741f477f0ec470c3030cf67e230ca1e7a5312e6b631969e0d	SAMEA7711578
PXD004242-19 plasma at 4 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150901_qep1_lc7_phge_sa_plate1e_19_3	20150901_QEp1_LC7_PhGe_SA_Plate1E_19_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_19_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	fe62f42f7364fef257ac69336b1d672965936a57d424d544ddf53af7107bb44c	SAMEA7711579
PXD004242-19 plasma at 13 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150901_qep1_lc7_phge_sa_plate1e_19_4	20150901_QEp1_LC7_PhGe_SA_Plate1E_19_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_19_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	1d006ca4ce38a05dfcda43e0eac5baab5bf9692c936aa97845a8b519b8c32d2f	SAMEA7711580
PXD004242-19 plasma at 26 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150901_qep1_lc7_phge_sa_plate1e_19_5	20150901_QEp1_LC7_PhGe_SA_Plate1E_19_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_19_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	c8dedc8a7e1e35e4528e67da1ee64ab587f70507e00d1696c69f3b39dd147516	SAMEA7711581
PXD004242-19 plasma at 39 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150901_qep1_lc7_phge_sa_plate1e_19_6	20150901_QEp1_LC7_PhGe_SA_Plate1E_19_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_19_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	80374a1050a4071a36adf13c34b7c6b5ef22d5f9e3507c83415a9c8a4f848389	SAMEA7711582
PXD004242-19 plasma at 52 weeks	Homo sapiens	blood plasma	19	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150901_qep1_lc7_phge_sa_plate1e_19_7	20150901_QEp1_LC7_PhGe_SA_Plate1E_19_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_19_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	3704aa7f26b6d64eb94b61988341c978911b082789f0d2fc5c09f672d0229dda	SAMEA7711583
PXD004242-20 plasma at -8 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150624_qep1_lc7_phge_sa_plate2a_20_1	20150624_QEp1_LC7_PhGe_SA_Plate2A_20_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_20_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	b3df4078d2d34b8956af82633bdde467b3ab6ccd1a0050a3a7aca08e38d02556	SAMEA7711584
PXD004242-20 plasma at 0 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150624_qep1_lc7_phge_sa_plate2a_20_2	20150624_QEp1_LC7_PhGe_SA_Plate2A_20_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_20_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	b8cfb2055a7ab7f5f95a1698219cb46b0560748e70625221f7eaccaf87199a35	SAMEA7711585
PXD004242-20 plasma at 4 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150624_qep1_lc7_phge_sa_plate2a_20_3	20150624_QEp1_LC7_PhGe_SA_Plate2A_20_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_20_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	abe74376db59f350344a81aa453e9d27cd72a2d6d54fb6882c6e95b7d93859fa	SAMEA7711586
PXD004242-20 plasma at 13 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150624_qep1_lc7_phge_sa_plate2a_20_4	20150624_QEp1_LC7_PhGe_SA_Plate2A_20_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_20_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	ba13629472f023def7d54a709b71a371361bc3a6497a310b720632036b66ed5c	SAMEA7711587
PXD004242-20 plasma at 26 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150624_qep1_lc7_phge_sa_plate2a_20_5	20150624_QEp1_LC7_PhGe_SA_Plate2A_20_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_20_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	98e3128a242a1e19f33074fa858675b3a68281290103ca52410bc791246ca211	SAMEA7711588
PXD004242-20 plasma at 39 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150624_qep1_lc7_phge_sa_plate2a_20_6	20150624_QEp1_LC7_PhGe_SA_Plate2A_20_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_20_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	7e92f06f14cb80f3066b18352e2739b68b3a15098fc10ac856dfa329665fc75b	SAMEA7711589
PXD004242-20 plasma at 52 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150624_qep1_lc7_phge_sa_plate2a_20_7	20150624_QEp1_LC7_PhGe_SA_Plate2A_20_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_20_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	43d080d9c28d25c13caf80ed8c722871329757895178c58ab2f23a85c4dccf0a	SAMEA7711590
PXD004242-20 plasma at -8 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150811_qep1_lc7_phge_sa_plate2b_20_1	20150811_QEp1_LC7_PhGe_SA_Plate2B_20_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_20_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	b3df4078d2d34b8956af82633bdde467b3ab6ccd1a0050a3a7aca08e38d02556	SAMEA7711584
PXD004242-20 plasma at 0 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150811_qep1_lc7_phge_sa_plate2b_20_2	20150811_QEp1_LC7_PhGe_SA_Plate2B_20_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_20_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	b8cfb2055a7ab7f5f95a1698219cb46b0560748e70625221f7eaccaf87199a35	SAMEA7711585
PXD004242-20 plasma at 4 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150811_qep1_lc7_phge_sa_plate2b_20_3	20150811_QEp1_LC7_PhGe_SA_Plate2B_20_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_20_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	abe74376db59f350344a81aa453e9d27cd72a2d6d54fb6882c6e95b7d93859fa	SAMEA7711586
PXD004242-20 plasma at 13 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150811_qep1_lc7_phge_sa_plate2b_20_4	20150811_QEp1_LC7_PhGe_SA_Plate2B_20_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_20_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	ba13629472f023def7d54a709b71a371361bc3a6497a310b720632036b66ed5c	SAMEA7711587
PXD004242-20 plasma at 26 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150811_qep1_lc7_phge_sa_plate2b_20_5	20150811_QEp1_LC7_PhGe_SA_Plate2B_20_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_20_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	98e3128a242a1e19f33074fa858675b3a68281290103ca52410bc791246ca211	SAMEA7711588
PXD004242-20 plasma at 39 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150811_qep1_lc7_phge_sa_plate2b_20_6	20150811_QEp1_LC7_PhGe_SA_Plate2B_20_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_20_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	7e92f06f14cb80f3066b18352e2739b68b3a15098fc10ac856dfa329665fc75b	SAMEA7711589
PXD004242-20 plasma at 52 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150811_qep1_lc7_phge_sa_plate2b_20_7	20150811_QEp1_LC7_PhGe_SA_Plate2B_20_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_20_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	43d080d9c28d25c13caf80ed8c722871329757895178c58ab2f23a85c4dccf0a	SAMEA7711590
PXD004242-20 plasma at -8 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150827_qep1_lc7_phge_sa_plate2c_20_1	20150827_QEp1_LC7_PhGe_SA_Plate2C_20_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_20_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	b3df4078d2d34b8956af82633bdde467b3ab6ccd1a0050a3a7aca08e38d02556	SAMEA7711584
PXD004242-20 plasma at 0 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150827_qep1_lc7_phge_sa_plate2c_20_2	20150827_QEp1_LC7_PhGe_SA_Plate2C_20_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_20_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	b8cfb2055a7ab7f5f95a1698219cb46b0560748e70625221f7eaccaf87199a35	SAMEA7711585
PXD004242-20 plasma at 4 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150827_qep1_lc7_phge_sa_plate2c_20_3	20150827_QEp1_LC7_PhGe_SA_Plate2C_20_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_20_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	abe74376db59f350344a81aa453e9d27cd72a2d6d54fb6882c6e95b7d93859fa	SAMEA7711586
PXD004242-20 plasma at 13 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150827_qep1_lc7_phge_sa_plate2c_20_4	20150827_QEp1_LC7_PhGe_SA_Plate2C_20_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_20_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	ba13629472f023def7d54a709b71a371361bc3a6497a310b720632036b66ed5c	SAMEA7711587
PXD004242-20 plasma at 26 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150827_qep1_lc7_phge_sa_plate2c_20_5	20150827_QEp1_LC7_PhGe_SA_Plate2C_20_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_20_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	98e3128a242a1e19f33074fa858675b3a68281290103ca52410bc791246ca211	SAMEA7711588
PXD004242-20 plasma at 39 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150827_qep1_lc7_phge_sa_plate2c_20_6	20150827_QEp1_LC7_PhGe_SA_Plate2C_20_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_20_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	7e92f06f14cb80f3066b18352e2739b68b3a15098fc10ac856dfa329665fc75b	SAMEA7711589
PXD004242-20 plasma at 52 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150827_qep1_lc7_phge_sa_plate2c_20_7	20150827_QEp1_LC7_PhGe_SA_Plate2C_20_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_20_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	43d080d9c28d25c13caf80ed8c722871329757895178c58ab2f23a85c4dccf0a	SAMEA7711590
PXD004242-20 plasma at -8 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150907_qep1_lc7_phge_sa_plate2d_20_1	20150907_QEp1_LC7_PhGe_SA_Plate2D_20_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_20_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	b3df4078d2d34b8956af82633bdde467b3ab6ccd1a0050a3a7aca08e38d02556	SAMEA7711584
PXD004242-20 plasma at 0 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150907_qep1_lc7_phge_sa_plate2d_20_2	20150907_QEp1_LC7_PhGe_SA_Plate2D_20_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_20_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	b8cfb2055a7ab7f5f95a1698219cb46b0560748e70625221f7eaccaf87199a35	SAMEA7711585
PXD004242-20 plasma at 4 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150907_qep1_lc7_phge_sa_plate2d_20_3	20150907_QEp1_LC7_PhGe_SA_Plate2D_20_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_20_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	abe74376db59f350344a81aa453e9d27cd72a2d6d54fb6882c6e95b7d93859fa	SAMEA7711586
PXD004242-20 plasma at 13 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150907_qep1_lc7_phge_sa_plate2d_20_4	20150907_QEp1_LC7_PhGe_SA_Plate2D_20_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_20_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	ba13629472f023def7d54a709b71a371361bc3a6497a310b720632036b66ed5c	SAMEA7711587
PXD004242-20 plasma at 26 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150907_qep1_lc7_phge_sa_plate2d_20_5	20150907_QEp1_LC7_PhGe_SA_Plate2D_20_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_20_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	98e3128a242a1e19f33074fa858675b3a68281290103ca52410bc791246ca211	SAMEA7711588
PXD004242-20 plasma at 39 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150907_qep1_lc7_phge_sa_plate2d_20_6	20150907_QEp1_LC7_PhGe_SA_Plate2D_20_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_20_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	7e92f06f14cb80f3066b18352e2739b68b3a15098fc10ac856dfa329665fc75b	SAMEA7711589
PXD004242-20 plasma at 52 weeks	Homo sapiens	blood plasma	20	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150907_qep1_lc7_phge_sa_plate2d_20_7	20150907_QEp1_LC7_PhGe_SA_Plate2D_20_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_20_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	43d080d9c28d25c13caf80ed8c722871329757895178c58ab2f23a85c4dccf0a	SAMEA7711590
PXD004242-21 plasma at -8 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150624_qep1_lc7_phge_sa_plate2a_21_1	20150624_QEp1_LC7_PhGe_SA_Plate2A_21_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_21_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	c4fad4a990ab2e8b86c52b8f85188d85d3a73f2e4327c577762703669a6b8f5d	SAMEA7711591
PXD004242-21 plasma at 0 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150624_qep1_lc7_phge_sa_plate2a_21_2	20150624_QEp1_LC7_PhGe_SA_Plate2A_21_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_21_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	7051d54ac087b262df442929fcb76164f75fd4c55c9bf1e8d88b2b388e29bddc	SAMEA7711592
PXD004242-21 plasma at 4 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150624_qep1_lc7_phge_sa_plate2a_21_3	20150624_QEp1_LC7_PhGe_SA_Plate2A_21_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_21_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	53d7d024b68de6c8911aecef15f78e8170401aababaa20aafead21c67ac98aeb	SAMEA7711593
PXD004242-21 plasma at 13 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150624_qep1_lc7_phge_sa_plate2a_21_4	20150624_QEp1_LC7_PhGe_SA_Plate2A_21_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_21_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	79218d7454c024682593b355b723730304184f4b2ac91900ab27fd9d085192eb	SAMEA7711594
PXD004242-21 plasma at 26 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150624_qep1_lc7_phge_sa_plate2a_21_5	20150624_QEp1_LC7_PhGe_SA_Plate2A_21_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_21_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	d109bcab89db1361c8a5416a5a2e597a85219648ed026e77da44e5108e3c800a	SAMEA7711595
PXD004242-21 plasma at 39 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150624_qep1_lc7_phge_sa_plate2a_21_6	20150624_QEp1_LC7_PhGe_SA_Plate2A_21_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_21_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	d74842b843aed275443cff02fc5076a8c069630a5ec165c6bf25c785bebf136a	SAMEA7711596
PXD004242-21 plasma at 52 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150624_qep1_lc7_phge_sa_plate2a_21_7	20150624_QEp1_LC7_PhGe_SA_Plate2A_21_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_21_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	ae2faf81766738f3c08841475e8354a85cdb3ae6a51b1c9a18d1e2cc12b8e3be	SAMEA7711597
PXD004242-21 plasma at -8 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150811_qep1_lc7_phge_sa_plate2b_21_1	20150811_QEp1_LC7_PhGe_SA_Plate2B_21_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_21_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	c4fad4a990ab2e8b86c52b8f85188d85d3a73f2e4327c577762703669a6b8f5d	SAMEA7711591
PXD004242-21 plasma at 0 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150811_qep1_lc7_phge_sa_plate2b_21_2	20150811_QEp1_LC7_PhGe_SA_Plate2B_21_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_21_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	7051d54ac087b262df442929fcb76164f75fd4c55c9bf1e8d88b2b388e29bddc	SAMEA7711592
PXD004242-21 plasma at 4 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150811_qep1_lc7_phge_sa_plate2b_21_3	20150811_QEp1_LC7_PhGe_SA_Plate2B_21_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_21_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	53d7d024b68de6c8911aecef15f78e8170401aababaa20aafead21c67ac98aeb	SAMEA7711593
PXD004242-21 plasma at 13 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150811_qep1_lc7_phge_sa_plate2b_21_4	20150811_QEp1_LC7_PhGe_SA_Plate2B_21_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_21_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	79218d7454c024682593b355b723730304184f4b2ac91900ab27fd9d085192eb	SAMEA7711594
PXD004242-21 plasma at 26 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150811_qep1_lc7_phge_sa_plate2b_21_5	20150811_QEp1_LC7_PhGe_SA_Plate2B_21_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_21_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	d109bcab89db1361c8a5416a5a2e597a85219648ed026e77da44e5108e3c800a	SAMEA7711595
PXD004242-21 plasma at 39 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150811_qep1_lc7_phge_sa_plate2b_21_6	20150811_QEp1_LC7_PhGe_SA_Plate2B_21_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_21_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	d74842b843aed275443cff02fc5076a8c069630a5ec165c6bf25c785bebf136a	SAMEA7711596
PXD004242-21 plasma at 52 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150811_qep1_lc7_phge_sa_plate2b_21_7	20150811_QEp1_LC7_PhGe_SA_Plate2B_21_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_21_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	ae2faf81766738f3c08841475e8354a85cdb3ae6a51b1c9a18d1e2cc12b8e3be	SAMEA7711597
PXD004242-21 plasma at -8 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150827_qep1_lc7_phge_sa_plate2c_21_1	20150827_QEp1_LC7_PhGe_SA_Plate2C_21_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_21_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	c4fad4a990ab2e8b86c52b8f85188d85d3a73f2e4327c577762703669a6b8f5d	SAMEA7711591
PXD004242-21 plasma at 0 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150827_qep1_lc7_phge_sa_plate2c_21_2	20150827_QEp1_LC7_PhGe_SA_Plate2C_21_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_21_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	7051d54ac087b262df442929fcb76164f75fd4c55c9bf1e8d88b2b388e29bddc	SAMEA7711592
PXD004242-21 plasma at 4 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150827_qep1_lc7_phge_sa_plate2c_21_3	20150827_QEp1_LC7_PhGe_SA_Plate2C_21_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_21_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	53d7d024b68de6c8911aecef15f78e8170401aababaa20aafead21c67ac98aeb	SAMEA7711593
PXD004242-21 plasma at 13 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150827_qep1_lc7_phge_sa_plate2c_21_4	20150827_QEp1_LC7_PhGe_SA_Plate2C_21_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_21_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	79218d7454c024682593b355b723730304184f4b2ac91900ab27fd9d085192eb	SAMEA7711594
PXD004242-21 plasma at 26 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150827_qep1_lc7_phge_sa_plate2c_21_5	20150827_QEp1_LC7_PhGe_SA_Plate2C_21_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_21_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	d109bcab89db1361c8a5416a5a2e597a85219648ed026e77da44e5108e3c800a	SAMEA7711595
PXD004242-21 plasma at 39 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150827_qep1_lc7_phge_sa_plate2c_21_6	20150827_QEp1_LC7_PhGe_SA_Plate2C_21_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_21_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	d74842b843aed275443cff02fc5076a8c069630a5ec165c6bf25c785bebf136a	SAMEA7711596
PXD004242-21 plasma at 52 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150827_qep1_lc7_phge_sa_plate2c_21_7	20150827_QEp1_LC7_PhGe_SA_Plate2C_21_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_21_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	ae2faf81766738f3c08841475e8354a85cdb3ae6a51b1c9a18d1e2cc12b8e3be	SAMEA7711597
PXD004242-21 plasma at -8 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150907_qep1_lc7_phge_sa_plate2d_21_1	20150907_QEp1_LC7_PhGe_SA_Plate2D_21_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_21_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	c4fad4a990ab2e8b86c52b8f85188d85d3a73f2e4327c577762703669a6b8f5d	SAMEA7711591
PXD004242-21 plasma at 0 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150907_qep1_lc7_phge_sa_plate2d_21_2	20150907_QEp1_LC7_PhGe_SA_Plate2D_21_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_21_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	7051d54ac087b262df442929fcb76164f75fd4c55c9bf1e8d88b2b388e29bddc	SAMEA7711592
PXD004242-21 plasma at 4 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150907_qep1_lc7_phge_sa_plate2d_21_3	20150907_QEp1_LC7_PhGe_SA_Plate2D_21_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_21_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	53d7d024b68de6c8911aecef15f78e8170401aababaa20aafead21c67ac98aeb	SAMEA7711593
PXD004242-21 plasma at 13 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150907_qep1_lc7_phge_sa_plate2d_21_4	20150907_QEp1_LC7_PhGe_SA_Plate2D_21_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_21_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	79218d7454c024682593b355b723730304184f4b2ac91900ab27fd9d085192eb	SAMEA7711594
PXD004242-21 plasma at 26 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150907_qep1_lc7_phge_sa_plate2d_21_5	20150907_QEp1_LC7_PhGe_SA_Plate2D_21_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_21_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	d109bcab89db1361c8a5416a5a2e597a85219648ed026e77da44e5108e3c800a	SAMEA7711595
PXD004242-21 plasma at 39 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150907_qep1_lc7_phge_sa_plate2d_21_6	20150907_QEp1_LC7_PhGe_SA_Plate2D_21_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_21_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	d74842b843aed275443cff02fc5076a8c069630a5ec165c6bf25c785bebf136a	SAMEA7711596
PXD004242-21 plasma at 52 weeks	Homo sapiens	blood plasma	21	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150907_qep1_lc7_phge_sa_plate2d_21_7	20150907_QEp1_LC7_PhGe_SA_Plate2D_21_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_21_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	ae2faf81766738f3c08841475e8354a85cdb3ae6a51b1c9a18d1e2cc12b8e3be	SAMEA7711597
PXD004242-22 plasma at -8 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150624_qep1_lc7_phge_sa_plate2a_22_1	20150624_QEp1_LC7_PhGe_SA_Plate2A_22_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_22_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	9217993cccc302f456c081a9200fd4ac9bec8c319e4732bd21c2ec89b6808630	SAMEA7711598
PXD004242-22 plasma at 0 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150624_qep1_lc7_phge_sa_plate2a_22_2	20150624_QEp1_LC7_PhGe_SA_Plate2A_22_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_22_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	c25fc4b60c1c88c3c8d95952a9c0347129735e1fd752c6148743dca5ee546cac	SAMEA7711599
PXD004242-22 plasma at 4 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150624_qep1_lc7_phge_sa_plate2a_22_3	20150624_QEp1_LC7_PhGe_SA_Plate2A_22_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_22_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	0cb37056e72744ed69ca0cbe93fa3d515120809dd92a8aa3ccd6b4f5a6c7c3ac	SAMEA7711600
PXD004242-22 plasma at 13 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150624_qep1_lc7_phge_sa_plate2a_22_4	20150624_QEp1_LC7_PhGe_SA_Plate2A_22_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_22_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	24726de90e3f4b9e1b9e4365d493edea3ca762b21a31ab4a47c20fa5845d6045	SAMEA7711601
PXD004242-22 plasma at 26 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150624_qep1_lc7_phge_sa_plate2a_22_5	20150624_QEp1_LC7_PhGe_SA_Plate2A_22_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_22_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	71c16165e8f94105debaa65cdc1762ef4c33e5af184e210ec785106b08b0c2fc	SAMEA7711602
PXD004242-22 plasma at 39 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150624_qep1_lc7_phge_sa_plate2a_22_6	20150624_QEp1_LC7_PhGe_SA_Plate2A_22_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_22_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	d352ffa2ec9394879802bea31408d97fe7255da30866c8646b5c265115adf65f	SAMEA7711603
PXD004242-22 plasma at 52 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150624_qep1_lc7_phge_sa_plate2a_22_7	20150624_QEp1_LC7_PhGe_SA_Plate2A_22_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_22_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	d2836353083545039091bbbe18564656c854c8289581d9825025ff572b1c5338	SAMEA7711604
PXD004242-22 plasma at -8 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150811_qep1_lc7_phge_sa_plate2b_22_1	20150811_QEp1_LC7_PhGe_SA_Plate2B_22_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_22_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	9217993cccc302f456c081a9200fd4ac9bec8c319e4732bd21c2ec89b6808630	SAMEA7711598
PXD004242-22 plasma at 0 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150811_qep1_lc7_phge_sa_plate2b_22_2	20150811_QEp1_LC7_PhGe_SA_Plate2B_22_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_22_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	c25fc4b60c1c88c3c8d95952a9c0347129735e1fd752c6148743dca5ee546cac	SAMEA7711599
PXD004242-22 plasma at 4 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150811_qep1_lc7_phge_sa_plate2b_22_3	20150811_QEp1_LC7_PhGe_SA_Plate2B_22_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_22_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	0cb37056e72744ed69ca0cbe93fa3d515120809dd92a8aa3ccd6b4f5a6c7c3ac	SAMEA7711600
PXD004242-22 plasma at 13 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150811_qep1_lc7_phge_sa_plate2b_22_4	20150811_QEp1_LC7_PhGe_SA_Plate2B_22_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_22_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	24726de90e3f4b9e1b9e4365d493edea3ca762b21a31ab4a47c20fa5845d6045	SAMEA7711601
PXD004242-22 plasma at 26 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150811_qep1_lc7_phge_sa_plate2b_22_5	20150811_QEp1_LC7_PhGe_SA_Plate2B_22_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_22_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	71c16165e8f94105debaa65cdc1762ef4c33e5af184e210ec785106b08b0c2fc	SAMEA7711602
PXD004242-22 plasma at 39 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150811_qep1_lc7_phge_sa_plate2b_22_6	20150811_QEp1_LC7_PhGe_SA_Plate2B_22_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_22_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	d352ffa2ec9394879802bea31408d97fe7255da30866c8646b5c265115adf65f	SAMEA7711603
PXD004242-22 plasma at 52 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150811_qep1_lc7_phge_sa_plate2b_22_7	20150811_QEp1_LC7_PhGe_SA_Plate2B_22_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_22_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	d2836353083545039091bbbe18564656c854c8289581d9825025ff572b1c5338	SAMEA7711604
PXD004242-22 plasma at -8 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150827_qep1_lc7_phge_sa_plate2c_22_1	20150827_QEp1_LC7_PhGe_SA_Plate2C_22_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_22_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	9217993cccc302f456c081a9200fd4ac9bec8c319e4732bd21c2ec89b6808630	SAMEA7711598
PXD004242-22 plasma at 0 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150827_qep1_lc7_phge_sa_plate2c_22_2	20150827_QEp1_LC7_PhGe_SA_Plate2C_22_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_22_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	c25fc4b60c1c88c3c8d95952a9c0347129735e1fd752c6148743dca5ee546cac	SAMEA7711599
PXD004242-22 plasma at 4 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150827_qep1_lc7_phge_sa_plate2c_22_3	20150827_QEp1_LC7_PhGe_SA_Plate2C_22_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_22_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	0cb37056e72744ed69ca0cbe93fa3d515120809dd92a8aa3ccd6b4f5a6c7c3ac	SAMEA7711600
PXD004242-22 plasma at 13 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150827_qep1_lc7_phge_sa_plate2c_22_4	20150827_QEp1_LC7_PhGe_SA_Plate2C_22_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_22_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	24726de90e3f4b9e1b9e4365d493edea3ca762b21a31ab4a47c20fa5845d6045	SAMEA7711601
PXD004242-22 plasma at 26 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150827_qep1_lc7_phge_sa_plate2c_22_5	20150827_QEp1_LC7_PhGe_SA_Plate2C_22_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_22_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	71c16165e8f94105debaa65cdc1762ef4c33e5af184e210ec785106b08b0c2fc	SAMEA7711602
PXD004242-22 plasma at 39 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150827_qep1_lc7_phge_sa_plate2c_22_6	20150827_QEp1_LC7_PhGe_SA_Plate2C_22_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_22_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	d352ffa2ec9394879802bea31408d97fe7255da30866c8646b5c265115adf65f	SAMEA7711603
PXD004242-22 plasma at 52 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150827_qep1_lc7_phge_sa_plate2c_22_7	20150827_QEp1_LC7_PhGe_SA_Plate2C_22_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_22_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	d2836353083545039091bbbe18564656c854c8289581d9825025ff572b1c5338	SAMEA7711604
PXD004242-22 plasma at -8 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150907_qep1_lc7_phge_sa_plate2d_22_1	20150907_QEp1_LC7_PhGe_SA_Plate2D_22_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_22_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	9217993cccc302f456c081a9200fd4ac9bec8c319e4732bd21c2ec89b6808630	SAMEA7711598
PXD004242-22 plasma at 0 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150907_qep1_lc7_phge_sa_plate2d_22_2	20150907_QEp1_LC7_PhGe_SA_Plate2D_22_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_22_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	c25fc4b60c1c88c3c8d95952a9c0347129735e1fd752c6148743dca5ee546cac	SAMEA7711599
PXD004242-22 plasma at 4 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150907_qep1_lc7_phge_sa_plate2d_22_3	20150907_QEp1_LC7_PhGe_SA_Plate2D_22_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_22_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	0cb37056e72744ed69ca0cbe93fa3d515120809dd92a8aa3ccd6b4f5a6c7c3ac	SAMEA7711600
PXD004242-22 plasma at 13 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150907_qep1_lc7_phge_sa_plate2d_22_4	20150907_QEp1_LC7_PhGe_SA_Plate2D_22_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_22_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	24726de90e3f4b9e1b9e4365d493edea3ca762b21a31ab4a47c20fa5845d6045	SAMEA7711601
PXD004242-22 plasma at 26 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150907_qep1_lc7_phge_sa_plate2d_22_5	20150907_QEp1_LC7_PhGe_SA_Plate2D_22_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_22_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	71c16165e8f94105debaa65cdc1762ef4c33e5af184e210ec785106b08b0c2fc	SAMEA7711602
PXD004242-22 plasma at 39 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150907_qep1_lc7_phge_sa_plate2d_22_6	20150907_QEp1_LC7_PhGe_SA_Plate2D_22_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_22_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	d352ffa2ec9394879802bea31408d97fe7255da30866c8646b5c265115adf65f	SAMEA7711603
PXD004242-22 plasma at 52 weeks	Homo sapiens	blood plasma	22	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150907_qep1_lc7_phge_sa_plate2d_22_7	20150907_QEp1_LC7_PhGe_SA_Plate2D_22_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_22_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	d2836353083545039091bbbe18564656c854c8289581d9825025ff572b1c5338	SAMEA7711604
PXD004242-23 plasma at -8 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150701_qep1_lc7_phge_sa_plate3a_23_1	20150701_QEp1_LC7_PhGe_SA_Plate3A_23_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_23_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	1154d89be1e9befc0f4d0847c3760ca83f5f4f2572698bb58539fb15852311d3	SAMEA7711605
PXD004242-23 plasma at 0 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150701_qep1_lc7_phge_sa_plate3a_23_2	20150701_QEp1_LC7_PhGe_SA_Plate3A_23_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_23_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	7f27e0d3c41bfbf5e2103455e588a048539b700554dfd2c0e6905a3dd8b8a497	SAMEA7711606
PXD004242-23 plasma at 4 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150701_qep1_lc7_phge_sa_plate3a_23_3	20150701_QEp1_LC7_PhGe_SA_Plate3A_23_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_23_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	149b3b6264cee4587e037f61a656d506938be68e910d6f3ecc2920db39bab038	SAMEA7711607
PXD004242-23 plasma at 13 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150701_qep1_lc7_phge_sa_plate3a_23_4	20150701_QEp1_LC7_PhGe_SA_Plate3A_23_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_23_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	9a580109cad9462410f29805621f449a41085ffe10ea58ddcd20b18d57cf159a	SAMEA7711608
PXD004242-23 plasma at 26 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150701_qep1_lc7_phge_sa_plate3a_23_5	20150701_QEp1_LC7_PhGe_SA_Plate3A_23_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_23_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	727b373cfd251bc3557493295284be1c7a066fd78f7ae38bfd7852cf10521c15	SAMEA7711609
PXD004242-23 plasma at 39 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150701_qep1_lc7_phge_sa_plate3a_23_6	20150701_QEp1_LC7_PhGe_SA_Plate3A_23_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_23_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	4b29050448e8e84afd4d5cbb1b778d23d222a4e848ef3398a68069c1ec634389	SAMEA7711610
PXD004242-23 plasma at 52 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150701_qep1_lc7_phge_sa_plate3a_23_7	20150701_QEp1_LC7_PhGe_SA_Plate3A_23_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_23_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f061bd24f460922a713ff14f89b55ba912a64941305148f8de0290578d0608a5	SAMEA7711611
PXD004242-23 plasma at 0 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150725_qep1_lc7_phge_sa_plate3b_23_2	20150725_QEp1_LC7_PhGe_SA_Plate3B_23_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_23_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	7f27e0d3c41bfbf5e2103455e588a048539b700554dfd2c0e6905a3dd8b8a497	SAMEA7711606
PXD004242-23 plasma at 4 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150725_qep1_lc7_phge_sa_plate3b_23_3	20150725_QEp1_LC7_PhGe_SA_Plate3B_23_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_23_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	149b3b6264cee4587e037f61a656d506938be68e910d6f3ecc2920db39bab038	SAMEA7711607
PXD004242-23 plasma at 26 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150725_qep1_lc7_phge_sa_plate3b_23_5	20150725_QEp1_LC7_PhGe_SA_Plate3B_23_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_23_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	727b373cfd251bc3557493295284be1c7a066fd78f7ae38bfd7852cf10521c15	SAMEA7711609
PXD004242-23 plasma at 52 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150725_qep1_lc7_phge_sa_plate3b_23_7	20150725_QEp1_LC7_PhGe_SA_Plate3B_23_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_23_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f061bd24f460922a713ff14f89b55ba912a64941305148f8de0290578d0608a5	SAMEA7711611
PXD004242-23 plasma at -8 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150818_qep1_lc7_phge_sa_plate3c_23_1	20150818_QEp1_LC7_PhGe_SA_Plate3C_23_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_23_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	1154d89be1e9befc0f4d0847c3760ca83f5f4f2572698bb58539fb15852311d3	SAMEA7711605
PXD004242-23 plasma at 0 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150818_qep1_lc7_phge_sa_plate3c_23_2	20150818_QEp1_LC7_PhGe_SA_Plate3C_23_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_23_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	7f27e0d3c41bfbf5e2103455e588a048539b700554dfd2c0e6905a3dd8b8a497	SAMEA7711606
PXD004242-23 plasma at 4 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150818_qep1_lc7_phge_sa_plate3c_23_3	20150818_QEp1_LC7_PhGe_SA_Plate3C_23_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_23_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	149b3b6264cee4587e037f61a656d506938be68e910d6f3ecc2920db39bab038	SAMEA7711607
PXD004242-23 plasma at 13 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150818_qep1_lc7_phge_sa_plate3c_23_4	20150818_QEp1_LC7_PhGe_SA_Plate3C_23_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_23_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	9a580109cad9462410f29805621f449a41085ffe10ea58ddcd20b18d57cf159a	SAMEA7711608
PXD004242-23 plasma at 26 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150818_qep1_lc7_phge_sa_plate3c_23_5	20150818_QEp1_LC7_PhGe_SA_Plate3C_23_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_23_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	727b373cfd251bc3557493295284be1c7a066fd78f7ae38bfd7852cf10521c15	SAMEA7711609
PXD004242-23 plasma at 39 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150818_qep1_lc7_phge_sa_plate3c_23_6	20150818_QEp1_LC7_PhGe_SA_Plate3C_23_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_23_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	4b29050448e8e84afd4d5cbb1b778d23d222a4e848ef3398a68069c1ec634389	SAMEA7711610
PXD004242-23 plasma at 52 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150818_qep1_lc7_phge_sa_plate3c_23_7	20150818_QEp1_LC7_PhGe_SA_Plate3C_23_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_23_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f061bd24f460922a713ff14f89b55ba912a64941305148f8de0290578d0608a5	SAMEA7711611
PXD004242-23 plasma at -8 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150912_qep1_lc7_phge_sa_plate3d_23_1	20150912_QEp1_LC7_PhGe_SA_Plate3D_23_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_23_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	1154d89be1e9befc0f4d0847c3760ca83f5f4f2572698bb58539fb15852311d3	SAMEA7711605
PXD004242-23 plasma at 0 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150912_qep1_lc7_phge_sa_plate3d_23_2	20150912_QEp1_LC7_PhGe_SA_Plate3D_23_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_23_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	7f27e0d3c41bfbf5e2103455e588a048539b700554dfd2c0e6905a3dd8b8a497	SAMEA7711606
PXD004242-23 plasma at 4 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150912_qep1_lc7_phge_sa_plate3d_23_3	20150912_QEp1_LC7_PhGe_SA_Plate3D_23_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_23_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	149b3b6264cee4587e037f61a656d506938be68e910d6f3ecc2920db39bab038	SAMEA7711607
PXD004242-23 plasma at 13 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150912_qep1_lc7_phge_sa_plate3d_23_4	20150912_QEp1_LC7_PhGe_SA_Plate3D_23_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_23_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	9a580109cad9462410f29805621f449a41085ffe10ea58ddcd20b18d57cf159a	SAMEA7711608
PXD004242-23 plasma at 26 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150912_qep1_lc7_phge_sa_plate3d_23_5	20150912_QEp1_LC7_PhGe_SA_Plate3D_23_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_23_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	727b373cfd251bc3557493295284be1c7a066fd78f7ae38bfd7852cf10521c15	SAMEA7711609
PXD004242-23 plasma at 39 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150912_qep1_lc7_phge_sa_plate3d_23_6	20150912_QEp1_LC7_PhGe_SA_Plate3D_23_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_23_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	4b29050448e8e84afd4d5cbb1b778d23d222a4e848ef3398a68069c1ec634389	SAMEA7711610
PXD004242-23 plasma at 52 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150912_qep1_lc7_phge_sa_plate3d_23_7	20150912_QEp1_LC7_PhGe_SA_Plate3D_23_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_23_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f061bd24f460922a713ff14f89b55ba912a64941305148f8de0290578d0608a5	SAMEA7711611
PXD004242-23 plasma at -8 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150917_qep1_lc7_phge_sa_plate3b_23_1	20150917_QEp1_LC7_PhGe_SA_Plate3B_23_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_23_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	1154d89be1e9befc0f4d0847c3760ca83f5f4f2572698bb58539fb15852311d3	SAMEA7711605
PXD004242-23 plasma at 13 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150917_qep1_lc7_phge_sa_plate3b_23_4	20150917_QEp1_LC7_PhGe_SA_Plate3B_23_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_23_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	9a580109cad9462410f29805621f449a41085ffe10ea58ddcd20b18d57cf159a	SAMEA7711608
PXD004242-23 plasma at 39 weeks	Homo sapiens	blood plasma	23	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150917_qep1_lc7_phge_sa_plate3b_23_6	20150917_QEp1_LC7_PhGe_SA_Plate3B_23_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_23_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	4b29050448e8e84afd4d5cbb1b778d23d222a4e848ef3398a68069c1ec634389	SAMEA7711610
PXD004242-24 plasma at -8 weeks	Homo sapiens	blood plasma	24	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150618_qep1_lc7_phge_sa_plate1b_24_1	20150618_QEp1_LC7_PhGe_SA_Plate1B_24_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_24_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	c05933f6fb2d8297ed07540b5230d47baa523549a6103223e8d2d7edede297b4	SAMEA7711612
PXD004242-24 plasma at 0 weeks	Homo sapiens	blood plasma	24	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150618_qep1_lc7_phge_sa_plate1b_24_2	20150618_QEp1_LC7_PhGe_SA_Plate1B_24_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_24_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	f8779442a04b9022cfa0b914d01f83bfc17fb9edb9531c1906c6555242aa9f64	SAMEA7711613
PXD004242-24 plasma at -8 weeks	Homo sapiens	blood plasma	24	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150708_qep1_lc7_phge_sa_plate1c_24_1	20150708_QEp1_LC7_PhGe_SA_Plate1C_24_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_24_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	c05933f6fb2d8297ed07540b5230d47baa523549a6103223e8d2d7edede297b4	SAMEA7711612
PXD004242-24 plasma at 0 weeks	Homo sapiens	blood plasma	24	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150708_qep1_lc7_phge_sa_plate1c_24_2	20150708_QEp1_LC7_PhGe_SA_Plate1C_24_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_24_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	f8779442a04b9022cfa0b914d01f83bfc17fb9edb9531c1906c6555242aa9f64	SAMEA7711613
PXD004242-24 plasma at -8 weeks	Homo sapiens	blood plasma	24	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150805_qep1_lc7_phge_sa_plate1d_24_1	20150805_QEp1_LC7_PhGe_SA_Plate1D_24_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_24_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	c05933f6fb2d8297ed07540b5230d47baa523549a6103223e8d2d7edede297b4	SAMEA7711612
PXD004242-24 plasma at 0 weeks	Homo sapiens	blood plasma	24	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150805_qep1_lc7_phge_sa_plate1d_24_2	20150805_QEp1_LC7_PhGe_SA_Plate1D_24_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_24_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	f8779442a04b9022cfa0b914d01f83bfc17fb9edb9531c1906c6555242aa9f64	SAMEA7711613
PXD004242-24 plasma at -8 weeks	Homo sapiens	blood plasma	24	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150901_qep1_lc7_phge_sa_plate1e_24_1	20150901_QEp1_LC7_PhGe_SA_Plate1E_24_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_24_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	c05933f6fb2d8297ed07540b5230d47baa523549a6103223e8d2d7edede297b4	SAMEA7711612
PXD004242-24 plasma at 0 weeks	Homo sapiens	blood plasma	24	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150901_qep1_lc7_phge_sa_plate1e_24_2	20150901_QEp1_LC7_PhGe_SA_Plate1E_24_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_24_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	f8779442a04b9022cfa0b914d01f83bfc17fb9edb9531c1906c6555242aa9f64	SAMEA7711613
PXD004242-25 plasma at 0 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150624_qep1_lc7_phge_sa_plate2a_25_2	20150624_QEp1_LC7_PhGe_SA_Plate2A_25_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_25_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	171b354e20297faebb031062efa0fa08fd2572ea0e1b79d930543186a9f16027	SAMEA7711614
PXD004242-25 plasma at 4 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150624_qep1_lc7_phge_sa_plate2a_25_3	20150624_QEp1_LC7_PhGe_SA_Plate2A_25_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_25_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	062b4338c0ca76c8134004218ec60058dc4d39b49df4cee05da5f6b6355a8202	SAMEA7711615
PXD004242-25 plasma at 26 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150624_qep1_lc7_phge_sa_plate2a_25_5	20150624_QEp1_LC7_PhGe_SA_Plate2A_25_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_25_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	16de8c6fa598e7e415b852aa75f6b4bebecd9a7e1d8885e390c53d2d92d60c12	SAMEA7711616
PXD004242-25 plasma at 39 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150624_qep1_lc7_phge_sa_plate2a_25_6	20150624_QEp1_LC7_PhGe_SA_Plate2A_25_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_25_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	441e2b18c573972c274eb526a92d19baed48e357214f1a375af9e7f67bea3521	SAMEA7711617
PXD004242-25 plasma at 52 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150624_qep1_lc7_phge_sa_plate2a_25_7	20150624_QEp1_LC7_PhGe_SA_Plate2A_25_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_25_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	9ae771aea72a3c8f8ff1ef4d9ad2745c07841452cd62d7129cc1abbd79cda371	SAMEA7711618
PXD004242-25 plasma at -8 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150811_qep1_lc7_phge_sa_plate2b_25_1	20150811_QEp1_LC7_PhGe_SA_Plate2B_25_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_25_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	257bb018c780bd8fbf25a810df5b6bc9ae5a6e11b67c1de89ffc3c7398e5974c	SAMEA7711619
PXD004242-25 plasma at 0 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150811_qep1_lc7_phge_sa_plate2b_25_2	20150811_QEp1_LC7_PhGe_SA_Plate2B_25_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_25_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	171b354e20297faebb031062efa0fa08fd2572ea0e1b79d930543186a9f16027	SAMEA7711614
PXD004242-25 plasma at 4 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150811_qep1_lc7_phge_sa_plate2b_25_3	20150811_QEp1_LC7_PhGe_SA_Plate2B_25_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_25_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	062b4338c0ca76c8134004218ec60058dc4d39b49df4cee05da5f6b6355a8202	SAMEA7711615
PXD004242-25 plasma at 13 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150811_qep1_lc7_phge_sa_plate2b_25_4	20150811_QEp1_LC7_PhGe_SA_Plate2B_25_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_25_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	36d198e130f50b8b9cc2bb41712079a999e06ce75b18f2097a3fb9c76b8c6e67	SAMEA7711620
PXD004242-25 plasma at 26 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150811_qep1_lc7_phge_sa_plate2b_25_5	20150811_QEp1_LC7_PhGe_SA_Plate2B_25_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_25_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	16de8c6fa598e7e415b852aa75f6b4bebecd9a7e1d8885e390c53d2d92d60c12	SAMEA7711616
PXD004242-25 plasma at 39 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150811_qep1_lc7_phge_sa_plate2b_25_6	20150811_QEp1_LC7_PhGe_SA_Plate2B_25_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_25_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	441e2b18c573972c274eb526a92d19baed48e357214f1a375af9e7f67bea3521	SAMEA7711617
PXD004242-25 plasma at 52 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150811_qep1_lc7_phge_sa_plate2b_25_7	20150811_QEp1_LC7_PhGe_SA_Plate2B_25_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_25_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	9ae771aea72a3c8f8ff1ef4d9ad2745c07841452cd62d7129cc1abbd79cda371	SAMEA7711618
PXD004242-25 plasma at -8 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150827_qep1_lc7_phge_sa_plate2c_25_1	20150827_QEp1_LC7_PhGe_SA_Plate2C_25_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_25_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	257bb018c780bd8fbf25a810df5b6bc9ae5a6e11b67c1de89ffc3c7398e5974c	SAMEA7711619
PXD004242-25 plasma at 0 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150827_qep1_lc7_phge_sa_plate2c_25_2	20150827_QEp1_LC7_PhGe_SA_Plate2C_25_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_25_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	171b354e20297faebb031062efa0fa08fd2572ea0e1b79d930543186a9f16027	SAMEA7711614
PXD004242-25 plasma at 4 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150827_qep1_lc7_phge_sa_plate2c_25_3	20150827_QEp1_LC7_PhGe_SA_Plate2C_25_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_25_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	062b4338c0ca76c8134004218ec60058dc4d39b49df4cee05da5f6b6355a8202	SAMEA7711615
PXD004242-25 plasma at 13 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150827_qep1_lc7_phge_sa_plate2c_25_4	20150827_QEp1_LC7_PhGe_SA_Plate2C_25_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_25_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	36d198e130f50b8b9cc2bb41712079a999e06ce75b18f2097a3fb9c76b8c6e67	SAMEA7711620
PXD004242-25 plasma at 26 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150827_qep1_lc7_phge_sa_plate2c_25_5	20150827_QEp1_LC7_PhGe_SA_Plate2C_25_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_25_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	16de8c6fa598e7e415b852aa75f6b4bebecd9a7e1d8885e390c53d2d92d60c12	SAMEA7711616
PXD004242-25 plasma at 39 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150827_qep1_lc7_phge_sa_plate2c_25_6	20150827_QEp1_LC7_PhGe_SA_Plate2C_25_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_25_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	441e2b18c573972c274eb526a92d19baed48e357214f1a375af9e7f67bea3521	SAMEA7711617
PXD004242-25 plasma at 52 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150827_qep1_lc7_phge_sa_plate2c_25_7	20150827_QEp1_LC7_PhGe_SA_Plate2C_25_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_25_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	9ae771aea72a3c8f8ff1ef4d9ad2745c07841452cd62d7129cc1abbd79cda371	SAMEA7711618
PXD004242-25 plasma at -8 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150907_qep1_lc7_phge_sa_plate2d_25_1	20150907_QEp1_LC7_PhGe_SA_Plate2D_25_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_25_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	257bb018c780bd8fbf25a810df5b6bc9ae5a6e11b67c1de89ffc3c7398e5974c	SAMEA7711619
PXD004242-25 plasma at 0 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150907_qep1_lc7_phge_sa_plate2d_25_2	20150907_QEp1_LC7_PhGe_SA_Plate2D_25_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_25_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	171b354e20297faebb031062efa0fa08fd2572ea0e1b79d930543186a9f16027	SAMEA7711614
PXD004242-25 plasma at 4 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150907_qep1_lc7_phge_sa_plate2d_25_3	20150907_QEp1_LC7_PhGe_SA_Plate2D_25_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_25_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	062b4338c0ca76c8134004218ec60058dc4d39b49df4cee05da5f6b6355a8202	SAMEA7711615
PXD004242-25 plasma at 13 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150907_qep1_lc7_phge_sa_plate2d_25_4	20150907_QEp1_LC7_PhGe_SA_Plate2D_25_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_25_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	36d198e130f50b8b9cc2bb41712079a999e06ce75b18f2097a3fb9c76b8c6e67	SAMEA7711620
PXD004242-25 plasma at 26 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150907_qep1_lc7_phge_sa_plate2d_25_5	20150907_QEp1_LC7_PhGe_SA_Plate2D_25_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_25_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	16de8c6fa598e7e415b852aa75f6b4bebecd9a7e1d8885e390c53d2d92d60c12	SAMEA7711616
PXD004242-25 plasma at 39 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150907_qep1_lc7_phge_sa_plate2d_25_6	20150907_QEp1_LC7_PhGe_SA_Plate2D_25_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_25_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	441e2b18c573972c274eb526a92d19baed48e357214f1a375af9e7f67bea3521	SAMEA7711617
PXD004242-25 plasma at 52 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150907_qep1_lc7_phge_sa_plate2d_25_7	20150907_QEp1_LC7_PhGe_SA_Plate2D_25_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_25_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	9ae771aea72a3c8f8ff1ef4d9ad2745c07841452cd62d7129cc1abbd79cda371	SAMEA7711618
PXD004242-25 plasma at -8 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150917_qep1_lc7_phge_sa_plate2a_25_1	20150917_QEp1_LC7_PhGe_SA_Plate2A_25_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate2A_25_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	257bb018c780bd8fbf25a810df5b6bc9ae5a6e11b67c1de89ffc3c7398e5974c	SAMEA7711619
PXD004242-25 plasma at 13 weeks	Homo sapiens	blood plasma	25	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150917_qep1_lc7_phge_sa_plate2a_25_4	20150917_QEp1_LC7_PhGe_SA_Plate2A_25_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate2A_25_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	36d198e130f50b8b9cc2bb41712079a999e06ce75b18f2097a3fb9c76b8c6e67	SAMEA7711620
PXD004242-26 plasma at -8 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150701_qep1_lc7_phge_sa_plate3a_26_1	20150701_QEp1_LC7_PhGe_SA_Plate3A_26_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_26_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	17822c7b1f188e108fd00bd4af0638799109228642c97821b405797be5c55899	SAMEA7711621
PXD004242-26 plasma at 0 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150701_qep1_lc7_phge_sa_plate3a_26_2	20150701_QEp1_LC7_PhGe_SA_Plate3A_26_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_26_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	d98aa892c74996c51341e823a2edc12bf0821b9f11acc655762f68d01c062852	SAMEA7711622
PXD004242-26 plasma at 4 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150701_qep1_lc7_phge_sa_plate3a_26_3	20150701_QEp1_LC7_PhGe_SA_Plate3A_26_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_26_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	2481d1e43532f7b325267c1af2bfb022bc2baff47cf49a7dd809932e9fb01930	SAMEA7711623
PXD004242-26 plasma at 13 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150701_qep1_lc7_phge_sa_plate3a_26_4	20150701_QEp1_LC7_PhGe_SA_Plate3A_26_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_26_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	d1350b9e886a32cb7ebe6c7e9a90ea01ef48fe378d2fbbc8038352d9543989fb	SAMEA7711624
PXD004242-26 plasma at 39 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150701_qep1_lc7_phge_sa_plate3a_26_6	20150701_QEp1_LC7_PhGe_SA_Plate3A_26_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_26_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	5321669e7c94d8c29b4c465d77ec1397fbf45c29dcb2ca78403b01a657d2da03	SAMEA7711625
PXD004242-26 plasma at 52 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150701_qep1_lc7_phge_sa_plate3a_26_7	20150701_QEp1_LC7_PhGe_SA_Plate3A_26_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_26_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	cfeb17ff1ee75789e2b86307da80a1c3c467497f01a8fcc5e84f1bca7931065b	SAMEA7711626
PXD004242-26 plasma at -8 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150725_qep1_lc7_phge_sa_plate3b_26_1	20150725_QEp1_LC7_PhGe_SA_Plate3B_26_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_26_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	17822c7b1f188e108fd00bd4af0638799109228642c97821b405797be5c55899	SAMEA7711621
PXD004242-26 plasma at 0 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150725_qep1_lc7_phge_sa_plate3b_26_2	20150725_QEp1_LC7_PhGe_SA_Plate3B_26_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_26_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	d98aa892c74996c51341e823a2edc12bf0821b9f11acc655762f68d01c062852	SAMEA7711622
PXD004242-26 plasma at 4 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150725_qep1_lc7_phge_sa_plate3b_26_3	20150725_QEp1_LC7_PhGe_SA_Plate3B_26_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_26_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	2481d1e43532f7b325267c1af2bfb022bc2baff47cf49a7dd809932e9fb01930	SAMEA7711623
PXD004242-26 plasma at 13 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150725_qep1_lc7_phge_sa_plate3b_26_4	20150725_QEp1_LC7_PhGe_SA_Plate3B_26_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_26_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	d1350b9e886a32cb7ebe6c7e9a90ea01ef48fe378d2fbbc8038352d9543989fb	SAMEA7711624
PXD004242-26 plasma at 39 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150725_qep1_lc7_phge_sa_plate3b_26_6	20150725_QEp1_LC7_PhGe_SA_Plate3B_26_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_26_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	5321669e7c94d8c29b4c465d77ec1397fbf45c29dcb2ca78403b01a657d2da03	SAMEA7711625
PXD004242-26 plasma at 52 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150725_qep1_lc7_phge_sa_plate3b_26_7	20150725_QEp1_LC7_PhGe_SA_Plate3B_26_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_26_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	cfeb17ff1ee75789e2b86307da80a1c3c467497f01a8fcc5e84f1bca7931065b	SAMEA7711626
PXD004242-26 plasma at -8 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150818_qep1_lc7_phge_sa_plate3c_26_1	20150818_QEp1_LC7_PhGe_SA_Plate3C_26_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_26_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	17822c7b1f188e108fd00bd4af0638799109228642c97821b405797be5c55899	SAMEA7711621
PXD004242-26 plasma at 0 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150818_qep1_lc7_phge_sa_plate3c_26_2	20150818_QEp1_LC7_PhGe_SA_Plate3C_26_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_26_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	d98aa892c74996c51341e823a2edc12bf0821b9f11acc655762f68d01c062852	SAMEA7711622
PXD004242-26 plasma at 4 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150818_qep1_lc7_phge_sa_plate3c_26_3	20150818_QEp1_LC7_PhGe_SA_Plate3C_26_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_26_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	2481d1e43532f7b325267c1af2bfb022bc2baff47cf49a7dd809932e9fb01930	SAMEA7711623
PXD004242-26 plasma at 13 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150818_qep1_lc7_phge_sa_plate3c_26_4	20150818_QEp1_LC7_PhGe_SA_Plate3C_26_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_26_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	d1350b9e886a32cb7ebe6c7e9a90ea01ef48fe378d2fbbc8038352d9543989fb	SAMEA7711624
PXD004242-26 plasma at 26 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150818_qep1_lc7_phge_sa_plate3c_26_5	20150818_QEp1_LC7_PhGe_SA_Plate3C_26_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_26_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	e679a207bb6835e9b70af8dcbe28598360ed0a6452be13ba35d91166a1362ff6	SAMEA7711627
PXD004242-26 plasma at 39 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150818_qep1_lc7_phge_sa_plate3c_26_6	20150818_QEp1_LC7_PhGe_SA_Plate3C_26_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_26_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	5321669e7c94d8c29b4c465d77ec1397fbf45c29dcb2ca78403b01a657d2da03	SAMEA7711625
PXD004242-26 plasma at 52 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150818_qep1_lc7_phge_sa_plate3c_26_7	20150818_QEp1_LC7_PhGe_SA_Plate3C_26_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_26_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	cfeb17ff1ee75789e2b86307da80a1c3c467497f01a8fcc5e84f1bca7931065b	SAMEA7711626
PXD004242-26 plasma at -8 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150912_qep1_lc7_phge_sa_plate3d_26_1	20150912_QEp1_LC7_PhGe_SA_Plate3D_26_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_26_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	17822c7b1f188e108fd00bd4af0638799109228642c97821b405797be5c55899	SAMEA7711621
PXD004242-26 plasma at 0 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150912_qep1_lc7_phge_sa_plate3d_26_2	20150912_QEp1_LC7_PhGe_SA_Plate3D_26_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_26_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	d98aa892c74996c51341e823a2edc12bf0821b9f11acc655762f68d01c062852	SAMEA7711622
PXD004242-26 plasma at 4 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150912_qep1_lc7_phge_sa_plate3d_26_3	20150912_QEp1_LC7_PhGe_SA_Plate3D_26_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_26_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	2481d1e43532f7b325267c1af2bfb022bc2baff47cf49a7dd809932e9fb01930	SAMEA7711623
PXD004242-26 plasma at 13 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150912_qep1_lc7_phge_sa_plate3d_26_4	20150912_QEp1_LC7_PhGe_SA_Plate3D_26_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_26_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	d1350b9e886a32cb7ebe6c7e9a90ea01ef48fe378d2fbbc8038352d9543989fb	SAMEA7711624
PXD004242-26 plasma at 26 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150912_qep1_lc7_phge_sa_plate3d_26_5	20150912_QEp1_LC7_PhGe_SA_Plate3D_26_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_26_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	e679a207bb6835e9b70af8dcbe28598360ed0a6452be13ba35d91166a1362ff6	SAMEA7711627
PXD004242-26 plasma at 39 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150912_qep1_lc7_phge_sa_plate3d_26_6	20150912_QEp1_LC7_PhGe_SA_Plate3D_26_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_26_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	5321669e7c94d8c29b4c465d77ec1397fbf45c29dcb2ca78403b01a657d2da03	SAMEA7711625
PXD004242-26 plasma at 52 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150912_qep1_lc7_phge_sa_plate3d_26_7	20150912_QEp1_LC7_PhGe_SA_Plate3D_26_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_26_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	cfeb17ff1ee75789e2b86307da80a1c3c467497f01a8fcc5e84f1bca7931065b	SAMEA7711626
PXD004242-26 plasma at 26 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150917_qep1_lc7_phge_sa_plate3a_26_5	20150917_QEp1_LC7_PhGe_SA_Plate3A_26_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3A_26_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	e679a207bb6835e9b70af8dcbe28598360ed0a6452be13ba35d91166a1362ff6	SAMEA7711627
PXD004242-26 plasma at 26 weeks	Homo sapiens	blood plasma	26	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150917_qep1_lc7_phge_sa_plate3b_26_5	20150917_QEp1_LC7_PhGe_SA_Plate3B_26_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_26_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	e679a207bb6835e9b70af8dcbe28598360ed0a6452be13ba35d91166a1362ff6	SAMEA7711627
PXD004242-27 plasma at -8 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150701_qep1_lc7_phge_sa_plate3a_27_1	20150701_QEp1_LC7_PhGe_SA_Plate3A_27_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_27_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	8a3cd1ee739e68057d096d006dbc0d8140617426a2dc450c7c4340634a109453	SAMEA7711628
PXD004242-27 plasma at 0 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150701_qep1_lc7_phge_sa_plate3a_27_2	20150701_QEp1_LC7_PhGe_SA_Plate3A_27_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_27_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	2f50c7fad6af53b2faa2f8f62ad06bc0071b61805e8fa9c8a94cc2f9e16a165d	SAMEA7711629
PXD004242-27 plasma at 4 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150701_qep1_lc7_phge_sa_plate3a_27_3	20150701_QEp1_LC7_PhGe_SA_Plate3A_27_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_27_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	23cf19d4c0f7c1729f6f9f14d94cafcf7ec64dc6b87a378df0c18ee6952e99af	SAMEA7711630
PXD004242-27 plasma at 13 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150701_qep1_lc7_phge_sa_plate3a_27_4	20150701_QEp1_LC7_PhGe_SA_Plate3A_27_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_27_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	e7ca308915089c29c847cb38da49961e04e147724acdac975c25b835b3055667	SAMEA7711631
PXD004242-27 plasma at 26 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150701_qep1_lc7_phge_sa_plate3a_27_5	20150701_QEp1_LC7_PhGe_SA_Plate3A_27_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_27_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	50211c82df857406a8e22e57d303416774d0028cea663268acd411892182f47a	SAMEA7711632
PXD004242-27 plasma at 39 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150701_qep1_lc7_phge_sa_plate3a_27_6	20150701_QEp1_LC7_PhGe_SA_Plate3A_27_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_27_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	994752b25c6c056101c57090c620c2e4ff6f31955dc2306aedaa8b8fcccd2bb1	SAMEA7711633
PXD004242-27 plasma at 52 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150701_qep1_lc7_phge_sa_plate3a_27_7	20150701_QEp1_LC7_PhGe_SA_Plate3A_27_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_27_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	0b5cf711a4d8a91783431f2d05ec7a208a521d52ae98aa858c44b6f8b638002b	SAMEA7711634
PXD004242-27 plasma at -8 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150725_qep1_lc7_phge_sa_plate3b_27_1	20150725_QEp1_LC7_PhGe_SA_Plate3B_27_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_27_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	8a3cd1ee739e68057d096d006dbc0d8140617426a2dc450c7c4340634a109453	SAMEA7711628
PXD004242-27 plasma at 0 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150725_qep1_lc7_phge_sa_plate3b_27_2	20150725_QEp1_LC7_PhGe_SA_Plate3B_27_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_27_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	2f50c7fad6af53b2faa2f8f62ad06bc0071b61805e8fa9c8a94cc2f9e16a165d	SAMEA7711629
PXD004242-27 plasma at 4 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150725_qep1_lc7_phge_sa_plate3b_27_3	20150725_QEp1_LC7_PhGe_SA_Plate3B_27_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_27_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	23cf19d4c0f7c1729f6f9f14d94cafcf7ec64dc6b87a378df0c18ee6952e99af	SAMEA7711630
PXD004242-27 plasma at 13 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150725_qep1_lc7_phge_sa_plate3b_27_4	20150725_QEp1_LC7_PhGe_SA_Plate3B_27_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_27_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	e7ca308915089c29c847cb38da49961e04e147724acdac975c25b835b3055667	SAMEA7711631
PXD004242-27 plasma at 26 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150725_qep1_lc7_phge_sa_plate3b_27_5	20150725_QEp1_LC7_PhGe_SA_Plate3B_27_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_27_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	50211c82df857406a8e22e57d303416774d0028cea663268acd411892182f47a	SAMEA7711632
PXD004242-27 plasma at 39 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150725_qep1_lc7_phge_sa_plate3b_27_6	20150725_QEp1_LC7_PhGe_SA_Plate3B_27_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_27_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	994752b25c6c056101c57090c620c2e4ff6f31955dc2306aedaa8b8fcccd2bb1	SAMEA7711633
PXD004242-27 plasma at 52 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150725_qep1_lc7_phge_sa_plate3b_27_7	20150725_QEp1_LC7_PhGe_SA_Plate3B_27_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_27_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	0b5cf711a4d8a91783431f2d05ec7a208a521d52ae98aa858c44b6f8b638002b	SAMEA7711634
PXD004242-27 plasma at -8 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150818_qep1_lc7_phge_sa_plate3c_27_1	20150818_QEp1_LC7_PhGe_SA_Plate3C_27_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_27_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	8a3cd1ee739e68057d096d006dbc0d8140617426a2dc450c7c4340634a109453	SAMEA7711628
PXD004242-27 plasma at 0 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150818_qep1_lc7_phge_sa_plate3c_27_2	20150818_QEp1_LC7_PhGe_SA_Plate3C_27_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_27_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	2f50c7fad6af53b2faa2f8f62ad06bc0071b61805e8fa9c8a94cc2f9e16a165d	SAMEA7711629
PXD004242-27 plasma at 4 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150818_qep1_lc7_phge_sa_plate3c_27_3	20150818_QEp1_LC7_PhGe_SA_Plate3C_27_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_27_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	23cf19d4c0f7c1729f6f9f14d94cafcf7ec64dc6b87a378df0c18ee6952e99af	SAMEA7711630
PXD004242-27 plasma at 13 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150818_qep1_lc7_phge_sa_plate3c_27_4	20150818_QEp1_LC7_PhGe_SA_Plate3C_27_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_27_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	e7ca308915089c29c847cb38da49961e04e147724acdac975c25b835b3055667	SAMEA7711631
PXD004242-27 plasma at 26 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150818_qep1_lc7_phge_sa_plate3c_27_5	20150818_QEp1_LC7_PhGe_SA_Plate3C_27_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_27_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	50211c82df857406a8e22e57d303416774d0028cea663268acd411892182f47a	SAMEA7711632
PXD004242-27 plasma at 39 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150818_qep1_lc7_phge_sa_plate3c_27_6	20150818_QEp1_LC7_PhGe_SA_Plate3C_27_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_27_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	994752b25c6c056101c57090c620c2e4ff6f31955dc2306aedaa8b8fcccd2bb1	SAMEA7711633
PXD004242-27 plasma at 52 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150818_qep1_lc7_phge_sa_plate3c_27_7	20150818_QEp1_LC7_PhGe_SA_Plate3C_27_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_27_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	0b5cf711a4d8a91783431f2d05ec7a208a521d52ae98aa858c44b6f8b638002b	SAMEA7711634
PXD004242-27 plasma at -8 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150912_qep1_lc7_phge_sa_plate3d_27_1	20150912_QEp1_LC7_PhGe_SA_Plate3D_27_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_27_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	8a3cd1ee739e68057d096d006dbc0d8140617426a2dc450c7c4340634a109453	SAMEA7711628
PXD004242-27 plasma at 0 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150912_qep1_lc7_phge_sa_plate3d_27_2	20150912_QEp1_LC7_PhGe_SA_Plate3D_27_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_27_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	2f50c7fad6af53b2faa2f8f62ad06bc0071b61805e8fa9c8a94cc2f9e16a165d	SAMEA7711629
PXD004242-27 plasma at 4 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150912_qep1_lc7_phge_sa_plate3d_27_3	20150912_QEp1_LC7_PhGe_SA_Plate3D_27_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_27_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	23cf19d4c0f7c1729f6f9f14d94cafcf7ec64dc6b87a378df0c18ee6952e99af	SAMEA7711630
PXD004242-27 plasma at 13 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150912_qep1_lc7_phge_sa_plate3d_27_4	20150912_QEp1_LC7_PhGe_SA_Plate3D_27_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_27_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	e7ca308915089c29c847cb38da49961e04e147724acdac975c25b835b3055667	SAMEA7711631
PXD004242-27 plasma at 26 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150912_qep1_lc7_phge_sa_plate3d_27_5	20150912_QEp1_LC7_PhGe_SA_Plate3D_27_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_27_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	50211c82df857406a8e22e57d303416774d0028cea663268acd411892182f47a	SAMEA7711632
PXD004242-27 plasma at 39 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150912_qep1_lc7_phge_sa_plate3d_27_6	20150912_QEp1_LC7_PhGe_SA_Plate3D_27_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_27_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	994752b25c6c056101c57090c620c2e4ff6f31955dc2306aedaa8b8fcccd2bb1	SAMEA7711633
PXD004242-27 plasma at 52 weeks	Homo sapiens	blood plasma	27	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150912_qep1_lc7_phge_sa_plate3d_27_7	20150912_QEp1_LC7_PhGe_SA_Plate3D_27_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_27_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	0b5cf711a4d8a91783431f2d05ec7a208a521d52ae98aa858c44b6f8b638002b	SAMEA7711634
PXD004242-28 plasma at -8 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150618_qep1_lc7_phge_sa_plate1b_28_1	20150618_QEp1_LC7_PhGe_SA_Plate1B_28_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_28_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	b6f9a54023f14642057c3ecd59d8bba51f4ff502084ca7798c51f01884fa76da	SAMEA7711635
PXD004242-28 plasma at 0 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150618_qep1_lc7_phge_sa_plate1b_28_2	20150618_QEp1_LC7_PhGe_SA_Plate1B_28_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_28_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	72818996ff17e6cbc927d8e29805e584f41ba915dee27035b5cc3f3813703aa0	SAMEA7711636
PXD004242-28 plasma at 4 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150618_qep1_lc7_phge_sa_plate1b_28_3	20150618_QEp1_LC7_PhGe_SA_Plate1B_28_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_28_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	2919414d2ce602b74c9795e13df401895dfc2aedc5f271951fe4d837d2879b25	SAMEA7711637
PXD004242-28 plasma at 13 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150618_qep1_lc7_phge_sa_plate1b_28_4	20150618_QEp1_LC7_PhGe_SA_Plate1B_28_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_28_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	932733c2aae96c8beb3b7dc15acfb8d14cf461fdabef1aa5de04918a4564ab14	SAMEA7711638
PXD004242-28 plasma at 26 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150618_qep1_lc7_phge_sa_plate1b_28_5	20150618_QEp1_LC7_PhGe_SA_Plate1B_28_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_28_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	f844cc6c4f946c2c78357a8718ddd50ac3606a195218fb27be930badaf5f0189	SAMEA7711639
PXD004242-28 plasma at 39 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150618_qep1_lc7_phge_sa_plate1b_28_6	20150618_QEp1_LC7_PhGe_SA_Plate1B_28_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_28_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	eec142c9b5483da80069a32e84d3f984bee7dfbedaeff708833d3dc05025f2e5	SAMEA7711640
PXD004242-28 plasma at 52 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150618_qep1_lc7_phge_sa_plate1b_28_7	20150618_QEp1_LC7_PhGe_SA_Plate1B_28_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_28_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f63f5ff17ba1ebc22801e309ef6f8a2f8eb540c1632b94499ecb9ea16c378d86	SAMEA7711641
PXD004242-28 plasma at -8 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150708_qep1_lc7_phge_sa_plate1c_28_1	20150708_QEp1_LC7_PhGe_SA_Plate1C_28_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_28_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	b6f9a54023f14642057c3ecd59d8bba51f4ff502084ca7798c51f01884fa76da	SAMEA7711635
PXD004242-28 plasma at 0 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150708_qep1_lc7_phge_sa_plate1c_28_2	20150708_QEp1_LC7_PhGe_SA_Plate1C_28_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_28_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	72818996ff17e6cbc927d8e29805e584f41ba915dee27035b5cc3f3813703aa0	SAMEA7711636
PXD004242-28 plasma at 4 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150708_qep1_lc7_phge_sa_plate1c_28_3	20150708_QEp1_LC7_PhGe_SA_Plate1C_28_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_28_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	2919414d2ce602b74c9795e13df401895dfc2aedc5f271951fe4d837d2879b25	SAMEA7711637
PXD004242-28 plasma at 13 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150708_qep1_lc7_phge_sa_plate1c_28_4	20150708_QEp1_LC7_PhGe_SA_Plate1C_28_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_28_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	932733c2aae96c8beb3b7dc15acfb8d14cf461fdabef1aa5de04918a4564ab14	SAMEA7711638
PXD004242-28 plasma at 39 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150708_qep1_lc7_phge_sa_plate1c_28_6	20150708_QEp1_LC7_PhGe_SA_Plate1C_28_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_28_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	eec142c9b5483da80069a32e84d3f984bee7dfbedaeff708833d3dc05025f2e5	SAMEA7711640
PXD004242-28 plasma at 52 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150708_qep1_lc7_phge_sa_plate1c_28_7	20150708_QEp1_LC7_PhGe_SA_Plate1C_28_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_28_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f63f5ff17ba1ebc22801e309ef6f8a2f8eb540c1632b94499ecb9ea16c378d86	SAMEA7711641
PXD004242-28 plasma at -8 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150805_qep1_lc7_phge_sa_plate1d_28_1	20150805_QEp1_LC7_PhGe_SA_Plate1D_28_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_28_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	b6f9a54023f14642057c3ecd59d8bba51f4ff502084ca7798c51f01884fa76da	SAMEA7711635
PXD004242-28 plasma at 0 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150805_qep1_lc7_phge_sa_plate1d_28_2	20150805_QEp1_LC7_PhGe_SA_Plate1D_28_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_28_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	72818996ff17e6cbc927d8e29805e584f41ba915dee27035b5cc3f3813703aa0	SAMEA7711636
PXD004242-28 plasma at 4 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150805_qep1_lc7_phge_sa_plate1d_28_3	20150805_QEp1_LC7_PhGe_SA_Plate1D_28_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_28_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	2919414d2ce602b74c9795e13df401895dfc2aedc5f271951fe4d837d2879b25	SAMEA7711637
PXD004242-28 plasma at 13 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150805_qep1_lc7_phge_sa_plate1d_28_4	20150805_QEp1_LC7_PhGe_SA_Plate1D_28_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_28_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	932733c2aae96c8beb3b7dc15acfb8d14cf461fdabef1aa5de04918a4564ab14	SAMEA7711638
PXD004242-28 plasma at 26 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150805_qep1_lc7_phge_sa_plate1d_28_5	20150805_QEp1_LC7_PhGe_SA_Plate1D_28_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_28_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	f844cc6c4f946c2c78357a8718ddd50ac3606a195218fb27be930badaf5f0189	SAMEA7711639
PXD004242-28 plasma at 39 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150805_qep1_lc7_phge_sa_plate1d_28_6	20150805_QEp1_LC7_PhGe_SA_Plate1D_28_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_28_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	eec142c9b5483da80069a32e84d3f984bee7dfbedaeff708833d3dc05025f2e5	SAMEA7711640
PXD004242-28 plasma at 52 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150805_qep1_lc7_phge_sa_plate1d_28_7	20150805_QEp1_LC7_PhGe_SA_Plate1D_28_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_28_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f63f5ff17ba1ebc22801e309ef6f8a2f8eb540c1632b94499ecb9ea16c378d86	SAMEA7711641
PXD004242-28 plasma at -8 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150901_qep1_lc7_phge_sa_plate1e_28_1	20150901_QEp1_LC7_PhGe_SA_Plate1E_28_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_28_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	b6f9a54023f14642057c3ecd59d8bba51f4ff502084ca7798c51f01884fa76da	SAMEA7711635
PXD004242-28 plasma at 0 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150901_qep1_lc7_phge_sa_plate1e_28_2	20150901_QEp1_LC7_PhGe_SA_Plate1E_28_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_28_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	72818996ff17e6cbc927d8e29805e584f41ba915dee27035b5cc3f3813703aa0	SAMEA7711636
PXD004242-28 plasma at 4 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150901_qep1_lc7_phge_sa_plate1e_28_3	20150901_QEp1_LC7_PhGe_SA_Plate1E_28_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_28_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	2919414d2ce602b74c9795e13df401895dfc2aedc5f271951fe4d837d2879b25	SAMEA7711637
PXD004242-28 plasma at 13 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150901_qep1_lc7_phge_sa_plate1e_28_4	20150901_QEp1_LC7_PhGe_SA_Plate1E_28_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_28_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	932733c2aae96c8beb3b7dc15acfb8d14cf461fdabef1aa5de04918a4564ab14	SAMEA7711638
PXD004242-28 plasma at 26 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150901_qep1_lc7_phge_sa_plate1e_28_5	20150901_QEp1_LC7_PhGe_SA_Plate1E_28_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_28_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	f844cc6c4f946c2c78357a8718ddd50ac3606a195218fb27be930badaf5f0189	SAMEA7711639
PXD004242-28 plasma at 39 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150901_qep1_lc7_phge_sa_plate1e_28_6	20150901_QEp1_LC7_PhGe_SA_Plate1E_28_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_28_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	eec142c9b5483da80069a32e84d3f984bee7dfbedaeff708833d3dc05025f2e5	SAMEA7711640
PXD004242-28 plasma at 52 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150901_qep1_lc7_phge_sa_plate1e_28_7	20150901_QEp1_LC7_PhGe_SA_Plate1E_28_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_28_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f63f5ff17ba1ebc22801e309ef6f8a2f8eb540c1632b94499ecb9ea16c378d86	SAMEA7711641
PXD004242-28 plasma at 26 weeks	Homo sapiens	blood plasma	28	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150917_qep1_lc8_phge_sa_plate1c_28_5	20150917_QEp1_LC8_PhGe_SA_Plate1C_28_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_Plate1C_28_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	f844cc6c4f946c2c78357a8718ddd50ac3606a195218fb27be930badaf5f0189	SAMEA7711639
PXD004242-29 plasma at -8 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150624_qep1_lc7_phge_sa_plate2a_29_1	20150624_QEp1_LC7_PhGe_SA_Plate2A_29_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_29_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	77987e3f06306779419241135448151080d5ee86f2e471efd7732a0d13b20144	SAMEA7711642
PXD004242-29 plasma at 0 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150624_qep1_lc7_phge_sa_plate2a_29_2	20150624_QEp1_LC7_PhGe_SA_Plate2A_29_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_29_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	c831cb84ed2cb1e87b30ad85567a7b0cc01c462371b7a7c532472c2d1f6c8954	SAMEA7711643
PXD004242-29 plasma at 4 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150624_qep1_lc7_phge_sa_plate2a_29_3	20150624_QEp1_LC7_PhGe_SA_Plate2A_29_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_29_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	4d26363da025ac48ab4f90a9aac67a03aab78334023342d717f45abd20aec8fd	SAMEA7711644
PXD004242-29 plasma at 13 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150624_qep1_lc7_phge_sa_plate2a_29_4	20150624_QEp1_LC7_PhGe_SA_Plate2A_29_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_29_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	136a4f04f410d31c3c93aaa28f697a188e220e2de7607a24b9e6bd4c5a07731c	SAMEA7711645
PXD004242-29 plasma at 26 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150624_qep1_lc7_phge_sa_plate2a_29_5	20150624_QEp1_LC7_PhGe_SA_Plate2A_29_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_29_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	51708244eb3cd06445cdae52003a3fc8dc934c145f70ca84181bc700ff4b14f9	SAMEA7711646
PXD004242-29 plasma at 39 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150624_qep1_lc7_phge_sa_plate2a_29_6	20150624_QEp1_LC7_PhGe_SA_Plate2A_29_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_29_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	a9cdafe9573701891549c267166cc144c3fa44eabb07c93da31465c518367e81	SAMEA7711647
PXD004242-29 plasma at 52 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150624_qep1_lc7_phge_sa_plate2a_29_7	20150624_QEp1_LC7_PhGe_SA_Plate2A_29_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_29_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	97750bf3ae5e80a1dde87a69811b7c673dd71327a0c80bf2c019eb031ea03068	SAMEA7711648
PXD004242-29 plasma at -8 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150811_qep1_lc7_phge_sa_plate2b_29_1	20150811_QEp1_LC7_PhGe_SA_Plate2B_29_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_29_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	77987e3f06306779419241135448151080d5ee86f2e471efd7732a0d13b20144	SAMEA7711642
PXD004242-29 plasma at 0 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150811_qep1_lc7_phge_sa_plate2b_29_2	20150811_QEp1_LC7_PhGe_SA_Plate2B_29_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_29_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	c831cb84ed2cb1e87b30ad85567a7b0cc01c462371b7a7c532472c2d1f6c8954	SAMEA7711643
PXD004242-29 plasma at 4 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150811_qep1_lc7_phge_sa_plate2b_29_3	20150811_QEp1_LC7_PhGe_SA_Plate2B_29_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_29_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	4d26363da025ac48ab4f90a9aac67a03aab78334023342d717f45abd20aec8fd	SAMEA7711644
PXD004242-29 plasma at 13 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150811_qep1_lc7_phge_sa_plate2b_29_4	20150811_QEp1_LC7_PhGe_SA_Plate2B_29_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_29_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	136a4f04f410d31c3c93aaa28f697a188e220e2de7607a24b9e6bd4c5a07731c	SAMEA7711645
PXD004242-29 plasma at 26 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150811_qep1_lc7_phge_sa_plate2b_29_5	20150811_QEp1_LC7_PhGe_SA_Plate2B_29_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_29_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	51708244eb3cd06445cdae52003a3fc8dc934c145f70ca84181bc700ff4b14f9	SAMEA7711646
PXD004242-29 plasma at 39 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150811_qep1_lc7_phge_sa_plate2b_29_6	20150811_QEp1_LC7_PhGe_SA_Plate2B_29_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_29_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	a9cdafe9573701891549c267166cc144c3fa44eabb07c93da31465c518367e81	SAMEA7711647
PXD004242-29 plasma at 52 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150811_qep1_lc7_phge_sa_plate2b_29_7	20150811_QEp1_LC7_PhGe_SA_Plate2B_29_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_29_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	97750bf3ae5e80a1dde87a69811b7c673dd71327a0c80bf2c019eb031ea03068	SAMEA7711648
PXD004242-29 plasma at -8 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150827_qep1_lc7_phge_sa_plate2c_29_1	20150827_QEp1_LC7_PhGe_SA_Plate2C_29_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_29_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	77987e3f06306779419241135448151080d5ee86f2e471efd7732a0d13b20144	SAMEA7711642
PXD004242-29 plasma at 0 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150827_qep1_lc7_phge_sa_plate2c_29_2	20150827_QEp1_LC7_PhGe_SA_Plate2C_29_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_29_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	c831cb84ed2cb1e87b30ad85567a7b0cc01c462371b7a7c532472c2d1f6c8954	SAMEA7711643
PXD004242-29 plasma at 4 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150827_qep1_lc7_phge_sa_plate2c_29_3	20150827_QEp1_LC7_PhGe_SA_Plate2C_29_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_29_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	4d26363da025ac48ab4f90a9aac67a03aab78334023342d717f45abd20aec8fd	SAMEA7711644
PXD004242-29 plasma at 13 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150827_qep1_lc7_phge_sa_plate2c_29_4	20150827_QEp1_LC7_PhGe_SA_Plate2C_29_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_29_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	136a4f04f410d31c3c93aaa28f697a188e220e2de7607a24b9e6bd4c5a07731c	SAMEA7711645
PXD004242-29 plasma at 26 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150827_qep1_lc7_phge_sa_plate2c_29_5	20150827_QEp1_LC7_PhGe_SA_Plate2C_29_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_29_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	51708244eb3cd06445cdae52003a3fc8dc934c145f70ca84181bc700ff4b14f9	SAMEA7711646
PXD004242-29 plasma at 39 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150827_qep1_lc7_phge_sa_plate2c_29_6	20150827_QEp1_LC7_PhGe_SA_Plate2C_29_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_29_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	a9cdafe9573701891549c267166cc144c3fa44eabb07c93da31465c518367e81	SAMEA7711647
PXD004242-29 plasma at 52 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150827_qep1_lc7_phge_sa_plate2c_29_7	20150827_QEp1_LC7_PhGe_SA_Plate2C_29_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_29_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	97750bf3ae5e80a1dde87a69811b7c673dd71327a0c80bf2c019eb031ea03068	SAMEA7711648
PXD004242-29 plasma at -8 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150907_qep1_lc7_phge_sa_plate2d_29_1	20150907_QEp1_LC7_PhGe_SA_Plate2D_29_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_29_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	77987e3f06306779419241135448151080d5ee86f2e471efd7732a0d13b20144	SAMEA7711642
PXD004242-29 plasma at 0 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150907_qep1_lc7_phge_sa_plate2d_29_2	20150907_QEp1_LC7_PhGe_SA_Plate2D_29_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_29_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	c831cb84ed2cb1e87b30ad85567a7b0cc01c462371b7a7c532472c2d1f6c8954	SAMEA7711643
PXD004242-29 plasma at 4 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150907_qep1_lc7_phge_sa_plate2d_29_3	20150907_QEp1_LC7_PhGe_SA_Plate2D_29_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_29_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	4d26363da025ac48ab4f90a9aac67a03aab78334023342d717f45abd20aec8fd	SAMEA7711644
PXD004242-29 plasma at 13 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150907_qep1_lc7_phge_sa_plate2d_29_4	20150907_QEp1_LC7_PhGe_SA_Plate2D_29_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_29_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	136a4f04f410d31c3c93aaa28f697a188e220e2de7607a24b9e6bd4c5a07731c	SAMEA7711645
PXD004242-29 plasma at 26 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150907_qep1_lc7_phge_sa_plate2d_29_5	20150907_QEp1_LC7_PhGe_SA_Plate2D_29_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_29_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	51708244eb3cd06445cdae52003a3fc8dc934c145f70ca84181bc700ff4b14f9	SAMEA7711646
PXD004242-29 plasma at 39 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150907_qep1_lc7_phge_sa_plate2d_29_6	20150907_QEp1_LC7_PhGe_SA_Plate2D_29_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_29_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	a9cdafe9573701891549c267166cc144c3fa44eabb07c93da31465c518367e81	SAMEA7711647
PXD004242-29 plasma at 52 weeks	Homo sapiens	blood plasma	29	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150907_qep1_lc7_phge_sa_plate2d_29_7	20150907_QEp1_LC7_PhGe_SA_Plate2D_29_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_29_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	97750bf3ae5e80a1dde87a69811b7c673dd71327a0c80bf2c019eb031ea03068	SAMEA7711648
PXD004242-30 plasma at -8 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150618_qep1_lc7_phge_sa_plate1b_30_1	20150618_QEp1_LC7_PhGe_SA_Plate1B_30_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_30_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	e0b6db06ad2ef0718174fe2b5e8603ee6afa7b8ff303dfae04e30b1c52ef1588	SAMEA7711649
PXD004242-30 plasma at 0 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150618_qep1_lc7_phge_sa_plate1b_30_2	20150618_QEp1_LC7_PhGe_SA_Plate1B_30_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_30_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	f2170ec4cb93cde7fff312d4ae006534573611eef32ef0bac5e643bb125057d8	SAMEA7711650
PXD004242-30 plasma at 4 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150618_qep1_lc7_phge_sa_plate1b_30_3	20150618_QEp1_LC7_PhGe_SA_Plate1B_30_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_30_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	97f50684a38355326c0f45ae0b8f9b1373424367dd01c9c6aeb4755d75fd77aa	SAMEA7711651
PXD004242-30 plasma at 13 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150618_qep1_lc7_phge_sa_plate1b_30_4	20150618_QEp1_LC7_PhGe_SA_Plate1B_30_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_30_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	6c060e33ffea488682d2d97f55707cbbaf2a69cd4c6b8204c4c8a616335dd7b3	SAMEA7711652
PXD004242-30 plasma at 26 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150618_qep1_lc7_phge_sa_plate1b_30_5	20150618_QEp1_LC7_PhGe_SA_Plate1B_30_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_30_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	0e53a3ccbe721c9dae9dd89e1ae444cc5769d5371f2de3a3b875d25b724d2ac1	SAMEA7711653
PXD004242-30 plasma at 39 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150618_qep1_lc7_phge_sa_plate1b_30_6	20150618_QEp1_LC7_PhGe_SA_Plate1B_30_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_30_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	abc05cce8bce22317765a88493c3fc5658d6f9ced3b74d7ae03ccf58c2898332	SAMEA7711654
PXD004242-30 plasma at 52 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150618_qep1_lc7_phge_sa_plate1b_30_7	20150618_QEp1_LC7_PhGe_SA_Plate1B_30_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_30_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	a09b2c57858dcae819008322d2bb503f1dbe2545a95bb8ae1dcfa2af67f7d8e6	SAMEA7711655
PXD004242-30 plasma at -8 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150708_qep1_lc7_phge_sa_plate1c_30_1	20150708_QEp1_LC7_PhGe_SA_Plate1C_30_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_30_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	e0b6db06ad2ef0718174fe2b5e8603ee6afa7b8ff303dfae04e30b1c52ef1588	SAMEA7711649
PXD004242-30 plasma at 0 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150708_qep1_lc7_phge_sa_plate1c_30_2	20150708_QEp1_LC7_PhGe_SA_Plate1C_30_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_30_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	f2170ec4cb93cde7fff312d4ae006534573611eef32ef0bac5e643bb125057d8	SAMEA7711650
PXD004242-30 plasma at 4 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150708_qep1_lc7_phge_sa_plate1c_30_3	20150708_QEp1_LC7_PhGe_SA_Plate1C_30_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_30_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	97f50684a38355326c0f45ae0b8f9b1373424367dd01c9c6aeb4755d75fd77aa	SAMEA7711651
PXD004242-30 plasma at 13 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150708_qep1_lc7_phge_sa_plate1c_30_4	20150708_QEp1_LC7_PhGe_SA_Plate1C_30_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_30_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	6c060e33ffea488682d2d97f55707cbbaf2a69cd4c6b8204c4c8a616335dd7b3	SAMEA7711652
PXD004242-30 plasma at 26 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150708_qep1_lc7_phge_sa_plate1c_30_5	20150708_QEp1_LC7_PhGe_SA_Plate1C_30_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_30_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	0e53a3ccbe721c9dae9dd89e1ae444cc5769d5371f2de3a3b875d25b724d2ac1	SAMEA7711653
PXD004242-30 plasma at 39 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150708_qep1_lc7_phge_sa_plate1c_30_6	20150708_QEp1_LC7_PhGe_SA_Plate1C_30_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_30_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	abc05cce8bce22317765a88493c3fc5658d6f9ced3b74d7ae03ccf58c2898332	SAMEA7711654
PXD004242-30 plasma at 52 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150708_qep1_lc7_phge_sa_plate1c_30_7	20150708_QEp1_LC7_PhGe_SA_Plate1C_30_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_30_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	a09b2c57858dcae819008322d2bb503f1dbe2545a95bb8ae1dcfa2af67f7d8e6	SAMEA7711655
PXD004242-30 plasma at -8 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150805_qep1_lc7_phge_sa_plate1d_30_1	20150805_QEp1_LC7_PhGe_SA_Plate1D_30_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_30_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	e0b6db06ad2ef0718174fe2b5e8603ee6afa7b8ff303dfae04e30b1c52ef1588	SAMEA7711649
PXD004242-30 plasma at 0 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150805_qep1_lc7_phge_sa_plate1d_30_2	20150805_QEp1_LC7_PhGe_SA_Plate1D_30_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_30_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	f2170ec4cb93cde7fff312d4ae006534573611eef32ef0bac5e643bb125057d8	SAMEA7711650
PXD004242-30 plasma at 4 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150805_qep1_lc7_phge_sa_plate1d_30_3	20150805_QEp1_LC7_PhGe_SA_Plate1D_30_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_30_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	97f50684a38355326c0f45ae0b8f9b1373424367dd01c9c6aeb4755d75fd77aa	SAMEA7711651
PXD004242-30 plasma at 13 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150805_qep1_lc7_phge_sa_plate1d_30_4	20150805_QEp1_LC7_PhGe_SA_Plate1D_30_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_30_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	6c060e33ffea488682d2d97f55707cbbaf2a69cd4c6b8204c4c8a616335dd7b3	SAMEA7711652
PXD004242-30 plasma at 26 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150805_qep1_lc7_phge_sa_plate1d_30_5	20150805_QEp1_LC7_PhGe_SA_Plate1D_30_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_30_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	0e53a3ccbe721c9dae9dd89e1ae444cc5769d5371f2de3a3b875d25b724d2ac1	SAMEA7711653
PXD004242-30 plasma at 39 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150805_qep1_lc7_phge_sa_plate1d_30_6	20150805_QEp1_LC7_PhGe_SA_Plate1D_30_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_30_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	abc05cce8bce22317765a88493c3fc5658d6f9ced3b74d7ae03ccf58c2898332	SAMEA7711654
PXD004242-30 plasma at 52 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150805_qep1_lc7_phge_sa_plate1d_30_7	20150805_QEp1_LC7_PhGe_SA_Plate1D_30_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_30_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	a09b2c57858dcae819008322d2bb503f1dbe2545a95bb8ae1dcfa2af67f7d8e6	SAMEA7711655
PXD004242-30 plasma at -8 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150901_qep1_lc7_phge_sa_plate1e_30_1	20150901_QEp1_LC7_PhGe_SA_Plate1E_30_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_30_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	e0b6db06ad2ef0718174fe2b5e8603ee6afa7b8ff303dfae04e30b1c52ef1588	SAMEA7711649
PXD004242-30 plasma at 0 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150901_qep1_lc7_phge_sa_plate1e_30_2	20150901_QEp1_LC7_PhGe_SA_Plate1E_30_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_30_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	f2170ec4cb93cde7fff312d4ae006534573611eef32ef0bac5e643bb125057d8	SAMEA7711650
PXD004242-30 plasma at 4 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150901_qep1_lc7_phge_sa_plate1e_30_3	20150901_QEp1_LC7_PhGe_SA_Plate1E_30_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_30_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	97f50684a38355326c0f45ae0b8f9b1373424367dd01c9c6aeb4755d75fd77aa	SAMEA7711651
PXD004242-30 plasma at 13 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150901_qep1_lc7_phge_sa_plate1e_30_4	20150901_QEp1_LC7_PhGe_SA_Plate1E_30_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_30_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	6c060e33ffea488682d2d97f55707cbbaf2a69cd4c6b8204c4c8a616335dd7b3	SAMEA7711652
PXD004242-30 plasma at 26 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150901_qep1_lc7_phge_sa_plate1e_30_5	20150901_QEp1_LC7_PhGe_SA_Plate1E_30_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_30_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	0e53a3ccbe721c9dae9dd89e1ae444cc5769d5371f2de3a3b875d25b724d2ac1	SAMEA7711653
PXD004242-30 plasma at 39 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150901_qep1_lc7_phge_sa_plate1e_30_6	20150901_QEp1_LC7_PhGe_SA_Plate1E_30_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_30_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	abc05cce8bce22317765a88493c3fc5658d6f9ced3b74d7ae03ccf58c2898332	SAMEA7711654
PXD004242-30 plasma at 52 weeks	Homo sapiens	blood plasma	30	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150901_qep1_lc7_phge_sa_plate1e_30_7	20150901_QEp1_LC7_PhGe_SA_Plate1E_30_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_30_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	a09b2c57858dcae819008322d2bb503f1dbe2545a95bb8ae1dcfa2af67f7d8e6	SAMEA7711655
PXD004242-31 plasma at -8 weeks	Homo sapiens	blood plasma	31	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150624_qep1_lc7_phge_sa_plate2a_31_1	20150624_QEp1_LC7_PhGe_SA_Plate2A_31_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_31_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	9e7905e4cec035133cbee59acd7d827ad8980af4c07a8dbb154b3487f9902170	SAMEA7711656
PXD004242-31 plasma at 0 weeks	Homo sapiens	blood plasma	31	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150624_qep1_lc7_phge_sa_plate2a_31_2	20150624_QEp1_LC7_PhGe_SA_Plate2A_31_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_31_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	e8d5de1c09619c0032d499058d82897e636d89e8cb854f70856d35a032ad2c8b	SAMEA7711657
PXD004242-31 plasma at -8 weeks	Homo sapiens	blood plasma	31	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150811_qep1_lc7_phge_sa_plate2b_31_1	20150811_QEp1_LC7_PhGe_SA_Plate2B_31_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_31_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	9e7905e4cec035133cbee59acd7d827ad8980af4c07a8dbb154b3487f9902170	SAMEA7711656
PXD004242-31 plasma at 0 weeks	Homo sapiens	blood plasma	31	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150811_qep1_lc7_phge_sa_plate2b_31_2	20150811_QEp1_LC7_PhGe_SA_Plate2B_31_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_31_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	e8d5de1c09619c0032d499058d82897e636d89e8cb854f70856d35a032ad2c8b	SAMEA7711657
PXD004242-31 plasma at -8 weeks	Homo sapiens	blood plasma	31	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150827_qep1_lc7_phge_sa_plate2c_31_1	20150827_QEp1_LC7_PhGe_SA_Plate2C_31_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_31_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	9e7905e4cec035133cbee59acd7d827ad8980af4c07a8dbb154b3487f9902170	SAMEA7711656
PXD004242-31 plasma at 0 weeks	Homo sapiens	blood plasma	31	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150827_qep1_lc7_phge_sa_plate2c_31_2	20150827_QEp1_LC7_PhGe_SA_Plate2C_31_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_31_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	e8d5de1c09619c0032d499058d82897e636d89e8cb854f70856d35a032ad2c8b	SAMEA7711657
PXD004242-31 plasma at -8 weeks	Homo sapiens	blood plasma	31	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150907_qep1_lc7_phge_sa_plate2d_31_1	20150907_QEp1_LC7_PhGe_SA_Plate2D_31_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_31_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	9e7905e4cec035133cbee59acd7d827ad8980af4c07a8dbb154b3487f9902170	SAMEA7711656
PXD004242-31 plasma at 0 weeks	Homo sapiens	blood plasma	31	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150907_qep1_lc7_phge_sa_plate2d_31_2	20150907_QEp1_LC7_PhGe_SA_Plate2D_31_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_31_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	e8d5de1c09619c0032d499058d82897e636d89e8cb854f70856d35a032ad2c8b	SAMEA7711657
PXD004242-33 plasma at -8 weeks	Homo sapiens	blood plasma	33	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150701_qep1_lc7_phge_sa_plate3a_33_1	20150701_QEp1_LC7_PhGe_SA_Plate3A_33_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_33_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	dd54a1966941f0cd27e5c501193bd893d897c2c208ee20524373cb5812d04099	SAMEA7711658
PXD004242-33 plasma at 0 weeks	Homo sapiens	blood plasma	33	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150701_qep1_lc7_phge_sa_plate3a_33_2	20150701_QEp1_LC7_PhGe_SA_Plate3A_33_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_33_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	1896b99e5996e134b3a4d519c17b9c443fef7308ef167b6ef773887f61971cc9	SAMEA7711659
PXD004242-33 plasma at -8 weeks	Homo sapiens	blood plasma	33	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150725_qep1_lc7_phge_sa_plate3b_33_1	20150725_QEp1_LC7_PhGe_SA_Plate3B_33_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_33_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	dd54a1966941f0cd27e5c501193bd893d897c2c208ee20524373cb5812d04099	SAMEA7711658
PXD004242-33 plasma at 0 weeks	Homo sapiens	blood plasma	33	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150725_qep1_lc7_phge_sa_plate3b_33_2	20150725_QEp1_LC7_PhGe_SA_Plate3B_33_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_33_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	1896b99e5996e134b3a4d519c17b9c443fef7308ef167b6ef773887f61971cc9	SAMEA7711659
PXD004242-33 plasma at 0 weeks	Homo sapiens	blood plasma	33	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150818_qep1_lc7_phge_sa_plate3c_33_2	20150818_QEp1_LC7_PhGe_SA_Plate3C_33_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_33_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	1896b99e5996e134b3a4d519c17b9c443fef7308ef167b6ef773887f61971cc9	SAMEA7711659
PXD004242-33 plasma at -8 weeks	Homo sapiens	blood plasma	33	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150912_qep1_lc7_phge_sa_plate3d_33_1	20150912_QEp1_LC7_PhGe_SA_Plate3D_33_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_33_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	dd54a1966941f0cd27e5c501193bd893d897c2c208ee20524373cb5812d04099	SAMEA7711658
PXD004242-33 plasma at -8 weeks	Homo sapiens	blood plasma	33	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150917_qep1_lc7_phge_sa_plate3c_33_1	20150917_QEp1_LC7_PhGe_SA_Plate3C_33_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3C_33_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	dd54a1966941f0cd27e5c501193bd893d897c2c208ee20524373cb5812d04099	SAMEA7711658
PXD004242-33 plasma at 0 weeks	Homo sapiens	blood plasma	33	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150917_qep1_lc7_phge_sa_plate3d_33_2	20150917_QEp1_LC7_PhGe_SA_Plate3D_33_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3D_33_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	1896b99e5996e134b3a4d519c17b9c443fef7308ef167b6ef773887f61971cc9	SAMEA7711659
PXD004242-34 plasma at -8 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150701_qep1_lc7_phge_sa_plate3a_34_1	20150701_QEp1_LC7_PhGe_SA_Plate3A_34_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_34_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	a3cbe8d2b59526e746f2d7bd9e4565dbb720ea32404982f0844cdd72ccf00568	SAMEA7711660
PXD004242-34 plasma at 0 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150701_qep1_lc7_phge_sa_plate3a_34_2	20150701_QEp1_LC7_PhGe_SA_Plate3A_34_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_34_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	23c19c83482f8241c9d6688a58a09ec9b24f0ccf26bb3e9ded0b0628b379b3c2	SAMEA7711661
PXD004242-34 plasma at 4 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150701_qep1_lc7_phge_sa_plate3a_34_3	20150701_QEp1_LC7_PhGe_SA_Plate3A_34_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_34_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	c5e23e0c758f0f83cf487b025f7a1749efb2f7b6fdcb486dfc3260580d52c740	SAMEA7711662
PXD004242-34 plasma at 13 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150701_qep1_lc7_phge_sa_plate3a_34_4	20150701_QEp1_LC7_PhGe_SA_Plate3A_34_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_34_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	df132057a3030b77bef335a7fca868d72db3bdde54edcb3cd7df290c6e37cc56	SAMEA7711663
PXD004242-34 plasma at 26 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150701_qep1_lc7_phge_sa_plate3a_34_5	20150701_QEp1_LC7_PhGe_SA_Plate3A_34_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_34_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	c76ee0204b827e963ef197c0ae0228a821a1c7f9801f790dda198b7dfc969717	SAMEA7711664
PXD004242-34 plasma at 39 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150701_qep1_lc7_phge_sa_plate3a_34_6	20150701_QEp1_LC7_PhGe_SA_Plate3A_34_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_34_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	ff2613656d4011f8f703f10aeb44189f5b86890b9e9f793be64a774f9ff2c784	SAMEA7711665
PXD004242-34 plasma at 52 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150701_qep1_lc7_phge_sa_plate3a_34_7	20150701_QEp1_LC7_PhGe_SA_Plate3A_34_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_34_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	4b785f95553541af0953b9050ba8a14ff4b6e285dbe5e180a9dc189f156baebb	SAMEA7711666
PXD004242-34 plasma at -8 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150725_qep1_lc7_phge_sa_plate3b_34_1	20150725_QEp1_LC7_PhGe_SA_Plate3B_34_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_34_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	a3cbe8d2b59526e746f2d7bd9e4565dbb720ea32404982f0844cdd72ccf00568	SAMEA7711660
PXD004242-34 plasma at 0 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150725_qep1_lc7_phge_sa_plate3b_34_2	20150725_QEp1_LC7_PhGe_SA_Plate3B_34_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_34_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	23c19c83482f8241c9d6688a58a09ec9b24f0ccf26bb3e9ded0b0628b379b3c2	SAMEA7711661
PXD004242-34 plasma at 26 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150725_qep1_lc7_phge_sa_plate3b_34_5	20150725_QEp1_LC7_PhGe_SA_Plate3B_34_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_34_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	c76ee0204b827e963ef197c0ae0228a821a1c7f9801f790dda198b7dfc969717	SAMEA7711664
PXD004242-34 plasma at 52 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150725_qep1_lc7_phge_sa_plate3b_34_7	20150725_QEp1_LC7_PhGe_SA_Plate3B_34_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_34_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	4b785f95553541af0953b9050ba8a14ff4b6e285dbe5e180a9dc189f156baebb	SAMEA7711666
PXD004242-34 plasma at -8 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150818_qep1_lc7_phge_sa_plate3c_34_1	20150818_QEp1_LC7_PhGe_SA_Plate3C_34_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_34_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	a3cbe8d2b59526e746f2d7bd9e4565dbb720ea32404982f0844cdd72ccf00568	SAMEA7711660
PXD004242-34 plasma at 0 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150818_qep1_lc7_phge_sa_plate3c_34_2	20150818_QEp1_LC7_PhGe_SA_Plate3C_34_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_34_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	23c19c83482f8241c9d6688a58a09ec9b24f0ccf26bb3e9ded0b0628b379b3c2	SAMEA7711661
PXD004242-34 plasma at 4 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150818_qep1_lc7_phge_sa_plate3c_34_3	20150818_QEp1_LC7_PhGe_SA_Plate3C_34_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_34_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	c5e23e0c758f0f83cf487b025f7a1749efb2f7b6fdcb486dfc3260580d52c740	SAMEA7711662
PXD004242-34 plasma at 13 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150818_qep1_lc7_phge_sa_plate3c_34_4	20150818_QEp1_LC7_PhGe_SA_Plate3C_34_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_34_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	df132057a3030b77bef335a7fca868d72db3bdde54edcb3cd7df290c6e37cc56	SAMEA7711663
PXD004242-34 plasma at 26 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150818_qep1_lc7_phge_sa_plate3c_34_5	20150818_QEp1_LC7_PhGe_SA_Plate3C_34_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_34_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	c76ee0204b827e963ef197c0ae0228a821a1c7f9801f790dda198b7dfc969717	SAMEA7711664
PXD004242-34 plasma at 39 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150818_qep1_lc7_phge_sa_plate3c_34_6	20150818_QEp1_LC7_PhGe_SA_Plate3C_34_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_34_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	ff2613656d4011f8f703f10aeb44189f5b86890b9e9f793be64a774f9ff2c784	SAMEA7711665
PXD004242-34 plasma at 52 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150818_qep1_lc7_phge_sa_plate3c_34_7	20150818_QEp1_LC7_PhGe_SA_Plate3C_34_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_34_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	4b785f95553541af0953b9050ba8a14ff4b6e285dbe5e180a9dc189f156baebb	SAMEA7711666
PXD004242-34 plasma at -8 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150912_qep1_lc7_phge_sa_plate3d_34_1	20150912_QEp1_LC7_PhGe_SA_Plate3D_34_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_34_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	a3cbe8d2b59526e746f2d7bd9e4565dbb720ea32404982f0844cdd72ccf00568	SAMEA7711660
PXD004242-34 plasma at 0 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150912_qep1_lc7_phge_sa_plate3d_34_2	20150912_QEp1_LC7_PhGe_SA_Plate3D_34_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_34_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	23c19c83482f8241c9d6688a58a09ec9b24f0ccf26bb3e9ded0b0628b379b3c2	SAMEA7711661
PXD004242-34 plasma at 4 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150912_qep1_lc7_phge_sa_plate3d_34_3	20150912_QEp1_LC7_PhGe_SA_Plate3D_34_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_34_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	c5e23e0c758f0f83cf487b025f7a1749efb2f7b6fdcb486dfc3260580d52c740	SAMEA7711662
PXD004242-34 plasma at 13 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150912_qep1_lc7_phge_sa_plate3d_34_4	20150912_QEp1_LC7_PhGe_SA_Plate3D_34_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_34_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	df132057a3030b77bef335a7fca868d72db3bdde54edcb3cd7df290c6e37cc56	SAMEA7711663
PXD004242-34 plasma at 26 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150912_qep1_lc7_phge_sa_plate3d_34_5	20150912_QEp1_LC7_PhGe_SA_Plate3D_34_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_34_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	c76ee0204b827e963ef197c0ae0228a821a1c7f9801f790dda198b7dfc969717	SAMEA7711664
PXD004242-34 plasma at 39 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150912_qep1_lc7_phge_sa_plate3d_34_6	20150912_QEp1_LC7_PhGe_SA_Plate3D_34_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_34_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	ff2613656d4011f8f703f10aeb44189f5b86890b9e9f793be64a774f9ff2c784	SAMEA7711665
PXD004242-34 plasma at 52 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150912_qep1_lc7_phge_sa_plate3d_34_7	20150912_QEp1_LC7_PhGe_SA_Plate3D_34_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_34_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	4b785f95553541af0953b9050ba8a14ff4b6e285dbe5e180a9dc189f156baebb	SAMEA7711666
PXD004242-34 plasma at 4 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150917_qep1_lc7_phge_sa_plate3b_34_3	20150917_QEp1_LC7_PhGe_SA_Plate3B_34_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_34_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	c5e23e0c758f0f83cf487b025f7a1749efb2f7b6fdcb486dfc3260580d52c740	SAMEA7711662
PXD004242-34 plasma at 13 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150917_qep1_lc7_phge_sa_plate3b_34_4	20150917_QEp1_LC7_PhGe_SA_Plate3B_34_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_34_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	df132057a3030b77bef335a7fca868d72db3bdde54edcb3cd7df290c6e37cc56	SAMEA7711663
PXD004242-34 plasma at 39 weeks	Homo sapiens	blood plasma	34	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150917_qep1_lc7_phge_sa_plate3b_34_6	20150917_QEp1_LC7_PhGe_SA_Plate3B_34_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_34_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	ff2613656d4011f8f703f10aeb44189f5b86890b9e9f793be64a774f9ff2c784	SAMEA7711665
PXD004242-35 plasma at -8 weeks	Homo sapiens	blood plasma	35	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150701_qep1_lc7_phge_sa_plate3a_35_1	20150701_QEp1_LC7_PhGe_SA_Plate3A_35_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_35_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	a7687ddf03715df99264ad8315f80ea4c64f8a78c4c364a2c0f1c31425dacca9	SAMEA7711667
PXD004242-35 plasma at 0 weeks	Homo sapiens	blood plasma	35	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150701_qep1_lc7_phge_sa_plate3a_35_2	20150701_QEp1_LC7_PhGe_SA_Plate3A_35_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_35_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	542784e0826111be0f2f07a4f76327260613079c18542effe4cafc03d2ef1ada	SAMEA7711668
PXD004242-35 plasma at 0 weeks	Homo sapiens	blood plasma	35	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150725_qep1_lc7_phge_sa_plate3b_35_2	20150725_QEp1_LC7_PhGe_SA_Plate3B_35_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_35_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	542784e0826111be0f2f07a4f76327260613079c18542effe4cafc03d2ef1ada	SAMEA7711668
PXD004242-35 plasma at -8 weeks	Homo sapiens	blood plasma	35	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150818_qep1_lc7_phge_sa_plate3c_35_1	20150818_QEp1_LC7_PhGe_SA_Plate3C_35_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_35_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	a7687ddf03715df99264ad8315f80ea4c64f8a78c4c364a2c0f1c31425dacca9	SAMEA7711667
PXD004242-35 plasma at 0 weeks	Homo sapiens	blood plasma	35	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150818_qep1_lc7_phge_sa_plate3c_35_2	20150818_QEp1_LC7_PhGe_SA_Plate3C_35_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_35_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	542784e0826111be0f2f07a4f76327260613079c18542effe4cafc03d2ef1ada	SAMEA7711668
PXD004242-35 plasma at -8 weeks	Homo sapiens	blood plasma	35	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150912_qep1_lc7_phge_sa_plate3d_35_1	20150912_QEp1_LC7_PhGe_SA_Plate3D_35_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_35_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	a7687ddf03715df99264ad8315f80ea4c64f8a78c4c364a2c0f1c31425dacca9	SAMEA7711667
PXD004242-35 plasma at 0 weeks	Homo sapiens	blood plasma	35	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150912_qep1_lc7_phge_sa_plate3d_35_2	20150912_QEp1_LC7_PhGe_SA_Plate3D_35_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_35_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	542784e0826111be0f2f07a4f76327260613079c18542effe4cafc03d2ef1ada	SAMEA7711668
PXD004242-35 plasma at -8 weeks	Homo sapiens	blood plasma	35	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150917_qep1_lc7_phge_sa_plate3b_35_1	20150917_QEp1_LC7_PhGe_SA_Plate3B_35_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_35_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	a7687ddf03715df99264ad8315f80ea4c64f8a78c4c364a2c0f1c31425dacca9	SAMEA7711667
PXD004242-36 plasma at -8 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150624_qep1_lc7_phge_sa_plate2a_36_1	20150624_QEp1_LC7_PhGe_SA_Plate2A_36_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_36_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	cd4e87e3271d6a417d12cce6a4bca8979311f9f676483321a020e2dffa1af48d	SAMEA7711669
PXD004242-36 plasma at 0 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150624_qep1_lc7_phge_sa_plate2a_36_2	20150624_QEp1_LC7_PhGe_SA_Plate2A_36_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_36_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	4d2349675acbebc10393e4ff8acbebb5a3e05bd992a8a27a5865d20ebeed303a	SAMEA7711670
PXD004242-36 plasma at 4 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150624_qep1_lc7_phge_sa_plate2a_36_3	20150624_QEp1_LC7_PhGe_SA_Plate2A_36_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_36_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	190759e1249c14bc1cc6a9b134224d13ca7d1cf3ece091912640aa1329777970	SAMEA7711671
PXD004242-36 plasma at 13 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150624_qep1_lc7_phge_sa_plate2a_36_4	20150624_QEp1_LC7_PhGe_SA_Plate2A_36_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_36_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	94d4a5b1c6cc301c8a5b3a801e02b18dda87a1f6a2ea19002b9a7a9e23aae9fb	SAMEA7711672
PXD004242-36 plasma at 26 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150624_qep1_lc7_phge_sa_plate2a_36_5	20150624_QEp1_LC7_PhGe_SA_Plate2A_36_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_36_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	0a6fff0f8f6fc0ba0e58f82bbf4ee3c2dfdd5e4303e15534c42b2e5c124eed22	SAMEA7711673
PXD004242-36 plasma at 39 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150624_qep1_lc7_phge_sa_plate2a_36_6	20150624_QEp1_LC7_PhGe_SA_Plate2A_36_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_36_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	f4cfd6e2c8c6195c7677e932310977ffb83bc18dc885962388f19fb5ca3b7921	SAMEA7711674
PXD004242-36 plasma at 52 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150624_qep1_lc7_phge_sa_plate2a_36_7	20150624_QEp1_LC7_PhGe_SA_Plate2A_36_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_36_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	169524f97e383c4a207f6badbd0fbc4bb63b8891fe41b39519f79d3a015f3dcf	SAMEA7711675
PXD004242-36 plasma at -8 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150811_qep1_lc7_phge_sa_plate2b_36_1	20150811_QEp1_LC7_PhGe_SA_Plate2B_36_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_36_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	cd4e87e3271d6a417d12cce6a4bca8979311f9f676483321a020e2dffa1af48d	SAMEA7711669
PXD004242-36 plasma at 0 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150811_qep1_lc7_phge_sa_plate2b_36_2	20150811_QEp1_LC7_PhGe_SA_Plate2B_36_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_36_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	4d2349675acbebc10393e4ff8acbebb5a3e05bd992a8a27a5865d20ebeed303a	SAMEA7711670
PXD004242-36 plasma at 4 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150811_qep1_lc7_phge_sa_plate2b_36_3	20150811_QEp1_LC7_PhGe_SA_Plate2B_36_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_36_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	190759e1249c14bc1cc6a9b134224d13ca7d1cf3ece091912640aa1329777970	SAMEA7711671
PXD004242-36 plasma at 13 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150811_qep1_lc7_phge_sa_plate2b_36_4	20150811_QEp1_LC7_PhGe_SA_Plate2B_36_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_36_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	94d4a5b1c6cc301c8a5b3a801e02b18dda87a1f6a2ea19002b9a7a9e23aae9fb	SAMEA7711672
PXD004242-36 plasma at 26 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150811_qep1_lc7_phge_sa_plate2b_36_5	20150811_QEp1_LC7_PhGe_SA_Plate2B_36_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_36_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	0a6fff0f8f6fc0ba0e58f82bbf4ee3c2dfdd5e4303e15534c42b2e5c124eed22	SAMEA7711673
PXD004242-36 plasma at 39 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150811_qep1_lc7_phge_sa_plate2b_36_6	20150811_QEp1_LC7_PhGe_SA_Plate2B_36_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_36_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	f4cfd6e2c8c6195c7677e932310977ffb83bc18dc885962388f19fb5ca3b7921	SAMEA7711674
PXD004242-36 plasma at 52 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150811_qep1_lc7_phge_sa_plate2b_36_7	20150811_QEp1_LC7_PhGe_SA_Plate2B_36_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_36_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	169524f97e383c4a207f6badbd0fbc4bb63b8891fe41b39519f79d3a015f3dcf	SAMEA7711675
PXD004242-36 plasma at -8 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150827_qep1_lc7_phge_sa_plate2c_36_1	20150827_QEp1_LC7_PhGe_SA_Plate2C_36_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_36_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	cd4e87e3271d6a417d12cce6a4bca8979311f9f676483321a020e2dffa1af48d	SAMEA7711669
PXD004242-36 plasma at 0 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150827_qep1_lc7_phge_sa_plate2c_36_2	20150827_QEp1_LC7_PhGe_SA_Plate2C_36_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_36_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	4d2349675acbebc10393e4ff8acbebb5a3e05bd992a8a27a5865d20ebeed303a	SAMEA7711670
PXD004242-36 plasma at 4 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150827_qep1_lc7_phge_sa_plate2c_36_3	20150827_QEp1_LC7_PhGe_SA_Plate2C_36_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_36_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	190759e1249c14bc1cc6a9b134224d13ca7d1cf3ece091912640aa1329777970	SAMEA7711671
PXD004242-36 plasma at 13 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150827_qep1_lc7_phge_sa_plate2c_36_4	20150827_QEp1_LC7_PhGe_SA_Plate2C_36_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_36_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	94d4a5b1c6cc301c8a5b3a801e02b18dda87a1f6a2ea19002b9a7a9e23aae9fb	SAMEA7711672
PXD004242-36 plasma at 26 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150827_qep1_lc7_phge_sa_plate2c_36_5	20150827_QEp1_LC7_PhGe_SA_Plate2C_36_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_36_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	0a6fff0f8f6fc0ba0e58f82bbf4ee3c2dfdd5e4303e15534c42b2e5c124eed22	SAMEA7711673
PXD004242-36 plasma at 39 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150827_qep1_lc7_phge_sa_plate2c_36_6	20150827_QEp1_LC7_PhGe_SA_Plate2C_36_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_36_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	f4cfd6e2c8c6195c7677e932310977ffb83bc18dc885962388f19fb5ca3b7921	SAMEA7711674
PXD004242-36 plasma at 52 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150827_qep1_lc7_phge_sa_plate2c_36_7	20150827_QEp1_LC7_PhGe_SA_Plate2C_36_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_36_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	169524f97e383c4a207f6badbd0fbc4bb63b8891fe41b39519f79d3a015f3dcf	SAMEA7711675
PXD004242-36 plasma at -8 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150907_qep1_lc7_phge_sa_plate2d_36_1	20150907_QEp1_LC7_PhGe_SA_Plate2D_36_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_36_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	cd4e87e3271d6a417d12cce6a4bca8979311f9f676483321a020e2dffa1af48d	SAMEA7711669
PXD004242-36 plasma at 0 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150907_qep1_lc7_phge_sa_plate2d_36_2	20150907_QEp1_LC7_PhGe_SA_Plate2D_36_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_36_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	4d2349675acbebc10393e4ff8acbebb5a3e05bd992a8a27a5865d20ebeed303a	SAMEA7711670
PXD004242-36 plasma at 4 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150907_qep1_lc7_phge_sa_plate2d_36_3	20150907_QEp1_LC7_PhGe_SA_Plate2D_36_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_36_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	190759e1249c14bc1cc6a9b134224d13ca7d1cf3ece091912640aa1329777970	SAMEA7711671
PXD004242-36 plasma at 13 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150907_qep1_lc7_phge_sa_plate2d_36_4	20150907_QEp1_LC7_PhGe_SA_Plate2D_36_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_36_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	94d4a5b1c6cc301c8a5b3a801e02b18dda87a1f6a2ea19002b9a7a9e23aae9fb	SAMEA7711672
PXD004242-36 plasma at 26 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150907_qep1_lc7_phge_sa_plate2d_36_5	20150907_QEp1_LC7_PhGe_SA_Plate2D_36_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_36_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	0a6fff0f8f6fc0ba0e58f82bbf4ee3c2dfdd5e4303e15534c42b2e5c124eed22	SAMEA7711673
PXD004242-36 plasma at 39 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150907_qep1_lc7_phge_sa_plate2d_36_6	20150907_QEp1_LC7_PhGe_SA_Plate2D_36_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_36_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	f4cfd6e2c8c6195c7677e932310977ffb83bc18dc885962388f19fb5ca3b7921	SAMEA7711674
PXD004242-36 plasma at 52 weeks	Homo sapiens	blood plasma	36	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150907_qep1_lc7_phge_sa_plate2d_36_7	20150907_QEp1_LC7_PhGe_SA_Plate2D_36_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_36_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	169524f97e383c4a207f6badbd0fbc4bb63b8891fe41b39519f79d3a015f3dcf	SAMEA7711675
PXD004242-37 plasma at -8 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150701_qep1_lc7_phge_sa_plate3a_37_1	20150701_QEp1_LC7_PhGe_SA_Plate3A_37_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_37_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	ef35f9fcae1b44f94a916fa5d5633fdf60acb1d53b6b488e867716440de7b896	SAMEA7711676
PXD004242-37 plasma at 0 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150701_qep1_lc7_phge_sa_plate3a_37_2	20150701_QEp1_LC7_PhGe_SA_Plate3A_37_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_37_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	97e6a433548b32ab09b9973635eca9b4a21b845e3768c3de7bf640980713259e	SAMEA7711677
PXD004242-37 plasma at 4 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150701_qep1_lc7_phge_sa_plate3a_37_3	20150701_QEp1_LC7_PhGe_SA_Plate3A_37_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_37_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	c09dd07637951fc4031e6dd966dbe8a40262e3cd2aebeccdb26fb805f90b1292	SAMEA7711678
PXD004242-37 plasma at 13 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150701_qep1_lc7_phge_sa_plate3a_37_4	20150701_QEp1_LC7_PhGe_SA_Plate3A_37_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_37_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	33e40034760830f5d49a9c43e4b339580dda2dba89cb8194f052863c33f24716	SAMEA7711679
PXD004242-37 plasma at 26 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150701_qep1_lc7_phge_sa_plate3a_37_5	20150701_QEp1_LC7_PhGe_SA_Plate3A_37_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_37_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	cc973b12551f1e6277265cad7cf6c4c66ac95bc40f35bdc3eea88a365b464dfe	SAMEA7711680
PXD004242-37 plasma at 39 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150701_qep1_lc7_phge_sa_plate3a_37_6	20150701_QEp1_LC7_PhGe_SA_Plate3A_37_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_37_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	91fec24a84494ea33ebfe8f198804aa192ae635691fe98c7c6835ef17c4f4a07	SAMEA7711681
PXD004242-37 plasma at 52 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150701_qep1_lc7_phge_sa_plate3a_37_7	20150701_QEp1_LC7_PhGe_SA_Plate3A_37_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_37_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	36734203ea4f5170f996b212469e5003932bd5c72222fee66f0c25d64af5b93f	SAMEA7711682
PXD004242-37 plasma at -8 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150725_qep1_lc7_phge_sa_plate3b_37_1	20150725_QEp1_LC7_PhGe_SA_Plate3B_37_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_37_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	ef35f9fcae1b44f94a916fa5d5633fdf60acb1d53b6b488e867716440de7b896	SAMEA7711676
PXD004242-37 plasma at 0 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150725_qep1_lc7_phge_sa_plate3b_37_2	20150725_QEp1_LC7_PhGe_SA_Plate3B_37_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_37_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	97e6a433548b32ab09b9973635eca9b4a21b845e3768c3de7bf640980713259e	SAMEA7711677
PXD004242-37 plasma at 4 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150725_qep1_lc7_phge_sa_plate3b_37_3	20150725_QEp1_LC7_PhGe_SA_Plate3B_37_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_37_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	c09dd07637951fc4031e6dd966dbe8a40262e3cd2aebeccdb26fb805f90b1292	SAMEA7711678
PXD004242-37 plasma at 13 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150725_qep1_lc7_phge_sa_plate3b_37_4	20150725_QEp1_LC7_PhGe_SA_Plate3B_37_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_37_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	33e40034760830f5d49a9c43e4b339580dda2dba89cb8194f052863c33f24716	SAMEA7711679
PXD004242-37 plasma at 26 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150725_qep1_lc7_phge_sa_plate3b_37_5	20150725_QEp1_LC7_PhGe_SA_Plate3B_37_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_37_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	cc973b12551f1e6277265cad7cf6c4c66ac95bc40f35bdc3eea88a365b464dfe	SAMEA7711680
PXD004242-37 plasma at 39 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150725_qep1_lc7_phge_sa_plate3b_37_6	20150725_QEp1_LC7_PhGe_SA_Plate3B_37_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_37_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	91fec24a84494ea33ebfe8f198804aa192ae635691fe98c7c6835ef17c4f4a07	SAMEA7711681
PXD004242-37 plasma at 52 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150725_qep1_lc7_phge_sa_plate3b_37_7	20150725_QEp1_LC7_PhGe_SA_Plate3B_37_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_37_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	36734203ea4f5170f996b212469e5003932bd5c72222fee66f0c25d64af5b93f	SAMEA7711682
PXD004242-37 plasma at -8 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150818_qep1_lc7_phge_sa_plate3c_37_1	20150818_QEp1_LC7_PhGe_SA_Plate3C_37_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_37_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	ef35f9fcae1b44f94a916fa5d5633fdf60acb1d53b6b488e867716440de7b896	SAMEA7711676
PXD004242-37 plasma at 0 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150818_qep1_lc7_phge_sa_plate3c_37_2	20150818_QEp1_LC7_PhGe_SA_Plate3C_37_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_37_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	97e6a433548b32ab09b9973635eca9b4a21b845e3768c3de7bf640980713259e	SAMEA7711677
PXD004242-37 plasma at 4 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150818_qep1_lc7_phge_sa_plate3c_37_3	20150818_QEp1_LC7_PhGe_SA_Plate3C_37_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_37_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	c09dd07637951fc4031e6dd966dbe8a40262e3cd2aebeccdb26fb805f90b1292	SAMEA7711678
PXD004242-37 plasma at 13 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150818_qep1_lc7_phge_sa_plate3c_37_4	20150818_QEp1_LC7_PhGe_SA_Plate3C_37_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_37_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	33e40034760830f5d49a9c43e4b339580dda2dba89cb8194f052863c33f24716	SAMEA7711679
PXD004242-37 plasma at 26 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150818_qep1_lc7_phge_sa_plate3c_37_5	20150818_QEp1_LC7_PhGe_SA_Plate3C_37_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_37_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	cc973b12551f1e6277265cad7cf6c4c66ac95bc40f35bdc3eea88a365b464dfe	SAMEA7711680
PXD004242-37 plasma at 52 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150818_qep1_lc7_phge_sa_plate3c_37_7	20150818_QEp1_LC7_PhGe_SA_Plate3C_37_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_37_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	36734203ea4f5170f996b212469e5003932bd5c72222fee66f0c25d64af5b93f	SAMEA7711682
PXD004242-37 plasma at -8 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150912_qep1_lc7_phge_sa_plate3d_37_1	20150912_QEp1_LC7_PhGe_SA_Plate3D_37_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_37_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	ef35f9fcae1b44f94a916fa5d5633fdf60acb1d53b6b488e867716440de7b896	SAMEA7711676
PXD004242-37 plasma at 0 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150912_qep1_lc7_phge_sa_plate3d_37_2	20150912_QEp1_LC7_PhGe_SA_Plate3D_37_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_37_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	97e6a433548b32ab09b9973635eca9b4a21b845e3768c3de7bf640980713259e	SAMEA7711677
PXD004242-37 plasma at 4 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150912_qep1_lc7_phge_sa_plate3d_37_3	20150912_QEp1_LC7_PhGe_SA_Plate3D_37_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_37_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	c09dd07637951fc4031e6dd966dbe8a40262e3cd2aebeccdb26fb805f90b1292	SAMEA7711678
PXD004242-37 plasma at 13 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150912_qep1_lc7_phge_sa_plate3d_37_4	20150912_QEp1_LC7_PhGe_SA_Plate3D_37_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_37_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	33e40034760830f5d49a9c43e4b339580dda2dba89cb8194f052863c33f24716	SAMEA7711679
PXD004242-37 plasma at 26 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150912_qep1_lc7_phge_sa_plate3d_37_5	20150912_QEp1_LC7_PhGe_SA_Plate3D_37_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_37_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	cc973b12551f1e6277265cad7cf6c4c66ac95bc40f35bdc3eea88a365b464dfe	SAMEA7711680
PXD004242-37 plasma at 39 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150912_qep1_lc7_phge_sa_plate3d_37_6	20150912_QEp1_LC7_PhGe_SA_Plate3D_37_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_37_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	91fec24a84494ea33ebfe8f198804aa192ae635691fe98c7c6835ef17c4f4a07	SAMEA7711681
PXD004242-37 plasma at 52 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150912_qep1_lc7_phge_sa_plate3d_37_7	20150912_QEp1_LC7_PhGe_SA_Plate3D_37_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_37_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	36734203ea4f5170f996b212469e5003932bd5c72222fee66f0c25d64af5b93f	SAMEA7711682
PXD004242-37 plasma at 39 weeks	Homo sapiens	blood plasma	37	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150917_qep1_lc7_phge_sa_plate3c_37_6	20150917_QEp1_LC7_PhGe_SA_Plate3C_37_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3C_37_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	91fec24a84494ea33ebfe8f198804aa192ae635691fe98c7c6835ef17c4f4a07	SAMEA7711681
PXD004242-38 plasma at -8 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150624_qep1_lc7_phge_sa_plate2a_38_1	20150624_QEp1_LC7_PhGe_SA_Plate2A_38_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_38_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	d95a485a4f49b6ef528237cdb3c0934126b36cbc05dcef3599cc546e8c308056	SAMEA7711683
PXD004242-38 plasma at 0 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150624_qep1_lc7_phge_sa_plate2a_38_2	20150624_QEp1_LC7_PhGe_SA_Plate2A_38_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_38_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	ea4b779801040277c8ac8c2906d7142fe240e9bb2168be8923eb6174368e9191	SAMEA7711684
PXD004242-38 plasma at 4 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150624_qep1_lc7_phge_sa_plate2a_38_3	20150624_QEp1_LC7_PhGe_SA_Plate2A_38_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_38_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	4ccaeb277fd64a522831977f4196865a1547f7f2aaa868b63bf0138ed6ec8c0e	SAMEA7711685
PXD004242-38 plasma at 13 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150624_qep1_lc7_phge_sa_plate2a_38_4	20150624_QEp1_LC7_PhGe_SA_Plate2A_38_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_38_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	fa94e9b6d4cca9b155c290ca26fecca7a84c871f896820c3608a38d88bd16597	SAMEA7711686
PXD004242-38 plasma at 26 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150624_qep1_lc7_phge_sa_plate2a_38_5	20150624_QEp1_LC7_PhGe_SA_Plate2A_38_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_38_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	56d550918b4aedca49706881043de350b6f1bc972e43f376643d7dc31b2e6e75	SAMEA7711687
PXD004242-38 plasma at 39 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150624_qep1_lc7_phge_sa_plate2a_38_6	20150624_QEp1_LC7_PhGe_SA_Plate2A_38_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_38_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	7d7bb0a8032866636b32443d26baf3d6735708f283c0d6f6e693c87ef9aa6fee	SAMEA7711688
PXD004242-38 plasma at 52 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150624_qep1_lc7_phge_sa_plate2a_38_7	20150624_QEp1_LC7_PhGe_SA_Plate2A_38_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_38_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	e25c69282c7d7f23cd87ee53c744eaf16cf240a3d5309d20ccb667261f8efa7e	SAMEA7711689
PXD004242-38 plasma at -8 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150811_qep1_lc7_phge_sa_plate2b_38_1	20150811_QEp1_LC7_PhGe_SA_Plate2B_38_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_38_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	d95a485a4f49b6ef528237cdb3c0934126b36cbc05dcef3599cc546e8c308056	SAMEA7711683
PXD004242-38 plasma at 0 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150811_qep1_lc7_phge_sa_plate2b_38_2	20150811_QEp1_LC7_PhGe_SA_Plate2B_38_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_38_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	ea4b779801040277c8ac8c2906d7142fe240e9bb2168be8923eb6174368e9191	SAMEA7711684
PXD004242-38 plasma at 4 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150811_qep1_lc7_phge_sa_plate2b_38_3	20150811_QEp1_LC7_PhGe_SA_Plate2B_38_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_38_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	4ccaeb277fd64a522831977f4196865a1547f7f2aaa868b63bf0138ed6ec8c0e	SAMEA7711685
PXD004242-38 plasma at 13 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150811_qep1_lc7_phge_sa_plate2b_38_4	20150811_QEp1_LC7_PhGe_SA_Plate2B_38_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_38_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	fa94e9b6d4cca9b155c290ca26fecca7a84c871f896820c3608a38d88bd16597	SAMEA7711686
PXD004242-38 plasma at 26 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150811_qep1_lc7_phge_sa_plate2b_38_5	20150811_QEp1_LC7_PhGe_SA_Plate2B_38_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_38_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	56d550918b4aedca49706881043de350b6f1bc972e43f376643d7dc31b2e6e75	SAMEA7711687
PXD004242-38 plasma at 39 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150811_qep1_lc7_phge_sa_plate2b_38_6	20150811_QEp1_LC7_PhGe_SA_Plate2B_38_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_38_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	7d7bb0a8032866636b32443d26baf3d6735708f283c0d6f6e693c87ef9aa6fee	SAMEA7711688
PXD004242-38 plasma at 52 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150811_qep1_lc7_phge_sa_plate2b_38_7	20150811_QEp1_LC7_PhGe_SA_Plate2B_38_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_38_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	e25c69282c7d7f23cd87ee53c744eaf16cf240a3d5309d20ccb667261f8efa7e	SAMEA7711689
PXD004242-38 plasma at -8 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150827_qep1_lc7_phge_sa_plate2c_38_1	20150827_QEp1_LC7_PhGe_SA_Plate2C_38_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_38_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	d95a485a4f49b6ef528237cdb3c0934126b36cbc05dcef3599cc546e8c308056	SAMEA7711683
PXD004242-38 plasma at 0 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150827_qep1_lc7_phge_sa_plate2c_38_2	20150827_QEp1_LC7_PhGe_SA_Plate2C_38_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_38_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	ea4b779801040277c8ac8c2906d7142fe240e9bb2168be8923eb6174368e9191	SAMEA7711684
PXD004242-38 plasma at 4 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150827_qep1_lc7_phge_sa_plate2c_38_3	20150827_QEp1_LC7_PhGe_SA_Plate2C_38_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_38_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	4ccaeb277fd64a522831977f4196865a1547f7f2aaa868b63bf0138ed6ec8c0e	SAMEA7711685
PXD004242-38 plasma at 13 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150827_qep1_lc7_phge_sa_plate2c_38_4	20150827_QEp1_LC7_PhGe_SA_Plate2C_38_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_38_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	fa94e9b6d4cca9b155c290ca26fecca7a84c871f896820c3608a38d88bd16597	SAMEA7711686
PXD004242-38 plasma at 26 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150827_qep1_lc7_phge_sa_plate2c_38_5	20150827_QEp1_LC7_PhGe_SA_Plate2C_38_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_38_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	56d550918b4aedca49706881043de350b6f1bc972e43f376643d7dc31b2e6e75	SAMEA7711687
PXD004242-38 plasma at 39 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150827_qep1_lc7_phge_sa_plate2c_38_6	20150827_QEp1_LC7_PhGe_SA_Plate2C_38_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_38_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	7d7bb0a8032866636b32443d26baf3d6735708f283c0d6f6e693c87ef9aa6fee	SAMEA7711688
PXD004242-38 plasma at 52 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150827_qep1_lc7_phge_sa_plate2c_38_7	20150827_QEp1_LC7_PhGe_SA_Plate2C_38_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_38_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	e25c69282c7d7f23cd87ee53c744eaf16cf240a3d5309d20ccb667261f8efa7e	SAMEA7711689
PXD004242-38 plasma at -8 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150907_qep1_lc7_phge_sa_plate2d_38_1	20150907_QEp1_LC7_PhGe_SA_Plate2D_38_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_38_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	d95a485a4f49b6ef528237cdb3c0934126b36cbc05dcef3599cc546e8c308056	SAMEA7711683
PXD004242-38 plasma at 0 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150907_qep1_lc7_phge_sa_plate2d_38_2	20150907_QEp1_LC7_PhGe_SA_Plate2D_38_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_38_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	ea4b779801040277c8ac8c2906d7142fe240e9bb2168be8923eb6174368e9191	SAMEA7711684
PXD004242-38 plasma at 4 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150907_qep1_lc7_phge_sa_plate2d_38_3	20150907_QEp1_LC7_PhGe_SA_Plate2D_38_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_38_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	4ccaeb277fd64a522831977f4196865a1547f7f2aaa868b63bf0138ed6ec8c0e	SAMEA7711685
PXD004242-38 plasma at 13 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150907_qep1_lc7_phge_sa_plate2d_38_4	20150907_QEp1_LC7_PhGe_SA_Plate2D_38_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_38_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	fa94e9b6d4cca9b155c290ca26fecca7a84c871f896820c3608a38d88bd16597	SAMEA7711686
PXD004242-38 plasma at 26 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150907_qep1_lc7_phge_sa_plate2d_38_5	20150907_QEp1_LC7_PhGe_SA_Plate2D_38_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_38_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	56d550918b4aedca49706881043de350b6f1bc972e43f376643d7dc31b2e6e75	SAMEA7711687
PXD004242-38 plasma at 39 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150907_qep1_lc7_phge_sa_plate2d_38_6	20150907_QEp1_LC7_PhGe_SA_Plate2D_38_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_38_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	7d7bb0a8032866636b32443d26baf3d6735708f283c0d6f6e693c87ef9aa6fee	SAMEA7711688
PXD004242-38 plasma at 52 weeks	Homo sapiens	blood plasma	38	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150907_qep1_lc7_phge_sa_plate2d_38_7	20150907_QEp1_LC7_PhGe_SA_Plate2D_38_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_38_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	e25c69282c7d7f23cd87ee53c744eaf16cf240a3d5309d20ccb667261f8efa7e	SAMEA7711689
PXD004242-39 plasma at -8 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150701_qep1_lc7_phge_sa_plate3a_39_1	20150701_QEp1_LC7_PhGe_SA_Plate3A_39_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_39_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	6d49e064367c9108ad767f8917453a568069be19bdbb9eb8f74e044829ba5910	SAMEA7711690
PXD004242-39 plasma at 0 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150701_qep1_lc7_phge_sa_plate3a_39_2	20150701_QEp1_LC7_PhGe_SA_Plate3A_39_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_39_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	297ae619156fe1ab2e783a1d941b67d9d93fcbc80008978d8a65ba793bd0889b	SAMEA7711691
PXD004242-39 plasma at 4 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150701_qep1_lc7_phge_sa_plate3a_39_3	20150701_QEp1_LC7_PhGe_SA_Plate3A_39_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_39_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	8cdd527a89e0045c1eba462a5922db36fe9a19e4b03eb9d1a55196a166325f3b	SAMEA7711692
PXD004242-39 plasma at 13 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150701_qep1_lc7_phge_sa_plate3a_39_4	20150701_QEp1_LC7_PhGe_SA_Plate3A_39_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_39_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	a9245cbbd7c92fb6b11dec7e1814c14058b5c22da947c0cbeec323321b3804c5	SAMEA7711693
PXD004242-39 plasma at 26 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150701_qep1_lc7_phge_sa_plate3a_39_5	20150701_QEp1_LC7_PhGe_SA_Plate3A_39_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_39_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	e0074989a7161627a95f3be98a38f852807aaa6b78dac1a832b90960dfa4c9ee	SAMEA7711694
PXD004242-39 plasma at 39 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150701_qep1_lc7_phge_sa_plate3a_39_6	20150701_QEp1_LC7_PhGe_SA_Plate3A_39_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_39_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	18c46f5886b77d26af371d1392378702d1b2fea8dd0215259ab6c227920dae30	SAMEA7711695
PXD004242-39 plasma at 52 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150701_qep1_lc7_phge_sa_plate3a_39_7	20150701_QEp1_LC7_PhGe_SA_Plate3A_39_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_39_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	6c5ada4ba074684c4c865644d6813b7b4be45600e23def2a07ea0419deeb8705	SAMEA7711696
PXD004242-39 plasma at 0 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150725_qep1_lc7_phge_sa_plate3b_39_2	20150725_QEp1_LC7_PhGe_SA_Plate3B_39_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_39_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	297ae619156fe1ab2e783a1d941b67d9d93fcbc80008978d8a65ba793bd0889b	SAMEA7711691
PXD004242-39 plasma at 4 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150725_qep1_lc7_phge_sa_plate3b_39_3	20150725_QEp1_LC7_PhGe_SA_Plate3B_39_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_39_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	8cdd527a89e0045c1eba462a5922db36fe9a19e4b03eb9d1a55196a166325f3b	SAMEA7711692
PXD004242-39 plasma at 13 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150725_qep1_lc7_phge_sa_plate3b_39_4	20150725_QEp1_LC7_PhGe_SA_Plate3B_39_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_39_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	a9245cbbd7c92fb6b11dec7e1814c14058b5c22da947c0cbeec323321b3804c5	SAMEA7711693
PXD004242-39 plasma at 26 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150725_qep1_lc7_phge_sa_plate3b_39_5	20150725_QEp1_LC7_PhGe_SA_Plate3B_39_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_39_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	e0074989a7161627a95f3be98a38f852807aaa6b78dac1a832b90960dfa4c9ee	SAMEA7711694
PXD004242-39 plasma at 39 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150725_qep1_lc7_phge_sa_plate3b_39_6	20150725_QEp1_LC7_PhGe_SA_Plate3B_39_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_39_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	18c46f5886b77d26af371d1392378702d1b2fea8dd0215259ab6c227920dae30	SAMEA7711695
PXD004242-39 plasma at 52 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150725_qep1_lc7_phge_sa_plate3b_39_7	20150725_QEp1_LC7_PhGe_SA_Plate3B_39_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_39_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	6c5ada4ba074684c4c865644d6813b7b4be45600e23def2a07ea0419deeb8705	SAMEA7711696
PXD004242-39 plasma at -8 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150818_qep1_lc7_phge_sa_plate3c_39_1	20150818_QEp1_LC7_PhGe_SA_Plate3C_39_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_39_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	6d49e064367c9108ad767f8917453a568069be19bdbb9eb8f74e044829ba5910	SAMEA7711690
PXD004242-39 plasma at 0 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150818_qep1_lc7_phge_sa_plate3c_39_2	20150818_QEp1_LC7_PhGe_SA_Plate3C_39_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_39_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	297ae619156fe1ab2e783a1d941b67d9d93fcbc80008978d8a65ba793bd0889b	SAMEA7711691
PXD004242-39 plasma at 4 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150818_qep1_lc7_phge_sa_plate3c_39_3	20150818_QEp1_LC7_PhGe_SA_Plate3C_39_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_39_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	8cdd527a89e0045c1eba462a5922db36fe9a19e4b03eb9d1a55196a166325f3b	SAMEA7711692
PXD004242-39 plasma at 13 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150818_qep1_lc7_phge_sa_plate3c_39_4	20150818_QEp1_LC7_PhGe_SA_Plate3C_39_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_39_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	a9245cbbd7c92fb6b11dec7e1814c14058b5c22da947c0cbeec323321b3804c5	SAMEA7711693
PXD004242-39 plasma at 26 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150818_qep1_lc7_phge_sa_plate3c_39_5	20150818_QEp1_LC7_PhGe_SA_Plate3C_39_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_39_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	e0074989a7161627a95f3be98a38f852807aaa6b78dac1a832b90960dfa4c9ee	SAMEA7711694
PXD004242-39 plasma at 39 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150818_qep1_lc7_phge_sa_plate3c_39_6	20150818_QEp1_LC7_PhGe_SA_Plate3C_39_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_39_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	18c46f5886b77d26af371d1392378702d1b2fea8dd0215259ab6c227920dae30	SAMEA7711695
PXD004242-39 plasma at 52 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150818_qep1_lc7_phge_sa_plate3c_39_7	20150818_QEp1_LC7_PhGe_SA_Plate3C_39_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_39_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	6c5ada4ba074684c4c865644d6813b7b4be45600e23def2a07ea0419deeb8705	SAMEA7711696
PXD004242-39 plasma at -8 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150912_qep1_lc7_phge_sa_plate3d_39_1	20150912_QEp1_LC7_PhGe_SA_Plate3D_39_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_39_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	6d49e064367c9108ad767f8917453a568069be19bdbb9eb8f74e044829ba5910	SAMEA7711690
PXD004242-39 plasma at 0 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150912_qep1_lc7_phge_sa_plate3d_39_2	20150912_QEp1_LC7_PhGe_SA_Plate3D_39_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_39_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	297ae619156fe1ab2e783a1d941b67d9d93fcbc80008978d8a65ba793bd0889b	SAMEA7711691
PXD004242-39 plasma at 4 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150912_qep1_lc7_phge_sa_plate3d_39_3	20150912_QEp1_LC7_PhGe_SA_Plate3D_39_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_39_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	8cdd527a89e0045c1eba462a5922db36fe9a19e4b03eb9d1a55196a166325f3b	SAMEA7711692
PXD004242-39 plasma at 26 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150912_qep1_lc7_phge_sa_plate3d_39_5	20150912_QEp1_LC7_PhGe_SA_Plate3D_39_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_39_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	e0074989a7161627a95f3be98a38f852807aaa6b78dac1a832b90960dfa4c9ee	SAMEA7711694
PXD004242-39 plasma at 39 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150912_qep1_lc7_phge_sa_plate3d_39_6	20150912_QEp1_LC7_PhGe_SA_Plate3D_39_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_39_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	18c46f5886b77d26af371d1392378702d1b2fea8dd0215259ab6c227920dae30	SAMEA7711695
PXD004242-39 plasma at 52 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150912_qep1_lc7_phge_sa_plate3d_39_7	20150912_QEp1_LC7_PhGe_SA_Plate3D_39_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_39_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	6c5ada4ba074684c4c865644d6813b7b4be45600e23def2a07ea0419deeb8705	SAMEA7711696
PXD004242-39 plasma at -8 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150917_qep1_lc7_phge_sa_plate3b_39_1	20150917_QEp1_LC7_PhGe_SA_Plate3B_39_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_39_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	6d49e064367c9108ad767f8917453a568069be19bdbb9eb8f74e044829ba5910	SAMEA7711690
PXD004242-39 plasma at 13 weeks	Homo sapiens	blood plasma	39	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150917_qep1_lc7_phge_sa_plate3d_39_4	20150917_QEp1_LC7_PhGe_SA_Plate3D_39_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3D_39_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	a9245cbbd7c92fb6b11dec7e1814c14058b5c22da947c0cbeec323321b3804c5	SAMEA7711693
PXD004242-40 plasma at -8 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150701_qep1_lc7_phge_sa_plate3a_40_1	20150701_QEp1_LC7_PhGe_SA_Plate3A_40_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_40_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	586be5fb292663553e58dfa4833a18a63d196df325080be44fcfe34ef98a9bf0	SAMEA7711697
PXD004242-40 plasma at 0 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150701_qep1_lc7_phge_sa_plate3a_40_2	20150701_QEp1_LC7_PhGe_SA_Plate3A_40_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_40_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	635644ddef86f90ce16e874a1e2f984525a09bd23373b371b5cd7abc39e81021	SAMEA7711698
PXD004242-40 plasma at 4 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150701_qep1_lc7_phge_sa_plate3a_40_3	20150701_QEp1_LC7_PhGe_SA_Plate3A_40_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_40_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	59f4ab8d1489c89c42db49afbef19b91a37803ba7f5672a8f4f5aa2bbb119e6c	SAMEA7711699
PXD004242-40 plasma at 13 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150701_qep1_lc7_phge_sa_plate3a_40_4	20150701_QEp1_LC7_PhGe_SA_Plate3A_40_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_40_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	e1bde1031b3b5c9be6929be8aab0570a9231310a99fc0f2496c2d2d63e74c11e	SAMEA7711700
PXD004242-40 plasma at 26 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150701_qep1_lc7_phge_sa_plate3a_40_5	20150701_QEp1_LC7_PhGe_SA_Plate3A_40_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_40_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	27e02ffa37e40ac8bc1bf0f67c199f5c07f5295bb5b587614f52745f6d15fb92	SAMEA7711701
PXD004242-40 plasma at 39 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150701_qep1_lc7_phge_sa_plate3a_40_6	20150701_QEp1_LC7_PhGe_SA_Plate3A_40_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_40_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	9572d2e90fdd755b65ee6aa7fcb9154989fddfbab3945c1b24361c6a18822a18	SAMEA7711702
PXD004242-40 plasma at 52 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150701_qep1_lc7_phge_sa_plate3a_40_7	20150701_QEp1_LC7_PhGe_SA_Plate3A_40_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_40_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	c60e3645c3b093fbf127462102ca8f7d6a4418fef3c7452644ded654341533de	SAMEA7711703
PXD004242-40 plasma at -8 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150725_qep1_lc7_phge_sa_plate3b_40_1	20150725_QEp1_LC7_PhGe_SA_Plate3B_40_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_40_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	586be5fb292663553e58dfa4833a18a63d196df325080be44fcfe34ef98a9bf0	SAMEA7711697
PXD004242-40 plasma at 0 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150725_qep1_lc7_phge_sa_plate3b_40_2	20150725_QEp1_LC7_PhGe_SA_Plate3B_40_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_40_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	635644ddef86f90ce16e874a1e2f984525a09bd23373b371b5cd7abc39e81021	SAMEA7711698
PXD004242-40 plasma at 4 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150725_qep1_lc7_phge_sa_plate3b_40_3	20150725_QEp1_LC7_PhGe_SA_Plate3B_40_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_40_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	59f4ab8d1489c89c42db49afbef19b91a37803ba7f5672a8f4f5aa2bbb119e6c	SAMEA7711699
PXD004242-40 plasma at 13 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150725_qep1_lc7_phge_sa_plate3b_40_4	20150725_QEp1_LC7_PhGe_SA_Plate3B_40_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_40_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	e1bde1031b3b5c9be6929be8aab0570a9231310a99fc0f2496c2d2d63e74c11e	SAMEA7711700
PXD004242-40 plasma at 26 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150725_qep1_lc7_phge_sa_plate3b_40_5	20150725_QEp1_LC7_PhGe_SA_Plate3B_40_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_40_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	27e02ffa37e40ac8bc1bf0f67c199f5c07f5295bb5b587614f52745f6d15fb92	SAMEA7711701
PXD004242-40 plasma at 39 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150725_qep1_lc7_phge_sa_plate3b_40_6	20150725_QEp1_LC7_PhGe_SA_Plate3B_40_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_40_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	9572d2e90fdd755b65ee6aa7fcb9154989fddfbab3945c1b24361c6a18822a18	SAMEA7711702
PXD004242-40 plasma at 52 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150725_qep1_lc7_phge_sa_plate3b_40_7	20150725_QEp1_LC7_PhGe_SA_Plate3B_40_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_40_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	c60e3645c3b093fbf127462102ca8f7d6a4418fef3c7452644ded654341533de	SAMEA7711703
PXD004242-40 plasma at -8 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150818_qep1_lc7_phge_sa_plate3c_40_1	20150818_QEp1_LC7_PhGe_SA_Plate3C_40_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_40_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	586be5fb292663553e58dfa4833a18a63d196df325080be44fcfe34ef98a9bf0	SAMEA7711697
PXD004242-40 plasma at 0 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150818_qep1_lc7_phge_sa_plate3c_40_2	20150818_QEp1_LC7_PhGe_SA_Plate3C_40_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_40_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	635644ddef86f90ce16e874a1e2f984525a09bd23373b371b5cd7abc39e81021	SAMEA7711698
PXD004242-40 plasma at 4 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150818_qep1_lc7_phge_sa_plate3c_40_3	20150818_QEp1_LC7_PhGe_SA_Plate3C_40_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_40_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	59f4ab8d1489c89c42db49afbef19b91a37803ba7f5672a8f4f5aa2bbb119e6c	SAMEA7711699
PXD004242-40 plasma at 13 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150818_qep1_lc7_phge_sa_plate3c_40_4	20150818_QEp1_LC7_PhGe_SA_Plate3C_40_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_40_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	e1bde1031b3b5c9be6929be8aab0570a9231310a99fc0f2496c2d2d63e74c11e	SAMEA7711700
PXD004242-40 plasma at 26 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150818_qep1_lc7_phge_sa_plate3c_40_5	20150818_QEp1_LC7_PhGe_SA_Plate3C_40_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_40_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	27e02ffa37e40ac8bc1bf0f67c199f5c07f5295bb5b587614f52745f6d15fb92	SAMEA7711701
PXD004242-40 plasma at 39 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150818_qep1_lc7_phge_sa_plate3c_40_6	20150818_QEp1_LC7_PhGe_SA_Plate3C_40_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_40_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	9572d2e90fdd755b65ee6aa7fcb9154989fddfbab3945c1b24361c6a18822a18	SAMEA7711702
PXD004242-40 plasma at 52 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150818_qep1_lc7_phge_sa_plate3c_40_7	20150818_QEp1_LC7_PhGe_SA_Plate3C_40_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_40_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	c60e3645c3b093fbf127462102ca8f7d6a4418fef3c7452644ded654341533de	SAMEA7711703
PXD004242-40 plasma at -8 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150912_qep1_lc7_phge_sa_plate3d_40_1	20150912_QEp1_LC7_PhGe_SA_Plate3D_40_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_40_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	586be5fb292663553e58dfa4833a18a63d196df325080be44fcfe34ef98a9bf0	SAMEA7711697
PXD004242-40 plasma at 0 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150912_qep1_lc7_phge_sa_plate3d_40_2	20150912_QEp1_LC7_PhGe_SA_Plate3D_40_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_40_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	635644ddef86f90ce16e874a1e2f984525a09bd23373b371b5cd7abc39e81021	SAMEA7711698
PXD004242-40 plasma at 4 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150912_qep1_lc7_phge_sa_plate3d_40_3	20150912_QEp1_LC7_PhGe_SA_Plate3D_40_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_40_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	59f4ab8d1489c89c42db49afbef19b91a37803ba7f5672a8f4f5aa2bbb119e6c	SAMEA7711699
PXD004242-40 plasma at 13 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150912_qep1_lc7_phge_sa_plate3d_40_4	20150912_QEp1_LC7_PhGe_SA_Plate3D_40_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_40_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	e1bde1031b3b5c9be6929be8aab0570a9231310a99fc0f2496c2d2d63e74c11e	SAMEA7711700
PXD004242-40 plasma at 26 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150912_qep1_lc7_phge_sa_plate3d_40_5	20150912_QEp1_LC7_PhGe_SA_Plate3D_40_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_40_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	27e02ffa37e40ac8bc1bf0f67c199f5c07f5295bb5b587614f52745f6d15fb92	SAMEA7711701
PXD004242-40 plasma at 39 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150912_qep1_lc7_phge_sa_plate3d_40_6	20150912_QEp1_LC7_PhGe_SA_Plate3D_40_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_40_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	9572d2e90fdd755b65ee6aa7fcb9154989fddfbab3945c1b24361c6a18822a18	SAMEA7711702
PXD004242-40 plasma at 52 weeks	Homo sapiens	blood plasma	40	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150912_qep1_lc7_phge_sa_plate3d_40_7	20150912_QEp1_LC7_PhGe_SA_Plate3D_40_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_40_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	c60e3645c3b093fbf127462102ca8f7d6a4418fef3c7452644ded654341533de	SAMEA7711703
PXD004242-41 plasma at -8 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150618_qep1_lc7_phge_sa_plate1b_41_1	20150618_QEp1_LC7_PhGe_SA_Plate1B_41_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_41_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	8014847add6a43d7520ec669681dfe2e08f65d770202d485481319d80bc9f28f	SAMEA7711704
PXD004242-41 plasma at 0 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150618_qep1_lc7_phge_sa_plate1b_41_2	20150618_QEp1_LC7_PhGe_SA_Plate1B_41_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_41_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	0a07d294c370a656caba55a070322884b2e2ed98f270584a5c884a174a5d73b4	SAMEA7711705
PXD004242-41 plasma at 4 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150618_qep1_lc7_phge_sa_plate1b_41_3	20150618_QEp1_LC7_PhGe_SA_Plate1B_41_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_41_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	f6b7b0db92114da89719509f01e7d80a944dc1641a93b74b5ae561397b917ebe	SAMEA7711706
PXD004242-41 plasma at 13 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150618_qep1_lc7_phge_sa_plate1b_41_4	20150618_QEp1_LC7_PhGe_SA_Plate1B_41_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_41_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	2e8502b6b7ace333f1be2f3c98c00baba8474eff0d0d57df7046d571cda15a3c	SAMEA7711707
PXD004242-41 plasma at 26 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150618_qep1_lc7_phge_sa_plate1b_41_5	20150618_QEp1_LC7_PhGe_SA_Plate1B_41_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_41_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	b4fa638b27bf9556ea4ad2e501b98abb8620872801a8a25cb903f188c4d9dc83	SAMEA7711708
PXD004242-41 plasma at 39 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150618_qep1_lc7_phge_sa_plate1b_41_6	20150618_QEp1_LC7_PhGe_SA_Plate1B_41_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_41_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	60067f5f6cbf0a0516aebe8348059c4cbb021040245174125616bbe11efc4cb1	SAMEA7711709
PXD004242-41 plasma at 52 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150618_qep1_lc7_phge_sa_plate1b_41_7	20150618_QEp1_LC7_PhGe_SA_Plate1B_41_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_41_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f7b994bc71b40426f9cd026f97a5f69b1b04cd3f7caeabae041ac9bbf3852d8f	SAMEA7711710
PXD004242-41 plasma at -8 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150708_qep1_lc7_phge_sa_plate1c_41_1	20150708_QEp1_LC7_PhGe_SA_Plate1C_41_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_41_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	8014847add6a43d7520ec669681dfe2e08f65d770202d485481319d80bc9f28f	SAMEA7711704
PXD004242-41 plasma at 0 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150708_qep1_lc7_phge_sa_plate1c_41_2	20150708_QEp1_LC7_PhGe_SA_Plate1C_41_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_41_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	0a07d294c370a656caba55a070322884b2e2ed98f270584a5c884a174a5d73b4	SAMEA7711705
PXD004242-41 plasma at 4 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150708_qep1_lc7_phge_sa_plate1c_41_3	20150708_QEp1_LC7_PhGe_SA_Plate1C_41_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_41_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	f6b7b0db92114da89719509f01e7d80a944dc1641a93b74b5ae561397b917ebe	SAMEA7711706
PXD004242-41 plasma at 13 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150708_qep1_lc7_phge_sa_plate1c_41_4	20150708_QEp1_LC7_PhGe_SA_Plate1C_41_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_41_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	2e8502b6b7ace333f1be2f3c98c00baba8474eff0d0d57df7046d571cda15a3c	SAMEA7711707
PXD004242-41 plasma at 26 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150708_qep1_lc7_phge_sa_plate1c_41_5	20150708_QEp1_LC7_PhGe_SA_Plate1C_41_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_41_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	b4fa638b27bf9556ea4ad2e501b98abb8620872801a8a25cb903f188c4d9dc83	SAMEA7711708
PXD004242-41 plasma at 39 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150708_qep1_lc7_phge_sa_plate1c_41_6	20150708_QEp1_LC7_PhGe_SA_Plate1C_41_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_41_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	60067f5f6cbf0a0516aebe8348059c4cbb021040245174125616bbe11efc4cb1	SAMEA7711709
PXD004242-41 plasma at 52 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150708_qep1_lc7_phge_sa_plate1c_41_7	20150708_QEp1_LC7_PhGe_SA_Plate1C_41_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_41_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f7b994bc71b40426f9cd026f97a5f69b1b04cd3f7caeabae041ac9bbf3852d8f	SAMEA7711710
PXD004242-41 plasma at -8 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150805_qep1_lc7_phge_sa_plate1d_41_1	20150805_QEp1_LC7_PhGe_SA_Plate1D_41_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_41_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	8014847add6a43d7520ec669681dfe2e08f65d770202d485481319d80bc9f28f	SAMEA7711704
PXD004242-41 plasma at 0 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150805_qep1_lc7_phge_sa_plate1d_41_2	20150805_QEp1_LC7_PhGe_SA_Plate1D_41_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_41_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	0a07d294c370a656caba55a070322884b2e2ed98f270584a5c884a174a5d73b4	SAMEA7711705
PXD004242-41 plasma at 4 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150805_qep1_lc7_phge_sa_plate1d_41_3	20150805_QEp1_LC7_PhGe_SA_Plate1D_41_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_41_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	f6b7b0db92114da89719509f01e7d80a944dc1641a93b74b5ae561397b917ebe	SAMEA7711706
PXD004242-41 plasma at 13 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150805_qep1_lc7_phge_sa_plate1d_41_4	20150805_QEp1_LC7_PhGe_SA_Plate1D_41_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_41_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	2e8502b6b7ace333f1be2f3c98c00baba8474eff0d0d57df7046d571cda15a3c	SAMEA7711707
PXD004242-41 plasma at 26 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150805_qep1_lc7_phge_sa_plate1d_41_5	20150805_QEp1_LC7_PhGe_SA_Plate1D_41_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_41_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	b4fa638b27bf9556ea4ad2e501b98abb8620872801a8a25cb903f188c4d9dc83	SAMEA7711708
PXD004242-41 plasma at 39 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150805_qep1_lc7_phge_sa_plate1d_41_6	20150805_QEp1_LC7_PhGe_SA_Plate1D_41_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_41_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	60067f5f6cbf0a0516aebe8348059c4cbb021040245174125616bbe11efc4cb1	SAMEA7711709
PXD004242-41 plasma at 52 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150805_qep1_lc7_phge_sa_plate1d_41_7	20150805_QEp1_LC7_PhGe_SA_Plate1D_41_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_41_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f7b994bc71b40426f9cd026f97a5f69b1b04cd3f7caeabae041ac9bbf3852d8f	SAMEA7711710
PXD004242-41 plasma at -8 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150901_qep1_lc7_phge_sa_plate1e_41_1	20150901_QEp1_LC7_PhGe_SA_Plate1E_41_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_41_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	8014847add6a43d7520ec669681dfe2e08f65d770202d485481319d80bc9f28f	SAMEA7711704
PXD004242-41 plasma at 0 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150901_qep1_lc7_phge_sa_plate1e_41_2	20150901_QEp1_LC7_PhGe_SA_Plate1E_41_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_41_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	0a07d294c370a656caba55a070322884b2e2ed98f270584a5c884a174a5d73b4	SAMEA7711705
PXD004242-41 plasma at 4 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150901_qep1_lc7_phge_sa_plate1e_41_3	20150901_QEp1_LC7_PhGe_SA_Plate1E_41_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_41_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	f6b7b0db92114da89719509f01e7d80a944dc1641a93b74b5ae561397b917ebe	SAMEA7711706
PXD004242-41 plasma at 13 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150901_qep1_lc7_phge_sa_plate1e_41_4	20150901_QEp1_LC7_PhGe_SA_Plate1E_41_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_41_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	2e8502b6b7ace333f1be2f3c98c00baba8474eff0d0d57df7046d571cda15a3c	SAMEA7711707
PXD004242-41 plasma at 26 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150901_qep1_lc7_phge_sa_plate1e_41_5	20150901_QEp1_LC7_PhGe_SA_Plate1E_41_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_41_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	b4fa638b27bf9556ea4ad2e501b98abb8620872801a8a25cb903f188c4d9dc83	SAMEA7711708
PXD004242-41 plasma at 39 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150901_qep1_lc7_phge_sa_plate1e_41_6	20150901_QEp1_LC7_PhGe_SA_Plate1E_41_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_41_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	60067f5f6cbf0a0516aebe8348059c4cbb021040245174125616bbe11efc4cb1	SAMEA7711709
PXD004242-41 plasma at 52 weeks	Homo sapiens	blood plasma	41	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150901_qep1_lc7_phge_sa_plate1e_41_7	20150901_QEp1_LC7_PhGe_SA_Plate1E_41_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_41_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	f7b994bc71b40426f9cd026f97a5f69b1b04cd3f7caeabae041ac9bbf3852d8f	SAMEA7711710
PXD004242-42 plasma at -8 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150624_qep1_lc7_phge_sa_plate2a_42_1	20150624_QEp1_LC7_PhGe_SA_Plate2A_42_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_42_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	7b55535a46919b9d237b294b14882d2b9a34e0e93816e2188e45ed91d890608d	SAMEA7711711
PXD004242-42 plasma at 0 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150624_qep1_lc7_phge_sa_plate2a_42_2	20150624_QEp1_LC7_PhGe_SA_Plate2A_42_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_42_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	49499da8c6b4c90229f974dd88c14a8a66881b192d538bc23c1372ac2545ce8f	SAMEA7711712
PXD004242-42 plasma at 4 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150624_qep1_lc7_phge_sa_plate2a_42_3	20150624_QEp1_LC7_PhGe_SA_Plate2A_42_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_42_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	a4ce527458f5528819ccb2d588bf9664ae8eec209cbe29dd2d6df0daede661d2	SAMEA7711713
PXD004242-42 plasma at 13 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150624_qep1_lc7_phge_sa_plate2a_42_4	20150624_QEp1_LC7_PhGe_SA_Plate2A_42_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_42_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	0746f781b89ca6ec9de0fe11dbb1276ae0bb83c99a3c65e8a6e4e76f0fa8bf0e	SAMEA7711714
PXD004242-42 plasma at 39 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150624_qep1_lc7_phge_sa_plate2a_42_6	20150624_QEp1_LC7_PhGe_SA_Plate2A_42_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_42_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	86dfd1e420f56830a34f72daa1d25eb708c466db7f83eeaa15811f7a3c33a5ce	SAMEA7711715
PXD004242-42 plasma at 52 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150624_qep1_lc7_phge_sa_plate2a_42_7	20150624_QEp1_LC7_PhGe_SA_Plate2A_42_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_42_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	cf90b6f2d11b737d088daabefac4bcf52141206b7e53b4c2b22fef681d7811b6	SAMEA7711716
PXD004242-42 plasma at -8 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150811_qep1_lc7_phge_sa_plate2b_42_1	20150811_QEp1_LC7_PhGe_SA_Plate2B_42_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_42_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	7b55535a46919b9d237b294b14882d2b9a34e0e93816e2188e45ed91d890608d	SAMEA7711711
PXD004242-42 plasma at 0 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150811_qep1_lc7_phge_sa_plate2b_42_2	20150811_QEp1_LC7_PhGe_SA_Plate2B_42_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_42_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	49499da8c6b4c90229f974dd88c14a8a66881b192d538bc23c1372ac2545ce8f	SAMEA7711712
PXD004242-42 plasma at 4 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150811_qep1_lc7_phge_sa_plate2b_42_3	20150811_QEp1_LC7_PhGe_SA_Plate2B_42_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_42_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	a4ce527458f5528819ccb2d588bf9664ae8eec209cbe29dd2d6df0daede661d2	SAMEA7711713
PXD004242-42 plasma at 13 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150811_qep1_lc7_phge_sa_plate2b_42_4	20150811_QEp1_LC7_PhGe_SA_Plate2B_42_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_42_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	0746f781b89ca6ec9de0fe11dbb1276ae0bb83c99a3c65e8a6e4e76f0fa8bf0e	SAMEA7711714
PXD004242-42 plasma at 39 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150811_qep1_lc7_phge_sa_plate2b_42_6	20150811_QEp1_LC7_PhGe_SA_Plate2B_42_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_42_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	86dfd1e420f56830a34f72daa1d25eb708c466db7f83eeaa15811f7a3c33a5ce	SAMEA7711715
PXD004242-42 plasma at 52 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150811_qep1_lc7_phge_sa_plate2b_42_7	20150811_QEp1_LC7_PhGe_SA_Plate2B_42_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_42_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	cf90b6f2d11b737d088daabefac4bcf52141206b7e53b4c2b22fef681d7811b6	SAMEA7711716
PXD004242-42 plasma at -8 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150827_qep1_lc7_phge_sa_plate2c_42_1	20150827_QEp1_LC7_PhGe_SA_Plate2C_42_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_42_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	7b55535a46919b9d237b294b14882d2b9a34e0e93816e2188e45ed91d890608d	SAMEA7711711
PXD004242-42 plasma at 0 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150827_qep1_lc7_phge_sa_plate2c_42_2	20150827_QEp1_LC7_PhGe_SA_Plate2C_42_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_42_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	49499da8c6b4c90229f974dd88c14a8a66881b192d538bc23c1372ac2545ce8f	SAMEA7711712
PXD004242-42 plasma at 4 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150827_qep1_lc7_phge_sa_plate2c_42_3	20150827_QEp1_LC7_PhGe_SA_Plate2C_42_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_42_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	a4ce527458f5528819ccb2d588bf9664ae8eec209cbe29dd2d6df0daede661d2	SAMEA7711713
PXD004242-42 plasma at 13 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150827_qep1_lc7_phge_sa_plate2c_42_4	20150827_QEp1_LC7_PhGe_SA_Plate2C_42_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_42_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	0746f781b89ca6ec9de0fe11dbb1276ae0bb83c99a3c65e8a6e4e76f0fa8bf0e	SAMEA7711714
PXD004242-42 plasma at 26 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150827_qep1_lc7_phge_sa_plate2c_42_5	20150827_QEp1_LC7_PhGe_SA_Plate2C_42_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_42_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	eaa9444f221dbb64b2d6608f5b9ba1a33655ecbf3a16ba8f0ab8ed120d525930	SAMEA7711717
PXD004242-42 plasma at 39 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150827_qep1_lc7_phge_sa_plate2c_42_6	20150827_QEp1_LC7_PhGe_SA_Plate2C_42_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_42_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	86dfd1e420f56830a34f72daa1d25eb708c466db7f83eeaa15811f7a3c33a5ce	SAMEA7711715
PXD004242-42 plasma at 52 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150827_qep1_lc7_phge_sa_plate2c_42_7	20150827_QEp1_LC7_PhGe_SA_Plate2C_42_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_42_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	cf90b6f2d11b737d088daabefac4bcf52141206b7e53b4c2b22fef681d7811b6	SAMEA7711716
PXD004242-42 plasma at -8 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150907_qep1_lc7_phge_sa_plate2d_42_1	20150907_QEp1_LC7_PhGe_SA_Plate2D_42_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_42_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	7b55535a46919b9d237b294b14882d2b9a34e0e93816e2188e45ed91d890608d	SAMEA7711711
PXD004242-42 plasma at 0 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150907_qep1_lc7_phge_sa_plate2d_42_2	20150907_QEp1_LC7_PhGe_SA_Plate2D_42_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_42_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	49499da8c6b4c90229f974dd88c14a8a66881b192d538bc23c1372ac2545ce8f	SAMEA7711712
PXD004242-42 plasma at 4 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150907_qep1_lc7_phge_sa_plate2d_42_3	20150907_QEp1_LC7_PhGe_SA_Plate2D_42_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_42_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	a4ce527458f5528819ccb2d588bf9664ae8eec209cbe29dd2d6df0daede661d2	SAMEA7711713
PXD004242-42 plasma at 13 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150907_qep1_lc7_phge_sa_plate2d_42_4	20150907_QEp1_LC7_PhGe_SA_Plate2D_42_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_42_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	0746f781b89ca6ec9de0fe11dbb1276ae0bb83c99a3c65e8a6e4e76f0fa8bf0e	SAMEA7711714
PXD004242-42 plasma at 26 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150907_qep1_lc7_phge_sa_plate2d_42_5	20150907_QEp1_LC7_PhGe_SA_Plate2D_42_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_42_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	eaa9444f221dbb64b2d6608f5b9ba1a33655ecbf3a16ba8f0ab8ed120d525930	SAMEA7711717
PXD004242-42 plasma at 39 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150907_qep1_lc7_phge_sa_plate2d_42_6	20150907_QEp1_LC7_PhGe_SA_Plate2D_42_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_42_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	86dfd1e420f56830a34f72daa1d25eb708c466db7f83eeaa15811f7a3c33a5ce	SAMEA7711715
PXD004242-42 plasma at 52 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150907_qep1_lc7_phge_sa_plate2d_42_7	20150907_QEp1_LC7_PhGe_SA_Plate2D_42_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_42_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	cf90b6f2d11b737d088daabefac4bcf52141206b7e53b4c2b22fef681d7811b6	SAMEA7711716
PXD004242-42 plasma at 26 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150917_qep1_lc8_phge_sa_plate2a_42_5	20150917_QEp1_LC8_PhGe_SA_Plate2A_42_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_Plate2A_42_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	eaa9444f221dbb64b2d6608f5b9ba1a33655ecbf3a16ba8f0ab8ed120d525930	SAMEA7711717
PXD004242-42 plasma at 26 weeks	Homo sapiens	blood plasma	42	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150917_qep1_lc8_phge_sa_plate2b_42_5	20150917_QEp1_LC8_PhGe_SA_Plate2B_42_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_Plate2B_42_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	eaa9444f221dbb64b2d6608f5b9ba1a33655ecbf3a16ba8f0ab8ed120d525930	SAMEA7711717
PXD004242-43 plasma at -8 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150731_qep1_lc7_phge_sa_plate4b_43_1	20150731_QEp1_LC7_PhGe_SA_Plate4B_43_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_43_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	23e1e5648a8abf13b8eb70af5e4a27780873fa6f1cf05ad7c8ddb4663a2be6e3	SAMEA7711718
PXD004242-43 plasma at 0 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150731_qep1_lc7_phge_sa_plate4b_43_2	20150731_QEp1_LC7_PhGe_SA_Plate4B_43_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_43_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	cccd83d875ae12f43ebeb24599f6f4fe07347166d0630863cfb221ed1f3e7ce8	SAMEA7711719
PXD004242-43 plasma at 4 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150731_qep1_lc7_phge_sa_plate4b_43_3	20150731_QEp1_LC7_PhGe_SA_Plate4B_43_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_43_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	6a87cde57033cd7fee2e14ee3f43c19d1d9ba014115f5100a66c169c11140c0b	SAMEA7711720
PXD004242-43 plasma at 13 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150731_qep1_lc7_phge_sa_plate4b_43_4	20150731_QEp1_LC7_PhGe_SA_Plate4B_43_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_43_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	0007b1548324b293e432d9d8689e7a6643ae8a9de7462f98fd748c8913d501c2	SAMEA7711721
PXD004242-43 plasma at 26 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150731_qep1_lc7_phge_sa_plate4b_43_5	20150731_QEp1_LC7_PhGe_SA_Plate4B_43_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_43_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	b9ac1c06da4a86c9a2e11f21aa23b9dba5a7aa95bd17fcbce555a46dc1b81ce7	SAMEA7711722
PXD004242-43 plasma at 39 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150731_qep1_lc7_phge_sa_plate4b_43_6	20150731_QEp1_LC7_PhGe_SA_Plate4B_43_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_43_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	78f34c645e5e4de0ffe56a61b3e9bad2108d190703401634f4758bf447163809	SAMEA7711723
PXD004242-43 plasma at 52 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150731_qep1_lc7_phge_sa_plate4b_43_7	20150731_QEp1_LC7_PhGe_SA_Plate4B_43_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_43_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	c09d5288a0cd3394b1d8c89f99606e81b5dc63d7757e88552c2c4fa748ca08ff	SAMEA7711724
PXD004242-43 plasma at -8 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150731_qep1_lc7_phge_sa_plate4e_43_1	20150731_QEp1_LC7_PhGe_SA_Plate4E_43_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_43_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	23e1e5648a8abf13b8eb70af5e4a27780873fa6f1cf05ad7c8ddb4663a2be6e3	SAMEA7711718
PXD004242-43 plasma at 0 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150731_qep1_lc7_phge_sa_plate4e_43_2	20150731_QEp1_LC7_PhGe_SA_Plate4E_43_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_43_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	cccd83d875ae12f43ebeb24599f6f4fe07347166d0630863cfb221ed1f3e7ce8	SAMEA7711719
PXD004242-43 plasma at 4 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150731_qep1_lc7_phge_sa_plate4e_43_3	20150731_QEp1_LC7_PhGe_SA_Plate4E_43_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_43_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	6a87cde57033cd7fee2e14ee3f43c19d1d9ba014115f5100a66c169c11140c0b	SAMEA7711720
PXD004242-43 plasma at 13 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150731_qep1_lc7_phge_sa_plate4e_43_4	20150731_QEp1_LC7_PhGe_SA_Plate4E_43_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_43_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	0007b1548324b293e432d9d8689e7a6643ae8a9de7462f98fd748c8913d501c2	SAMEA7711721
PXD004242-43 plasma at 26 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150731_qep1_lc7_phge_sa_plate4e_43_5	20150731_QEp1_LC7_PhGe_SA_Plate4E_43_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_43_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	b9ac1c06da4a86c9a2e11f21aa23b9dba5a7aa95bd17fcbce555a46dc1b81ce7	SAMEA7711722
PXD004242-43 plasma at 39 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150731_qep1_lc7_phge_sa_plate4e_43_6	20150731_QEp1_LC7_PhGe_SA_Plate4E_43_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_43_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	78f34c645e5e4de0ffe56a61b3e9bad2108d190703401634f4758bf447163809	SAMEA7711723
PXD004242-43 plasma at 52 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150731_qep1_lc7_phge_sa_plate4e_43_7	20150731_QEp1_LC7_PhGe_SA_Plate4E_43_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_43_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	c09d5288a0cd3394b1d8c89f99606e81b5dc63d7757e88552c2c4fa748ca08ff	SAMEA7711724
PXD004242-43 plasma at -8 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150824_qep1_lc7_phge_sa_plate4d_43_1	20150824_QEp1_LC7_PhGe_SA_Plate4D_43_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_43_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	23e1e5648a8abf13b8eb70af5e4a27780873fa6f1cf05ad7c8ddb4663a2be6e3	SAMEA7711718
PXD004242-43 plasma at 0 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150824_qep1_lc7_phge_sa_plate4d_43_2	20150824_QEp1_LC7_PhGe_SA_Plate4D_43_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_43_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	cccd83d875ae12f43ebeb24599f6f4fe07347166d0630863cfb221ed1f3e7ce8	SAMEA7711719
PXD004242-43 plasma at 4 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150824_qep1_lc7_phge_sa_plate4d_43_3	20150824_QEp1_LC7_PhGe_SA_Plate4D_43_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_43_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	6a87cde57033cd7fee2e14ee3f43c19d1d9ba014115f5100a66c169c11140c0b	SAMEA7711720
PXD004242-43 plasma at 13 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150824_qep1_lc7_phge_sa_plate4d_43_4	20150824_QEp1_LC7_PhGe_SA_Plate4D_43_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_43_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	0007b1548324b293e432d9d8689e7a6643ae8a9de7462f98fd748c8913d501c2	SAMEA7711721
PXD004242-43 plasma at 26 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150824_qep1_lc7_phge_sa_plate4d_43_5	20150824_QEp1_LC7_PhGe_SA_Plate4D_43_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_43_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	b9ac1c06da4a86c9a2e11f21aa23b9dba5a7aa95bd17fcbce555a46dc1b81ce7	SAMEA7711722
PXD004242-43 plasma at 39 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150824_qep1_lc7_phge_sa_plate4d_43_6	20150824_QEp1_LC7_PhGe_SA_Plate4D_43_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_43_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	78f34c645e5e4de0ffe56a61b3e9bad2108d190703401634f4758bf447163809	SAMEA7711723
PXD004242-43 plasma at 52 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150824_qep1_lc7_phge_sa_plate4d_43_7	20150824_QEp1_LC7_PhGe_SA_Plate4D_43_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_43_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	c09d5288a0cd3394b1d8c89f99606e81b5dc63d7757e88552c2c4fa748ca08ff	SAMEA7711724
PXD004242-43 plasma at -8 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150917_qep1_lc7_phge_sa_plate4c_43_1	20150917_QEp1_LC7_PhGe_SA_Plate4C_43_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_43_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	23e1e5648a8abf13b8eb70af5e4a27780873fa6f1cf05ad7c8ddb4663a2be6e3	SAMEA7711718
PXD004242-43 plasma at 0 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150917_qep1_lc7_phge_sa_plate4c_43_2	20150917_QEp1_LC7_PhGe_SA_Plate4C_43_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_43_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	cccd83d875ae12f43ebeb24599f6f4fe07347166d0630863cfb221ed1f3e7ce8	SAMEA7711719
PXD004242-43 plasma at 4 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150917_qep1_lc7_phge_sa_plate4c_43_3	20150917_QEp1_LC7_PhGe_SA_Plate4C_43_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_43_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	6a87cde57033cd7fee2e14ee3f43c19d1d9ba014115f5100a66c169c11140c0b	SAMEA7711720
PXD004242-43 plasma at 13 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150917_qep1_lc7_phge_sa_plate4c_43_4	20150917_QEp1_LC7_PhGe_SA_Plate4C_43_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_43_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	0007b1548324b293e432d9d8689e7a6643ae8a9de7462f98fd748c8913d501c2	SAMEA7711721
PXD004242-43 plasma at 26 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150917_qep1_lc7_phge_sa_plate4c_43_5	20150917_QEp1_LC7_PhGe_SA_Plate4C_43_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_43_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	b9ac1c06da4a86c9a2e11f21aa23b9dba5a7aa95bd17fcbce555a46dc1b81ce7	SAMEA7711722
PXD004242-43 plasma at 39 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150917_qep1_lc7_phge_sa_plate4c_43_6	20150917_QEp1_LC7_PhGe_SA_Plate4C_43_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_43_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	78f34c645e5e4de0ffe56a61b3e9bad2108d190703401634f4758bf447163809	SAMEA7711723
PXD004242-43 plasma at 52 weeks	Homo sapiens	blood plasma	43	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150917_qep1_lc7_phge_sa_plate4c_43_7	20150917_QEp1_LC7_PhGe_SA_Plate4C_43_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_43_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	c09d5288a0cd3394b1d8c89f99606e81b5dc63d7757e88552c2c4fa748ca08ff	SAMEA7711724
PXD004242-44 plasma at 0 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150618_qep1_lc7_phge_sa_plate1b_44_2	20150618_QEp1_LC7_PhGe_SA_Plate1B_44_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_44_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	abe3de2a287f74f013c94566cc605641707a3b73658807de4a88d756cd0a57fc	SAMEA7711725
PXD004242-44 plasma at 4 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150618_qep1_lc7_phge_sa_plate1b_44_3	20150618_QEp1_LC7_PhGe_SA_Plate1B_44_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_44_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	a9f77f12da20dbf38c5878044636d6f5d69ad2467135c83d48693bf362c14f8e	SAMEA7711726
PXD004242-44 plasma at 13 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150618_qep1_lc7_phge_sa_plate1b_44_4	20150618_QEp1_LC7_PhGe_SA_Plate1B_44_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_44_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	91c2dab75390e04bf939d9f7a2574a58f65bd5d2831a7fdc1325cec20f05df3a	SAMEA7711727
PXD004242-44 plasma at 26 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150618_qep1_lc7_phge_sa_plate1b_44_5	20150618_QEp1_LC7_PhGe_SA_Plate1B_44_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_44_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	fcb287b439c9ca487cff0e742343aeb131ab97035aa9ad087262184eedb2c62b	SAMEA7711728
PXD004242-44 plasma at 39 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150618_qep1_lc7_phge_sa_plate1b_44_6	20150618_QEp1_LC7_PhGe_SA_Plate1B_44_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_44_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	4b9405fc5ebbf4b93521ace94390e800692e03290fadb2b0108a0ae8d2744e15	SAMEA7711729
PXD004242-44 plasma at 52 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150618_qep1_lc7_phge_sa_plate1b_44_7	20150618_QEp1_LC7_PhGe_SA_Plate1B_44_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_44_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	adc978f36cd13b7e598cb7754a8254cbd0eec30d3fceac3cdeca756c0d3b97dc	SAMEA7711730
PXD004242-44 plasma at 4 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150708_qep1_lc7_phge_sa_plate1c_44_3	20150708_QEp1_LC7_PhGe_SA_Plate1C_44_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_44_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	a9f77f12da20dbf38c5878044636d6f5d69ad2467135c83d48693bf362c14f8e	SAMEA7711726
PXD004242-44 plasma at 13 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150708_qep1_lc7_phge_sa_plate1c_44_4	20150708_QEp1_LC7_PhGe_SA_Plate1C_44_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_44_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	91c2dab75390e04bf939d9f7a2574a58f65bd5d2831a7fdc1325cec20f05df3a	SAMEA7711727
PXD004242-44 plasma at 26 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150708_qep1_lc7_phge_sa_plate1c_44_5	20150708_QEp1_LC7_PhGe_SA_Plate1C_44_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_44_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	fcb287b439c9ca487cff0e742343aeb131ab97035aa9ad087262184eedb2c62b	SAMEA7711728
PXD004242-44 plasma at 39 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150708_qep1_lc7_phge_sa_plate1c_44_6	20150708_QEp1_LC7_PhGe_SA_Plate1C_44_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_44_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	4b9405fc5ebbf4b93521ace94390e800692e03290fadb2b0108a0ae8d2744e15	SAMEA7711729
PXD004242-44 plasma at 52 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150708_qep1_lc7_phge_sa_plate1c_44_7	20150708_QEp1_LC7_PhGe_SA_Plate1C_44_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_44_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	adc978f36cd13b7e598cb7754a8254cbd0eec30d3fceac3cdeca756c0d3b97dc	SAMEA7711730
PXD004242-44 plasma at 0 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150805_qep1_lc7_phge_sa_plate1d_44_2	20150805_QEp1_LC7_PhGe_SA_Plate1D_44_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_44_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	abe3de2a287f74f013c94566cc605641707a3b73658807de4a88d756cd0a57fc	SAMEA7711725
PXD004242-44 plasma at 4 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150805_qep1_lc7_phge_sa_plate1d_44_3	20150805_QEp1_LC7_PhGe_SA_Plate1D_44_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_44_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	a9f77f12da20dbf38c5878044636d6f5d69ad2467135c83d48693bf362c14f8e	SAMEA7711726
PXD004242-44 plasma at 13 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150805_qep1_lc7_phge_sa_plate1d_44_4	20150805_QEp1_LC7_PhGe_SA_Plate1D_44_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_44_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	91c2dab75390e04bf939d9f7a2574a58f65bd5d2831a7fdc1325cec20f05df3a	SAMEA7711727
PXD004242-44 plasma at 26 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150805_qep1_lc7_phge_sa_plate1d_44_5	20150805_QEp1_LC7_PhGe_SA_Plate1D_44_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_44_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	fcb287b439c9ca487cff0e742343aeb131ab97035aa9ad087262184eedb2c62b	SAMEA7711728
PXD004242-44 plasma at 39 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150805_qep1_lc7_phge_sa_plate1d_44_6	20150805_QEp1_LC7_PhGe_SA_Plate1D_44_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_44_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	4b9405fc5ebbf4b93521ace94390e800692e03290fadb2b0108a0ae8d2744e15	SAMEA7711729
PXD004242-44 plasma at 52 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150805_qep1_lc7_phge_sa_plate1d_44_7	20150805_QEp1_LC7_PhGe_SA_Plate1D_44_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_44_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	adc978f36cd13b7e598cb7754a8254cbd0eec30d3fceac3cdeca756c0d3b97dc	SAMEA7711730
PXD004242-44 plasma at 0 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150901_qep1_lc7_phge_sa_plate1e_44_2	20150901_QEp1_LC7_PhGe_SA_Plate1E_44_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_44_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	abe3de2a287f74f013c94566cc605641707a3b73658807de4a88d756cd0a57fc	SAMEA7711725
PXD004242-44 plasma at 4 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150901_qep1_lc7_phge_sa_plate1e_44_3	20150901_QEp1_LC7_PhGe_SA_Plate1E_44_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_44_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	a9f77f12da20dbf38c5878044636d6f5d69ad2467135c83d48693bf362c14f8e	SAMEA7711726
PXD004242-44 plasma at 13 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150901_qep1_lc7_phge_sa_plate1e_44_4	20150901_QEp1_LC7_PhGe_SA_Plate1E_44_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_44_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	91c2dab75390e04bf939d9f7a2574a58f65bd5d2831a7fdc1325cec20f05df3a	SAMEA7711727
PXD004242-44 plasma at 26 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150901_qep1_lc7_phge_sa_plate1e_44_5	20150901_QEp1_LC7_PhGe_SA_Plate1E_44_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_44_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	fcb287b439c9ca487cff0e742343aeb131ab97035aa9ad087262184eedb2c62b	SAMEA7711728
PXD004242-44 plasma at 39 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150901_qep1_lc7_phge_sa_plate1e_44_6	20150901_QEp1_LC7_PhGe_SA_Plate1E_44_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_44_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	4b9405fc5ebbf4b93521ace94390e800692e03290fadb2b0108a0ae8d2744e15	SAMEA7711729
PXD004242-44 plasma at 52 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150901_qep1_lc7_phge_sa_plate1e_44_7	20150901_QEp1_LC7_PhGe_SA_Plate1E_44_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_44_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	adc978f36cd13b7e598cb7754a8254cbd0eec30d3fceac3cdeca756c0d3b97dc	SAMEA7711730
PXD004242-44 plasma at 0 weeks	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150917_qep1_lc8_phge_sa_plate1c_44_2	20150917_QEp1_LC8_PhGe_SA_Plate1C_44_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_Plate1C_44_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	abe3de2a287f74f013c94566cc605641707a3b73658807de4a88d756cd0a57fc	SAMEA7711725
PXD004242-45 plasma at -8 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150618_qep1_lc7_phge_sa_plate1b_45_1	20150618_QEp1_LC7_PhGe_SA_Plate1B_45_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_45_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	92c4ca13c29384f4f32ff145458d86c80061c1b0f1208d0ba4748257618301e9	SAMEA7711731
PXD004242-45 plasma at 0 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150618_qep1_lc7_phge_sa_plate1b_45_2	20150618_QEp1_LC7_PhGe_SA_Plate1B_45_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_45_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	0940b830f5bed85745611929f14ff92a2002d736cb159068f9d5f1b905f59203	SAMEA7711732
PXD004242-45 plasma at 4 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150618_qep1_lc7_phge_sa_plate1b_45_3	20150618_QEp1_LC7_PhGe_SA_Plate1B_45_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_45_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	4f0908091d62794838d8b2b7eb2c64eb804c39b72fd50a3835edf1f827fe9de9	SAMEA7711733
PXD004242-45 plasma at 13 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150618_qep1_lc7_phge_sa_plate1b_45_4	20150618_QEp1_LC7_PhGe_SA_Plate1B_45_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_45_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	1a6d12ef7e4536f82fd275495816b0c0cc0e0cf73f5647e021feda61d8aebfa1	SAMEA7711734
PXD004242-45 plasma at 26 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150618_qep1_lc7_phge_sa_plate1b_45_5	20150618_QEp1_LC7_PhGe_SA_Plate1B_45_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_45_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	50be9e3e7a8dc124c478f1b110f62830bfc20b8c2259e56d625851591b2082c3	SAMEA7711735
PXD004242-45 plasma at 39 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150618_qep1_lc7_phge_sa_plate1b_45_6	20150618_QEp1_LC7_PhGe_SA_Plate1B_45_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_45_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	3a6bd6affe1e747d459074cede5846eafbb5f4a75c22ff986004e4466692b881	SAMEA7711736
PXD004242-45 plasma at 52 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150618_qep1_lc7_phge_sa_plate1b_45_7	20150618_QEp1_LC7_PhGe_SA_Plate1B_45_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_45_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	227e8f7b0729f57c85d728ea864b22f9c56d496bd672797938acaa68e8d74484	SAMEA7711737
PXD004242-45 plasma at -8 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150708_qep1_lc7_phge_sa_plate1c_45_1	20150708_QEp1_LC7_PhGe_SA_Plate1C_45_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_45_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	92c4ca13c29384f4f32ff145458d86c80061c1b0f1208d0ba4748257618301e9	SAMEA7711731
PXD004242-45 plasma at 0 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150708_qep1_lc7_phge_sa_plate1c_45_2	20150708_QEp1_LC7_PhGe_SA_Plate1C_45_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_45_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	0940b830f5bed85745611929f14ff92a2002d736cb159068f9d5f1b905f59203	SAMEA7711732
PXD004242-45 plasma at 4 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150708_qep1_lc7_phge_sa_plate1c_45_3	20150708_QEp1_LC7_PhGe_SA_Plate1C_45_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_45_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	4f0908091d62794838d8b2b7eb2c64eb804c39b72fd50a3835edf1f827fe9de9	SAMEA7711733
PXD004242-45 plasma at 13 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150708_qep1_lc7_phge_sa_plate1c_45_4	20150708_QEp1_LC7_PhGe_SA_Plate1C_45_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_45_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	1a6d12ef7e4536f82fd275495816b0c0cc0e0cf73f5647e021feda61d8aebfa1	SAMEA7711734
PXD004242-45 plasma at 26 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150708_qep1_lc7_phge_sa_plate1c_45_5	20150708_QEp1_LC7_PhGe_SA_Plate1C_45_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_45_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	50be9e3e7a8dc124c478f1b110f62830bfc20b8c2259e56d625851591b2082c3	SAMEA7711735
PXD004242-45 plasma at 39 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150708_qep1_lc7_phge_sa_plate1c_45_6	20150708_QEp1_LC7_PhGe_SA_Plate1C_45_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_45_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	3a6bd6affe1e747d459074cede5846eafbb5f4a75c22ff986004e4466692b881	SAMEA7711736
PXD004242-45 plasma at 52 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150708_qep1_lc7_phge_sa_plate1c_45_7	20150708_QEp1_LC7_PhGe_SA_Plate1C_45_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_45_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	227e8f7b0729f57c85d728ea864b22f9c56d496bd672797938acaa68e8d74484	SAMEA7711737
PXD004242-45 plasma at -8 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150805_qep1_lc7_phge_sa_plate1d_45_1	20150805_QEp1_LC7_PhGe_SA_Plate1D_45_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_45_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	92c4ca13c29384f4f32ff145458d86c80061c1b0f1208d0ba4748257618301e9	SAMEA7711731
PXD004242-45 plasma at 0 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150805_qep1_lc7_phge_sa_plate1d_45_2	20150805_QEp1_LC7_PhGe_SA_Plate1D_45_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_45_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	0940b830f5bed85745611929f14ff92a2002d736cb159068f9d5f1b905f59203	SAMEA7711732
PXD004242-45 plasma at 4 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150805_qep1_lc7_phge_sa_plate1d_45_3	20150805_QEp1_LC7_PhGe_SA_Plate1D_45_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_45_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	4f0908091d62794838d8b2b7eb2c64eb804c39b72fd50a3835edf1f827fe9de9	SAMEA7711733
PXD004242-45 plasma at 13 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150805_qep1_lc7_phge_sa_plate1d_45_4	20150805_QEp1_LC7_PhGe_SA_Plate1D_45_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_45_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	1a6d12ef7e4536f82fd275495816b0c0cc0e0cf73f5647e021feda61d8aebfa1	SAMEA7711734
PXD004242-45 plasma at 26 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150805_qep1_lc7_phge_sa_plate1d_45_5	20150805_QEp1_LC7_PhGe_SA_Plate1D_45_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_45_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	50be9e3e7a8dc124c478f1b110f62830bfc20b8c2259e56d625851591b2082c3	SAMEA7711735
PXD004242-45 plasma at 39 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150805_qep1_lc7_phge_sa_plate1d_45_6	20150805_QEp1_LC7_PhGe_SA_Plate1D_45_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_45_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	3a6bd6affe1e747d459074cede5846eafbb5f4a75c22ff986004e4466692b881	SAMEA7711736
PXD004242-45 plasma at 52 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150805_qep1_lc7_phge_sa_plate1d_45_7	20150805_QEp1_LC7_PhGe_SA_Plate1D_45_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_45_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	227e8f7b0729f57c85d728ea864b22f9c56d496bd672797938acaa68e8d74484	SAMEA7711737
PXD004242-45 plasma at -8 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150901_qep1_lc7_phge_sa_plate1e_45_1	20150901_QEp1_LC7_PhGe_SA_Plate1E_45_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_45_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	92c4ca13c29384f4f32ff145458d86c80061c1b0f1208d0ba4748257618301e9	SAMEA7711731
PXD004242-45 plasma at 0 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150901_qep1_lc7_phge_sa_plate1e_45_2	20150901_QEp1_LC7_PhGe_SA_Plate1E_45_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_45_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	0940b830f5bed85745611929f14ff92a2002d736cb159068f9d5f1b905f59203	SAMEA7711732
PXD004242-45 plasma at 4 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150901_qep1_lc7_phge_sa_plate1e_45_3	20150901_QEp1_LC7_PhGe_SA_Plate1E_45_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_45_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	4f0908091d62794838d8b2b7eb2c64eb804c39b72fd50a3835edf1f827fe9de9	SAMEA7711733
PXD004242-45 plasma at 13 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150901_qep1_lc7_phge_sa_plate1e_45_4	20150901_QEp1_LC7_PhGe_SA_Plate1E_45_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_45_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	1a6d12ef7e4536f82fd275495816b0c0cc0e0cf73f5647e021feda61d8aebfa1	SAMEA7711734
PXD004242-45 plasma at 26 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150901_qep1_lc7_phge_sa_plate1e_45_5	20150901_QEp1_LC7_PhGe_SA_Plate1E_45_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_45_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	50be9e3e7a8dc124c478f1b110f62830bfc20b8c2259e56d625851591b2082c3	SAMEA7711735
PXD004242-45 plasma at 39 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150901_qep1_lc7_phge_sa_plate1e_45_6	20150901_QEp1_LC7_PhGe_SA_Plate1E_45_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_45_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	3a6bd6affe1e747d459074cede5846eafbb5f4a75c22ff986004e4466692b881	SAMEA7711736
PXD004242-45 plasma at 52 weeks	Homo sapiens	blood plasma	45	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150901_qep1_lc7_phge_sa_plate1e_45_7	20150901_QEp1_LC7_PhGe_SA_Plate1E_45_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_45_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	227e8f7b0729f57c85d728ea864b22f9c56d496bd672797938acaa68e8d74484	SAMEA7711737
PXD004242-46 plasma at -8 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150701_qep1_lc7_phge_sa_plate3a_46_1	20150701_QEp1_LC7_PhGe_SA_Plate3A_46_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_46_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	ac9a2fd3ba0fa991046c359354a6d9871fe31a4d933ac61c2fcef0b4f2c2b227	SAMEA7711738
PXD004242-46 plasma at 0 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150701_qep1_lc7_phge_sa_plate3a_46_2	20150701_QEp1_LC7_PhGe_SA_Plate3A_46_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_46_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	ca12aa018e647b918f96bf2f4701895350aa4263879a1f799996bf3b8358a359	SAMEA7711739
PXD004242-46 plasma at 4 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150701_qep1_lc7_phge_sa_plate3a_46_3	20150701_QEp1_LC7_PhGe_SA_Plate3A_46_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_46_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	2d10c52a9f448c69c8de02f8e3d77e1ea1c2f0a1b8199686fb6cda078f1f65c9	SAMEA7711740
PXD004242-46 plasma at 13 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150701_qep1_lc7_phge_sa_plate3a_46_4	20150701_QEp1_LC7_PhGe_SA_Plate3A_46_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_46_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	40447a3fea08c189c9b0f2104cebfea7ca8aa3f5172de4a7762c2af9ff9a6235	SAMEA7711741
PXD004242-46 plasma at 26 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150701_qep1_lc7_phge_sa_plate3a_46_5	20150701_QEp1_LC7_PhGe_SA_Plate3A_46_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_46_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	c9909bb17998ceee979e1ef0c02f6e986d835ec8bd953dc7340485c7aaf5f145	SAMEA7711742
PXD004242-46 plasma at 39 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150701_qep1_lc7_phge_sa_plate3a_46_6	20150701_QEp1_LC7_PhGe_SA_Plate3A_46_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_46_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	9ed2bcf2afc5aea18b375773e5d53c2efbe7d0112ebf048818b36416706e06f6	SAMEA7711743
PXD004242-46 plasma at 52 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150701_qep1_lc7_phge_sa_plate3a_46_7	20150701_QEp1_LC7_PhGe_SA_Plate3A_46_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_46_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	5bda46dc7bb905fe7a7e2c7054964babca83921313d4709df88b2b7078e20bad	SAMEA7711744
PXD004242-46 plasma at 0 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150725_qep1_lc7_phge_sa_plate3b_46_2	20150725_QEp1_LC7_PhGe_SA_Plate3B_46_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_46_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	ca12aa018e647b918f96bf2f4701895350aa4263879a1f799996bf3b8358a359	SAMEA7711739
PXD004242-46 plasma at 4 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150725_qep1_lc7_phge_sa_plate3b_46_3	20150725_QEp1_LC7_PhGe_SA_Plate3B_46_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_46_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	2d10c52a9f448c69c8de02f8e3d77e1ea1c2f0a1b8199686fb6cda078f1f65c9	SAMEA7711740
PXD004242-46 plasma at 13 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150725_qep1_lc7_phge_sa_plate3b_46_4	20150725_QEp1_LC7_PhGe_SA_Plate3B_46_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_46_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	40447a3fea08c189c9b0f2104cebfea7ca8aa3f5172de4a7762c2af9ff9a6235	SAMEA7711741
PXD004242-46 plasma at 26 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150725_qep1_lc7_phge_sa_plate3b_46_5	20150725_QEp1_LC7_PhGe_SA_Plate3B_46_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_46_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	c9909bb17998ceee979e1ef0c02f6e986d835ec8bd953dc7340485c7aaf5f145	SAMEA7711742
PXD004242-46 plasma at 52 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150725_qep1_lc7_phge_sa_plate3b_46_7	20150725_QEp1_LC7_PhGe_SA_Plate3B_46_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_46_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	5bda46dc7bb905fe7a7e2c7054964babca83921313d4709df88b2b7078e20bad	SAMEA7711744
PXD004242-46 plasma at -8 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150818_qep1_lc7_phge_sa_plate3c_46_1	20150818_QEp1_LC7_PhGe_SA_Plate3C_46_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_46_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	ac9a2fd3ba0fa991046c359354a6d9871fe31a4d933ac61c2fcef0b4f2c2b227	SAMEA7711738
PXD004242-46 plasma at 0 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150818_qep1_lc7_phge_sa_plate3c_46_2	20150818_QEp1_LC7_PhGe_SA_Plate3C_46_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_46_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	ca12aa018e647b918f96bf2f4701895350aa4263879a1f799996bf3b8358a359	SAMEA7711739
PXD004242-46 plasma at 4 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150818_qep1_lc7_phge_sa_plate3c_46_3	20150818_QEp1_LC7_PhGe_SA_Plate3C_46_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_46_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	2d10c52a9f448c69c8de02f8e3d77e1ea1c2f0a1b8199686fb6cda078f1f65c9	SAMEA7711740
PXD004242-46 plasma at 13 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150818_qep1_lc7_phge_sa_plate3c_46_4	20150818_QEp1_LC7_PhGe_SA_Plate3C_46_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_46_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	40447a3fea08c189c9b0f2104cebfea7ca8aa3f5172de4a7762c2af9ff9a6235	SAMEA7711741
PXD004242-46 plasma at 26 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150818_qep1_lc7_phge_sa_plate3c_46_5	20150818_QEp1_LC7_PhGe_SA_Plate3C_46_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_46_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	c9909bb17998ceee979e1ef0c02f6e986d835ec8bd953dc7340485c7aaf5f145	SAMEA7711742
PXD004242-46 plasma at 39 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150818_qep1_lc7_phge_sa_plate3c_46_6	20150818_QEp1_LC7_PhGe_SA_Plate3C_46_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_46_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	9ed2bcf2afc5aea18b375773e5d53c2efbe7d0112ebf048818b36416706e06f6	SAMEA7711743
PXD004242-46 plasma at 52 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150818_qep1_lc7_phge_sa_plate3c_46_7	20150818_QEp1_LC7_PhGe_SA_Plate3C_46_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_46_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	5bda46dc7bb905fe7a7e2c7054964babca83921313d4709df88b2b7078e20bad	SAMEA7711744
PXD004242-46 plasma at -8 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150912_qep1_lc7_phge_sa_plate3d_46_1	20150912_QEp1_LC7_PhGe_SA_Plate3D_46_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_46_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	ac9a2fd3ba0fa991046c359354a6d9871fe31a4d933ac61c2fcef0b4f2c2b227	SAMEA7711738
PXD004242-46 plasma at 0 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150912_qep1_lc7_phge_sa_plate3d_46_2	20150912_QEp1_LC7_PhGe_SA_Plate3D_46_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_46_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	ca12aa018e647b918f96bf2f4701895350aa4263879a1f799996bf3b8358a359	SAMEA7711739
PXD004242-46 plasma at 4 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150912_qep1_lc7_phge_sa_plate3d_46_3	20150912_QEp1_LC7_PhGe_SA_Plate3D_46_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_46_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	2d10c52a9f448c69c8de02f8e3d77e1ea1c2f0a1b8199686fb6cda078f1f65c9	SAMEA7711740
PXD004242-46 plasma at 13 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150912_qep1_lc7_phge_sa_plate3d_46_4	20150912_QEp1_LC7_PhGe_SA_Plate3D_46_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_46_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	40447a3fea08c189c9b0f2104cebfea7ca8aa3f5172de4a7762c2af9ff9a6235	SAMEA7711741
PXD004242-46 plasma at 26 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150912_qep1_lc7_phge_sa_plate3d_46_5	20150912_QEp1_LC7_PhGe_SA_Plate3D_46_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_46_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	c9909bb17998ceee979e1ef0c02f6e986d835ec8bd953dc7340485c7aaf5f145	SAMEA7711742
PXD004242-46 plasma at 39 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150912_qep1_lc7_phge_sa_plate3d_46_6	20150912_QEp1_LC7_PhGe_SA_Plate3D_46_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_46_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	9ed2bcf2afc5aea18b375773e5d53c2efbe7d0112ebf048818b36416706e06f6	SAMEA7711743
PXD004242-46 plasma at 52 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150912_qep1_lc7_phge_sa_plate3d_46_7	20150912_QEp1_LC7_PhGe_SA_Plate3D_46_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_46_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	5bda46dc7bb905fe7a7e2c7054964babca83921313d4709df88b2b7078e20bad	SAMEA7711744
PXD004242-46 plasma at -8 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150917_qep1_lc7_phge_sa_plate3b_46_1	20150917_QEp1_LC7_PhGe_SA_Plate3B_46_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_46_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	ac9a2fd3ba0fa991046c359354a6d9871fe31a4d933ac61c2fcef0b4f2c2b227	SAMEA7711738
PXD004242-46 plasma at 39 weeks	Homo sapiens	blood plasma	46	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150917_qep1_lc7_phge_sa_plate3b_46_6	20150917_QEp1_LC7_PhGe_SA_Plate3B_46_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_46_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	9ed2bcf2afc5aea18b375773e5d53c2efbe7d0112ebf048818b36416706e06f6	SAMEA7711743
PXD004242-47 plasma at -8 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150624_qep1_lc7_phge_sa_plate2a_47_1	20150624_QEp1_LC7_PhGe_SA_Plate2A_47_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_47_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	105d3931b83b8bee6127f4bc392bc1e1f0a9e9bfd2dfdc2896d0688a9893ce3e	SAMEA7711745
PXD004242-47 plasma at 0 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150624_qep1_lc7_phge_sa_plate2a_47_2	20150624_QEp1_LC7_PhGe_SA_Plate2A_47_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_47_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	d315d616c56c736d593bfcd70d6e58c7b40a9e1fd53bd40024aa10d6e932e5fd	SAMEA7711746
PXD004242-47 plasma at 4 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150624_qep1_lc7_phge_sa_plate2a_47_3	20150624_QEp1_LC7_PhGe_SA_Plate2A_47_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_47_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	93d6d07deb58757d76b81a52c5ebc1689d06e6d66df6436341d1d500d3b9e0bd	SAMEA7711747
PXD004242-47 plasma at 13 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150624_qep1_lc7_phge_sa_plate2a_47_4	20150624_QEp1_LC7_PhGe_SA_Plate2A_47_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_47_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	5a36dc555801223c1cdc0f3fbbe416ef1fe5d0078df13a7d187c30a388fcced7	SAMEA7711748
PXD004242-47 plasma at 26 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150624_qep1_lc7_phge_sa_plate2a_47_5	20150624_QEp1_LC7_PhGe_SA_Plate2A_47_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_47_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	27ea159d004b3f3193795cde6c4485c9c4ea991d3ab54b03183e67d92689cb18	SAMEA7711749
PXD004242-47 plasma at 39 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150624_qep1_lc7_phge_sa_plate2a_47_6	20150624_QEp1_LC7_PhGe_SA_Plate2A_47_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_47_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	89124687aa54807c9c71bb9789bcec9a8b855c14e617c3899d88059370fb7672	SAMEA7711750
PXD004242-47 plasma at 52 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150624_qep1_lc7_phge_sa_plate2a_47_7	20150624_QEp1_LC7_PhGe_SA_Plate2A_47_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_47_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	88d504ecf61892ab359f4ffb156d5c29ac91563f33ff585dacc0c179ee7250fe	SAMEA7711751
PXD004242-47 plasma at -8 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150811_qep1_lc7_phge_sa_plate2b_47_1	20150811_QEp1_LC7_PhGe_SA_Plate2B_47_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_47_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	105d3931b83b8bee6127f4bc392bc1e1f0a9e9bfd2dfdc2896d0688a9893ce3e	SAMEA7711745
PXD004242-47 plasma at 0 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150811_qep1_lc7_phge_sa_plate2b_47_2	20150811_QEp1_LC7_PhGe_SA_Plate2B_47_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_47_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	d315d616c56c736d593bfcd70d6e58c7b40a9e1fd53bd40024aa10d6e932e5fd	SAMEA7711746
PXD004242-47 plasma at 4 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150811_qep1_lc7_phge_sa_plate2b_47_3	20150811_QEp1_LC7_PhGe_SA_Plate2B_47_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_47_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	93d6d07deb58757d76b81a52c5ebc1689d06e6d66df6436341d1d500d3b9e0bd	SAMEA7711747
PXD004242-47 plasma at 13 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150811_qep1_lc7_phge_sa_plate2b_47_4	20150811_QEp1_LC7_PhGe_SA_Plate2B_47_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_47_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	5a36dc555801223c1cdc0f3fbbe416ef1fe5d0078df13a7d187c30a388fcced7	SAMEA7711748
PXD004242-47 plasma at 26 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150811_qep1_lc7_phge_sa_plate2b_47_5	20150811_QEp1_LC7_PhGe_SA_Plate2B_47_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_47_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	27ea159d004b3f3193795cde6c4485c9c4ea991d3ab54b03183e67d92689cb18	SAMEA7711749
PXD004242-47 plasma at 39 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150811_qep1_lc7_phge_sa_plate2b_47_6	20150811_QEp1_LC7_PhGe_SA_Plate2B_47_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_47_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	89124687aa54807c9c71bb9789bcec9a8b855c14e617c3899d88059370fb7672	SAMEA7711750
PXD004242-47 plasma at 52 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150811_qep1_lc7_phge_sa_plate2b_47_7	20150811_QEp1_LC7_PhGe_SA_Plate2B_47_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_47_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	88d504ecf61892ab359f4ffb156d5c29ac91563f33ff585dacc0c179ee7250fe	SAMEA7711751
PXD004242-47 plasma at -8 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150827_qep1_lc7_phge_sa_plate2c_47_1	20150827_QEp1_LC7_PhGe_SA_Plate2C_47_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_47_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	105d3931b83b8bee6127f4bc392bc1e1f0a9e9bfd2dfdc2896d0688a9893ce3e	SAMEA7711745
PXD004242-47 plasma at 0 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150827_qep1_lc7_phge_sa_plate2c_47_2	20150827_QEp1_LC7_PhGe_SA_Plate2C_47_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_47_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	d315d616c56c736d593bfcd70d6e58c7b40a9e1fd53bd40024aa10d6e932e5fd	SAMEA7711746
PXD004242-47 plasma at 4 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150827_qep1_lc7_phge_sa_plate2c_47_3	20150827_QEp1_LC7_PhGe_SA_Plate2C_47_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_47_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	93d6d07deb58757d76b81a52c5ebc1689d06e6d66df6436341d1d500d3b9e0bd	SAMEA7711747
PXD004242-47 plasma at 13 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150827_qep1_lc7_phge_sa_plate2c_47_4	20150827_QEp1_LC7_PhGe_SA_Plate2C_47_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_47_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	5a36dc555801223c1cdc0f3fbbe416ef1fe5d0078df13a7d187c30a388fcced7	SAMEA7711748
PXD004242-47 plasma at 26 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150827_qep1_lc7_phge_sa_plate2c_47_5	20150827_QEp1_LC7_PhGe_SA_Plate2C_47_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_47_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	27ea159d004b3f3193795cde6c4485c9c4ea991d3ab54b03183e67d92689cb18	SAMEA7711749
PXD004242-47 plasma at 39 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150827_qep1_lc7_phge_sa_plate2c_47_6	20150827_QEp1_LC7_PhGe_SA_Plate2C_47_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_47_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	89124687aa54807c9c71bb9789bcec9a8b855c14e617c3899d88059370fb7672	SAMEA7711750
PXD004242-47 plasma at 52 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150827_qep1_lc7_phge_sa_plate2c_47_7	20150827_QEp1_LC7_PhGe_SA_Plate2C_47_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_47_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	88d504ecf61892ab359f4ffb156d5c29ac91563f33ff585dacc0c179ee7250fe	SAMEA7711751
PXD004242-47 plasma at -8 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150907_qep1_lc7_phge_sa_plate2d_47_1	20150907_QEp1_LC7_PhGe_SA_Plate2D_47_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_47_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	105d3931b83b8bee6127f4bc392bc1e1f0a9e9bfd2dfdc2896d0688a9893ce3e	SAMEA7711745
PXD004242-47 plasma at 0 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150907_qep1_lc7_phge_sa_plate2d_47_2	20150907_QEp1_LC7_PhGe_SA_Plate2D_47_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_47_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	d315d616c56c736d593bfcd70d6e58c7b40a9e1fd53bd40024aa10d6e932e5fd	SAMEA7711746
PXD004242-47 plasma at 4 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150907_qep1_lc7_phge_sa_plate2d_47_3	20150907_QEp1_LC7_PhGe_SA_Plate2D_47_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_47_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	93d6d07deb58757d76b81a52c5ebc1689d06e6d66df6436341d1d500d3b9e0bd	SAMEA7711747
PXD004242-47 plasma at 13 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150907_qep1_lc7_phge_sa_plate2d_47_4	20150907_QEp1_LC7_PhGe_SA_Plate2D_47_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_47_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	5a36dc555801223c1cdc0f3fbbe416ef1fe5d0078df13a7d187c30a388fcced7	SAMEA7711748
PXD004242-47 plasma at 26 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150907_qep1_lc7_phge_sa_plate2d_47_5	20150907_QEp1_LC7_PhGe_SA_Plate2D_47_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_47_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	27ea159d004b3f3193795cde6c4485c9c4ea991d3ab54b03183e67d92689cb18	SAMEA7711749
PXD004242-47 plasma at 39 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150907_qep1_lc7_phge_sa_plate2d_47_6	20150907_QEp1_LC7_PhGe_SA_Plate2D_47_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_47_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	89124687aa54807c9c71bb9789bcec9a8b855c14e617c3899d88059370fb7672	SAMEA7711750
PXD004242-47 plasma at 52 weeks	Homo sapiens	blood plasma	47	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150907_qep1_lc7_phge_sa_plate2d_47_7	20150907_QEp1_LC7_PhGe_SA_Plate2D_47_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_47_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	88d504ecf61892ab359f4ffb156d5c29ac91563f33ff585dacc0c179ee7250fe	SAMEA7711751
PXD004242-48 plasma at -8 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150701_qep1_lc7_phge_sa_plate3a_48_1	20150701_QEp1_LC7_PhGe_SA_Plate3A_48_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_48_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	e53dd24f61a9077a42a81b01e5a2b5ec1e6c092d05c89e7ae4213ff1858c701f	SAMEA7711752
PXD004242-48 plasma at 0 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150701_qep1_lc7_phge_sa_plate3a_48_2	20150701_QEp1_LC7_PhGe_SA_Plate3A_48_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_48_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	09c023b683ae96330d82cd9709ac20f74ab270d9aa462fbd0b29f46b23ced802	SAMEA7711753
PXD004242-48 plasma at 4 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150701_qep1_lc7_phge_sa_plate3a_48_3	20150701_QEp1_LC7_PhGe_SA_Plate3A_48_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_48_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	c6b25571930b4c898091b38e23518dfb2ceb04e864c31259db06748e5f7018fe	SAMEA7711754
PXD004242-48 plasma at 13 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150701_qep1_lc7_phge_sa_plate3a_48_4	20150701_QEp1_LC7_PhGe_SA_Plate3A_48_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_48_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	f83858f606da31dc2780bc9068f231af520e33abe4963b54bfebe7d06808d1e5	SAMEA7711755
PXD004242-48 plasma at 26 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150701_qep1_lc7_phge_sa_plate3a_48_5	20150701_QEp1_LC7_PhGe_SA_Plate3A_48_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_48_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	a26efd1632d6db2e79bd612835de3c3e1df9e9aaae8e5222ab91be1da95e85da	SAMEA7711756
PXD004242-48 plasma at 39 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150701_qep1_lc7_phge_sa_plate3a_48_6	20150701_QEp1_LC7_PhGe_SA_Plate3A_48_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_48_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	d0aad6129915f45d9fc87e991e27b9ae96465eee3a3929638a39bb44438c19e7	SAMEA7711757
PXD004242-48 plasma at 52 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150701_qep1_lc7_phge_sa_plate3a_48_7	20150701_QEp1_LC7_PhGe_SA_Plate3A_48_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_48_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	62b1299dec485e1f37102eef52214be75dc1c7461994d63a92f65d710f38384b	SAMEA7711758
PXD004242-48 plasma at -8 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150725_qep1_lc7_phge_sa_plate3b_48_1	20150725_QEp1_LC7_PhGe_SA_Plate3B_48_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_48_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	e53dd24f61a9077a42a81b01e5a2b5ec1e6c092d05c89e7ae4213ff1858c701f	SAMEA7711752
PXD004242-48 plasma at 4 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150725_qep1_lc7_phge_sa_plate3b_48_3	20150725_QEp1_LC7_PhGe_SA_Plate3B_48_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_48_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	c6b25571930b4c898091b38e23518dfb2ceb04e864c31259db06748e5f7018fe	SAMEA7711754
PXD004242-48 plasma at 13 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150725_qep1_lc7_phge_sa_plate3b_48_4	20150725_QEp1_LC7_PhGe_SA_Plate3B_48_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_48_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	f83858f606da31dc2780bc9068f231af520e33abe4963b54bfebe7d06808d1e5	SAMEA7711755
PXD004242-48 plasma at 26 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150725_qep1_lc7_phge_sa_plate3b_48_5	20150725_QEp1_LC7_PhGe_SA_Plate3B_48_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_48_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	a26efd1632d6db2e79bd612835de3c3e1df9e9aaae8e5222ab91be1da95e85da	SAMEA7711756
PXD004242-48 plasma at 39 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150725_qep1_lc7_phge_sa_plate3b_48_6	20150725_QEp1_LC7_PhGe_SA_Plate3B_48_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_48_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	d0aad6129915f45d9fc87e991e27b9ae96465eee3a3929638a39bb44438c19e7	SAMEA7711757
PXD004242-48 plasma at 52 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150725_qep1_lc7_phge_sa_plate3b_48_7	20150725_QEp1_LC7_PhGe_SA_Plate3B_48_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_48_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	62b1299dec485e1f37102eef52214be75dc1c7461994d63a92f65d710f38384b	SAMEA7711758
PXD004242-48 plasma at -8 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150818_qep1_lc7_phge_sa_plate3c_48_1	20150818_QEp1_LC7_PhGe_SA_Plate3C_48_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_48_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	e53dd24f61a9077a42a81b01e5a2b5ec1e6c092d05c89e7ae4213ff1858c701f	SAMEA7711752
PXD004242-48 plasma at 0 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150818_qep1_lc7_phge_sa_plate3c_48_2	20150818_QEp1_LC7_PhGe_SA_Plate3C_48_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_48_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	09c023b683ae96330d82cd9709ac20f74ab270d9aa462fbd0b29f46b23ced802	SAMEA7711753
PXD004242-48 plasma at 4 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150818_qep1_lc7_phge_sa_plate3c_48_3	20150818_QEp1_LC7_PhGe_SA_Plate3C_48_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_48_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	c6b25571930b4c898091b38e23518dfb2ceb04e864c31259db06748e5f7018fe	SAMEA7711754
PXD004242-48 plasma at 13 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150818_qep1_lc7_phge_sa_plate3c_48_4	20150818_QEp1_LC7_PhGe_SA_Plate3C_48_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_48_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	f83858f606da31dc2780bc9068f231af520e33abe4963b54bfebe7d06808d1e5	SAMEA7711755
PXD004242-48 plasma at 26 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150818_qep1_lc7_phge_sa_plate3c_48_5	20150818_QEp1_LC7_PhGe_SA_Plate3C_48_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_48_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	a26efd1632d6db2e79bd612835de3c3e1df9e9aaae8e5222ab91be1da95e85da	SAMEA7711756
PXD004242-48 plasma at 39 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150818_qep1_lc7_phge_sa_plate3c_48_6	20150818_QEp1_LC7_PhGe_SA_Plate3C_48_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_48_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	d0aad6129915f45d9fc87e991e27b9ae96465eee3a3929638a39bb44438c19e7	SAMEA7711757
PXD004242-48 plasma at 52 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150818_qep1_lc7_phge_sa_plate3c_48_7	20150818_QEp1_LC7_PhGe_SA_Plate3C_48_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_48_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	62b1299dec485e1f37102eef52214be75dc1c7461994d63a92f65d710f38384b	SAMEA7711758
PXD004242-48 plasma at -8 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150912_qep1_lc7_phge_sa_plate3d_48_1	20150912_QEp1_LC7_PhGe_SA_Plate3D_48_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_48_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	e53dd24f61a9077a42a81b01e5a2b5ec1e6c092d05c89e7ae4213ff1858c701f	SAMEA7711752
PXD004242-48 plasma at 0 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150912_qep1_lc7_phge_sa_plate3d_48_2	20150912_QEp1_LC7_PhGe_SA_Plate3D_48_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_48_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	09c023b683ae96330d82cd9709ac20f74ab270d9aa462fbd0b29f46b23ced802	SAMEA7711753
PXD004242-48 plasma at 4 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150912_qep1_lc7_phge_sa_plate3d_48_3	20150912_QEp1_LC7_PhGe_SA_Plate3D_48_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_48_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	c6b25571930b4c898091b38e23518dfb2ceb04e864c31259db06748e5f7018fe	SAMEA7711754
PXD004242-48 plasma at 13 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150912_qep1_lc7_phge_sa_plate3d_48_4	20150912_QEp1_LC7_PhGe_SA_Plate3D_48_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_48_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	f83858f606da31dc2780bc9068f231af520e33abe4963b54bfebe7d06808d1e5	SAMEA7711755
PXD004242-48 plasma at 26 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150912_qep1_lc7_phge_sa_plate3d_48_5	20150912_QEp1_LC7_PhGe_SA_Plate3D_48_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_48_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	a26efd1632d6db2e79bd612835de3c3e1df9e9aaae8e5222ab91be1da95e85da	SAMEA7711756
PXD004242-48 plasma at 39 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150912_qep1_lc7_phge_sa_plate3d_48_6	20150912_QEp1_LC7_PhGe_SA_Plate3D_48_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_48_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	d0aad6129915f45d9fc87e991e27b9ae96465eee3a3929638a39bb44438c19e7	SAMEA7711757
PXD004242-48 plasma at 52 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150912_qep1_lc7_phge_sa_plate3d_48_7	20150912_QEp1_LC7_PhGe_SA_Plate3D_48_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_48_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	62b1299dec485e1f37102eef52214be75dc1c7461994d63a92f65d710f38384b	SAMEA7711758
PXD004242-48 plasma at 0 weeks	Homo sapiens	blood plasma	48	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150917_qep1_lc7_phge_sa_plate3b_48_2	20150917_QEp1_LC7_PhGe_SA_Plate3B_48_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate3B_48_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	09c023b683ae96330d82cd9709ac20f74ab270d9aa462fbd0b29f46b23ced802	SAMEA7711753
PXD004242-49 plasma at -8 weeks	Homo sapiens	blood plasma	49	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150624_qep1_lc7_phge_sa_plate2a_49_1	20150624_QEp1_LC7_PhGe_SA_Plate2A_49_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_49_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	4f532dfa553ed782ec645c5ef5e9e2fc0671fa8e1790ecfd99cde2e9e07e4729	SAMEA7711759
PXD004242-49 plasma at 0 weeks	Homo sapiens	blood plasma	49	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150624_qep1_lc7_phge_sa_plate2a_49_2	20150624_QEp1_LC7_PhGe_SA_Plate2A_49_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_49_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	22e0231698e1b2dc27ad5262383dacfb10eac4bded795d7e3d7f22e6cf57dc2e	SAMEA7711760
PXD004242-49 plasma at -8 weeks	Homo sapiens	blood plasma	49	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150811_qep1_lc7_phge_sa_plate2b_49_1	20150811_QEp1_LC7_PhGe_SA_Plate2B_49_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_49_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	4f532dfa553ed782ec645c5ef5e9e2fc0671fa8e1790ecfd99cde2e9e07e4729	SAMEA7711759
PXD004242-49 plasma at 0 weeks	Homo sapiens	blood plasma	49	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150811_qep1_lc7_phge_sa_plate2b_49_2	20150811_QEp1_LC7_PhGe_SA_Plate2B_49_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_49_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	22e0231698e1b2dc27ad5262383dacfb10eac4bded795d7e3d7f22e6cf57dc2e	SAMEA7711760
PXD004242-49 plasma at -8 weeks	Homo sapiens	blood plasma	49	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150827_qep1_lc7_phge_sa_plate2c_49_1	20150827_QEp1_LC7_PhGe_SA_Plate2C_49_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_49_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	4f532dfa553ed782ec645c5ef5e9e2fc0671fa8e1790ecfd99cde2e9e07e4729	SAMEA7711759
PXD004242-49 plasma at 0 weeks	Homo sapiens	blood plasma	49	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150827_qep1_lc7_phge_sa_plate2c_49_2	20150827_QEp1_LC7_PhGe_SA_Plate2C_49_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_49_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	22e0231698e1b2dc27ad5262383dacfb10eac4bded795d7e3d7f22e6cf57dc2e	SAMEA7711760
PXD004242-49 plasma at -8 weeks	Homo sapiens	blood plasma	49	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150907_qep1_lc7_phge_sa_plate2d_49_1	20150907_QEp1_LC7_PhGe_SA_Plate2D_49_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_49_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	4f532dfa553ed782ec645c5ef5e9e2fc0671fa8e1790ecfd99cde2e9e07e4729	SAMEA7711759
PXD004242-49 plasma at 0 weeks	Homo sapiens	blood plasma	49	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150907_qep1_lc7_phge_sa_plate2d_49_2	20150907_QEp1_LC7_PhGe_SA_Plate2D_49_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_49_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	22e0231698e1b2dc27ad5262383dacfb10eac4bded795d7e3d7f22e6cf57dc2e	SAMEA7711760
PXD004242-50 plasma at -8 weeks	Homo sapiens	blood plasma	50	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150618_qep1_lc7_phge_sa_plate1b_50_1	20150618_QEp1_LC7_PhGe_SA_Plate1B_50_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_50_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	6856d067fc48d40b9160bba5fb181b1b1a7e91ab76a334431ac0c90ee6015d4b	SAMEA7711761
PXD004242-50 plasma at 0 weeks	Homo sapiens	blood plasma	50	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150618_qep1_lc7_phge_sa_plate1b_50_2	20150618_QEp1_LC7_PhGe_SA_Plate1B_50_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_50_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	9f9d5a956af4f2c76032143359adcd699b44dae8f8c94a0b01a5d0e83779a11a	SAMEA7711762
PXD004242-50 plasma at -8 weeks	Homo sapiens	blood plasma	50	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150708_qep1_lc7_phge_sa_plate1c_50_1	20150708_QEp1_LC7_PhGe_SA_Plate1C_50_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_50_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	6856d067fc48d40b9160bba5fb181b1b1a7e91ab76a334431ac0c90ee6015d4b	SAMEA7711761
PXD004242-50 plasma at 0 weeks	Homo sapiens	blood plasma	50	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150708_qep1_lc7_phge_sa_plate1c_50_2	20150708_QEp1_LC7_PhGe_SA_Plate1C_50_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_50_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	9f9d5a956af4f2c76032143359adcd699b44dae8f8c94a0b01a5d0e83779a11a	SAMEA7711762
PXD004242-50 plasma at -8 weeks	Homo sapiens	blood plasma	50	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150805_qep1_lc7_phge_sa_plate1d_50_1	20150805_QEp1_LC7_PhGe_SA_Plate1D_50_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_50_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	6856d067fc48d40b9160bba5fb181b1b1a7e91ab76a334431ac0c90ee6015d4b	SAMEA7711761
PXD004242-50 plasma at 0 weeks	Homo sapiens	blood plasma	50	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150805_qep1_lc7_phge_sa_plate1d_50_2	20150805_QEp1_LC7_PhGe_SA_Plate1D_50_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_50_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	9f9d5a956af4f2c76032143359adcd699b44dae8f8c94a0b01a5d0e83779a11a	SAMEA7711762
PXD004242-50 plasma at -8 weeks	Homo sapiens	blood plasma	50	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150901_qep1_lc7_phge_sa_plate1e_50_1	20150901_QEp1_LC7_PhGe_SA_Plate1E_50_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_50_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	6856d067fc48d40b9160bba5fb181b1b1a7e91ab76a334431ac0c90ee6015d4b	SAMEA7711761
PXD004242-50 plasma at 0 weeks	Homo sapiens	blood plasma	50	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150901_qep1_lc7_phge_sa_plate1e_50_2	20150901_QEp1_LC7_PhGe_SA_Plate1E_50_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_50_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	9f9d5a956af4f2c76032143359adcd699b44dae8f8c94a0b01a5d0e83779a11a	SAMEA7711762
PXD004242-51 plasma at -8 weeks	Homo sapiens	blood plasma	51	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150701_qep1_lc7_phge_sa_plate3a_51_1	20150701_QEp1_LC7_PhGe_SA_Plate3A_51_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_51_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	8b83e575a157fc22da8c7080f0593a42e99eb594bdf28ea82f9f2432e9515922	SAMEA7711763
PXD004242-51 plasma at 0 weeks	Homo sapiens	blood plasma	51	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150701_qep1_lc7_phge_sa_plate3a_51_2	20150701_QEp1_LC7_PhGe_SA_Plate3A_51_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_51_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	013f0003f2d01aa381fde6c90d7ec9419aba0b45610a9366d128fd055e30e770	SAMEA7711764
PXD004242-51 plasma at -8 weeks	Homo sapiens	blood plasma	51	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150725_qep1_lc7_phge_sa_plate3b_51_1	20150725_QEp1_LC7_PhGe_SA_Plate3B_51_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_51_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	8b83e575a157fc22da8c7080f0593a42e99eb594bdf28ea82f9f2432e9515922	SAMEA7711763
PXD004242-51 plasma at 0 weeks	Homo sapiens	blood plasma	51	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150725_qep1_lc7_phge_sa_plate3b_51_2	20150725_QEp1_LC7_PhGe_SA_Plate3B_51_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_51_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	013f0003f2d01aa381fde6c90d7ec9419aba0b45610a9366d128fd055e30e770	SAMEA7711764
PXD004242-51 plasma at -8 weeks	Homo sapiens	blood plasma	51	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150818_qep1_lc7_phge_sa_plate3c_51_1	20150818_QEp1_LC7_PhGe_SA_Plate3C_51_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_51_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	8b83e575a157fc22da8c7080f0593a42e99eb594bdf28ea82f9f2432e9515922	SAMEA7711763
PXD004242-51 plasma at 0 weeks	Homo sapiens	blood plasma	51	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150818_qep1_lc7_phge_sa_plate3c_51_2	20150818_QEp1_LC7_PhGe_SA_Plate3C_51_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_51_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	013f0003f2d01aa381fde6c90d7ec9419aba0b45610a9366d128fd055e30e770	SAMEA7711764
PXD004242-51 plasma at -8 weeks	Homo sapiens	blood plasma	51	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150912_qep1_lc7_phge_sa_plate3d_51_1	20150912_QEp1_LC7_PhGe_SA_Plate3D_51_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_51_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	8b83e575a157fc22da8c7080f0593a42e99eb594bdf28ea82f9f2432e9515922	SAMEA7711763
PXD004242-51 plasma at 0 weeks	Homo sapiens	blood plasma	51	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150917_qep1_lc8_phge_sa_plate3d_51_2	20150917_QEp1_LC8_PhGe_SA_Plate3D_51_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_Plate3D_51_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	013f0003f2d01aa381fde6c90d7ec9419aba0b45610a9366d128fd055e30e770	SAMEA7711764
PXD004242-52 plasma at -8 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150624_qep1_lc7_phge_sa_plate2a_52_1	20150624_QEp1_LC7_PhGe_SA_Plate2A_52_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_52_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	a2da4b350b03a2f1472f8837ef078542e22d480ce914095a16638044c4e3835a	SAMEA7711765
PXD004242-52 plasma at 0 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150624_qep1_lc7_phge_sa_plate2a_52_2	20150624_QEp1_LC7_PhGe_SA_Plate2A_52_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_52_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	54e88c3c6d32707d9a9bbc1294d88a2748a766a5288a2b434bfc649519cfc7fd	SAMEA7711766
PXD004242-52 plasma at 4 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150624_qep1_lc7_phge_sa_plate2a_52_3	20150624_QEp1_LC7_PhGe_SA_Plate2A_52_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_52_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	deac184ef499b2a0d7a1d4fcd947f6bd5636c6b2984c7e52c041ea8ff616285e	SAMEA7711767
PXD004242-52 plasma at 13 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150624_qep1_lc7_phge_sa_plate2a_52_4	20150624_QEp1_LC7_PhGe_SA_Plate2A_52_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_52_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	99abaeddcf99cb7903ecba3db994317cabcd6df24e4b04ba2d1809aa9a3e5b15	SAMEA7711768
PXD004242-52 plasma at 26 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150624_qep1_lc7_phge_sa_plate2a_52_5	20150624_QEp1_LC7_PhGe_SA_Plate2A_52_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_52_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	4c8dbdfd221e075971d08c03b95fde9771d639258ba877acdaee44a58d9e632c	SAMEA7711769
PXD004242-52 plasma at 39 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150624_qep1_lc7_phge_sa_plate2a_52_6	20150624_QEp1_LC7_PhGe_SA_Plate2A_52_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_52_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	5d658aade8cd5e6cd087eb6d1b58316b27b79fbc55eacbb9492e56d103b86174	SAMEA7711770
PXD004242-52 plasma at 52 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150624_qep1_lc7_phge_sa_plate2a_52_7	20150624_QEp1_LC7_PhGe_SA_Plate2A_52_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150624_QEp1_LC7_PhGe_SA_Plate2A_52_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	960f459af2ac6d94312f475465ced475d19d610318a4708577ff37d054366360	SAMEA7711771
PXD004242-52 plasma at -8 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150811_qep1_lc7_phge_sa_plate2b_52_1	20150811_QEp1_LC7_PhGe_SA_Plate2B_52_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_52_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	a2da4b350b03a2f1472f8837ef078542e22d480ce914095a16638044c4e3835a	SAMEA7711765
PXD004242-52 plasma at 0 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150811_qep1_lc7_phge_sa_plate2b_52_2	20150811_QEp1_LC7_PhGe_SA_Plate2B_52_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_52_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	54e88c3c6d32707d9a9bbc1294d88a2748a766a5288a2b434bfc649519cfc7fd	SAMEA7711766
PXD004242-52 plasma at 4 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150811_qep1_lc7_phge_sa_plate2b_52_3	20150811_QEp1_LC7_PhGe_SA_Plate2B_52_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_52_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	deac184ef499b2a0d7a1d4fcd947f6bd5636c6b2984c7e52c041ea8ff616285e	SAMEA7711767
PXD004242-52 plasma at 13 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150811_qep1_lc7_phge_sa_plate2b_52_4	20150811_QEp1_LC7_PhGe_SA_Plate2B_52_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_52_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	99abaeddcf99cb7903ecba3db994317cabcd6df24e4b04ba2d1809aa9a3e5b15	SAMEA7711768
PXD004242-52 plasma at 26 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150811_qep1_lc7_phge_sa_plate2b_52_5	20150811_QEp1_LC7_PhGe_SA_Plate2B_52_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_52_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	4c8dbdfd221e075971d08c03b95fde9771d639258ba877acdaee44a58d9e632c	SAMEA7711769
PXD004242-52 plasma at 39 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150811_qep1_lc7_phge_sa_plate2b_52_6	20150811_QEp1_LC7_PhGe_SA_Plate2B_52_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_52_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	5d658aade8cd5e6cd087eb6d1b58316b27b79fbc55eacbb9492e56d103b86174	SAMEA7711770
PXD004242-52 plasma at 52 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150811_qep1_lc7_phge_sa_plate2b_52_7	20150811_QEp1_LC7_PhGe_SA_Plate2B_52_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150811_QEp1_LC7_PhGe_SA_Plate2B_52_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	960f459af2ac6d94312f475465ced475d19d610318a4708577ff37d054366360	SAMEA7711771
PXD004242-52 plasma at -8 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150827_qep1_lc7_phge_sa_plate2c_52_1	20150827_QEp1_LC7_PhGe_SA_Plate2C_52_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_52_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	a2da4b350b03a2f1472f8837ef078542e22d480ce914095a16638044c4e3835a	SAMEA7711765
PXD004242-52 plasma at 0 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150827_qep1_lc7_phge_sa_plate2c_52_2	20150827_QEp1_LC7_PhGe_SA_Plate2C_52_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_52_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	54e88c3c6d32707d9a9bbc1294d88a2748a766a5288a2b434bfc649519cfc7fd	SAMEA7711766
PXD004242-52 plasma at 4 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150827_qep1_lc7_phge_sa_plate2c_52_3	20150827_QEp1_LC7_PhGe_SA_Plate2C_52_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_52_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	deac184ef499b2a0d7a1d4fcd947f6bd5636c6b2984c7e52c041ea8ff616285e	SAMEA7711767
PXD004242-52 plasma at 13 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150827_qep1_lc7_phge_sa_plate2c_52_4	20150827_QEp1_LC7_PhGe_SA_Plate2C_52_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_52_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	99abaeddcf99cb7903ecba3db994317cabcd6df24e4b04ba2d1809aa9a3e5b15	SAMEA7711768
PXD004242-52 plasma at 26 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150827_qep1_lc7_phge_sa_plate2c_52_5	20150827_QEp1_LC7_PhGe_SA_Plate2C_52_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_52_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	4c8dbdfd221e075971d08c03b95fde9771d639258ba877acdaee44a58d9e632c	SAMEA7711769
PXD004242-52 plasma at 39 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150827_qep1_lc7_phge_sa_plate2c_52_6	20150827_QEp1_LC7_PhGe_SA_Plate2C_52_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_52_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	5d658aade8cd5e6cd087eb6d1b58316b27b79fbc55eacbb9492e56d103b86174	SAMEA7711770
PXD004242-52 plasma at 52 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150827_qep1_lc7_phge_sa_plate2c_52_7	20150827_QEp1_LC7_PhGe_SA_Plate2C_52_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150827_QEp1_LC7_PhGe_SA_Plate2C_52_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	960f459af2ac6d94312f475465ced475d19d610318a4708577ff37d054366360	SAMEA7711771
PXD004242-52 plasma at -8 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150907_qep1_lc7_phge_sa_plate2d_52_1	20150907_QEp1_LC7_PhGe_SA_Plate2D_52_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_52_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	a2da4b350b03a2f1472f8837ef078542e22d480ce914095a16638044c4e3835a	SAMEA7711765
PXD004242-52 plasma at 0 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150907_qep1_lc7_phge_sa_plate2d_52_2	20150907_QEp1_LC7_PhGe_SA_Plate2D_52_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_52_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	54e88c3c6d32707d9a9bbc1294d88a2748a766a5288a2b434bfc649519cfc7fd	SAMEA7711766
PXD004242-52 plasma at 4 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150907_qep1_lc7_phge_sa_plate2d_52_3	20150907_QEp1_LC7_PhGe_SA_Plate2D_52_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_52_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	deac184ef499b2a0d7a1d4fcd947f6bd5636c6b2984c7e52c041ea8ff616285e	SAMEA7711767
PXD004242-52 plasma at 13 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150907_qep1_lc7_phge_sa_plate2d_52_4	20150907_QEp1_LC7_PhGe_SA_Plate2D_52_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_52_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	99abaeddcf99cb7903ecba3db994317cabcd6df24e4b04ba2d1809aa9a3e5b15	SAMEA7711768
PXD004242-52 plasma at 26 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150907_qep1_lc7_phge_sa_plate2d_52_5	20150907_QEp1_LC7_PhGe_SA_Plate2D_52_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_52_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	4c8dbdfd221e075971d08c03b95fde9771d639258ba877acdaee44a58d9e632c	SAMEA7711769
PXD004242-52 plasma at 39 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150907_qep1_lc7_phge_sa_plate2d_52_6	20150907_QEp1_LC7_PhGe_SA_Plate2D_52_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_52_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	5d658aade8cd5e6cd087eb6d1b58316b27b79fbc55eacbb9492e56d103b86174	SAMEA7711770
PXD004242-52 plasma at 52 weeks	Homo sapiens	blood plasma	52	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150907_qep1_lc7_phge_sa_plate2d_52_7	20150907_QEp1_LC7_PhGe_SA_Plate2D_52_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150907_QEp1_LC7_PhGe_SA_Plate2D_52_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	960f459af2ac6d94312f475465ced475d19d610318a4708577ff37d054366360	SAMEA7711771
PXD004242-53 plasma at -8 weeks	Homo sapiens	blood plasma	53	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150618_qep1_lc7_phge_sa_plate1b_53_1	20150618_QEp1_LC7_PhGe_SA_Plate1B_53_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_53_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	396f52ad8dceede5c4d7184e3fc09314726a034d0545fa9cc1691fcfdd51e9af	SAMEA7711772
PXD004242-53 plasma at 0 weeks	Homo sapiens	blood plasma	53	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150618_qep1_lc7_phge_sa_plate1b_53_2	20150618_QEp1_LC7_PhGe_SA_Plate1B_53_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_53_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	4787d4bd66e26c8016899f2a9f353ee0e1ad60b40b51ab0766563d98ed3385fb	SAMEA7711773
PXD004242-53 plasma at -8 weeks	Homo sapiens	blood plasma	53	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150708_qep1_lc7_phge_sa_plate1c_53_1	20150708_QEp1_LC7_PhGe_SA_Plate1C_53_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_53_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	396f52ad8dceede5c4d7184e3fc09314726a034d0545fa9cc1691fcfdd51e9af	SAMEA7711772
PXD004242-53 plasma at 0 weeks	Homo sapiens	blood plasma	53	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150708_qep1_lc7_phge_sa_plate1c_53_2	20150708_QEp1_LC7_PhGe_SA_Plate1C_53_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_53_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	4787d4bd66e26c8016899f2a9f353ee0e1ad60b40b51ab0766563d98ed3385fb	SAMEA7711773
PXD004242-53 plasma at -8 weeks	Homo sapiens	blood plasma	53	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150805_qep1_lc7_phge_sa_plate1d_53_1	20150805_QEp1_LC7_PhGe_SA_Plate1D_53_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_53_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	396f52ad8dceede5c4d7184e3fc09314726a034d0545fa9cc1691fcfdd51e9af	SAMEA7711772
PXD004242-53 plasma at 0 weeks	Homo sapiens	blood plasma	53	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150805_qep1_lc7_phge_sa_plate1d_53_2	20150805_QEp1_LC7_PhGe_SA_Plate1D_53_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_53_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	4787d4bd66e26c8016899f2a9f353ee0e1ad60b40b51ab0766563d98ed3385fb	SAMEA7711773
PXD004242-53 plasma at -8 weeks	Homo sapiens	blood plasma	53	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150901_qep1_lc7_phge_sa_plate1e_53_1	20150901_QEp1_LC7_PhGe_SA_Plate1E_53_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_53_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	396f52ad8dceede5c4d7184e3fc09314726a034d0545fa9cc1691fcfdd51e9af	SAMEA7711772
PXD004242-53 plasma at 0 weeks	Homo sapiens	blood plasma	53	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150901_qep1_lc7_phge_sa_plate1e_53_2	20150901_QEp1_LC7_PhGe_SA_Plate1E_53_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_53_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	4787d4bd66e26c8016899f2a9f353ee0e1ad60b40b51ab0766563d98ed3385fb	SAMEA7711773
PXD004242-54 plasma at -8 weeks	Homo sapiens	blood plasma	54	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150701_qep1_lc7_phge_sa_plate3a_54_1	20150701_QEp1_LC7_PhGe_SA_Plate3A_54_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_54_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	a1ac1ba9027e7a776c6d621fed316720909e1583f19c8b8fc4ecefdb4de30884	SAMEA7711774
PXD004242-54 plasma at 0 weeks	Homo sapiens	blood plasma	54	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150701_qep1_lc7_phge_sa_plate3a_54_2	20150701_QEp1_LC7_PhGe_SA_Plate3A_54_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150701_QEp1_LC7_PhGe_SA_Plate3A_54_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	f43ddf0f9add9f394339b3dc853df5c3b90528a880afd808c8f249611099c4fd	SAMEA7711775
PXD004242-54 plasma at -8 weeks	Homo sapiens	blood plasma	54	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150725_qep1_lc7_phge_sa_plate3b_54_1	20150725_QEp1_LC7_PhGe_SA_Plate3B_54_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_54_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	a1ac1ba9027e7a776c6d621fed316720909e1583f19c8b8fc4ecefdb4de30884	SAMEA7711774
PXD004242-54 plasma at 0 weeks	Homo sapiens	blood plasma	54	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150725_qep1_lc7_phge_sa_plate3b_54_2	20150725_QEp1_LC7_PhGe_SA_Plate3B_54_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150725_QEp1_LC7_PhGe_SA_Plate3B_54_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	f43ddf0f9add9f394339b3dc853df5c3b90528a880afd808c8f249611099c4fd	SAMEA7711775
PXD004242-54 plasma at -8 weeks	Homo sapiens	blood plasma	54	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150818_qep1_lc7_phge_sa_plate3c_54_1	20150818_QEp1_LC7_PhGe_SA_Plate3C_54_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_54_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	a1ac1ba9027e7a776c6d621fed316720909e1583f19c8b8fc4ecefdb4de30884	SAMEA7711774
PXD004242-54 plasma at 0 weeks	Homo sapiens	blood plasma	54	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150818_qep1_lc7_phge_sa_plate3c_54_2	20150818_QEp1_LC7_PhGe_SA_Plate3C_54_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150818_QEp1_LC7_PhGe_SA_Plate3C_54_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	f43ddf0f9add9f394339b3dc853df5c3b90528a880afd808c8f249611099c4fd	SAMEA7711775
PXD004242-54 plasma at -8 weeks	Homo sapiens	blood plasma	54	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150912_qep1_lc7_phge_sa_plate3d_54_1	20150912_QEp1_LC7_PhGe_SA_Plate3D_54_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_54_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	a1ac1ba9027e7a776c6d621fed316720909e1583f19c8b8fc4ecefdb4de30884	SAMEA7711774
PXD004242-54 plasma at 0 weeks	Homo sapiens	blood plasma	54	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150912_qep1_lc7_phge_sa_plate3d_54_2	20150912_QEp1_LC7_PhGe_SA_Plate3D_54_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150912_QEp1_LC7_PhGe_SA_Plate3D_54_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	f43ddf0f9add9f394339b3dc853df5c3b90528a880afd808c8f249611099c4fd	SAMEA7711775
PXD004242-57 plasma at -8 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150618_qep1_lc7_phge_sa_plate1b_57_1	20150618_QEp1_LC7_PhGe_SA_Plate1B_57_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_57_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	9597715d5eabb39ee944aa60bba767090369ac663babd1b8e7d7c8c56051b0f3	SAMEA7711776
PXD004242-57 plasma at 0 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150618_qep1_lc7_phge_sa_plate1b_57_2	20150618_QEp1_LC7_PhGe_SA_Plate1B_57_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_57_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	227309b98909149e129a6f89d61097d5c29d0bf68e62725ed2e0580dec7046da	SAMEA7711777
PXD004242-57 plasma at 4 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150618_qep1_lc7_phge_sa_plate1b_57_3	20150618_QEp1_LC7_PhGe_SA_Plate1B_57_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_57_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	cb032d5c174701abe0bef1f2b1441a5d819e893d845f383eae61f8aa814eb0e9	SAMEA7711778
PXD004242-57 plasma at 13 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150618_qep1_lc7_phge_sa_plate1b_57_4	20150618_QEp1_LC7_PhGe_SA_Plate1B_57_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_57_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	5d878cf64c4cb57008b71f5fa8073a0204e04a8047a7aa4355bf6973be788aad	SAMEA7711779
PXD004242-57 plasma at 26 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150618_qep1_lc7_phge_sa_plate1b_57_5	20150618_QEp1_LC7_PhGe_SA_Plate1B_57_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_57_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	b3dac09b0ce5db539d3047a0c46880e22508e7a914edfa294046c4489f7dc812	SAMEA7711780
PXD004242-57 plasma at 39 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150618_qep1_lc7_phge_sa_plate1b_57_6	20150618_QEp1_LC7_PhGe_SA_Plate1B_57_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_57_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	f90c661a6c1840f12a83ad8594d50ffe47fadca4de992d76930fd0e9b23ea195	SAMEA7711781
PXD004242-57 plasma at 52 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150618_qep1_lc7_phge_sa_plate1b_57_7	20150618_QEp1_LC7_PhGe_SA_Plate1B_57_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_57_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	e0aa0bb7d35963274ef6218a57029b1c08e9758b132ae00a6029ea6c59fc7f0f	SAMEA7711782
PXD004242-57 plasma at -8 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150708_qep1_lc7_phge_sa_plate1c_57_1	20150708_QEp1_LC7_PhGe_SA_Plate1C_57_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_57_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	9597715d5eabb39ee944aa60bba767090369ac663babd1b8e7d7c8c56051b0f3	SAMEA7711776
PXD004242-57 plasma at 0 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150708_qep1_lc7_phge_sa_plate1c_57_2	20150708_QEp1_LC7_PhGe_SA_Plate1C_57_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_57_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	227309b98909149e129a6f89d61097d5c29d0bf68e62725ed2e0580dec7046da	SAMEA7711777
PXD004242-57 plasma at 4 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150708_qep1_lc7_phge_sa_plate1c_57_3	20150708_QEp1_LC7_PhGe_SA_Plate1C_57_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_57_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	cb032d5c174701abe0bef1f2b1441a5d819e893d845f383eae61f8aa814eb0e9	SAMEA7711778
PXD004242-57 plasma at 13 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150708_qep1_lc7_phge_sa_plate1c_57_4	20150708_QEp1_LC7_PhGe_SA_Plate1C_57_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_57_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	5d878cf64c4cb57008b71f5fa8073a0204e04a8047a7aa4355bf6973be788aad	SAMEA7711779
PXD004242-57 plasma at 26 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150708_qep1_lc7_phge_sa_plate1c_57_5	20150708_QEp1_LC7_PhGe_SA_Plate1C_57_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_57_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	b3dac09b0ce5db539d3047a0c46880e22508e7a914edfa294046c4489f7dc812	SAMEA7711780
PXD004242-57 plasma at 39 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150708_qep1_lc7_phge_sa_plate1c_57_6	20150708_QEp1_LC7_PhGe_SA_Plate1C_57_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_57_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	f90c661a6c1840f12a83ad8594d50ffe47fadca4de992d76930fd0e9b23ea195	SAMEA7711781
PXD004242-57 plasma at 52 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150708_qep1_lc7_phge_sa_plate1c_57_7	20150708_QEp1_LC7_PhGe_SA_Plate1C_57_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_57_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	e0aa0bb7d35963274ef6218a57029b1c08e9758b132ae00a6029ea6c59fc7f0f	SAMEA7711782
PXD004242-57 plasma at -8 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150805_qep1_lc7_phge_sa_plate1d_57_1	20150805_QEp1_LC7_PhGe_SA_Plate1D_57_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_57_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	9597715d5eabb39ee944aa60bba767090369ac663babd1b8e7d7c8c56051b0f3	SAMEA7711776
PXD004242-57 plasma at 0 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150805_qep1_lc7_phge_sa_plate1d_57_2	20150805_QEp1_LC7_PhGe_SA_Plate1D_57_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_57_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	227309b98909149e129a6f89d61097d5c29d0bf68e62725ed2e0580dec7046da	SAMEA7711777
PXD004242-57 plasma at 4 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150805_qep1_lc7_phge_sa_plate1d_57_3	20150805_QEp1_LC7_PhGe_SA_Plate1D_57_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_57_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	cb032d5c174701abe0bef1f2b1441a5d819e893d845f383eae61f8aa814eb0e9	SAMEA7711778
PXD004242-57 plasma at 13 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150805_qep1_lc7_phge_sa_plate1d_57_4	20150805_QEp1_LC7_PhGe_SA_Plate1D_57_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_57_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	5d878cf64c4cb57008b71f5fa8073a0204e04a8047a7aa4355bf6973be788aad	SAMEA7711779
PXD004242-57 plasma at 26 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150805_qep1_lc7_phge_sa_plate1d_57_5	20150805_QEp1_LC7_PhGe_SA_Plate1D_57_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_57_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	b3dac09b0ce5db539d3047a0c46880e22508e7a914edfa294046c4489f7dc812	SAMEA7711780
PXD004242-57 plasma at 39 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150805_qep1_lc7_phge_sa_plate1d_57_6	20150805_QEp1_LC7_PhGe_SA_Plate1D_57_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_57_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	f90c661a6c1840f12a83ad8594d50ffe47fadca4de992d76930fd0e9b23ea195	SAMEA7711781
PXD004242-57 plasma at 52 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150805_qep1_lc7_phge_sa_plate1d_57_7	20150805_QEp1_LC7_PhGe_SA_Plate1D_57_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_57_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	e0aa0bb7d35963274ef6218a57029b1c08e9758b132ae00a6029ea6c59fc7f0f	SAMEA7711782
PXD004242-57 plasma at -8 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150901_qep1_lc7_phge_sa_plate1e_57_1	20150901_QEp1_LC7_PhGe_SA_Plate1E_57_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_57_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	9597715d5eabb39ee944aa60bba767090369ac663babd1b8e7d7c8c56051b0f3	SAMEA7711776
PXD004242-57 plasma at 0 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150901_qep1_lc7_phge_sa_plate1e_57_2	20150901_QEp1_LC7_PhGe_SA_Plate1E_57_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_57_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	227309b98909149e129a6f89d61097d5c29d0bf68e62725ed2e0580dec7046da	SAMEA7711777
PXD004242-57 plasma at 4 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150901_qep1_lc7_phge_sa_plate1e_57_3	20150901_QEp1_LC7_PhGe_SA_Plate1E_57_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_57_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	cb032d5c174701abe0bef1f2b1441a5d819e893d845f383eae61f8aa814eb0e9	SAMEA7711778
PXD004242-57 plasma at 13 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150901_qep1_lc7_phge_sa_plate1e_57_4	20150901_QEp1_LC7_PhGe_SA_Plate1E_57_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_57_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	5d878cf64c4cb57008b71f5fa8073a0204e04a8047a7aa4355bf6973be788aad	SAMEA7711779
PXD004242-57 plasma at 26 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150901_qep1_lc7_phge_sa_plate1e_57_5	20150901_QEp1_LC7_PhGe_SA_Plate1E_57_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_57_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	b3dac09b0ce5db539d3047a0c46880e22508e7a914edfa294046c4489f7dc812	SAMEA7711780
PXD004242-57 plasma at 39 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150901_qep1_lc7_phge_sa_plate1e_57_6	20150901_QEp1_LC7_PhGe_SA_Plate1E_57_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_57_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	f90c661a6c1840f12a83ad8594d50ffe47fadca4de992d76930fd0e9b23ea195	SAMEA7711781
PXD004242-57 plasma at 52 weeks	Homo sapiens	blood plasma	57	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150901_qep1_lc7_phge_sa_plate1e_57_7	20150901_QEp1_LC7_PhGe_SA_Plate1E_57_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_57_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	e0aa0bb7d35963274ef6218a57029b1c08e9758b132ae00a6029ea6c59fc7f0f	SAMEA7711782
PXD004242-58 plasma at -8 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150731_qep1_lc7_phge_sa_plate4b_58_1	20150731_QEp1_LC7_PhGe_SA_Plate4B_58_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_58_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	12e934016e052bcabdc7097bb2b886175fefa824940c6ae4f14071a931206d58	SAMEA7711783
PXD004242-58 plasma at 0 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150731_qep1_lc7_phge_sa_plate4b_58_2	20150731_QEp1_LC7_PhGe_SA_Plate4B_58_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_58_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	95c2a12752f765d50f5a42f35a749cab5fe2c7094e670c7828accabc9eb76dcc	SAMEA7711784
PXD004242-58 plasma at 4 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150731_qep1_lc7_phge_sa_plate4b_58_3	20150731_QEp1_LC7_PhGe_SA_Plate4B_58_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_58_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	34fe969b662f87f916ec55e4d1528a3ac7abe0807630aafda6692eb35b59ad5f	SAMEA7711785
PXD004242-58 plasma at 13 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150731_qep1_lc7_phge_sa_plate4b_58_4	20150731_QEp1_LC7_PhGe_SA_Plate4B_58_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_58_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	29b759ac60441449e6bb623c4e6f0b0c56ece4e98347e5d37ba8ce51f477db77	SAMEA7711786
PXD004242-58 plasma at 26 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150731_qep1_lc7_phge_sa_plate4b_58_5	20150731_QEp1_LC7_PhGe_SA_Plate4B_58_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_58_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	0ce7d1e132137c4199ea14f27ac28a661f57b7aa5d73f66d5764432d35cd6952	SAMEA7711787
PXD004242-58 plasma at 39 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150731_qep1_lc7_phge_sa_plate4b_58_6	20150731_QEp1_LC7_PhGe_SA_Plate4B_58_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_58_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	ce95a7e17cd2a021b1853064bafa13e9cf2089911bcc27c508c2e926e3497566	SAMEA7711788
PXD004242-58 plasma at 52 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150731_qep1_lc7_phge_sa_plate4b_58_7	20150731_QEp1_LC7_PhGe_SA_Plate4B_58_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4B_58_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	4f0a9c8600c57bf142f967ad4ef2b759d12242e0a8ed260afcaa3051dd1adbff	SAMEA7711789
PXD004242-58 plasma at -8 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150731_qep1_lc7_phge_sa_plate4e_58_1	20150731_QEp1_LC7_PhGe_SA_Plate4E_58_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_58_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	12e934016e052bcabdc7097bb2b886175fefa824940c6ae4f14071a931206d58	SAMEA7711783
PXD004242-58 plasma at 0 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150731_qep1_lc7_phge_sa_plate4e_58_2	20150731_QEp1_LC7_PhGe_SA_Plate4E_58_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_58_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	95c2a12752f765d50f5a42f35a749cab5fe2c7094e670c7828accabc9eb76dcc	SAMEA7711784
PXD004242-58 plasma at 4 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150731_qep1_lc7_phge_sa_plate4e_58_3	20150731_QEp1_LC7_PhGe_SA_Plate4E_58_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_58_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	34fe969b662f87f916ec55e4d1528a3ac7abe0807630aafda6692eb35b59ad5f	SAMEA7711785
PXD004242-58 plasma at 13 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150731_qep1_lc7_phge_sa_plate4e_58_4	20150731_QEp1_LC7_PhGe_SA_Plate4E_58_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_58_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	29b759ac60441449e6bb623c4e6f0b0c56ece4e98347e5d37ba8ce51f477db77	SAMEA7711786
PXD004242-58 plasma at 26 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150731_qep1_lc7_phge_sa_plate4e_58_5	20150731_QEp1_LC7_PhGe_SA_Plate4E_58_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_58_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	0ce7d1e132137c4199ea14f27ac28a661f57b7aa5d73f66d5764432d35cd6952	SAMEA7711787
PXD004242-58 plasma at 39 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150731_qep1_lc7_phge_sa_plate4e_58_6	20150731_QEp1_LC7_PhGe_SA_Plate4E_58_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_58_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	ce95a7e17cd2a021b1853064bafa13e9cf2089911bcc27c508c2e926e3497566	SAMEA7711788
PXD004242-58 plasma at 52 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150731_qep1_lc7_phge_sa_plate4e_58_7	20150731_QEp1_LC7_PhGe_SA_Plate4E_58_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150731_QEp1_LC7_PhGe_SA_Plate4E_58_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	4f0a9c8600c57bf142f967ad4ef2b759d12242e0a8ed260afcaa3051dd1adbff	SAMEA7711789
PXD004242-58 plasma at -8 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150824_qep1_lc7_phge_sa_plate4d_58_1	20150824_QEp1_LC7_PhGe_SA_Plate4D_58_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_58_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	12e934016e052bcabdc7097bb2b886175fefa824940c6ae4f14071a931206d58	SAMEA7711783
PXD004242-58 plasma at 0 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150824_qep1_lc7_phge_sa_plate4d_58_2	20150824_QEp1_LC7_PhGe_SA_Plate4D_58_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_58_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	95c2a12752f765d50f5a42f35a749cab5fe2c7094e670c7828accabc9eb76dcc	SAMEA7711784
PXD004242-58 plasma at 4 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150824_qep1_lc7_phge_sa_plate4d_58_3	20150824_QEp1_LC7_PhGe_SA_Plate4D_58_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_58_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	34fe969b662f87f916ec55e4d1528a3ac7abe0807630aafda6692eb35b59ad5f	SAMEA7711785
PXD004242-58 plasma at 13 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150824_qep1_lc7_phge_sa_plate4d_58_4	20150824_QEp1_LC7_PhGe_SA_Plate4D_58_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_58_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	29b759ac60441449e6bb623c4e6f0b0c56ece4e98347e5d37ba8ce51f477db77	SAMEA7711786
PXD004242-58 plasma at 26 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150824_qep1_lc7_phge_sa_plate4d_58_5	20150824_QEp1_LC7_PhGe_SA_Plate4D_58_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_58_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	0ce7d1e132137c4199ea14f27ac28a661f57b7aa5d73f66d5764432d35cd6952	SAMEA7711787
PXD004242-58 plasma at 39 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150824_qep1_lc7_phge_sa_plate4d_58_6	20150824_QEp1_LC7_PhGe_SA_Plate4D_58_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_58_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	ce95a7e17cd2a021b1853064bafa13e9cf2089911bcc27c508c2e926e3497566	SAMEA7711788
PXD004242-58 plasma at 52 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150824_qep1_lc7_phge_sa_plate4d_58_7	20150824_QEp1_LC7_PhGe_SA_Plate4D_58_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150824_QEp1_LC7_PhGe_SA_Plate4D_58_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	4f0a9c8600c57bf142f967ad4ef2b759d12242e0a8ed260afcaa3051dd1adbff	SAMEA7711789
PXD004242-58 plasma at -8 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	-8W	20150917_qep1_lc7_phge_sa_plate4c_58_1	20150917_QEp1_LC7_PhGe_SA_Plate4C_58_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_58_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	-8W	12e934016e052bcabdc7097bb2b886175fefa824940c6ae4f14071a931206d58	SAMEA7711783
PXD004242-58 plasma at 0 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150917_qep1_lc7_phge_sa_plate4c_58_2	20150917_QEp1_LC7_PhGe_SA_Plate4C_58_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_58_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	0W	95c2a12752f765d50f5a42f35a749cab5fe2c7094e670c7828accabc9eb76dcc	SAMEA7711784
PXD004242-58 plasma at 4 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150917_qep1_lc7_phge_sa_plate4c_58_3	20150917_QEp1_LC7_PhGe_SA_Plate4C_58_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_58_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	4W	34fe969b662f87f916ec55e4d1528a3ac7abe0807630aafda6692eb35b59ad5f	SAMEA7711785
PXD004242-58 plasma at 13 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150917_qep1_lc7_phge_sa_plate4c_58_4	20150917_QEp1_LC7_PhGe_SA_Plate4C_58_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_58_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	13W	29b759ac60441449e6bb623c4e6f0b0c56ece4e98347e5d37ba8ce51f477db77	SAMEA7711786
PXD004242-58 plasma at 26 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150917_qep1_lc7_phge_sa_plate4c_58_5	20150917_QEp1_LC7_PhGe_SA_Plate4C_58_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_58_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	26W	0ce7d1e132137c4199ea14f27ac28a661f57b7aa5d73f66d5764432d35cd6952	SAMEA7711787
PXD004242-58 plasma at 39 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150917_qep1_lc7_phge_sa_plate4c_58_6	20150917_QEp1_LC7_PhGe_SA_Plate4C_58_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_58_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	39W	ce95a7e17cd2a021b1853064bafa13e9cf2089911bcc27c508c2e926e3497566	SAMEA7711788
PXD004242-58 plasma at 52 weeks	Homo sapiens	blood plasma	58	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150917_qep1_lc7_phge_sa_plate4c_58_7	20150917_QEp1_LC7_PhGe_SA_Plate4C_58_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC7_PhGe_SA_Plate4C_58_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	52W	4f0a9c8600c57bf142f967ad4ef2b759d12242e0a8ed260afcaa3051dd1adbff	SAMEA7711789
PXD004242-F1 plasma at not applicable weeks	Homo sapiens	blood plasma	F1	not applicable	not available	not available	female	not available	uninfected	depleted fraction	not applicable	20150917_qep1_lc8_phge_sa_doubletop14_f1_1	20150917_QEp1_LC8_PhGe_SA_DoubleTop14_F1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_DoubleTop14_F1_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	not applicable	e680b18fda975d5f6b7f733782aa08a667c04504c03ffb46e0a7d740778dac1b	SAMEA7711790
PXD004242-F1 plasma at not applicable weeks	Homo sapiens	blood plasma	F1	not applicable	not available	not available	female	not available	uninfected	depleted fraction	not applicable	20150917_qep1_lc8_phge_sa_doubletop14_f1_2	20150917_QEp1_LC8_PhGe_SA_DoubleTop14_F1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_DoubleTop14_F1_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	not applicable	e680b18fda975d5f6b7f733782aa08a667c04504c03ffb46e0a7d740778dac1b	SAMEA7711790
PXD004242-F1 plasma at not applicable weeks	Homo sapiens	blood plasma	F1	not applicable	not available	not available	female	not available	uninfected	depleted fraction	not applicable	20150917_qep1_lc8_phge_sa_doubletop14_f1_3	20150917_QEp1_LC8_PhGe_SA_DoubleTop14_F1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_DoubleTop14_F1_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	not applicable	e680b18fda975d5f6b7f733782aa08a667c04504c03ffb46e0a7d740778dac1b	SAMEA7711790
PXD004242-F2 plasma at not applicable weeks	Homo sapiens	blood plasma	F2	not applicable	not available	not available	female	not available	uninfected	depleted fraction	not applicable	20150917_qep1_lc8_phge_sa_doubletop14_f2_1	20150917_QEp1_LC8_PhGe_SA_DoubleTop14_F2_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_DoubleTop14_F2_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	not applicable	a60668ab76d18ff1c0069934b445ed1fbaadbc45c425fbc70a1b35899a39264e	SAMEA7711791
PXD004242-F2 plasma at not applicable weeks	Homo sapiens	blood plasma	F2	not applicable	not available	not available	female	not available	uninfected	depleted fraction	not applicable	20150917_qep1_lc8_phge_sa_doubletop14_f2_2	20150917_QEp1_LC8_PhGe_SA_DoubleTop14_F2_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_DoubleTop14_F2_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	not applicable	a60668ab76d18ff1c0069934b445ed1fbaadbc45c425fbc70a1b35899a39264e	SAMEA7711791
PXD004242-F2 plasma at not applicable weeks	Homo sapiens	blood plasma	F2	not applicable	not available	not available	female	not available	uninfected	depleted fraction	not applicable	20150917_qep1_lc8_phge_sa_doubletop14_f2_3	20150917_QEp1_LC8_PhGe_SA_DoubleTop14_F2_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_DoubleTop14_F2_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	not applicable	a60668ab76d18ff1c0069934b445ed1fbaadbc45c425fbc70a1b35899a39264e	SAMEA7711791
PXD004242-F3 plasma at not applicable weeks	Homo sapiens	blood plasma	F3	not applicable	not available	not available	female	not available	uninfected	depleted fraction	not applicable	20150917_qep1_lc8_phge_sa_doubletop14_f3_1	20150917_QEp1_LC8_PhGe_SA_DoubleTop14_F3_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_DoubleTop14_F3_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	not applicable	18ce45cd2ec1556d850adf7639f5d1a96a1a37d11ccb2b60d513f57b1d61e7cd	SAMEA7711792
PXD004242-F3 plasma at not applicable weeks	Homo sapiens	blood plasma	F3	not applicable	not available	not available	female	not available	uninfected	depleted fraction	not applicable	20150917_qep1_lc8_phge_sa_doubletop14_f3_2	20150917_QEp1_LC8_PhGe_SA_DoubleTop14_F3_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_DoubleTop14_F3_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	not applicable	18ce45cd2ec1556d850adf7639f5d1a96a1a37d11ccb2b60d513f57b1d61e7cd	SAMEA7711792
PXD004242-F3 plasma at not applicable weeks	Homo sapiens	blood plasma	F3	not applicable	not available	not available	female	not available	uninfected	depleted fraction	not applicable	20150917_qep1_lc8_phge_sa_doubletop14_f3_3	20150917_QEp1_LC8_PhGe_SA_DoubleTop14_F3_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_DoubleTop14_F3_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	not applicable	18ce45cd2ec1556d850adf7639f5d1a96a1a37d11ccb2b60d513f57b1d61e7cd	SAMEA7711792
PXD004242-M1 plasma at not applicable weeks	Homo sapiens	blood plasma	M1	not applicable	not available	not available	male	not available	uninfected	depleted fraction	not applicable	20150917_qep1_lc8_phge_sa_doubletop14_m1_1	20150917_QEp1_LC8_PhGe_SA_DoubleTop14_M1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_DoubleTop14_M1_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	not applicable	f3c09b6ed73356880eb18ef5dbae94c9d882e001c3a687ea5e0aafdebe25d353	SAMEA7711793
PXD004242-M1 plasma at not applicable weeks	Homo sapiens	blood plasma	M1	not applicable	not available	not available	male	not available	uninfected	depleted fraction	not applicable	20150917_qep1_lc8_phge_sa_doubletop14_m1_2	20150917_QEp1_LC8_PhGe_SA_DoubleTop14_M1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_DoubleTop14_M1_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	not applicable	f3c09b6ed73356880eb18ef5dbae94c9d882e001c3a687ea5e0aafdebe25d353	SAMEA7711793
PXD004242-M1 plasma at not applicable weeks	Homo sapiens	blood plasma	M1	not applicable	not available	not available	male	not available	uninfected	depleted fraction	not applicable	20150917_qep1_lc8_phge_sa_doubletop14_m1_3	20150917_QEp1_LC8_PhGe_SA_DoubleTop14_M1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_DoubleTop14_M1_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	not applicable	f3c09b6ed73356880eb18ef5dbae94c9d882e001c3a687ea5e0aafdebe25d353	SAMEA7711793
PXD004242-M2 plasma at not applicable weeks	Homo sapiens	blood plasma	M2	not applicable	not available	not available	male	not available	uninfected	depleted fraction	not applicable	20150917_qep1_lc8_phge_sa_doubletop14_m2_1	20150917_QEp1_LC8_PhGe_SA_DoubleTop14_M2_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_DoubleTop14_M2_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	not applicable	bf00c9e5eca2bf61422911c96211e68422447250ed3ae4d1d142dff79702b1e8	SAMEA7711794
PXD004242-M2 plasma at not applicable weeks	Homo sapiens	blood plasma	M2	not applicable	not available	not available	male	not available	uninfected	depleted fraction	not applicable	20150917_qep1_lc8_phge_sa_doubletop14_m2_2	20150917_QEp1_LC8_PhGe_SA_DoubleTop14_M2_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_DoubleTop14_M2_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	not applicable	bf00c9e5eca2bf61422911c96211e68422447250ed3ae4d1d142dff79702b1e8	SAMEA7711794
PXD004242-M2 plasma at not applicable weeks	Homo sapiens	blood plasma	M2	not applicable	not available	not available	male	not available	uninfected	depleted fraction	not applicable	20150917_qep1_lc8_phge_sa_doubletop14_m2_3	20150917_QEp1_LC8_PhGe_SA_DoubleTop14_M2_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_DoubleTop14_M2_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	not applicable	bf00c9e5eca2bf61422911c96211e68422447250ed3ae4d1d142dff79702b1e8	SAMEA7711794
PXD004242-M3 plasma at not applicable weeks	Homo sapiens	blood plasma	M3	not applicable	not available	not available	male	not available	uninfected	depleted fraction	not applicable	20150917_qep1_lc8_phge_sa_doubletop14_m3_1	20150917_QEp1_LC8_PhGe_SA_DoubleTop14_M3_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_DoubleTop14_M3_1.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	not applicable	2531bd321b9bc4953b3f9495b67355c7c5b6a4398686a6dbe13d2edded02bab0	SAMEA7711795
PXD004242-M3 plasma at not applicable weeks	Homo sapiens	blood plasma	M3	not applicable	not available	not available	male	not available	uninfected	depleted fraction	not applicable	20150917_qep1_lc8_phge_sa_doubletop14_m3_2	20150917_QEp1_LC8_PhGe_SA_DoubleTop14_M3_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_DoubleTop14_M3_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	not applicable	2531bd321b9bc4953b3f9495b67355c7c5b6a4398686a6dbe13d2edded02bab0	SAMEA7711795
PXD004242-M3 plasma at not applicable weeks	Homo sapiens	blood plasma	M3	not applicable	not available	not available	male	not available	uninfected	depleted fraction	not applicable	20150917_qep1_lc8_phge_sa_doubletop14_m3_3	20150917_QEp1_LC8_PhGe_SA_DoubleTop14_M3_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_DoubleTop14_M3_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	not applicable	2531bd321b9bc4953b3f9495b67355c7c5b6a4398686a6dbe13d2edded02bab0	SAMEA7711795
